do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). see the package leaflets for peginterferon alfa and ribavirin for a list of their contraindications ( e . g . pregnancy precautions for men and women ) since incivo must be used in combination with peginterferon alfa and ribavirin . ask your doctor if you are unsure about any contraindications mentioned in the package leaflets . do not use incivo in combination with any of the following medicines as they may increase the risk of severe side effects , and / or affect the way incivo or the other medicine works : 56 medicine ( name of the active substance ) purpose of the medicine alfuzosin to treat symptoms of an enlarged prostate ( alpha - 1 - adrenoreceptor antagonists ) amiodarone , bepridil , quinidine , other class ia or iii antiarrhythmics to treat certain heart disorders such as irregular heart beat ( antiarrhythmics ) astemizole , terfenadine to treat allergy symptoms ( antihistamines ) rifampicin to treat some infections like tuberculosis ( antimycobacterial ) dihydroergotamine , ergonovine , ergotamine , methylergonovine to treat migraine and headaches ( ergot derivatives ) cisapride to treat some stomach conditions ( gastrointestinal motility agents ) st john ' s wort ( hypericum perforatum ) an herbal product to relieve anxiety atorvastatin , lovastatin , simvastatin to lower cholesterol levels ( hmg coa reductase inhibitors ) pimozide to treat psychiatric conditions ( neuroleptics ) sildenafil , tadalafil sildenafil or tadalafil must not be used to treat a heart and lung disorder called pulmonary arterial hypertension . there are other uses for sildenafil and tadalafil . please see section ' other medicines and incivo '. quetiapine to treat schizophrenia , bipolar disorder and major depressive disorder midazolam ( taken by mouth ), triazolam ( taken by mouth ) to help you sleep and / or relieve anxiety ( sedatives / hypnotics ) carbamazepine , phenobarbital , phenytoin to treat epileptic seizures ( anticonvulsants ) if you are taking any of the above , ask your doctor about switching to another medicine . warnings and precautions talk to your doctor or pharmacist before taking incivo . incivo must be taken in combination with peginterferon alfa and ribavirin . it is therefore very important that you read the package leaflets that are provided with these medicines , too . if you have any questions about your medicines , please ask your doctor or pharmacist . make sure that you check the following points and tell your doctor treating your hepatitis c virus ( hcv ) if any of these apply to you . - skin rash patients taking incivo may develop a skin rash . there may be itching with the rash . usually the rash is mild or moderate , but the rash may be , or may become , severe and / or life - threatening . you should contact your doctor immediately if you develop a rash or have a 57 rash that gets worse . incivo must not be restarted if discontinued by your doctor . you must carefully read the information under rash in section 4 possible side effects . - anaemia ( decrease in your red blood cells ) tell your doctor if you experience tiredness , weakness , shortness of breath , light - headedness , and / or the feeling of the heart racing . these may be symptoms of anaemia . - heart problems tell your doctor if you have heart failure , irregular heartbeat , slow heart rate , an abnormality shown in your heart tracing ( ecg ) called ' long qt syndrome ', or a family history of a heart condition called ' congenital qt syndrome '. your doctor may request additional monitoring during your incivo treatment . - liver problems tell your doctor if you have had other problems with your liver such as liver failure . signs might be yellowing of the skin or eyes ( jaundice ), swelling of the stomach ( ascites ) or legs due to fluid , and bleeding from swollen veins ( varices ) in the gullet ( oesophagus ). your doctor may evaluate how severe your liver disease is before deciding if you can take incivo . - infections tell your doctor if you have an hepatitis b infection so that your doctor can decide if incivo is right for you . - organ transplant tell your doctor if you have had or are going to have a liver or other organ transplant as incivo might not be right for you in this situation . blood tests your doctor will do blood tests before starting treatment and regularly during your treatment : - to see how much virus is in your blood and to determine if you have the type of virus ( genotype 1 ) that can be treated with incivo . decisions related to your treatment may be made based on the results of these tests . your doctor will monitor your early response to treatment and how much virus is in your blood . if your treatment is not working , your doctor may stop your medicines . if your doctor stops incivo , it should not be restarted . - to check if you have anaemia ( decrease in your red blood cells ). - to check for changes in some values of your blood cells or chemistry . these can be seen in the results from blood tests . your doctor will explain these to you . examples are : blood count levels , thyroid ( a gland in your neck that controls your metabolism ) levels , liver and kidney tests . incivo has only been used in a limited number of patients of 65 years or older . if you belong to this age group , please discuss the use of incivo with your doctor . children and adolescents incivo is not for use in children or adolescents , because it has not been sufficiently studied in patients under 18 years of age . other medicines and incivo incivo may affect other medicines or other medicines may affect incivo . tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . tell your doctor if you take any of the following medicines : medicine ( name of the active substance ) purpose of the medicine flecainide , propafenone to treat certain heart disorders such as irregular heart beat ( antiarrhythmics ) 58 alfentanil , fentanyl to treat pain ( analgesics ) or used during surgery to induce sleep digoxin , intravenous lidocaine to treat certain heart disorders such as abnormal heart beat ( antiarrhythmics ) clarithromycin , erythromycin , telithromycin , troleandomycin to treat bacterial infections ( antibacterials ) warfarin , dabigatran to prevent blood clots ( anticoagulants ) escitalopram , trazodone to treat mood disorders ( antidepressants ) metformin to treat diabetes ( antidiabetics ) domperidone to treat vomiting and nausea ( antiemetics ) itraconazole , ketoconazole , posaconazole , voriconazole to treat fungal infections ( antifungals ) colchicine to treat inflammatory arthritis ( anti - gout agents ) rifabutin to treat certain infections ( antimycobacterials ) alprazolam , midazolam through injection to help you sleep and / or relieve anxiety ( benzodiazepines ) zolpidem to help you sleep and / or relieve anxiety ( non - benzodiazepine sedatives ) amlodipine , diltiazem , felodipine , nicardipine , nifedipine , nisoldipine , verapamil to decrease blood pressure ( calcium channel blockers ) maraviroc to treat hiv infections ( ccr5 antagonist ) budesonide , inhaled / nasal fluticasone , dexamethasone if taken by mouth or through injection to treat asthma or to treat inflammatory and autoimmune conditions ( corticosteroids ) bosentan to treat a heart and lung disorder called pulmonary arterial hypertension ( endothelin receptor antagonist ) atazanavir / ritonavir , darunavir / ritonavir , fosamprenavir / ritonavir , lopinavir / ritonavir to treat hiv infections ( hiv - protease inhibitors ) abacavir , efavirenz , tenofovir disoproxil fumarate , zidovudine to treat hiv infections ( reverse transcriptase inhibitors ) fluvastatin , pitavastatin , pravastatin , rosuvastatin to lower cholesterol levels ( hmg coa reductase inhibitors ) all types of hormonal contraceptives (' the pill ') hormonal contraceptives oestrogen - based medicines hormone replacement therapy cyclosporine , sirolimus , tacrolimus to lower your immune system ( immunosuppressants ), medicines used in some rheumatic diseases or to avoid problems with organ transplants salmeterol to improve breathing for asthma ( inhaled beta agonists ) repaglinide to treat type ii diabetes ( blood glucose lowering medicine ) methadone for the treatment of opioid ( narcotic ) dependence sildenafil , tadalafil , vardenafil to treat erectile dysfunction or to treat a heart and lung disorder called pulmonary arterial hypertension ( pde - 5 inhibitors ) incivo with food and drink incivo must always be taken together with food . the food is important to get the right levels of medicine in your body . pregnancy and breast - feeding if you are pregnant , you must not take incivo . incivo must be used in combination with 59 peginterferon alfa and ribavirin . ribavirin can damage your unborn baby . it is therefore absolutely essential that you take all precautions not to get pregnant during this therapy . if you or your female partner become pregnant during incivo treatment or the months that follow , you must contact your doctor immediately ( see section ' pregnancy precautions for men and women ' below ). if you are breast - feeding , you must stop breast - feeding before starting to take incivo . it is not known whether telaprevir , the active ingredient in incivo , is found in human breast milk . ask your doctor or pharmacist for advice before taking any medicine . pregnancy precautions for men and women since incivo must be used in combination with ribavirin and ribavirin can be very damaging to an unborn baby , both female and male patients must take special precautions in order to prevent pregnancy . any birth control method can fail , and , therefore , you and your partner must use at least two effective birth control methods during incivo therapy and afterwards . following the end of the incivo treatment , please see the ribavirin package leaflet regarding continued contraception requirements . female patients of childbearing age and their male partners a hormonal contraceptive (' the pill ') may not be reliable during the treatment with incivo . therefore , you and your partner must use two other birth control methods during the time you are taking incivo and for 2 months after stopping this medicine . you must read the package leaflets for peginterferon alfa and ribavirin for additional information . driving and using machines some patients may experience fainting or problems with vision during incivo treatment . do not drive or operate machines if you feel faint or have problems with your vision while taking incivo . see also the package leaflets for peginterferon alfa and ribavirin . incivo contains sodium this medicine contains 2 . 3 mg sodium per tablet , which should be taken into consideration by patients on a controlled sodium diet . tell your doctor if you have to take care of your salt intake and follow a low sodium diet .
do not use zinbryta - if you have previously had a serious allergic reaction to any form of daclizumab , or any of the other ingredients of this medicine listed in section 6 . - if you have liver problems . warnings and precautions talk to your doctor before using zinbryta : - if you have any other autoimmune disorders in addition to ms - if you are taking , have recently taken or might take any other medicines and herbal supplements . your doctor will evaluate if any medicines or supplements you are taking have liver side effects and whether you should continue these medicines while taking zinbryta - if you have depression or have had it in the past . - if you have a serious infection , such as pneumonia . - if you have ever had tuberculosis ( also called tb ) or live in a region where tb infections are common , you may be at greater risk of tb . you may be tested for tb before starting zinbryta and monitored during treatment . possible liver problems zinbryta may cause serious liver problems that may be life - threatening or result in death . serious liver problems can occur both early after starting treatment with zinbryta , any time during treatment and several months after discontinuing treatment . even if you have had no previous liver problems , your doctor will carry out blood tests to test your liver function . you will need : - a blood test before starting treatment to check your liver function and if you have hepatitis b and c . if your blood test shows that you have some liver problems , your doctor will decide whether to start zinbryta - at least monthly blood tests during treatment , as close as possible before each dose of zinbryta , and more often if your doctor decides this is necessary - tests for up to 6 months after stopping treatment . side effects may occur even after stopping treatment ( see serious side effects in section 4 ). it is very important that you have these regular blood tests . if you do not not undergo your scheduled blood tests your doctor may decide to stop treatment with zinbryta . you will be given a patient card with further information about the things to watch out for while taking zinbryta . keep this card with you during treatment and for 6 months afterwards . when you have any medical treatment , even if it is not for your ms , show the patient card to the doctor , pharmacist or nurse . if you experience any of the following , contact your doctor immediately : unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite your skin or the whites of your eyes turn yellow 39 dark ( tea - coloured ) urine these symptoms may suggest problems with your liver . if you do develop liver problems your ms doctor may stop your treatment with zinbryta and refer you to a liver specialist ( see section 4 , possible side effects ). children and adolescents zinbryta is not to be used in children and adolescents younger than 18 years old . the safety and effectiveness of zinbryta in this age group are not known . elderly zinbryta has had very little testing in people older than 55 years old . if you are over 55 your doctor may still prescribe zinbryta . other medicines and zinbryta tell your doctor if you are taking , have recently taken or might take any other medicines and herbal supplements . your doctor will evaluate if any medicines or supplements you are taking have liver side effects and whether you should continue these medicines while receiving zinbryta . vaccinations if you need a vaccination , ask your doctor first because zinbryta may affect how well vaccines work . seasonal flu vaccines ( inactive vaccine ) have been shown to be effective when given to patients taking zinbryta . however , zinbryta ' s effect on other vaccines ( live vaccines ) is not known . pregnancy and breast - feeding as data on use of zinbryta during pregnancy are limited , the risk to the baby and benefit to the mother should be taken into consideration . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . it is not known whether zinbryta passes into breast milk . your doctor will help you decide whether you should stop breast - feeding , or stop using zinbryta . driving and using machines zinbryta is not expected to affect your ability to drive and use machines . your doctor will tell you whether your illness allows you to drive vehicles and use machines safely . zinbryta contains a small amount of sodium each dose of zinbryta contains 0 . 14 mmol sodium . it is essentially ' sodium - free ' and can be used by people on a sodium - restricted diet .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . take special care with wilzin wilzin is usually not recommended for initial therapy of patients with signs and symptoms of wilson ' s disease because of its slow onset of action . if you are currently treated with another anti - copper agent , for example , penicillamine , your doctor may add wilzin before stopping the initial treatment . as with other anti - copper agents such as penicillamine , your symptoms may get worse after starting the treatment . in this case , you must inform your doctor . in order to follow up your condition and treatment your doctor will check your blood and urine on a regular basis . this is to ensure that you receive sufficient treatment . monitoring may detect evidence 25 of insufficient treatment ( copper excess ) or excessive treatment ( copper deficiency ), both of which can be harmful , particularly to growing children and pregnant women . you should tell your doctor if you experience unusual muscle weakness or abnormal feeling in your limbs as this may indicate excessive treatment . taking other medicines please tell your doctor or your pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . please consult your doctor before taking any other medicines which may reduce the effectiveness of wilzin , such as iron , calcium supplements , tetracyclines ( antibiotics ) or phosphorus . conversely , the effectiveness of some medicines , such as iron , tetracyclines or fluoroquinolones ( antibiotics ), may be reduced by wilzin . taking wilzin with food and drink wilzin should be taken on an empty stomach , separated from mealtimes . dietary fibres and some dairy products , in particular , delay the absorption of zinc salts . some patients experience stomach upset after the morning dose . please discuss the matter with your wilson ' s disease doctor if this affects you . this side effect may be reduced by postponing the first dose of the day until mid - morning ( between breakfast and the midday meal ). it may also be minimised by taking the first dose of wilzin with a small amount of protein - containing food , such as meat ( but not milk ). pregnancy please consult your doctor if you plan to become pregnant . it is very important to continue anti - copper therapy during pregnancy . if you become pregnant during therapy with wilzin , your doctor will decide which treatment and which dose is best in your situation . breast - feeding breast - feeding should be avoided if you are on wilzin therapy . please discuss with your doctor . driving and using machines no studies of the effects on the ability to drive and use machines have been performed . important information about some of the ingredients of wilzin wilzin 50 mg hard capsules contains sunset yellow fcf ( e110 ) which may cause allergic reactions .
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you are currently taking any of the following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety , or products that contain it . if any of these apply to you , do not take biktarvy and tell your doctor immediately . warnings and precautions talk to your doctor before taking biktarvy : if you have liver problems or a history of liver disease , including hepatitis . patients with liver disease including chronic hepatitis b or c , who are treated with antiretrovirals , have a higher risk of severe and potentially fatal liver complications . if you have hepatitis b infection , your doctor will carefully consider the best treatment regimen for you . if you have hepatitis b infection . liver problems may become worse after you stop taking biktarvy . do not stop taking biktarvy if you have hepatitis b . talk to your doctor first . for more details , see section 3 , do not stop taking biktarvy . while you are taking biktarvy once you start taking biktarvy , look out for : signs of inflammation or infection joint pain , stiffness or bone problems if you notice any of these symptoms , tell your doctor immediately . for more information see section 4 , possible side effects . although kidney problems have not been observed with biktarvy , there is a possibility that you may experience kidney problems when taking biktarvy over a long period of time . you can still pass on hiv when taking this medicine , although the risk is lowered by effective antiretroviral therapy . discuss with your doctor the precautions needed to avoid infecting other people . this medicine is not a cure for hiv infection . while taking biktarvy you may still develop infections or other illnesses associated with hiv infection . children and adolescents do not give this medicine to children and adolescents under 18 years of age . the use of biktarvy in children and adolescents under 18 years of age has not yet been studied . other medicines and biktarvy tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . biktarvy may interact with other medicines . as a result , the amounts of biktarvy or other medicines in your blood may change . this may stop your medicines from working properly , or may make any side effects worse . in some cases , your doctor may need to adjust your dose or check your blood levels . medicines that must never be taken with biktarvy : rifampicin used to treat some bacterial infections such as tuberculosis st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety , or products that contain it . if you are taking any of these medicines , do not take biktarvy and tell your doctor immediately . talk to your doctor if you are taking : medicines used for treating hiv and / or hepatitis b , containing : - adefovir dipivoxil , atazanavir , bictegravir , emtricitabine , lamivudine , tenofovir alafenamide , or tenofovir disoproxil antibiotics used to treat bacterial infections , containing : - azithromycin , clarithromycin , rifabutin or rifapentine anticonvulsants used to treat epilepsy , containing : - carbamazepine , oxcarbazepine , phenobarbital or phenytoin immunosuppressants used to control your body ' s immune response after a transplant , containing ciclosporin ulcer - healing medicines containing sucralfate tell your doctor if you are taking any of these medicines . do not stop your treatment without contacting your doctor . get advice from a doctor or pharmacist if you are taking : antacids to treat stomach ulcers , heartburn , or acid reflux , containing aluminium and / or magnesium hydroxide mineral supplements or vitamins containing magnesium or iron get advice from your doctor or pharmacist before taking biktarvy if you are taking any of these medicines . antacids and magnesium supplements : you will need to take biktarvy at least 2 hours before antacids or supplements containing aluminium and / or magnesium . or you can take biktarvy with food at least 2 hours after . iron supplements : you will need to take biktarvy at least 2 hours before iron supplements , or you can take them together with food . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . tell your doctor immediately if you become pregnant and ask about the potential benefits and risks of your antiretroviral therapy to you and your child . if you have taken biktarvy during your pregnancy , your doctor may request regular blood tests and other diagnostic tests to monitor the development of your child . in children whose mothers took nucleoside reverse transcriptase inhibitors ( nrtis ) during pregnancy , the benefit from the protection against hiv outweighed the risk of side effects . do not breast - feed during treatment with biktarvy . this is because some of the active substances in this medicine pass into human breast milk . it is also recommended that you do not breast - feed to avoid passing the virus to the baby in breast milk . if you really want to breastfeed , talk to your doctor first . driving and using machines biktarvy can cause dizziness . if you feel dizzy when taking biktarvy , do not drive and do not use any tools or machines . biktarvy contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per tablet , that is to say essentially ' sodium - free '.
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). if you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). warnings and precautions talk to your doctor before taking novonorm : 47 if you have liver problems . novonorm is not recommended in patients with moderate liver disease . novonorm should not be taken if you have a severe liver disease ( see do not take novonorm ). if you have kidney problems . novonorm should be taken with caution . if you are about to have major surgery or you have recently suffered a severe illness or infection . at such times diabetic control may be lost . if you are under 18 or over 75 years of age . novonorm is not recommended . it has not been studied in these age groups . talk to your doctor if any of the above applies to you . novonorm may not be suitable for you . your doctor will advise you . children and adolescents do not take this medicine if you are under 18 years of age . if you get a hypo ( low blood sugar ) you may get a hypo ( short for hypoglycaemia ) if your blood sugar gets too low . this may happen : if you take too much novonorm if you exercise more than usual if you take other medicines or suffer from liver or kidney problems ( see other sections of 2 . what you need to know before you take novonorm ). the warning signs of a hypo may come on suddenly and can include : cold sweat ; cool pale skin ; headache ; rapid heart beat ; feeling sick ; feeling very hungry ; temporary changes in vision ; drowsiness ; unusual tiredness and weakness ; nervousness or tremor ; feeling anxious ; feeling confused ; difficulty in concentrating . if your blood sugar is low or you feel a hypo coming on : eat glucose tablets or a high sugar snack or drink , then rest . when symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue novonorm treatment . tell people you have diabetes and that if you pass out ( become unconscious ) due to a hypo , they must turn you on your side and get medical help straight away . they must not give you any food or drink . it could choke you . if severe hypoglycaemia is not treated , it can cause brain damage ( temporary or permanent ) and even death . if you have a hypo that makes you pass out , or a lot of hypos , talk to your doctor . the amount of novonorm , food or exercise may need to be adjusted . if your blood sugar gets too high your blood sugar may get too high ( hyperglycaemia ). this may happen : if you take too little novonorm if you have an infection or a fever if you eat more than usual if you exercise less than usual . the warning signs of too high blood sugar appear gradually . they include : increased urination ; feeling thirsty ; dry skin and dry mouth . talk to your doctor . the amount of novonorm , food or exercise may need to be adjusted . other medicines and novonorm 48 tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . you can take novonorm with metformin , another medicine for diabetes , if your doctor prescribes it . if you take gemfibrozil ( used to lower increased fat levels in the blood ) you should not take novonorm . your body ' s response to novonorm may change if you take other medicines , especially these : monoamine oxidase inhibitors ( maoi ) ( used to treat depression ) beta blockers ( used to treat high blood pressure or heart conditions ) ace - inhibitors ( used to treat heart conditions ) salicylates ( e . g . aspirin ) octreotide ( used to treat cancer ) nonsteroidal anti - inflammatory drugs ( nsaid ) ( a type of painkillers ) steroids ( anabolic steroids and corticosteroids used for anemia or to treat inflammation ) oral contraceptives ( birth control pills ) thiazides ( diuretics or ' water pills ') danazol ( used to treat breast cysts and endometriosis ) thyroid products ( used to treat low levels of thyroid hormones ) sympathomimetics ( used to treat asthma ) clarithromycin , trimethoprim , rifampicin ( antibiotic medicines ) itraconazole , ketokonazole ( antifungal medicines ) gemfibrozil ( used to treat high blood fats ) ciclosporin ( used to suppress the immune system ) deferasirox ( used to reduce chronic iron overload ) clopidogrel ( prevents blood clots ) phenytoin , carbamazepine , phenobarbital ( used to treat epilepsy ) st . john ' s wort ( herbal medicine ). novonorm with alcohol alcohol can change the ability of novonorm to reduce the blood sugar . watch for signs of a hypo . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . you should not take novonorm if you are pregnant or you are planning to become pregnant . you should not take novonorm if you are breast - feeding . driving and using machines your ability to drive or use a machine may be affected if your blood sugar is low or high . bear in mind that you could endanger yourself or others . please ask your doctor whether you can drive a car if you : have frequent hypos have few or no warning signs of hypos .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to anything else that may be present in very small amounts , such as : egg and chicken protein , ovalbumin , formaldehyde or sodium deoxycholate . - signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . - however , in a pandemic situation , you may still be given the vaccine . this is as long as medical treatment is available straight away , in case you have an allergic reaction . do not have pumarix if any of the above apply to you . if you are not sure , talk to your doctor or nurse before having this vaccine . warnings and precautions 33 talk to your doctor or nurse before you are given pumarix : if you have had any allergic reaction other than a sudden life - threatening allergic reaction to any ingredient contained in this vaccine ( listed in section 6 ) or to thiomersal , to egg and chicken protein , ovalbumin , formaldehyde or to sodium deoxycholate . if you have a serious infection with a high temperature ( over 38 ). if this applies to you then your vaccination will usually be postponed until you are feeling better . a minor infection such as a cold should not be a problem , but your doctor will advise whether you could still be vaccinated with pumarix . if you have problems with your immune system , since your response to the vaccine may then be poor . if you are having a blood test to look for evidence of infection with certain viruses . in the first few weeks after vaccination with pumarix the results of these tests may not be correct . tell the doctor requesting these tests that you have recently been given pumarix . if you have a bleeding problem or you bruise easily . if any of the above apply to you ( or you are not sure ), talk to your doctor or nurse before having pumarix . this is because the vaccination may not be recommended , or may need to be delayed . fainting can occur following , or even before , any needle injection . therefore tell the doctor or nurse if you fainted with a previous injection . children : if your child receives the vaccine , you should be aware that the side effects may be more intense after the second dose , especially temperature over 38 . therefore monitoring of temperature and measures to lower the temperature ( such as giving paracetamol or other medicines that lower fever ) after each dose are recommended . other medicines and pumarix tell your doctor or nurse if you are taking , have recently taken or might take any other medicines or have recently received any other vaccine . in particular , please tell your doctor or nurse if you are having any treatments ( such as corticosteroid treatments or chemotherapy for cancer ) that affect the immune system . pumarix can still be given but your response to the vaccine may be poor . pumarix is not intended to be given at the same time as some other vaccines . however , if this needs to happen , the other vaccine will be injected into the other arm . any side effects that happen may be more serious . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before you receive this vaccine . driving and using machines some effects listed in section 4 " possible side effects " may affect your ability to drive or use tools or machines . it is best to see how pumarix affects you before you try these activities . pumarix contains thiomersal pumarix contains thiomersal as a preservative and it is possible that you may experience an allergic reaction . tell your doctor if you have any known allergies . pumarix contains sodium and potassium pumarix contains less than 1 mmol sodium ( 23 mg ) and less than 1 mmol of potassium ( 39 mg ) per dose . it is essentially sodium - and potassium - free .
somakit toc must not be used - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your nuclear medicine specialist before you are given somakit toc : - if you experience any signs of allergic reaction ( listed in section 4 ) after previous administration of somakit toc ; - if you have kidney or liver problems ( renal or hepatic disease ); - if you are under 18 years of age ; - if you have signs of dehydration before and after the examination ; 28 - if you have others medical conditions , such as high level of cortisol in the body ( cushing syndrome ), inflammation , thyroid disease , other type of tumour ( of pituitary gland , lung , brain , breast , immune system , thyroid , adrenal gland or others ) or disease of spleen that may affect the interpretation of the images ; - if you have been taking other medicines , such as somatostatin analogues and glucocorticoids , which may interact with somakit toc ; - if you are pregnant or believe you may be pregnant ; - if you are breast - feeding . your nuclear medicine doctor will inform you if you need to take any other special precaution before or after using somakit toc . before administration of somakit toc you should drink plenty of water before the start of the examination in order to urinate as often as possible during the first hours after the procedure to ensure that somakit toc is removed as quickly as possible from the body . children and adolescents this medicine is not recommended in patients under 18 years of age because its safety and efficacy have not been established in this patient population . other medicines and somakit toc tell your nuclear medicine doctor if you are taking , have recently taken or might take any other medicines , including somatostatin analogues , glucocorticoids ( also called corticosteroids ), since they may interfere with the interpretation of the images . if you are taking somatostatin analogues you might be asked to stop your treatment for a short period of time . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your nuclear medicine doctor for advice before you are given this medicine . you must inform the nuclear medicine doctor before the administration of somakit toc if there is a possibility you might be pregnant , if you have missed your period or if you are breast - feeding . when in doubt , it is important to consult your nuclear medicine doctor who will supervise the procedure . there is no information about the safety and the efficacy of the use of this medicine during pregnancy . only essential investigations should be carried out during pregnancy , when the likely benefit far exceeds any risk to the mother and foetus . if you are breast - feeding the nuclear medicine doctor may either delay the medical procedure until you no longer breast - feed or ask you to stop breastfeeding and to discard this milk until there is no radioactivity in your body ( 8 hours after the administration of somakit toc ). please ask your nuclear medicine doctor when you can resume breast - feeding . driving and using machines it is considered unlikely that somakit toc will affect your ability to drive or to use machines . somakit toc contains sodium this medicine contains 1 . 5 mmol ( or 32 . 5 mg ) sodium per dose . take this into consideration if you are on a controlled sodium diet .
afinitor will only be prescribed for you by a doctor with experience in cancer treatment . follow all the doctor ' s instructions carefully . they may differ from the general information contained in this leaflet . if you have any questions about afinitor or why it has been prescribed for you , ask your doctor . do not take afinitor if you are allergic to everolimus , to related substances such as sirolimus or temsirolimus , or to any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking afinitor : if you have any problems with your liver or if you have ever had any disease which may have affected your liver . if this is the case , your doctor may need to prescribe a different dose of afinitor . if you have diabetes ( high level of sugar in your blood ). afinitor may increase blood sugar levels and worsen diabetes mellitus . this may result in the need for insulin and / or oral antidiabetic agent therapy . tell your doctor if you experience any excessive thirst or increased frequency of urination . if you need to receive a vaccine while taking afinitor . if you have high cholesterol . afinitor may elevate cholesterol and / or other blood fats . if you have had recent major surgery , or if you still have an unhealed wound following surgery . afinitor may increase the risk of problems with wound healing . if you have an infection . it may be necessary to treat your infection before starting afinitor . if you have previously had hepatitis b , because this may be reactivated during treatment with afinitor ( see section 4 ' possible side effects '). afinitor may also : weaken your immune system . therefore , you may be at risk of getting an infection while you are taking afinitor . if you have fever or other signs of an infection , consult with your doctor . some infections may be severe and may have fatal consequences . impact your kidney function . therefore , your doctor will monitor your kidney function while you are taking afinitor . cause shortness of breath , cough and fever . cause mouth ulcers and sores to develop . your doctor might need to interrupt or discontinue your treatment with afinitor . you might need treatment with a mouthwash , gel or other products . some mouthwashes and gels can make ulcers worse , so do not try anything without checking with your doctor first . your doctor might restart treatment with afinitor at the same dose or at a lower dose . tell your doctor if you experience these symptoms . you will have regular blood tests during treatment . these will check the amount of blood cells ( white blood cells , red blood cells and platelets ) in your body to see if afinitor is having an unwanted effect on these cells . blood tests will also be carried out to check your kidney function ( level of creatinine ) and liver function ( level of transaminases ) and your blood sugar and cholesterol levels . this is because these can also be affected by afinitor . children and adolescents afinitor is not to be used in children or adolescents ( age below 18 years ). other medicines and afinitor afinitor may affect the way some other medicines work . if you are taking other medicines at the same time as afinitor , your doctor may need to change the dose of afinitor or the other medicines . tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . the following may increase the risk of side effects with afinitor : ketoconazole , itraconazole , voriconazole , or fluconazole and other antifungals used to treat fungal infections . clarithromycin , telithromycin or erythromycin , antibiotics used to treat bacterial infections . ritonavir and other medicines used to treat hiv infection / aids . verapamil or diltiazem , used to treat heart conditions or high blood pressure . dronedarone , a medicine used to help regulate your heart beat . ciclosporin , a medicine used to stop the body from rejecting organ transplants . imatinib , used to inhibit the growth of abnormal cells . angiotensin - converting enzyme ( ace ) inhibitors ( such as ramipril ) used to treat high blood pressure or other cardiovascular problems . nefazodone , used to treat depression . the following may reduce the effectiveness of afinitor : rifampicin , used to treat tuberculosis ( tb ). efavirenz or nevirapine , used to treat hiv infection / aids . st . john ' s wort ( hypericum perforatum ), a herbal product used to treat depression and other conditions . dexamethasone , a corticosteroid used to treat a wide variety of conditions including inflammatory or immune problems . phenytoin , carbamazepine or phenobarbital and other anti - epileptics used to stop seizures or fits . these medicines should be avoided during your treatment with afinitor . if you are taking any of them , your doctor may switch you to a different medicine , or may change your dose of afinitor . afinitor with food and drink avoid grapefruit and grapefruit juice while you are on afinitor . pregnancy , breast - feeding and fertility pregnancy afinitor could harm your unborn baby and is not recommended during pregnancy . tell your doctor if you are pregnant or think that you may be pregnant . your doctor will discuss with you whether you should take this medicine during your pregnancy . women who could potentially become pregnant should use highly effective contraception during treatment and for up to 8 weeks after ending treatment . if , despite these measures , you think you may have become pregnant , ask your doctor for advice before taking any more afinitor . breast - feeding afinitor could harm your breast - fed baby . you should not breast - feed during treatment and for 2 weeks after the last dose of afinitor . tell your doctor if you are breast - feeding . female fertility absence of menstrual periods ( amenorrhoea ) has been observed in some female patients receiving afinitor . afinitor may have an impact on female fertility . talk to your doctor if you wish to have children . male fertility afinitor may affect male fertility . talk to your doctor if you wish to father a child . driving and using machines if you feel unusually tired ( fatigue is a very common side effect ), take special care when driving or using machines . afinitor contains lactose afinitor contains lactose ( milk sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not use laventair ellipta : 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , don ' t use this medicine until you have checked with your doctor . warnings and precautions talk to your doctor before using this medicine : - if you have asthma ( don ' t use laventair ellipta to treat asthma ) - if you have heart problems or high blood pressure - if you have an eye problem called narrow - angle glaucoma - if you have an enlarged prostate , difficulty passing urine or a blockage in your bladder - if you suffer from epilepsy - if you have thyroid gland problems - if you have diabetes - if you have severe liver problems check with your doctor if you think any of these may apply to you . immediate breathing difficulties if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using your laventair ellipta inhaler : stop using this medicine and seek medical help immediately , as you may have a serious condition called paradoxical bronchospasm . eye problems during treatment with laventair ellipta if you get eye pain or discomfort , temporary blurring of vision , visual halos or coloured images in association with red eyes during treatment with laventair ellipta : stop using this medicine and seek medical help immediately , these may be signs of an acute attack of narrow - angle glaucoma . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and laventair ellipta tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . if you are not sure what your medicine contains talk to your doctor or pharmacist . some medicines may affect how this medicine works , or make it more likely that you ' ll have side effects . these include : - medicines called beta blockers ( such as propranolol ), to treat high blood pressure or other heart problems - ketoconazole or itraconazole , to treat fungal infections - clarithromycin or telithromycin , to treat bacterial infections - ritonavir , to treat hiv infection - medicines that lower the amount of potassium in your blood , such as some diuretics ( water tablets ) or some medicines used to treat asthma ( such as methylxanthine or steroids ) - other long - acting medicines similar to this medicine that are used to treat breathing problems , e . g . tiotropium , indacaterol . don ' t use laventair ellipta if you already use these medicines . tell your doctor or pharmacist if you are taking any of these . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . don ' t use this medicine if you are pregnant unless your doctor tells you that you can . it is not known whether the ingredients of laventair ellipta can pass into breast milk . if you are breast - feeding , you must check with your doctor before you use laventair ellipta . don ' t use this medicine if you are breast - feeding unless your doctor tells you that you can . driving and using machines it is unlikely that laventair ellipta will affect your ability to drive or use machines . laventair ellipta contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before using this medicine .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice before using tremfya if you have an active infection , including active tuberculosis warnings and precautions talk to your doctor , pharmacist or nurse before using tremfya : if you are being treated for an infection if you have an infection that does not go away or that keeps coming back if you have tuberculosis or have been in close contact with someone with tuberculosis 36 if you think you have an infection or have symptoms of an infection ( see below under ' look out for infections and allergic reactions ') if you have recently had a vaccination or if you are due to have a vaccination during treatment with tremfya . if you are not sure if any of the above applies to you , talk to your doctor , pharmacist or nurse before using tremfya . look out for infections and allergic reactions tremfya can potentially cause serious side effects , including allergic reactions and infections . you must look out for signs of these conditions while you are taking tremfya . stop using tremfya and tell your doctor or seek medical help immediately if you notice any signs indicating a possible serious allergic reaction or an infection . signs of infections may include fever or flu like symptoms ; muscle aches ; cough ; shortness of breath ; burning when you urinate or urinating more often than usual ; blood in your phlegm ( mucus ); weight loss ; diarrhoea or stomach pain ; warm , red , or painful skin or sores on your body which are different from your psoriasis . serious allergic reactions , which can include symptoms of hives and shortness of breath , have occurred with tremfya ( see " serious side effects " in section 4 ). children and adolescents tremfya is not recommended for children and adolescents under 18 years of age because it has not been studied in this age group . other medicines and tremfya tell your doctor or pharmacist : if you are using , have recently used or might use any other medicines . if you recently had or are due to have a vaccination . you should not be given certain types of vaccines ( live vaccines ) while using tremfya . pregnancy and breast - feeding tremfya should not be used in pregnancy as the effects of this medicine in pregnant women are not known . if you are a woman of childbearing potential , you are advised to avoid becoming pregnant and must use adequate contraception while using tremfya and for at least 12 weeks after the last tremfya dose . talk to your doctor if you are pregnant , think you may be pregnant or are planning to have a baby . talk to your doctor if you are breast - feeding or are planning to breast - feed . you and your doctor should decide if you will breast - feed or use tremfya . driving and using machines tremfya is unlikely to influence your ability to drive and use machines .
do not use trepulmix : - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if you have been diagnosed with a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels that carry blood through your lungs become swollen and clogged resulting in a higher pressure in the blood vessels between the heart and the lungs . - if you have severe liver disease - if you have a heart problem , for example : a heart attack ( myocardial infarction ) within the last six months severe changes in heart rate severe coronary heart disease or unstable angina a heart defect has been diagnosed , such as a faulty heart valve that causes the heart to work poorly any disease of the heart which is not being treated or not under close medical observation - if you are at a specific high risk of bleeding for example active stomach ulcers , injuries or other bleeding conditions - if you have had a stroke within the last 3 months , or any other interruption of blood supply to the brain warnings and precautions talk to your doctor before using trepulmix if you : - suffer from any liver disease - suffer from kidney disease - have been advised that you are medically obese ( bmi greater than 30 kg / m2 ) - are on a low sodium diet during your treatment with trepulmix , tell your doctor : - if your blood pressure decreases ( hypotension ) - if you experience a rapid increase in breathing difficulties or persistent cough ( this can be related to congestion in the lungs or asthma or other condition ), consult your doctor immediately . - if you have excessive bleeding as treprostinil may increase the risk , by preventing your blood from clotting children and adolescents trepulmix must not be used in children and adolescents . other medicines and trepulmix tell your doctor if you are taking / using , have recently taken / used or might take / use any other medicines . please tell your doctor if you are taking : - medicines used to treat high blood pressure ( antihypertensive medicines or other vasodilators ) - medicines used to increase the rate of urination ( diuretics ) including furosemide - medicines that stop blood clotting ( anticoagulants ) such as warfarin , heparin or nitric oxide based products - any non - steroidal anti - inflammatory ( nsaid ) medicines ( e . g . acetylsalicylic acid , ibuprofen ) - medicines which may enhance or weaken the effects of trepulmix ( e . g . gemfibrozil , rifampicin , trimethoprim , deferasirox , phenytoin , carbamazepine , phenobarbital , st . john ' s wort .), as your doctor may need to adjust the dosage of trepulmix . pregnancy and breast - feeding trepulmix is not recommended if you are pregnant , planning to become pregnant , or think that you might be pregnant , unless considered essential by your doctor . the safety of this medicine for use during pregnancy has not been established . contraception is strongly recommended during trepulmix treatment . trepulmix is not recommended for use in breast - feeding , unless considered essential by your doctor . you are advised to stop breast - feeding if trepulmix is prescribed for you , because it is not known whether this medicine passes into breast milk . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . driving and using machines trepulmix may induce low blood pressure with dizziness or fainting . in such a case do not drive or operate machinery and ask your doctor for advice . trepulmix contains sodium please tell your doctor if you are on a controlled sodium diet . they will take into account : trepulmix 1 mg / ml solution for infusion this medicine contains 36 . 8 mg sodium ( main component of cooking / table salt ) in each vial . this is equivalent to 1 . 8 % of the recommended maximum daily dietary intake of sodium for an adult . trepulmix 2 . 5 mg / ml solution for infusion this medicine contains 37 . 3 mg sodium ( main component of cooking / table salt ) in each vial . this is equivalent to 1 . 9 % of the recommended maximum daily dietary intake of sodium for an adult . trepulmix 5 mg / ml solution for infusion this medicine contains 39 . 1 mg sodium ( main component of cooking / table salt ) in each vial . this is equivalent to 2 . 0 % of the recommended maximum daily dietary intake of sodium for an adult . trepulmix 10 mg / ml solution for infusion this medicine contains 37 . 4 mg sodium ( main component of cooking / table salt ) in each vial . this is equivalent to 1 . 9 % of the recommended maximum daily dietary intake of sodium for an adult .
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you are allergic to heparin or other low molecular weight heparins such as nadroparin , tinzaparin or dalteparin . if you have had a reaction to heparin that caused a severe drop in the number of your clotting cells ( platelets ) - this reaction is called heparin - induced thrombocytopenia - within the last 100 days or if you have antibodies against enoxaparin in your blood . if you are bleeding heavily or have a condition with a high risk of bleeding ( such as stomach ulcer , recent surgery of the brain or eyes ), including recent bleeding stroke . if you are using thorinane to treat blood clots in your body and going to receive spinal or epidural anaesthesia or lumbar puncture within 24 hours . warnings and precautions thorinane should not be used interchangeably with other medicines belonging to the group of low molecular weight heparins . this is because they are not exactly the same and do not have the same activity and instructions for use . talk to your doctor or pharmacist before using thorinane if : you have ever had a reaction to heparin that caused a severe drop in the number of your platelets you are going to receive spinal or epidural anesthesia or lumbar puncture ( see operations and anaesthetics ): a delay should be respected between thorinane use and this procedure you have had a heart valve fitted you have endocarditis ( an infection of the inner lining of the heart ) you have history of gastric ulcer you have had a recent stroke you have high blood pressure you have diabetes or problems with blood vessels in the eye caused by diabetes ( called diabetic retinopathy ) you have had an operation recently on your eyes or brain you are elderly ( over 65 years old ) and especially if you are over 75 years old you have kidney problems you have liver problems you are underweight or overweight you have high level of potassium in your blood ( this may be checked with a blood test ) are currently using medicines which affect bleeding ( see section below other medicines ). you may have a blood test before you start using this medicine and at intervals while you are using it ; this is to check the level of the clotting cells ( platelets ) and potassium in your blood . other medicines and thorinane tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . warfarin used for thinning the blood aspirin ( also known as acetylsalicylic acid or asa ), clopidogrel or other medicines used to stop blood clots from forming ( see also in section 3 , " changing of anticoagulant medicine ") dextran injection used as a blood replacer ibuprofen , diclofenac , ketorolac or other medicines known as non - steroidal anti - inflammatory agents which are used to treat pain and swelling in arthritis and other conditions prednisolone , dexamethasone or other medicines used to treat asthma , rheumatoid arthritis and other conditions medicines which increase potassium level in your blood such as potassium salts , water pills , some medicines for heart problems . operations and anesthetics if you are going to have a spinal puncture or an operation where an epidural or spinal anaesthetic is used , tell you doctor that you are using thorinane . see " do not use thorinane ". also , tell your doctor if you have any problem with your spine or if you ever had spinal surgery . pregnancy and breast - feeding if you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . if you are pregnant and have a mechanical heart valve , you may be at an increased risk of developing blood clots . your doctor should discuss this with you . if you are breast - feeding or plan to breast - feed , you should ask your doctor for advice before taking this medicine . driving and using machines thorinane does not affect the ability to drive and operate machinery . it is advised that the trade name and batch number of the product you are using are recorded by your healthcare professional . thorinane contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dose , i . e . essentially ' sodium - free '.
do not use senstend - if you or your sexual partner are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ); - if you or your sexual partner have a history of allergy or sensitivity to other local anaesthetics with a similar structure ( known as amide - type local anaesthetics ). warnings and precautions talk to your doctor or pharmacist before using senstend - if you , or your sexual partner , have been diagnosed with a genetic disease or other condition affecting your red blood cells ( glucose - 6 - phosphate deficiency , anaemia or methaemoglobinaemia ); - if you have a history of medicine sensitivities , especially if you are not certain which medicine causes sensitivity ; - if you suffer from severe liver problems . when you use this medicine , particularly during priming of the container , aim the container away from the face to avoid accidental contact with ears , eyes , nose and mouth . if some medicine accidentally gets into your eyes or your partner ' s eyes , rinse them immediately with cold water or saline solution and cover them gently until any effects , such as numbness , wear off . be aware that normal protective mechanisms , such as blinking , or sensation of a foreign body in the eye , may not occur until the numbness has worn off . senstend may also come into contact with other mucous membranes such as your , or your partner ' s , mouth , nose and throat , causing them to feel slightly numb for a short while . as this will reduce the ability to feel pain in these areas , extra care should be taken not to injure them until the numbness has worn off . during sexual intercourse , a small amount of this medicine may be transferred e . g . to the vagina or the anus . therefore , both partners may feel slight numbness for a short while and should take care not to injure themselves , particularly during sexual activity . senstend should not come into contact with a damaged ear drum . children and adolescents do not give this medicine to children or adolescents under 18 years of age . other medicines and senstend tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is particularly important if you are taking the following medicines which may interact with senstend : other local anaesthetics heart medicines ( anti - arrhythmic medicines ) medicines for high blood pressure and to regulate your heart rhythm ( so - called beta blockers ) medicines reducing your stomach acid ( cimetidine ) the risk of a disorder reducing the amount of oxygen in the blood ( methaemoglobinaemia ) may be increased if you are already taking medicines known to cause the condition , such as those listed below : benzocaine a local anaesthetic used to treat pain and itching chloroquine , pamaquine , primaquine , quinine - used to treat malaria metoclopramide used to treat feelings of sickness ( nausea ) and vomiting , including in patients with migraine glyceryl trinitrate ( gtn , nitroglycerin ), isosorbide mononitrate , erythrityl tetranitrate , pentaerythritol tetranitrate and other nitrate and nitrite medicines - used to treat angina ( chest pain caused by the heart ) sodium nitroprusside , isosorbide dinitrate used to treat high blood pressure and heart failure nitrofurantoin an antibiotic used to treat urinary and kidney infections sulphonamides ( also called sulpha medicines ) e . g . sulfamethoxazole an antibiotic used to treat urinary infections , and sulfasalazine used to treat crohn ' s disease , ulcerative colitis and rheumatoid arthritis dapsone used to treat skin conditions such as leprosy and dermatitis and also to prevent malaria and pneumonia in high - risk patients phenobarbital , phenytoin used to treat epilepsy para - aminosalicylic acid ( pas ) used to treat tuberculosis the risk of methaemoglobinaemia can also be increased by the use of certain dyes ( aniline dyes ), or the pesticide naphthalene , so let your doctor know if you work with any dyes or chemical pesticides . any barrier contraceptives ( e . g . male or female condom ), which are made from polyurethane - based material cannot be guaranteed to protect against disease or pregnancy when you are also using senstend . check the material that your contraceptive or your partner ' s contraceptive is made of . ask your pharmacist if you are unsure . if you use senstend with condoms , you may be more likely to be unable to develop or maintain an erection . you may also be more likely to have reduced feeling in and around the penis . pregnancy , breast - feeding and fertility senstend is not approved for use by women . ask your doctor or pharmacist for advice before taking any medicine . pregnancy senstend is not recommended for use whilst your partner is pregnant unless you use a male condom , as listed above , to prevent exposure of the unborn child . breast - feeding this medicine may be used while your partner is breast - feeding . fertility senstend may reduce the possibility of pregnancy , but is not a reliable contraceptive . therefore , patients hoping to achieve conception should either avoid using senstend , or , if this medicine is essential to achieve penetration , should wash the penis as thoroughly as possible five minutes after senstend has been applied , but prior to intercourse .
you should not be given opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 " contents of the pack and other information "). talk to your doctor if you are not sure . warnings and precautions talk to your doctor before using opdivo as it may cause : problems with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . problems with your lungs such as breathing difficulties or cough . these may be signs of inflammation of the lungs ( pneumonitis or interstitial lung disease ). diarrhoea ( watery , loose or soft stools ) or any symptoms of inflammation of the intestines ( colitis ), such as stomach pain and mucus or blood in stool . inflammation of the liver ( hepatitis ). signs and symptoms of hepatitis may include abnormal liver function tests , eye or skin yellowing ( jaundice ), pain on the right side of your stomach area , or tiredness . inflammation or problems with your kidneys . signs and symptoms may include abnormal kidney function tests , or decreased volume of urine . problems with your hormone producing glands ( including the pituitary , the thyroid , the parathyroid and adrenal glands ) that may affect how these glands work . signs and symptoms that these glands are not working properly may include fatigue ( extreme tiredness ), weight change or headache , decreased blood levels of calcium and visual disturbances . diabetes ( symptoms include excessive thirst , the passing of a greatly increased amount of urine , increase in appetite with a loss of weight , feeling tired , drowsy , weak , depressed , irritable and generally unwell ) or diabetic ketoacidosis ( acid in the blood produced from diabetes ). inflammation of the skin that can lead to severe skin reaction ( known as toxic epidermal necrolysis and stevens - johnson syndrome ). signs and symptoms of severe skin reaction may include rash , itching , and peeling of the skin ( possibly fatal ). inflammation of the muscles such as myocarditis ( inflammation of the heart muscle ), myositis ( inflammation of the muscles ) and rhabdomyolysis ( stiffness in muscles and joints , muscle spasm ). signs and symptoms may include muscle pain , stiffness , weakness , chest pain , or severe fatigue . solid organ transplant rejection . graft - versus - host disease . haemophagocytic lymphohistiocytosis . a rare disease in which our immune system makes too many of otherwise normal infection fighting cells called histiocytes and lymphocytes . symptoms may include enlarged liver and / or spleen , skin rash , lymph node enlargement , breathing problems , easy bruising , kidney abnormalities , and heart problems . tell your doctor immediately if you have any of these signs or symptoms or if they get worse . do not try to treat your symptoms with other medicines on your own . your doctor may give you other medicines in order to prevent complications and reduce your symptoms , withhold the next dose of opdivo , or stop your treatment with opdivo altogether . please note that these signs and symptoms are sometimes delayed , and may develop weeks or months after your last dose . before treatment , your doctor will check your general health . you will also have blood tests during your treatment . check with your doctor or nurse before you are given opdivo if : you have an autoimmune disease ( a condition where the body attacks its own cells ); you have melanoma of the eye ; you were previously given ipilimumab , another medicine for treating melanoma , and experienced serious side effects because of that medicine ; you have been told that your cancer has spread to your brain ; you have any history of inflammation of the lungs ; you have been taken medicines to suppress your immune system . complications of stem cell transplant that uses donor stem cells ( allogeneic ) after treatment with opdivo . these complications can be severe and can lead to death . your healthcare provider will monitor you for signs of complications if you have an allogeneic stem cell transplant . children and adolescents opdivo should not be used in children and adolescents below 18 years of age . other medicines and opdivo before you are given opdivo , tell your doctor if you are taking any medicines that suppress your immune system , such as corticosteroids , since these medicines may interfere with the effect of opdivo . however , once you are treated with opdivo , your doctor may give you corticosteroids to reduce any possible side effects that you may have during your treatment and this will not impact the effect of the medicine . tell your doctor if you are taking or have recently taken any other medicines . do not take any other medicines during your treatment without talking to your doctor first . pregnancy and breast - feeding tell your doctor if you are pregnant or think you might be , if you are planning to become pregnant , or if you are breast - feeding . do not use opdivo if you are pregnant unless your doctor specifically tells you to . the effects of opdivo in pregnant women are not known , but it is possible that the active substance , nivolumab , could harm an unborn baby . you must use effective contraception while you are being treated with opdivo and for at least 5 months following the last dose of opdivo , if you are a woman who could become pregnant . if you become pregnant while using opdivo tell your doctor . it is not known whether opdivo gets into breast milk . a risk to the breast - fed infant cannot be excluded . ask your doctor if you can breast - feed during or after treatment with opdivo . driving and using machines opdivo or opdivo in combination with ipilimumab may have a minor influence on the ability to drive and use machines ; however , use caution when performing these activities until you are sure that opdivo does not adversely affect you . opdivo contains sodium tell your doctor if you are on a low - sodium ( low - salt ) diet before you are given opdivo . this medicine contains 2 . 5 mg sodium ( main component of cooking / table salt ) in each ml of concentrate . opdivo contains 10 mg sodium per 4 ml vial , 25 mg sodium per 10 ml vial or 60 mg sodium per 24 ml vial , which is equivalent to 0 . 5 %, 1 . 25 % or 3 % respectively , of the recommended maximum daily dietary intake of sodium for an adult . you will also find key messages from this package leaflet in the patient alert card you have been given by your doctor . it is important that you keep this patient alert card and show it to your partner or caregivers .
do not take clopidogrel tad confidential 30 - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if you suffer from severe liver disease . if you think any of these apply to you , or if you are in any doubt at all , consult your doctor before taking clopidogrel tad . warnings and precautions if any of the situations mentioned below apply to you , you should tell your doctor before taking clopidogrel tad : - if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ) - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ). - a recent serious injury - a recent surgery ( including dental ) - a planned surgery ( including dental ) in the next seven days - if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred within the last seven days - if you have kidney or liver disease - if you have had an allergy or reaction to any medicine used to treat your disease . while you are taking clopidogrel tad : - you should tell your doctor if a surgery ( including dental ) is planned . - you should also tell your doctor immediately if you develop a medical condition ( also known as thrombotic thrombocytopenic purpura or ttp ) that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ' possible side effects '). - if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). - your doctor may order blood tests . children and adolescents do not give this medicine to children because it does not work . other medicines and clopidogrel tad tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . some other medicines may influence the use of clopidogrel tad or vice versa . you should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as : - oral anticoagulants , medicines used to reduce blood clotting , - a non - steroidal anti - inflammatory medicine , usually used to treat painful and / or inflammatory conditions of muscle or joints , - heparin or any other injectable medicine used to reduce blood clotting , - ticlopidine , other antiplatelet agent , - a selective serotonin reuptake inhibitor ( including but not restricted to fluoxetine or fluvoxamine ), medicines usually used to treat depression , - omeprazole or esomeprazole , medicines to treat upset stomach , - fluconazole or voriconazole , medicines to treat fungal infections , - efavirenz or other anti - retroviral medicines ( used to treat hiv infections ), confidential 31 - carbamazepine a medicine to treat some forms of epilepsy , - moclobemide , medicine to treat depression , - repaglinide , medicine to treat diabetes , - paclitaxel , medicine to treat cancer , - opioids : while you are treated with clopidogrel , you should inform your doctor before being prescribed any opioid ( used to treat severe pain ). if you have experienced severe chest pain ( unstable angina or heart attack ), you may be prescribed clopidogrel tad in combination with acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever . an occasional use of acetylsalicylic acid ( no more than 1000 mg in any 24 hour period ) should generally not cause a problem , but prolonged use in other circumstances should be discussed with your doctor . clopidogrel tad with food and drink clopidogrel tad may be taken with or without food . pregnancy and breast - feeding it is preferable not to take this medicine during pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking clopidogrel tad . if you become pregnant while taking clopidogrel tad , consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant . you should not breast - feed while taking this medicine . if you are breast - feeding or planning to breast - feed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines clopidogrel tad is unlikely to affect your ability to drive or to use machines .
do not take tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - if you are allergic to sirolimus or to any macrolide - antibiotic ( e . g . erythromycin , clarithromycin , josamycin ). warnings and precautions tacrolimus immediate release capsules ( e . g , tacni ) and tacforius prolonged - release capsules both contain the active substance , tacrolimus . however , tacforius prolonged - release capsules are taken once daily , whereas the immediate release capsules are taken twice daily . this is because tacforius capsules allow for a prolonged - release ( more slow release over a longer period ) of tacrolimus . tacforius prolonged - release capsules and tacrolimus immediate release capsules are not interchangeable . tell your doctor if any of the following apply to you : - if you are taking any medicines mentioned below under " other medicines and tacforius ". - if you have or have had liver problems - if you have diarrhoea for more than one day - if you feel strong abdominal pain accompanied or not with other symptoms , such as chills , fever , nausea or vomiting - if you have an alteration of the electrical activity of your heart called " qt prolongation ". tell your doctor immediately if during treatment you suffer from : - problems with your vision such as blurred vision , changes in colour vision , difficulty in seeing detail or if your field of vision becomes restricted . your doctor may need to adjust your dose of tacforius . you should keep in regular contact with your doctor . from time to time , your doctor may need to do blood , urine , heart , eye tests , to set the right dose of tacforius . you should limit your exposure to the sun and uv ( ultraviolet ) light whilst taking tacforius . this is because immunosuppressants could increase the risk of skin cancer . wear appropriate protective clothing and use a sunscreen with a high sun protection factor . children and adolescents the use of tacforius is not recommended in children and adolescents under 18 years . other medicines and tacforius tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines . it is not recommended that tacforius is taken with ciclosporin ( another medicine used for the prevention of transplant organ rejection ). tacforius blood levels can be affected by other medicines you take , and blood levels of other medicines can be affected by taking tacforius , which may require interruption , an increase or a decrease in tacforius dose . in particular , you should tell your doctor if you are taking or have recently taken medicines like : - antifungal medicines and antibiotics , particularly so - called macrolide antibiotics , used to treat infections e . g . ketoconazole , fluconazole , itraconazole , voriconazole , clotrimazole , and isavuconazole , erythromycin , clarithromycin , josamycin , and rifampicin - letermovir , used to prevent illness caused by cmv ( human cytomegalovirus ) - hiv protease inhibitors ( e . g ritonavir , nelfinavir , saquinavir ), the booster medicine cobicistat , and combination tablets , used to treat hiv infection - hcv protease inhibitors ( e . g . telaprevir , boceprevir and the combination ombitasvir / paritaprevir / ritonavir with or without dasabuvir ), used to treat hepatitis c infection - nilotinib and imatinib ( used to treat certain cancers ) - mycophenolic acid , used to suppress the immune system to prevent transplant rejection - medicines for stomach ulcer and acid reflux ( e . g . omeprazole , lansoprazole or cimetidine ) - antiemetics , used to treat nausea and vomiting ( e . g . metoclopramide ) - cisapride or the antacid magnesium - aluminium - hydroxide , used to treat heartburn - the contraceptive pill or other hormone treatments with ethinylestradiol , hormone treatments with danazol - medicines used to treat high blood pressure or heart problems ( e . g . nifedipine , nicardipine , diltiazem and verapamil ) - anti - arrhythmic medicines ( amiodarone ) used to control arrhythmia ( uneven beating of the heart ) - medicines known as " statins " used to treat elevated cholesterol and triglycerides - phenytoin or phenobarbital , used to treat epilepsy 34 - the corticosteroids prednisolone and methylprednisolone , belonging to the class of corticosteroids used to treat inflammations or suppress the immune system ( e . g . in transplant rejection ) - nefazodone , used to treat depression - herbal preparations containing st . john ' s wort ( hypericum perforatum ) or extracts of schisandra sphenanthera . tell your doctor if you are taking or need to take ibuprofen ( used to treat fever , inflammation and pain ), amphotericin b ( used to treat bacterial infections ) or antivirals ( used to treat viral infections e . g . aciclovir ). these may worsen kidney or nervous system problems when taken together with tacforius . your doctor also needs to know if you are taking potassium supplements or certain diuretics used for heart failure , hypertension and kidney disease , ( e . g . amiloride , triamterene , or spironolactone ), non - steroidal anti - inflammatory medicines ( nsaids , e . g . ibuprofen ) used for fever , inflammation and pain , anticoagulants ( blood thinners ), or oral medicines for diabetes , while you take tacforius . if you need to have any vaccinations , please tell your doctor before . tacforius with food and drink avoid grapefruit ( also as juice ) while on treatment with tacforius , since it can affect its levels in the blood . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you might be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . tacrolimus passes into breast milk . therefore , you should not breast - feed whilst using tacforius . driving and using machines do not drive or use any tools or machines if you feel dizzy or sleepy , or have problems seeing clearly after taking tacforius . these effects are more frequent if you also drink alcohol . tacforius contains lactose tacforius contains lactose ( milk sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine . tacforius 5 mg capsules contains ponceau 4r tacforius 5 mg capsules contain ponceau 4r . this may cause allergic reactions .
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if you suffer from severe liver disease . if you think any of these apply to you , or if you are in any doubt at all , consult your doctor before taking clopidogrel zentiva . warnings and precautions if any of the situations mentioned below apply to you , you should tell your doctor before taking clopidogrel zentiva : if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ). - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ). - a recent serious injury . - a recent surgery ( including dental ). - a planned surgery ( including dental ) in the next seven days . if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred within the last seven days . if you have kidney or liver disease . if you have had an allergy or reaction to any medicine used to treat your disease . while you are taking clopidogrel zentiva : you should tell your doctor if a surgery ( including dental ) is planned . you should also tell your doctor immediately if you develop a medical condition ( also known as thrombotic thrombocytopenic purpura or ttp ) that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ' possible side effects '). if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). your doctor may order blood tests . children and adolescents do not give this medicine to children because it does not work . other medicines and clopidogrel zentiva tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . some other medicines may influence the use of clopidogrel zentiva or vice versa . you should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as : o oral anticoagulants , medicines used to reduce blood clotting , o a non - steroidal anti - inflammatory medicine , usually used to treat painful and / or inflammatory conditions of muscle or joints , o heparin or any other injectable medicine used to reduce blood clotting , o ticlopidine , other antiplatelet agent , o a selective serotonin reuptake inhibitor ( including but not restricted to fluoxetine or fluvoxamine ), medicines usually used to treat depression , 38 o rifampicin ( used to treat severe infections ) - omeprazole or esomeprazole , medicines to treat upset stomach , - fluconazole or voriconazole , medicines to treat fungal infections , - efavirenz , or other anti - retroviral medicines ( used to treat hiv infections ), - carbamazepine , a medicine to treat some forms of epilepsy , - moclobemide , medicine to treat depression , - repaglinide , medicine to treat diabetes , - paclitaxel , medicine to treat cancer , - opioids : while you are treated with clopidogrel , you should inform your doctor before being prescribed any opioids ( used to treat severe pain ). if you have experienced severe chest pain ( unstable angina or heart attack ), you may be prescribed clopidogrel zentiva in combination with acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever . an occasional use of acetylsalicylic acid ( no more than 1 , 000 mg in any 24 hour period ) should generally not cause a problem , but prolonged use in other circumstances should be discussed with your doctor . clopidogrel zentiva with food and drink clopidogrel zentiva may be taken with or without food . pregnancy and breast - feeding it is preferable not to take this product during pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking clopidogrel zentiva . if you become pregnant while taking clopidogrel zentiva , consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant . you should not breast - feed while taking this medicine . if you are breast - feeding or planning to breast - feed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines clopidogrel zentiva is unlikely to affect your ability to drive or to use machines . clopidogrel zentiva contains lactose if you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product . clopidogrel zentiva contains hydrogenated castor oil this may cause stomach upset or diarrhoea .
do not use yttriga : - if you are allergic ( hypersensitive ) to yttrium ( 90y ) chloride or any of the other ingredients of yttriga . - if you are pregnant or if there is a possibility that you may be pregnant ( see below ). take special care with yttriga - yttriga is a radioactive medicine and is only used in combination with another medicinal product . it is not intended for direct use in patients . - because there are strict laws covering the use , handling and disposal of radiopharmaceuticals , yttriga will always be used in a hospital or a similar setting . it will only be handled and administered by people who are trained and qualified in the safe handling of radioactive material . particular care should be taken when administering radioactive medicinal products to children and adolescents ( from 2 to 16 years old ). taking other medicines please tell your doctor or pharmacist , if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . no interactions of yttrium ( 90y ) chloride with other medicines are known as no clinical studies are available . pregnancy yttriga is contraindicated in pregnancy . please tell your doctor if there is any possibility that you are pregnant . if you have missed a period , you should assume to be pregnant until a pregnancy test conducted is negative . your doctor will consider alternative techniques which do not involve ionising radiation . women of childbearing potential should use effective contraception during and after treatment . breast - feeding your doctor will ask you to stop breast - feeding . ask your doctor or pharmacist for advice before taking any medicine .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciambra ( listed in section 6 ). - if you are breast - feeding ; you must discontinue breast - feeding during treatment with ciambra . - if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before receiving ciambra . if you currently have or have previously had problems with your kidneys , talk to your doctor or hospital pharmacist as you may not be able to receive ciambra . before each infusion you will have samples of your blood taken to evaluate if you have sufficient kidney and liver function and to check that you have enough blood cells to receive ciambra . your doctor may decide to change the dose or delay treating you depending on your general condition and if your blood cell counts are too low . if you are also receiving cisplatin , your doctor will make sure that you are properly hydrated and receive appropriate treatment before and after receiving cisplatin to prevent vomiting . if you have had or are going to have radiation therapy , please tell your doctor , as there may be an early or late radiation reaction with ciambra . if you have been recently vaccinated , please tell your doctor , as this can possibly cause bad effects with ciambra . if you have heart disease or a history of heart disease , please tell your doctor . if you have an accumulation of fluid around your lungs , your doctor may decide to remove the fluid before giving you ciambra . children and adolescents ciambra is not to be given to children and adolescents because no studies were performed in these groups . other medicines and ciambra please tell your doctor if you are taking any medicine for pain or inflammation ( swelling ), such as medicines called " nonsteroidal anti - inflammatory drugs " ( nsaids ), including medicines purchased without a doctor ' s prescription ( such as ibuprofen ). there are many sorts of nsaids with different durations of activity . based on the planned date of your infusion of ciambra and / or on the status of your kidney function , your doctor needs to advise you on which medicines you can take and when you can take them . if you are unsure , ask your doctor or pharmacist if any of your medicines are nsaids . please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy if you are pregnant , think you may be pregnant or are planning to have a baby , tell your doctor . the use of ciambra should be avoided during pregnancy . your doctor will discuss with you the potential risk of taking ciambra during pregnancy . women must use effective contraception during treatment with ciambra . breast - feeding if you are breast - feeding , tell your doctor . breast - feeding must be discontinued during treatment with ciambra . fertility men are advised not to father a child during and up to 6 months following treatment with ciambra and should therefore use effective contraception during treatment with ciambra and for up to 6 51 months afterwards . if you would like to father a child during the treatment or in the 6 months following receipt of treatment , seek advice from your doctor or pharmacist . you may want to seek counselling on sperm storage before starting your therapy . driving and using machines ciambra may make you feel tired . be careful when driving a car or using machines . ciambra contains sodium ciambra 100 mg contains less than 1 mmol sodium ( 23 mg ) per vial , that is to say essentially ' sodium - free '. ciambra 500 mg contains 54 mg sodium ( main component of cooking salt ) in each vial . this is equivalent to 2 , 7 % of the recommended maximum daily dietary intake of sodium for an adult .
you should not be given immunogam - if you have previously developed an allergic reaction to human immunoglobulins , to other blood products or to any of the other ingredients of immunogam . - if you have an iga deficiency such that you have developed an allergic reaction to iga containing products 18 take special care with immunogam general warnings related to immunogam : immunoglobulins in general may cause adverse reactions such as chills , headache , fever , vomiting , allergic reactions , nausea , arthralgia ( joint pain ), low blood pressure and moderate low back pain . patients should be monitored for antibodies against human hepatitis b immunoglobulin regularly . human hepatitis b immunoglobulin injections can induce a drop in blood pressure with an allergic reaction , even in patients who have tolerated previous treatments with immunoglobulin . suspicion of allergic or anaphylactic type reactions requires immediate discontinuation of the injection . in case of shock , standard medical treatments for shock should be administered . immunoglobulin a : please tell your doctor if your blood does not have immunoglobulin a ( iga ). immunogam contains small amounts of iga . patients who have an iga deficiency may develop an allergic reaction to this medicine . immunogam contains maltose ( 10 % w / w ). serological testing immunogam may cause a rise of various transferred antibodies which may result in misleading positive results of certain blood serum tests . also transmission of antibodies to blood group antigens may interfere with some blood tests for red cell allo - antibodies ( e . g . coombs ' test ). blood glucose testing blood glucose testing : when administering immunogam , the measurement of blood glucose must be done with a glucose - specific method . this is because some types of blood glucose testing systems falsely interpret the maltose contained in immunogam as glucose . this may result in falsely elevated glucose readings and consequently in the inappropriate administration of insulin which may result in hypoglycemia . also cases of true hypoglycemia may go untreated if the hypoglycemic state is masked by falsely elevated glucose readings ." viral safety when medicines are made from human blood or plasma , certain measures are put in place to prevent infections being passed from blood donors on to patients . these include careful selection of blood and plasma donors to make sure those at risk of carrying infections are excluded , and the testing of each donation and pools of plasma for signs of virus / infections . manufacturers of these products also include steps in the processing of the blood or plasma that can inactivate or remove viruses . despite these measures , when medicines prepared from human blood or plasma are administered the possibility of passing on infection cannot be totally excluded . this also applies to any unknown or emerging viruses or other types of infections . the measures taken are considered effective for enveloped viruses such as human immunodeficiency virus ( hiv ), hepatitis b virus and hepatitis c virus . the measures taken may be of limited value against non - enveloped viruses such as hepatitis a virus and parvovirus b19 . immunoglobulins have not been associated with hepatitis a or parvovirus b19 infections possibly because the antibodies against these infections , which are contained in the product , are protective . it is strongly recommended that every time you receive a dose of immunogam , the name and batch number of the product are recorded in your physician ' s notes in order to maintain a record of the batches used . using other medicines please tell your doctor or nurse , if you are taking or have recently taken any other medicines , including medicines obtained without a prescription e . g . herbal medicines . please inform your doctor if you are planning to receive a vaccine or have been recently vaccinated in the last three months . this is because immunogam may interfere with the response to some attenuated vaccines , such as measles , rubella , mumps , and chicken pox . there are no available data on drug interactions of immunogam with other medications . pregnancy and breastfeeding ask your doctor for advice before using this medicine . your doctor will decide if immunogam can be used during pregnancy and breastfeeding . driving and using machines immunogam does not effect your ability to drive or use machines . important information about some of the ingredients of immunogam immunogam contains 0 . 16 g of maltose in a 500 iu dose . this should be taken into account in patients with diabetes mellitus .
you should not be given remicade if : you are allergic to infliximab or to any of the other ingredients in remicade ( listed in section 6 ). you are allergic ( hypersensitive ) to proteins that come from mice . you have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . you have heart failure that is moderate or severe . do not use remicade if any of the above applies to you . if you are not sure , talk to your doctor before you are given remicade . warnings and precautions talk to your doctor before or during treatment with remicade if you have : had treatment with remicade before tell your doctor if you have had treatment with remicade in the past and are now starting remicade treatment again . if you have had a break in your remicade treatment of more than 16 weeks , there is a higher risk for allergic reactions when you start the treatment again . infections tell your doctor before you are given remicade if you have an infection even if it is a very minor one . tell your doctor before you are given remicade if you have ever lived in or travelled to an area where infections called histoplasmosis , coccidioidomycosis , or blastomycosis are common . these infections are caused by specific types of fungi that can affect the lungs or other parts of your body . you may get infections more easily when you are being treated with remicade . if you are 65 or older , you have a greater risk . these infections may be serious and include tuberculosis , infections caused by viruses , fungi , bacteria , or other organisms in the environment and sepsis that may be life - threatening . tell your doctor straight away if you get signs of infection during treatment with remicade . signs include fever , cough , flu - like signs , feeling unwell , red or hot skin , wounds or dental problems . your doctor may recommend temporarily stopping remicade . tuberculosis ( tb ) it is very important that you tell your doctor if you have ever had tb or if you have been in close contact with someone who has had or has tb . your doctor will test you to see if you have tb . cases of tb have been reported in patients treated with remicade , even in patients who have already been treated with medicines for tb . your doctor will record these tests on your patient reminder card . if your doctor feels that you are at risk for tb , you may be treated with medicines for tb before you are given remicade . tell your doctor straight away if you get signs of tb during treatment with remicade . signs include persistent cough , weight loss , feeling tired , fever , night sweats . hepatitis b virus tell your doctor before you are given remicade if you are a carrier of hepatitis b or have ever had it . tell your doctor if you think you might be at risk of contracting hepatitis b . your doctor should test you for hepatitis b virus . treatment with tnf blockers such as remicade may result in reactivation of hepatitis b virus in patients who carry this virus , which can be life - threatening in some cases . heart problems tell your doctor if you have any heart problems , such as mild heart failure . your doctor will want to closely monitor your heart . tell your doctor straight away if you get new or worsening signs of heart failure during treatment with remicade . signs include shortness of breath or swelling of your feet . cancer and lymphoma tell your doctor before you are given remicade if you have or have ever had lymphoma ( a type of blood cancer ) or any other cancer . patients with severe rheumatoid arthritis , who have had the disease for a long time , may be at higher risk of developing lymphoma . children and adults taking remicade may have an increased risk of developing lymphoma or another cancer . some patients who have received tnf - blockers , including remicade have developed a rare type of cancer called hepatosplenic t - cell lymphoma . of these patients , most were teenage boys or young men and most had either crohn ' s disease or ulcerative colitis . this type of cancer has usually resulted in death . almost all patients had also received medicines containing azathioprine or 6 - mercaptopurine in addition to tnf - blockers . some patients treated with infliximab have developed certain kinds of skin cancer . if there are any changes in your skin or growths on the skin during or after therapy , tell your doctor . some women being treated for rheumatoid arthritis with remicade have developed cervical cancer . for women taking remicade including those over 60 years of age , your doctor may recommend regular screening for cervical cancer . lung disease or heavy smoking tell your doctor before you are given remicade if you have a lung disease called chronic obstructive pulmonary disease ( copd ) or if you are a heavy smoker . patients with copd and patients who are heavy smokers may have a higher risk of developing cancer with remicade treatment . nervous system disease tell your doctor if you have or have ever had a problem that affects your nervous system before you are given remicade . this includes multiple sclerosis , guillain - barre syndrome , if you have fits or have been diagnosed with ' optic neuritis '. tell your doctor straight away if you get symptoms of a nerve disease during treatment with remicade . signs include changes in your vision , weakness in your arms or legs , numbness or tingling in any part of your body . abnormal skin openings tell your doctor if you have any abnormal skin openings ( fistulae ) before you are given remicade . vaccinations talk to your doctor if you recently have had or are due to have a vaccine . you should receive recommended vaccinations before starting remicade treatment . you may receive some vaccines during treatment with remicade but you should not receive live vaccines ( vaccines that contain a living but weakened infectious agent ) while using remicade because they may cause infections . if you received remicade while you were pregnant , your baby may also be at higher risk for getting an infection with live vaccines for up to six months after birth . it is important that you tell your baby ' s doctors and other healthcare professionals about your remicade use so they can decide when your baby should receive any vaccine , including live vaccines such as bcg ( used to prevent tuberculosis ). for more information see section on pregnancy and breast - feeding . therapeutic infectious agents talk to you doctor if you have recently received or are scheduled to receive treatment with a therapeutic infectious agent ( such as bcg instillation used for the treatment of cancer ). operations or dental procedures tell your doctor if you are going to have any operations or dental procedures . tell your surgeon or dentist that you are having treatment with remicade by showing them your patient reminder card . liver problems some patients receiving remicade have developed serious liver problems . tell your doctor straight away if you get symptoms of liver problems during treatment with remicade . signs include yellowing of the skin and eyes , dark - brown coloured urine , pain or swelling in the upper right side of the stomach area , joint pain , skin rashes , or fever . low blood counts in some patients receiving remicade , the body may not make enough of the blood cells that help fight infections or help stop bleeding . tell your doctor straight away if you get symptoms of low blood counts during treatment with remicade . signs include persistent fever , bleeding or bruising more easily , small red or purple spots caused by bleeding under the skin , or looking pale . immune system disorder some patients receiving remicade have developed symptoms of an immune system disorder called lupus . tell your doctor straight away if you develop symptoms of lupus during treatment with remicade . signs include joint pain or a rash on cheeks or arms that is sensitive to the sun . children and adolescents the information above also applies to children and adolescents . in addition : some children and teenage patients who have received tnf - blockers such as remicade have developed cancers , including unusual types , which sometimes resulted in death . more children taking remicade developed infections as compared to adults . children should receive recommended vaccinations before starting remicade treatment . children may receive some vaccines during treatment with remicade but should not receive live vaccines while using remicade . if you are not sure if any of the above apply to you , talk to your doctor before you are given remicade . other medicines and remicade patients who have inflammatory diseases already take medicines to treat their problem . these medicines may cause side effects . your doctor will advise you what other medicines you must keep using while you are having remicade . tell your doctor if you are using or have recently used any other medicines , including any other medicines to treat crohn ' s disease , ulcerative colitis , rheumatoid arthritis , ankylosing spondylitis , psoriatic arthritis or psoriasis or medicines obtained without a prescription , such as vitamins and herbal medicines . in particular , tell your doctor if you are using any of the following medicines : medicines that affect your immune system . kineret ( anakinra ). remicade and kineret should not be used together . orencia ( abatacept ). remicade and orencia should not be used together . while using remicade you should not receive live vaccines . if you were using remicade during pregnancy , tell your baby ' s doctor and other healthcare professionals caring for your baby about your remicade use before the baby receives any vaccines . if you are not sure if any of the above apply to you , talk to your doctor or pharmacist before using remicade . pregnancy , breast - feeding , and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . remicade should only be used during pregnancy if your doctor feels it is necessary for you . you should avoid getting pregnant when you are being treated with remicade and for 6 months after you stop being treated with it . discuss the use of contraception during this time with your doctor . do not breast - feed when you are being treated with remicade or for 6 months after your last treatment with remicade . if you received remicade during your pregnancy , your baby may have a higher risk for getting an infection . it is important that you tell your baby ' s doctors and other healthcare professionals about your remicade use before your baby is given any vaccine . if you received remicade while pregnant , giving bcg vaccine ( used to prevent tuberculosis ) to your baby within 6 months after birth may result in infection with serious complications , including death . live vaccines such as bcg should not be given to your baby within 6 months after birth . for more information see section on vaccination . severely decreased numbers of white blood cells have been reported in infants born to women treated with remicade during pregnancy . if your baby has continual fevers or infections , contact your baby ' s doctor immediately . driving and using machines remicade is not likely to affect your ability to drive or use tools or machines . if you feel tired , dizzy , or unwell after having remicade , do not drive or use any tools or machines . remicade contains sodium remicade contains less than 1 mmol sodium ( 23 mg ) per dose , that is to say essentially ' sodium - free '. however , before remicade is given to you , it is mixed with a solution that contains sodium . talk to your doctor if you are on a low salt diet .
do not take rasagiline mylan : - if you are allergic to rasagiline or any of the other ingredients of this medicine ( listed in section 6 ). - if you have severe liver problems . do not take the following medicines while taking rasagaline mylan : - monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease , or used for any other indication ), including medicinal and natural products without prescription e . g . st . john ' s wort . - pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasagiline mylan treatment and starting treatment with mao inhibitors or pethidine . warnings and precautions talk to your doctor before taking rasagiline mylan . - if you have mild to moderate liver problems - if you have any suspicious skin changes . children and adolescents rasagiline mylan is not recommended for use under the age of 18 . other medicines and rasagiline mylan tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without prescription or if you are smoking or intend to stop smoking . ask your doctor for advice before taking any of the following medicines together with rasagiline mylan : certain antidepressants ( selective serotonin reuptake inhibitors , selective serotonin - norepinephrine reuptake inhibitors , tricyclic or tetracyclic antidepressants ) the antibiotic ciprofloxacin used against infections the cough suppressant dextromethorphan sympathomimetics such as those present in eye drops , nasal and oral decongestants and cold medicine containing ephedrine or pseudoephedrine the use of rasagiline mylan together with the antidepressants containing fluoxetine or fluvoxamine should be avoided . if you are starting treatment with rasagiline mylan , you should wait at least 5 weeks after stopping fluoxetine treatment . if you are starting treatment with fluoxetine or fluvoxamine , you should wait at least 14 days after stopping rasagiline mylan treatment . tell your doctor if you or your family / carer notices that you are developing unusual behaviours where you cannot resist the impulse , urges or cravings to carry out certain harmful or detrimental activities to yourself or others . these are called impulse control disorders . in patients taking rasagiline mylan and / or other medications used to treat parkinson ' s disease , behaviours such as compulsions , obsessive thoughts , addictive gambling , excessive spending , impulsive behaviour and an abnormally high sex drive or an increase in sexual thoughts or feelings have been observed . your doctor may need to adjust or stop your dose . rasagiline mylan with food and drink rasagiline mylan may be taken with or without food . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking any medicine . driving and using machines no studies on the effects on the ability to drive and use machines have been performed . ask your doctor for advice prior to driving or using machines .
do not give hulio - if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if your child has symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . if your child has moderate or severe heart failure . it is important to tell your doctor if your child has had or have a serious heart condition ( see " warnings and precautions "). warnings and precautions talk to your doctor or pharmacist before using hulio . allergic reaction if your child has allergic reactions with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash do not inject them more hulio and contact their doctor immediately since , in rare cases , these reactions can be life - threatening . infections if your child have an infection , including long - term or localised infection ( for example , leg ulcer ) consult your child ' s doctor before starting hulio . if you are unsure , contact your child ' s doctor . your child might get infections more easily while he / she is receiving hulio treatment . this risk may increase if your child lung function is reduced . these infections may be serious and include tuberculosis , infections caused by viruses , fungi , parasites or bacteria , or other unusual infectious organisms and sepsis ( blood poisoning ). in rare cases , these infections may be life - threatening . it is important to tell your child ' s doctor if your child gets symptoms such as fever , wounds , feeling tired or dental problems . your child ' s doctor may recommend temporarily stopping hulio . tuberculosis ( tb ) as cases of tuberculosis have been reported in patients treated with adalimumab , your child ' s doctor will check your child for signs and symptoms of tuberculosis before starting hulio . this will include a thorough medical evaluation including your medical history and screening tests ( for example chest x - ray and a tuberculin test ). the conduct and results of these tests should be recorded on child ' s patient reminder card . it is very important that you tell your child ' s doctor if he / she have ever had tuberculosis , or if he / she have been in close contact with someone who has had tuberculosis . tuberculosis can develop during therapy even if your child have had preventative treatment for tuberculosis . if symptoms of tuberculosis ( persistent cough , weight loss , listlessness , mild fever ), or any other infection appear during or after therapy tell your child ' s doctor immediately . travel / recurrent infection tell your child ' s doctor if you reside or travel in regions where fungal infections such as histoplasmosis , coccidioidomycosis or blastomycosis are common . tell your child ' s doctor if you have a history of recurrent infections or other conditions that increase the risk of infections . hepatitis b virus tell your child ' s doctor if your child is a carrier of the hepatitis b virus ( hbv ), if he / she has active hbv infection or if you think he / she might be at risk of contracting hbv . your child ' s doctor will test your child for hbv . hulio can reactivate hbv infection in people who carry this virus . in some rare cases , especially if your child is taking other medicines that suppress the immune system , reactivation of hbv infection can be life - threatening . surgery or dental procedure if your child is about to have surgery or dental procedures , tell your child ' s doctor that your child is taking hulio . their doctor may recommend temporarily stopping hulio . demyelinating disease if your child has or develops demyelinating disease ( a disease that affects the insulating layer around the nerves ), such as multiple sclerosis , your child ' s doctor will decide if he / she should receive or continue to receive hulio . tell your child ' s doctor immediately if your child gets symptoms like changes in vision , weakness in arms or legs or numbness or tingling in any part of the body . vaccine certain vaccines contain living but weakened forms of bacteria or viruses that cause diseases and should not be given during treatment with hulio in case they cause infections . check with child ' s doctor before receiving any vaccines . it is recommended that , if possible , children be given all the scheduled vaccinations for their age before they start treatment with hulio . if your child received hulio while pregnant , your child ' s baby may be at higher risk for getting an infection for up to about five months after the last dose she received during her pregnancy . it is important that you tell the baby ' s doctors and other health care professionals about hulio use during your child ' s pregnancy so they can decide when your child ' s baby should receive any vaccine . heart failure it is important to tell your child ' s doctor if your child had or have a serious heart condition . if your child has mild heart failure and are being treated with hulio , your child ' s heart failure status must be closely monitored by the doctor . if your child develops new or worsening symptoms of heart failure ( e . g . shortness of breath , or swelling of feet ), you must contact your child ' s doctor immediately . fever , bruising , bleeding or looking pale in some patients the body may fail to produce enough of the blood cells that fight infections or help you to stop bleeding . if your child develops a fever that does not go away , or bruises or bleeds very easily or look very pale , call your child ' s doctor right away . your child ' s doctor may decide to stop treatment . cancer there have been very rare cases of certain kinds of cancer in children and adults taking adalimumab or other tnf blockers . people with more serious rheumatoid arthritis who have had the disease for a long time may have a higher than average risk of getting lymphoma and leukaemia ( cancers that affect blood cells and bone marrow ). if your child takes hulio the risk of getting lymphoma , leukaemia , or other cancers may increase . on rare occasions , a specific and severe type of lymphoma has been observed in some patients taking adalimumab . some of those patients were also treated with the medicines azathioprine or mercaptopurine . tell your child ' s doctor if your child is taking azathioprine or mercaptopurine with hulio . in addition cases of non - melanoma skin cancer have been observed in patients taking adalimumab . if new areas of damaged skin appear during or after treatment or if existing marks or areas of damage change appearance , tell your child ' s doctor . there have been cases of cancers , other than lymphoma , have been reported in patients with a specific type of lung disease called chronic obstructive pulmonary disease ( copd ) treated with another tnf blocker . if your child has copd , or is a heavy smoker , you should discuss with your child ' s doctor whether treatment with a tnf blocker is appropriate for your child . other medicines and hulio tell your child ' s doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . hulio can be taken together with methotrexate or certain disease - modifying anti - rheumatic agents ( sulfasalazine , hydroxychloroquine , leflunomide and injectable gold preparations ), corticosteroids or pain medications including non - steroidal anti - inflammatory drugs ( nsaids ). your child should not take hulio with medicines containing the active substances anakinra or abatacept . the combination of hulio and anakinra or abatacept is not recommended based upon the possible increased risk for infections , including serious infections and other potential pharmacological interactions . if you have questions , please ask your child ' s doctor . pregnancy and breast - feeding your child should consider the use of adequate contraception to prevent pregnancy and continue its use for at least 5 months after their last hulio injection . if your child is pregnant , thinks she may be pregnant or is planning to have a baby , ask her doctor for advice about taking this medicine . hulio should only be used during a pregnancy if needed . according to a pregnancy study , there was no higher risk of birth defects when the mother had received hulio during pregnancy compared with mothers with the same disease who did not receive hulio . hulio can be used during breast - feeding . if your child receives hulio during her pregnancy , her baby may have a higher risk for getting an infection . it is important that you tell her baby ' s doctors and other health care professionals about her hulio ' s use during her pregnancy before the baby receives any vaccine . for more information on vaccines , see " warnings and precautions " section . driving and using machines hulio may have a minor influence on your ability to drive , cycle or use machines . room spinning sensation ( vertigo ) and vision disturbances may occur after taking hulio . hulio contains sodium and sorbitol each hulio vial contains 38 . 2 mg of sorbitol . sorbitol is a source of fructose . if your child ' s doctor has told you that your child has an intolerance to some sugars or if your child has been diagnosed with hereditary fructose intolerance ( hfi ), a rare genetic disorder in which a person cannot break down fructose , talk to your child ' s doctor before you give your child this medicine . also this medicine contains less than 1 mmol of sodium ( 23 mg ) per vial , that is to say essentially ' sodium - free '.
do not use yellox - if you are allergic to bromfenac or to any of the other ingredients of this medicine ( listed in section 6 ). - if you have experienced asthma , skin allergy or intense inflammation in your nose when using other nsaids . examples of nsaids are : acetylsalicylic acid , ibuprofen , ketoprofen , diclofenac . warning and precautions talk to your doctor or pharmacist before using this medicine - if you are using topical steroids ( e . g . cortisone ), as this may cause unwanted side effects . - if you have bleeding problems ( e . g . haemophilia ) or have had them in the past , or you are taking other medicines which may prolong bleeding time ( e . g . warfarin , clopidogrel , acetylsalicylic acid ). - if you have eye problems ( e . g . dry eye syndrome , corneal problems ). - if you have diabetes . - if you have rheumatoid arthritis . - if you had repeated eye surgery within a short period of time . wearing contact lenses is not recommended after cataract surgery . therefore , do not wear contact lenses whilst using yellox . children and adolescents yellox should not be used in children and adolescents . other medicines and yellox tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregnancy , breastfeeding and fertility if you are pregnant or breastfeeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before you use yellox . yellox should not be used during the last three months of pregnancy . the doctor may prescribe this medicine during pregnancy if expected benefit to mother outweigh possible risk to baby . yellox may be prescribed to breast - feeding woman and have no important influence on fertility . driving and using machines your vision may be blurred for a short time after using this eye drops . if you experience blurred vision upon instillation , do not drive or use machines until your vision is clear . yellox contains sodium sulphite and benzalkonium chloride - sodium sulphite may cause allergic reactions or asthma attacks , which may sometimes be severe and life - threatening . - benzalkonium chloride is a preservative which may cause eye irritation or eye surface problems . do not use yellox while wearing contact lenses , since benzalkonium chloride is known to discolour them .
do not use dzuveo : - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - if you have a serious lung or breathing problem warnings and precautions talk to your doctor or nurse before using dzuveo . tell your doctor or nurse before treatment if you : - are suffering from any condition that affects your breathing ( such as asthma , wheezing , or shortness of breath ). as dzuveo may affect your breathing , your doctor or nurse will check your breathing during treatment ; - have a head injury or brain tumour ; - have problems with your heart and circulation , especially slow heart rate , irregular heartbeat , low blood volume or low blood pressure ; - have moderate to severe liver problems or severe kidney problems , as these organs have an effect on the way in which your body breaks down and eliminates the medicine ; have abnormally slow bowel movements ; - have a disease of the gall bladder or pancreas ; - have a history of medicine or alcohol abuse ; children and adolescents dzuveo should not be used in children and adolescents below 18 years . other medicines and dzuveo tell your doctor if you are taking , have recently taken or might take any other medicines . in particular , 28 tell your doctor if you are taking any of the following : - ketoconazole , which is used for the treatment of fungal infections this medicine may have an effect on the way in which your body breaks down sufentanil . - any medicines which might make you sleepy ( have a sedative effect ), such as sleeping pills , medicines to treat anxiety ( e . g . benzodiazipines ), tranquillisers or other opioid medicines , as they can increase the risk of severe breathing problems , coma and may be life - threatening . - - medicines for the treatment of depression known as monoamine oxidase inhibitors ( maois ). these medicines must not be taken in the 2 weeks before or at the same time as dzuveo is given . - medicines for the treatment of depression known as selective serotonin reuptake inhibitors ( ssris ) and serotonin norepinephrine reuptake inhibitors ( snris ). it is not recommended to use these medicines at the same time as dzuveo . - other medicines which are also taken sublingually ( placed under the tongue where they dissolve ) or medicines which take effect in your mouth ( e . g . nystatin , a liquid or pastilles you hold in your mouth to treat fungus infections ), as the effect on dzuveo has not been studied . - regularly prescribed opioid medicine ( e . g . morphine , codeine , fentanyl , hydromorphone , oxycodone ). - medicines used to treat high blood pressure or angina ( chest pain ) known as calcium channel or beta blockers e . g . diltiazem and nifedipine . dzuveo with alcohol do not drink alcohol while using dzuveo . it can increase the risk of experiencing severe breathing problems . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . dzuveo should not be used during pregnancy or in women of childbearing potential not using effective contraception . dzuveo passes into breast milk and can cause side effects in the breast - fed child . breastfeeding is not recommended while you are taking dzuveo . driving and using machines dzuveo affects your ability to drive or use machines as it may cause sleepiness , dizziness or visual disturbances . you should not drive or operate machinery if you experience any of these symptoms whilst or after being treated with sufentanil . you should only drive and use machines if sufficient time has elapsed after your last dose of dzuveo .
do not take erleada if : you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). you are a woman who is pregnant or may become pregnant ( see the pregnancy and contraception section below for more information ). do not take this medicine if any of the above apply to you . if you are not sure , talk to your doctor or pharmacist before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have ever had fits or seizures you are taking any medicines to prevent blood clots ( e . g . warfarin , acenocoumarol ) you have any heart or blood vessel conditions , including heart rhythm problems ( arrhythmia ). falls have been observed in patients taking erleada . take extra care to reduce your risk of a fall . broken bones have been observed in patients taking erleada . blockage of the arteries in the heart that can lead to death has happened in some people during treatment with erleada . your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with erleada . call your healthcare provider or go to the nearest emergency room right away if you get chest pain or discomfort at rest or with activity or shortness of breath during your treatment with erleada . if you are taking any medicines , talk to your doctor or pharmacist to see if they are associated with an increased risk of seizure , bleeding or heart condition . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking erleada . children and adolescents this medicine is not for use in children and adolescents under 18 years of age . if a child or young person accidentally takes erleada : go to the hospital straight away take this package leaflet with you to show to the emergency doctor . other medicines and erleada tell your doctor or pharmacist if you are taking , have recently taken , or might take any other medicines . this is because erleada can affect the way some other medicines work . also , some other medicines can affect the way erleada works . tell your doctor if you are taking medicines that : lower high fat levels in the blood ( e . g . gemfibrozil ) treat bacterial infections ( e . g . moxifloxacin , clarithromycin ) treat fungal infections ( e . g . itraconazole , ketoconazole ) treat hiv infection ( e . g . ritonavir , efavirenz , darunavir ) treat anxiety ( e . g . midazolam , diazepam ) treat epilepsy ( e . g . phenytoin , valproic acid ) treat gastroesophageal reflux disease ( conditions where there is too much acid in the stomach ) ( e . g . omeprazole ) prevent blood clots ( e . g . warfarin , clopidogrel , dabigatran etexilate ) treat hayfever and allergies ( e . g . fexofenadine ) lower cholesterol levels ( e . g . ' statins ' such as rosuvastatin , simvastatin ) treat heart conditions or lower blood pressure ( e . g . digoxin , felodipine ) treat heart rhythm problems ( e . g . quinidine , disopyramide , amiodarone , sotalol , dofetilide , ibutilide ) treat thyroid conditions ( e . g . levothyroxine ) treat gout ( e . g . colchicine ) lower blood glucose ( e . g . repaglinide ) treat cancer ( e . g . lapatinib , methotrexate ) treat opioid addiction or pain ( e . g . methadone ) treat serious mental illnesses ( e . g . haloperidol ) 41 you need to list the names of the medicines you take and show the list to your doctor or pharmacist when you start a new medicine . mention to your doctor that you are taking erleada if the doctor wants to start you on any new medicine . the dose of erleada or any other medicines that you are taking may need to be changed . pregnancy and contraception information for men and women information for women erleada must not be taken by women who are pregnant , may become pregnant , or who are breast - feeding . erleada may harm your unborn baby . information for men follow this advice during treatment and for 3 months after stopping if you are having sex with a pregnant woman use a condom to protect the unborn baby . if you are having sex with a woman who can become pregnant - use a condom and another highly effective method of contraception . use contraception during treatment and for 3 months after stopping . talk to your doctor if you have any questions about contraception . erleada may reduce male fertility . driving and using machines this medicine is not likely to affect you being able to drive and use any tools or machines . the side effects for erleada include seizures . if you are at higher risk of seizures ( see section 2 warnings and precautions ), talk to your doctor . erleada contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per 240 mg dose ( 4 tablets ), that is to say essentially ' sodium - free '.
axumin must not be used : - if you are allergic to fluciclovine ( 18f ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your nuclear medicine doctor before you are given axumin if you : - have kidney problems - are on a low sodium diet ( see section " axumin contains sodium "). before administration of axumin you : - should avoid exercise for at least a day before the axumin scan . - should not eat or drink for at least 4 hours before the scan ( you can take your usual medicines with small amounts of water ). - may urinate at the latest 60 minutes before the axumin injection and you should avoid urination until after the scan has been completed . children and adolescents talk to your nuclear medicine doctor if you are under 18 years old . axumin is not intended for use in children and adolescents aged under 18 years . other medicines and axumin tell your nuclear medicine doctor if you are taking , have recently taken or might take any other medicines since they may interfere with the interpretation of the images . pregnancy and breast - feeding this medicine is not indicated for use in women . driving and using machines it is considered unlikely that axumin will affect your ability to drive or to use machines . axumin contains sodium this medicine contains up to 39 mg sodium per dose . this should be taken into consideration if you are on a controlled sodium diet .
do not use azopt - if you have severe kidney problems . - if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if you are allergic to medicines called sulphonamides . examples include medicines used to treat diabetes and infections and also diuretics ( water tablets ). azopt may cause the same allergy . - if you have too much acidity in your blood ( a condition called hyperchloraemic acidosis ). if you have further questions , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using azopt : - if you have kidney or liver problems . - if you have dry eyes or cornea problems . - if you are taking other sulphonamide medicines - if you have a specific form of glaucoma in which the pressure inside the eye rises due to deposits that block fluid draining out ( pseudoexfoliative glaucoma or pigmentary glaucoma ) or a specific form of glaucoma in which the pressure inside the eye ( sometimes rapidly ) rises because the eye bulges forward and blocks fluid draining out ( narrow - angle glaucoma ) 22 children and adolescents azopt is not to be used by infants , children or adolescents under 18 years of age unless advised by your doctor . other medicines and azopt tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . if you are taking another carbonic anhydrase inhibitor ( acetazolamide or dorzolamide , see section 1 what azopt is and what it is used for ), talk to your doctor . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before using this medicine . women who may become pregnant are advised to use effective contraception during azopt treatment . the use of azopt is not recommended during pregnancy or breast - feeding . do not use azopt unless clearly indicated by your doctor . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines do not drive or use machines until your vision is clear . you may find that your vision is blurred for a time just after using azopt . azopt may impair the ability to perform tasks requiring mental alertness and / or physical coordination . if affected , take care when driving or using machines . azopt contains benzalkonium chloride this medicine contains 3 . 35 g benzalkonium chloride per drop (= 1 dose ) which is equivalent to 0 . 01 % or 0 . 1 mg / ml . azopt contains a preservative ( benzalkonium chloride ) which may be absorbed by soft contact lenses and may change the colour of the contact lenses . you should remove contact lenses before using this medicine and put them back 15 minutes afterwards . benzalkonium chloride may also cause eye irritation , especially if you have dry eyes or disorders of the cornea ( the clear layer at the front of the eye ). if you feel abnormal eye sensation , stinging or pain in the eye after using this medicine , talk to your doctor .
do not take forxiga : if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions contact a doctor or the nearest hospital straight away : if you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , a sweet or metallic taste in your mouth , or a different odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - threatening problem you can get with diabetes because of increased levels of " ketone bodies " in your urine or blood , seen in tests . the risk of developing diabetic ketoacidosis may be increased with prolonged fasting , excessive alcohol consumption , dehydration , sudden reductions in insulin dose , or a higher need of insulin due to major surgery or serious illness . when you are treated with forxiga , diabetic ketoacidosis can occur even if your blood sugar is normal . the risk of getting diabetic ketoacidosis is different in the two types diabetes : - in type 2 diabetes it is rare . - in type 1 diabetes the risk is higher - this is because your body hardly produces any insulin , and diabetic ketoacidosis may occur at sudden decreases in insulin dose ( such as missed insulin injections , or issues with your insulin pen or pump ). if you have type 1 diabetes : talk with your doctor about the risk of diabetic ketoacidosis before you start to take forxiga . your doctor will tell you when you may need to measure ketones in your blood or urine and what you need to do when your ketone levels are raised : - at blood ketone readings from 0 . 6 to 1 . 5 mmol / l ( or urine ketones reading +) you may need to take extra insulin , drink water , and if your blood glucose is normal or low , you may need to eat carbohydrates . measure your ketone levels again in 2 hours . seek medical advice immediately and stop taking forxiga if levels persist and symptoms present . - at blood ketone readings over 1 . 5 to 3 . 0 mmol / l ( or urine ketones reading ++) you may be developing diabetic ketoacidosis , seek medical advice immediately and stop taking forxiga . you may need to take extra insulin , drink water , and if your blood glucose is normal or low , you may need to eat carbohydrates . measure your ketone levels again in 2 hours . - at blood ketone readings over 3 . 0 mmol / l ( or urine ketones reading +++) you probably have diabetic ketoacidosis , go to the emergency department without delay and stop taking forxiga . you may need to take extra insulin , drink water , and if your blood glucose is normal or low , you may need to eat carbohydrates . if you suspect you have diabetic ketoacidosis , contact a doctor or the nearest hospital straight away and do not take this medicine . talk to your doctor immediately if you develop a combination of symptoms of pain , tenderness , redness , or swelling of the genitals or the area between the genitals and the anus with fever or feeling generally unwell . these symptoms could be a sign of a rare but serious or even life - threatening infection , called necrotising fasciitis of the perineum or fournier ' s gangrene which destroys the tissue under the skin . fournier ' s gangrene has to be treated immediately . talk to your doctor , pharmacist or nurse before taking forxiga : if you have a kidney problem your doctor may ask you to take a different medicine . if you have a liver problem . if you are on medicines to lower your blood pressure ( anti - hypertensives ) and have a history of low blood pressure ( hypotension ). more information is given below under ' other medicines and forxiga '. if you have very high levels of sugar in your blood which may make you dehydrated ( lose too much body fluid ). possible signs of dehydration are listed at the top of section 4 . tell your doctor before you start taking forxiga if you have any of these signs . if you have or develop nausea ( feeling sick ), vomiting or fever or if you are not able to eat or drink . these conditions can cause dehydration . your doctor may ask you to stop taking forxiga until you recover to prevent dehydration . if you often get infections of the urinary tract . like for all diabetic patients it is important to check your feet regularly and adhere to any other advice regarding foot care given by your health care professional . if any of the above applies to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking forxiga . kidney function your kidneys should be checked before you start taking and whilst you are on this medicine . urine glucose because of how forxiga works , your urine will test positive for sugar while you are on this medicine . children and adolescents forxiga is not recommended for children and adolescents under 18 years of age , because it has not been studied in these patients . other medicines and forxiga tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . especially tell your doctor : if you are taking a medicine used to remove water from the body ( diuretic ). your doctor may ask you to stop taking forxiga . possible signs of losing too much fluid from your body are listed at the top of section 4 . if you have type 2 diabetes and are taking other medicines that lower the amount of sugar in your blood such as insulin or a " sulphonylurea " medicine . your doctor may want to lower the dose of these other medicines , to prevent you from getting low blood sugar levels ( hypoglycaemia ). if you are taking forxiga for type 1 diabetes , it is important that you keep using insulin . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . you should stop taking this medicine if you become pregnant , since it is not recommended during the second and third trimesters of pregnancy . talk to your doctor about the best way to control your blood sugar while you are pregnant . talk to your doctor if you would like to or are breast - feeding before taking this medicine . do not use forxiga if you are breast - feeding . it is not known if this medicine passes into human breast milk . driving and using machines forxiga has no or negligible influence on the ability to drive and use machines . taking this medicine with other medicines called sulphonylureas or with insulin can cause too low blood sugar levels ( hypoglycaemia ), which may cause symptoms such as shaking , sweating and change in vision , and may affect your ability to drive and use machines . do not drive or use any tools or machines , if you feel dizzy taking forxiga . forxiga contains lactose forxiga contains lactose ( milk sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - if you are taking medicines containing ciclosporin or other calcineurin inhibitors or high doses of non - steroidal - anti - inflammatory drugs ( nsaids ) ( see " using other medicines " below ). warnings and precautions talk to your doctor before using mepact : - if you have or have had problems with your heart or blood vessels , like blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). you should be more closely monitored while receiving mepact treatment . if you have long - lasting or worsening symptoms , you should contact your doctor , as mepact treatment may need to be delayed or discontinued . - if you have a history of asthma or other breathing disorders . before using mepact , you should discuss with your doctor whether you should take medicine for your asthma when using mepact . - if you have a history of inflammatory or autoimmune disease or have been treated with corticosteroids or other medicines that may affect your immune system . - if you have any allergic reactions to any medicines such as rash , breathlessness and high blood pressure . if you have worsening symptoms , you should contact your doctor , as these may have been caused by mepact . - if you have stomach problems such as nausea , vomiting and lack of appetite . if your problems increase , you should contact your doctor , as these may have been caused by mepact when used with chemotherapy . - if you develop chills or shivering , or feel warm . you should take your temperature as you may have a fever . a fever with a low white blood cell count ( neutropenia ) may be a sign of serious infection . detailed information on warnings and precautions relating to side effects that could occur while you are taking the medicine is presented in section 4 . children it is not recommended to give this medicine to children below the age of 2 years because information on how safe and how well this medicine works is not available for this age group . other medicines and mepact tell your doctor if you are taking , have recently taken or might take any other medicines . this includes medicines that may be obtained without a prescription . it is especially important to tell your doctor if you are taking medicines containing any of the following active substances : - ciclosporin , tacrolimus , used after a transplant to prevent rejection of transplanted organs , or other immunosuppressants used e . g . to treat psoriasis ( a skin disease ). - non - steroidal - anti - inflammatory drugs ( nsaids ), such as acetylsalicylic acid , ibuprofen , or diclofenac , used for treatment of headaches , fever or pain . you must not use mepact with high doses of nsaids . - corticosteroids , used to treat inflammations , allergies or asthma . regular use of corticosteroids should be avoided when using mepact as this may affect the way the medicine works . it is recommended to separate the times of administration of mepact and doxorubicin or other medicines if used in the same chemotherapy treatment regimen . pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or planning to have a baby , ask your doctor for advice before taking this medicine . mepact has not been tested in pregnant women . therefore , mepact should not be used during pregnancy and in women of childbearing potential not using effective contraception . you should use effective contraception if you are being treated with mepact . it is not known whether mepact passes to human milk . if you are breast - feeding , you should discuss with your doctor . driving and using machines some very common and common side effects of mepact treatment ( such as dizziness , vertigo , fatigue and blurred vision ) may affect your ability to drive and use machines . mepact contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dosage unit , that is to say essentially ' sodium - free '.
do not use mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). - in children below 2 years of age , as they may be at greater risk of side effects from any of the medicine absorbed through the skin . - if you are taking certain medicines used for depression or parkinson ' s disease including so - called monoamine oxidase ( mao ) inhibitors ( for example selegiline or moclobemide ) or tricyclic antidepressants ( such as imipramine ) or tetracyclic antidepressants ( such as maprotiline , mianserin or mirtazapin ). use of mirvaso when taking these medicines may result in a fall in blood pressure . warnings and precautions talk to your doctor or pharmacist , before using mirvaso especially if : - the skin of your face is irritated or has open wounds . - you have problems with your heart or your blood circulation . - you have depression , decreased blood flow to the brain or the heart , fall in blood pressure on standing up , decreased blood flow to the hands , feet or skin , or sjgren ' s syndrome ( a chronic disease in which the body ' s natural defence - the immune system - attacks the moisture - producing glands ). - you have kidney or liver problems or have had them in the past . - you have had , or plan to have any laser procedure on the skin of your face . it is important to start treatment with a small amount of gel , increase the dose gradually but do not exceed the maximum dose of 1 gram ( approximately 5 pea sized amounts ). see also instructions ' how to use mirvaso '. do not apply mirvaso more than once a day and do not exceed the maximum daily dose of 1gram ( approximately 5 pea sized amounts ). see also instructions ' how to use mirvaso '. worsening of skin redness , flushing or burning feeling of the skin up to 1 in 6 patients experience the return of their redness worse than it was initially . such worsening of redness usually develops within the first 2 weeks of treatment with mirvaso . generally , it resolves spontaneously after treatment is stopped . the effect should gradually disappear within a few days in most cases . before you restart the treatment with mirvaso , test it on a small area of the face on a day when you can stay at home . if you do not experience worsening of redness or burning , continue with the usual treatment ( see section 3 ). in case of worsening or unexpected redness , discontinue the treatment and contact your doctor . if any of the above applies to you , talk to your doctor since this medicine may not be suitable for you . children and adolescents do not give this medicine to children and adolescents under the age of 18 years because the safety and efficacy has not been established for this age group . this is particularly important in children under the age of 2 years ( see ' do not use mirvaso '). other medicines and mirvaso tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , because these medicines could affect your treatment with mirvaso or mirvaso could affect your treatment with these medicines . do not take mirvaso with selegiline , moclobemide , imipramine , mianserin , or maprotiline , which are medicines that can be used for depression or parkinson ' s disease , as this could lead to a change in the effectiveness of mirvaso or could increase the chances for side effects such as a fall in blood pressure ( see under ' do not use mirvaso '). also , tell your doctor if you are taking any of the following medicines : - medicines used for the treatment of pain , sleep disorders , or anxiety disorders - medicines used for the treatment of psychiatric disorders ( chlorpromazine ) or used for hyperactivity ( methylphenidate ) or used for high blood pressure ( reserpine ). - medicines which act on the same body mechanism as mirvaso ( other alpha agonists , e . g . clonidine ; so - called alpha blockers or alpha antagonists , e . g . prazosin , isoprenaline which are most often used for treatment of high blood pressure , slow heart rate or asthma ). - cardiac glycosides ( e . g . digoxin ), used to treat heart problems . - blood pressure lowering medicine such as beta - blockers or calcium channel blockers ( e . g . propranolol , amlodipine ). if any of the above applies to you , or if you are unsure , talk to your doctor . mirvaso with alcohol tell your doctor if you consume alcohol regularly as this could affect your treatment with this medicine . pregnancy and breast - feeding the use of mirvaso is not recommended during pregnancy . this is because its effects on your unborn baby are unknown . you should not use this medicine during breast - feeding , as it is unknown whether this medicine passes into the breast milk . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . driving and using machines mirvaso has no significant influence on the ability to drive and use machines . mirvaso contains : - methylparahydroxybenzoate ( e218 ) which may cause allergic reactions ( possibly delayed ). - propylene glycol ( e1520 ) which may cause skin irritation .
in order to improve the traceability of this medicine , your doctor or pharmacist should record the tradename and the lot number of the product you have been given in your patient file . you may also wish to make a note of these details in case you are asked for this information in the future . do not use mvasi if : you are allergic ( hypersensitive ) to bevacizumab or to any of the other ingredients of this medicine ( listed in section 6 ). you are allergic ( hypersensitive ) to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . you are pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using mvasi it is possible that mvasi may increase the risk of developing holes in the gut wall . if you have conditions causing inflammation inside the abdomen ( e . g . diverticulitis , stomach ulcers , colitis associated with chemotherapy ), please discuss this with your doctor . mvasi may increase the risk of developing an abnormal connection or passageway between two organs or vessels . the risk of developing connections between the vagina and any parts of the gut can increase if you have persistent , recurrent or metastatic cervical cancer . mvasi can increase the risk of bleeding or increase the risk of problems with wound healing after surgery . if you are going to have an operation , if you have had major surgery within the last 28 days or if you still have an unhealed wound following surgery , you should not receive this medicine . mvasi may increase the risk of developing serious infections of the skin or deeper layers under the skin , especially if you had holes in the gut wall or problems with wound healing . mvasi can increase the incidence of high blood pressure . if you have high blood pressure which is not well controlled with blood pressure medicines , please consult your doctor as it is important to make sure that your blood pressure is under control before starting mvasi treatment . mvasi increases the risk of having protein in your urine especially if you already have high blood pressure . the risk of developing blood clots in your arteries ( a type of blood vessel ) can increase if you are over 65 years old , if you have diabetes , or if you have had previous blood clots in your arteries . please talk to your doctor since blood clots can lead to heart attack and stroke . mvasi can also increase the risk of developing blood clots in your veins ( a type of blood vessel ). mvasi may cause bleeding , especially tumour - related bleeding . please consult your doctor if you or your family tend to suffer from bleeding problems or you are taking medicines to thin the blood for any reason . it is possible that mvasi may cause bleeding in and around your brain . please discuss this with your doctor if you have metastatic cancer affecting your brain . it is possible that mvasi can increase the risk of bleeding in your lungs , including coughing or spitting blood . please discuss with your doctor if you noticed this previously . mvasi can increase the risk of developing a weak heart . it is important that your doctor knows if you have ever received anthracyclines ( for example doxorubicin , a specific type of chemotherapy used to treat some cancers ) or had radiotherapy to your chest , or if you have heart disease . mvasi may cause infections and a decreased number of your neutrophils ( a type of blood cell important for your protection against bacteria ). it is possible that mvasi can cause hypersensitivity and / or infusion reactions ( reactions related to your injection of the medicine ). please let your doctor , pharmacist or nurse know if you have previously experienced problems after injections , such as dizziness / feeling of fainting , breathlessness , swelling or skin rash . a rare neurological side effect named posterior reversible encephalopathy syndrome ( pres ) has been associated with mvasi treatment . if you have headache , vision changes , confusion or seizure with or without high blood pressure , please contact your doctor . if you have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a blood vessel wall . please consult your doctor , even if these above statements were only applicable to you in the past . before you are given mvasi or while you are being treated with mvasi : if you have or have had pain in the mouth , teeth and / or jaw , swelling or sores inside the mouth , numbness or a feeling of heaviness in the jaw , or loosening of a tooth tell your doctor and dentist immediately . if you need to undergo an invasive dental treatment or dental surgery , tell your dentist that you are being treated with mvasi ( bevacizumab ), in particular when you are also receiving or have received an injection of bisphosphonate into your blood . you may be advised to have a dental check - up before you start treatment with mvasi . children and adolescents mvasi use is not recommended in children and adolescents under the age of 18 years because the safety and benefit have not been established in these patient populations . death of bone tissue ( osteonecrosis ) in bones other than the jaw have been reported in patients under 18 years old when treated with bevacizumab . other medicines and mvasi tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . combinations of mvasi with another medicine called sunitinib malate ( prescribed for renal and gastrointestinal cancer ) may cause severe side effects . discuss with your doctor to make sure that you do not combine these medicine . tell your doctor if you are using platinum - or taxane - based therapies for lung or metastatic breast cancer . these therapies in combination with mvasi may increase the risk of severe side effects . please tell your doctor if you have recently received , or are receiving , radiotherapy . pregnancy , breast - feeding and fertility you must not use this medicine if you are pregnant . mvasi may cause damage to your unborn baby as it may stop the formation of new blood vessels . your doctor should advise you about using contraception during treatment with mvasi and for at least 6 months after the last dose of mvasi . tell your doctor straightaway if you are pregnant , become pregnant during treatment with this medicine , or plan to become pregnant in the near future . you must not breast - feed your baby during treatment with mvasi and for at least 6 months after the last dose of mvasi , as this medicine may interfere with the growth and development of your baby . mvasi may impair female fertility . please consult your doctor for more information . ask your doctor , pharmacist or nurse for advice before taking any medicine . driving and using machines mvasi has not been shown to reduce your ability to drive or to use any tools or machines . however , sleepiness and fainting have been reported with mvasi use . if you experience symptoms that affect your vision or concentration , or your ability to react , do not drive and use machines until symptoms disappear . mvasi contains sodium mvasi 25 mg / ml concentrate for solution for infusion ( 4 ml ) this medicine contains 4 . 7 mg sodium ( main component of cooking / table salt ) in each 4 ml vial . this is equivalent to 0 . 2 % of the recommended maximum daily dietary intake of sodium for an adult . mvasi 25 mg / ml concentrate for solution for infusion ( 16 ml ) this medicine contains 18 . 8 mg sodium ( main component of cooking / table salt ) in each 16 ml vial . this is equivalent to 0 . 9 % of the recommended maximum daily dietary intake of sodium for an adult .
you are not to be given tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you can ' t receive the medicine to reduce the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see also section 3 , how tecartus is given ). warnings and precautions tecartus is made from your own white blood cells and should only be given to you ( autologous use ). tests and checks before you are given tecartus your doctor will : check your lungs , heart , kidney and blood pressure . look for signs of infection or inflammation ; and decide whether you need to be treated before you are given tecartus . check if your cancer is getting worse . look for signs of graft - versus - host disease that can happen after a transplant . this happens when transplanted cells attack your body , causing symptoms such as rash , nausea , vomiting , diarrhoea and bloody stools . check your blood for uric acid and for how many cancer cells there are in your blood . this will show if you are likely to develop a condition called tumour lysis syndrome . you may be given medicines to help prevent the condition . check for hepatitis b , hepatitis c or hiv infection . check if you had a vaccination in the previous 6 weeks or are planning to have one in the next few months . check if you have previously received a treatment that attaches to the protein called cd19 . in some cases , it might not be possible to go ahead with the planned treatment with tecartus . if tecartus infusion is delayed for more than 2 weeks after you have received lymphodepleting chemotherapy you may have to receive more chemotherapy ( see also section 3 , how tecartus is given ). after you have been given tecartus tell your doctor or nurse immediately or get emergency help right away if you have any of the following : chills , extreme tiredness , weakness , dizziness , headache , cough , shortness of breath , rapid or irregular heartbeat , severe nausea , vomiting , or diarrhoea which may be symptoms of a condition known as cytokine release syndrome . take your temperature twice a day for 3 to 4 weeks after treatment with tecartus . if your temperature is high , see your doctor immediately . fits , shaking , or difficulty speaking or slurred speech , loss of consciousness or decreased level of consciousness , confusion and disorientation , loss of balance or coordination . fever ( e . g . temperature above 38 ), which may be a symptom of an infection . extreme tiredness , weakness and shortness of breath , which may be symptoms of a lack of red blood cells . bleeding or bruising more easily , which may be symptoms of low levels of cells in the blood known as platelets . if any of the above apply to you ( or you are not sure ), talk to your doctor or nurse . your doctor will regularly check your blood counts as the number of blood cells and other blood components may decrease . you will be asked to enrol in a registry for at least 15 years in order to better understand the long - term effects of tecartus . do not donate blood , organs , tissues , or cells for transplants . children and adolescents tecartus should not be used in children and adolescents below 18 years of age . other medicines and tecartus tell your doctor or nurse if you are taking , have recently taken or might take any other medicines . before you are given tecartus tell your doctor or nurse if you are taking any medicines that weaken your immune system such as corticosteroids , since these medicines may interfere with the effect of tecartus . in particular , you must not be given certain vaccines called live vaccines : in the 6 weeks before you are given the short course of lymphodepleting chemotherapy to prepare your body for the tecartus cells . during tecartus treatment . after treatment while the immune system is recovering . talk to your doctor if you need to have any vaccinations . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before being given this medicine . this is because the effects of tecartus in pregnant or breast - feeding women are not known , and it may harm your unborn baby or your breast - fed child . if you are pregnant or think you may be pregnant after treatment with tecartus , talk to your doctor immediately . you will be given a pregnancy test before treatment starts . tecartus should only be given if the results show you are not pregnant . discuss pregnancy with your doctor if you have received tecartus . driving and using machines tecartus can cause problems such as altered or decreased consciousness , confusion and seizures ( fits ) in the 8 weeks after it is given . do not drive , use machines , or take part in activities that need you to be alert for at least 8 weeks after your tecartus treatment or until your doctor tells you that you have completely recovered . tecartus contains sodium , dimethylsulfoxide ( dmso ) and gentamicin this medicine contains 300 mg sodium ( main component of cooking / table salt ) in each infusion . this is equivalent to 15 % of the recommended maximum daily dietary intake of sodium for an adult . it also contains dmso and gentamicin which may cause severe hypersensitivity reactions .
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions cases of inflammation of the pancreas ( pancreatitis ) have been reported in patients receiving januvia ( see section 4 ). if you encounter blistering of the skin it may be a sign for a condition called bullous pemphigoid . your doctor may ask you to stop januvia . tell your doctor if you have or have had : - a disease of the pancreas ( such as pancreatitis ) - gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance of getting pancreatitis ( see section 4 ). - type 1 diabetes - diabetic ketoacidosis ( a complication of diabetes with high blood sugar , rapid weight loss , nausea or vomiting ) - any past or present kidney problems - an allergic reaction to januvia ( see section 4 ) this medicine is unlikely to cause low blood sugar because it does not work when your blood sugar is low . however , when this medicine is used in combination with a sulphonylurea medicine or with insulin , low blood sugar ( hypoglycaemia ) can occur . your doctor may reduce the dose of your sulphonylurea or insulin medicine . children and adolescents children and adolescents below 18 years should not use this medicine . it is not effective in children and adolescents between the ages of 10 and 17 years . it is not known if this medicine is safe and effective when used in children younger than 10 years . other medicines and januvia tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . in particular , tell your doctor if you are taking digoxin ( a medicine used to treat irregular heart beat and other heart problems ). the level of digoxin in your blood may need to be checked if taking with januvia . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . you should not take this medicine during pregnancy . it is not known if this medicine passes into breast milk . you should not take this medicine if you are breast - feeding or plan to breast - feed . driving and using machines this medicine has no or negligible influence on the ability to drive and use machines . however , dizziness and drowsiness have been reported , which may affect your ability to drive or use machines . taking this medicine in combination with medicines called sulphonylureas or with insulin can cause hypoglycaemia , which may affect your ability to drive and use machines or work without safe foothold . januvia contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per tablet , that is to say essentially ' sodium - free '.
do not use xultophy if you are allergic to insulin degludec or liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before using xultophy . if you are also taking a sulfonylurea ( such as glimepiride or glibenclamide ), your doctor may tell you to lower your sulfonylurea dose depending on your blood sugar levels . do not use xultophy if you have type 1 diabetes mellitus or if you have ' ketoacidosis ' ( a condition with a build - up of acid in the blood ). the use of xultophy is not recommended in patients with inflammatory bowel disease or delayed gastric emptying ( diabetic gastroparesis ). be especially aware of the following when using xultophy : low blood sugar ( hypoglycaemia ) if your blood sugar is low , follow the advice in section 4 ' low blood sugar ( hypoglycaemia )'. high blood sugar ( hyperglycaemia ) if your blood sugar is high , follow the advice in section 4 ' high blood sugar ( hyperglycaemia )'. ensuring you use the right medicine always check the pen label before each injection to avoid accidentally confusing xultophy with other products . important things to know before you use this medicine : tell your doctor if you : have eye problems . fast improvements in blood sugar control may make diabetic eye problems get worse for a short time . the long - term improvements in blood sugar control may ease the eye problems . have or have had a thyroid disease . important things to know while you are using this medicine : if you have a severe stomach ache which does not go away , tell your doctor this could be a sign of inflamed pancreas ( acute pancreatitis ). dehydration ( loss of fluids from the body ) can happen if you are feeling or being sick ( nausea or vomiting ) or have diarrhoea it is important to drink plenty of fluids to stop dehydration . children and adolescents do not give this medicine to children or adolescents . there is no experience with xultophy in children and adolescents under 18 years old . other medicines and xultophy tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . some medicines affect your blood sugar level this may mean your xultophy dose has to change . listed below are the most common medicines , which may affect your xultophy treatment . your blood sugar level may fall if you take : other medicines for diabetes ( tablets or injections ) sulfonamides for infections anabolic steroids such as testosterone beta - blockers for high blood pressure . they may make it harder to recognise the warning signs of low blood sugar ( see section 4 ' warning signs of low blood sugar these may come on suddenly ') acetylsalicylic acid ( and medicines called ' salicylates ') for pain and mild fever monoamine oxidase ( mao ) inhibitors for depression angiotensin converting enzyme ( ace ) inhibitors for some heart problems or high blood pressure . your blood sugar level may rise if you take : danazol medicine affecting ovulation oral contraceptives birth control pills thyroid hormones for thyroid disease growth hormone for low levels of growth hormone 40 medicines called ' glucocorticoids ' such as cortisone for inflammation medicines called ' sympathomimetics ' such as epinephrine ( adrenaline ), salbutamol or terbutaline for asthma water tablets called ' thiazides ' for high blood pressure or if your body is holding onto too much water ( water retention ). octreotide and lanreotide used for treatment of acromegaly ( a rare illness with too much growth hormone ). they may increase or decrease your blood sugar level . pioglitazone tablets used for the treatment of type 2 diabetes mellitus . some patients with long - standing type 2 diabetes mellitus and heart disease or previous stroke , who were treated with pioglitazone and insulin , experienced the development of heart failure . inform your doctor straight away if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling ( oedema ). warfarin or other blood thinners medicines used to prevent clotting of the blood . tell your doctor if you are taking warfarin or other blood thinners as you might need to have blood tests more often to measure how thick your blood is ( called ' international normalised ratio ' or inr test ). xultophy with alcohol if you drink alcohol , your need for xultophy may change . your blood sugar level may either rise or fall . you should therefore monitor your blood sugar level more often than usual . pregnancy and breast - feeding do not use xultophy if you are pregnant or plan to become pregnant . tell your doctor if you are pregnant , think you might be pregnant or are planning to have a baby . it is not known if xultophy affects the baby . do not use xultophy if you are breast - feeding . it is not known if xultophy passes into breast milk . driving and using machines having low or high blood sugar can affect your ability to drive or use any tools or machines . if your blood sugar is low or high , your ability to concentrate or react might be affected . this could be dangerous to yourself or others . ask your doctor whether you can drive if : you often get low blood sugar you find it hard to recognise low blood sugar . important information about some of the ingredients of xultophy xultophy contains less than 1 mmol sodium ( 23 mg ) per dose . this means that the medicine is essentially ' sodium - free '.
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine : if you are female , have a low body weight of less than 50 kg or have kidney problems . if any of these apply to you , your doctor may monitor you more closely as the side effects may be more pronounced . if you have a history of lung inflammation ( interstitial lung disease ). if you have liver problems . your doctor may do some liver tests . treatment with this medicine is not recommended if you have a severe liver disease . if you have a history of eye problems such as severe dry eyes , inflammation of the transparent layer at the front of the eye ( cornea ) or ulcers involving the outer part of the eye , or if you use contact lenses . if you have a history of heart problems . your doctor may want to monitor you more closely . inform your doctor immediately while taking this medicine : if you develop diarrhoea . treatment at the first signs of diarrhoea is important . if you develop skin rash . early treatment of skin rash is important . if you develop new or sudden worsening of shortness of breath , possibly with a cough or fever . these could be symptoms of an inflammation of the lungs ( interstitial lung disease ) and can be life - threatening . if you have severe pain in your stomach or intestines , fever , chills , sickness , vomiting , or abdominal rigidity or bloating , as these could be symptoms of a tear in the wall of your stomach or intestines (' gastrointestinal perforation '). also , tell your doctor if you had gastrointestinal ulcers or diverticular disease in the past , or are concomitantly treated with anti - inflammatory drugs ( nsaids ) ( used to treat pain relief and swelling ) or steroids ( used for inflammation and allergies ), as this may increase this risk . if you develop acute or worsening redness and pain in the eye , increased eye watering , blurred vision and / or sensitivity to light . you may need urgent treatment . see also section 4 " possible side effects ". children and adolescents giotrif has not been studied in children or adolescents . do not give this medicine to children or adolescents under the age of 18 years . other medicines and giotrif tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including herbal medicines and medicines obtained without a prescription . in particular , if taken before giotrif , the following medicines may increase the blood levels of giotrif and therefore the risk of side effects . they should therefore be taken as far apart in time as possible from giotrif . this means preferably 6 hours ( for medicines taken twice daily ) or 12 hours ( for medicines taken once daily ) apart from giotrif : ritonavir , ketoconazole ( except in shampoo ), itraconazole , erythromycin , nelfinavir , saquinavir - used to treat different kinds of infections . verapamil , quinidine , amiodarone - used to treat heart conditions . cyclosporine a , tacrolimus - medicines that affect your immune system . the following medicines may reduce the effectiveness of giotrif : carbamazepine , phenytoin , phenobarbital - used to treat seizures . st . john ' s wort ( hypericum perforatum ), a herbal medicine to treat depression . rifampicin , an antibiotic used to treat tuberculosis . ask your doctor if you are unsure of when to take these medicines . giotrif may increase the blood levels of other medicines including but not limited to : sulfasalazine , used to treat inflammation / infection . rosuvastatin , used for lowering cholesterol . tell your doctor before taking these medicines together with giotrif . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . pregnancy you should avoid becoming pregnant while taking this medicine . if you could become pregnant , you should use adequate birth control methods during treatment and for at least 1 month after taking the last dose of this medicine . this is because there may be a risk that an unborn baby is harmed . if you become pregnant while receiving this medicine , you should immediately inform your doctor . your doctor will decide with you whether treatment should be continued or not . if you plan to become pregnant after taking the last dose of this medicine , you should ask your doctor for advice as your body may not have fully eliminated this medicine . breast - feeding do not breast - feed while taking this medicine as a risk to the breast - fed child cannot be excluded . driving and using machines if you experience treatment - related symptoms affecting your eye sight ( e . g . redness and / or irritation of the eye , dry eye , tearing , light - sensitivity ) or your ability to concentrate and react , it is recommended that you do not drive or use machines until the side effect disappears ( see section 4 possible side effects ). giotrif contains lactose this medicine contains a sugar called lactose . if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not take orkambi if you are allergic to lumacaftor , ivacaftor , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkambi . orkambi should not be used in patients other than those who have two copies of the f508del mutation in their cftr gene . talk to your doctor before taking orkambi if you have been told you have liver or kidney disease as your doctor may need to adjust the dose of orkambi . abnormal blood tests of the liver have been commonly seen in some people receiving orkambi . tell your doctor straight away if you have any of these symptoms , which may be a sign of liver problems : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite nausea or vomiting dark urine confusion your doctor should do some blood tests to check your liver before and while you are taking orkambi , particularly during the first year . respiratory events such as shortness of breath or chest tightness or narrowing of the airways were seen in patients when starting orkambi , especially in patients who have poor lung function . if you have poor lung function your doctor may monitor you more closely when you start orkambi . an increase in blood pressure has been seen in some patients treated with orkambi . your doctor may monitor your blood pressure during treatment with orkambi . abnormality of the lens of the eye ( cataract ) without any effect on vision has been noted in some children and adolescents treated with orkambi and ivacaftor alone ( one of the components of orkambi ). your doctor may perform some eye examinations prior to and during treatment with orkambi . orkambi is not recommended in patients who have undergone an organ transplant . children under 6 years old orkambi tablets should not be used in children under the age of 6 years . other forms of this medicine ( granules in a sachet ) are more suitable for children under 6 years of age , ask your doctor or pharmacist . other medicines and orkambi tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . especially tell your doctor if you take any of the following medicines : antibiotic medicines ( used for the treatment of bacterial infections ) for example : telithromycin , clarithromycin , rifampicin , rifabutin , rifapentine , erythromycin anticonvulsant medicines ( used for the treatment of fits [ epileptic seizures ]) for example : phenobarbital , carbamazepine , phenytoin benzodiazepines ( used for the treatment of anxiety or sleeplessness [ insomnia ], agitation , etc .) for example : midazolam , triazolam antifungal medicines ( used for the treatment of fungal infections ) for example : fluconazole , ketoconazole , itraconazole , posaconazole , voriconazole 89 immunosuppressants ( used after an organ transplantation ) for example : ciclosporin , everolimus , sirolimus , tacrolimus herbal medicines , for example : st . john ' s wort ( hypericum perforatum ) anti - allergic medicines ( used for the treatment of allergies and / or asthma ) for example : montelukast , fexofenadine antidepressant medicines ( used for the treatment of depression ) for example : citalopram , escitalopram , sertraline , bupropion anti - inflammatory medicines ( used for the treatment of inflammation ) for example : ibuprofen h2 antagonist medicines ( used to reduce stomach acid ) for example : ranitidine cardiac glycosides ( used for the treatment of mild to moderate congestive heart failure and an abnormal heart rhythm called atrial fibrillation ) for example : digoxin anticoagulants ( used to prevent blood clots from forming or growing larger in blood and blood vessels ) for example : warfarin , dabigatran contraceptive medicines ( used for the prevention of pregnancy ): oral , injectable , and implantable contraceptives as well as contraceptive skin patches ; that may include ethinyl estradiol , norethindrone , and other progestogens . these should not be relied upon as an effective method of birth control when given with orkambi corticosteroid medicines ( used to treat inflammation ): methylprednisolone , prednisone proton pump inhibitor medicines ( used to treat acid reflux disease and ulcers ): omeprazole , esomeprazole , lansoprazole oral hypoglycaemics ( used for the management of type 2 diabetes ): repaglinide there have been reports of false positive urine screening tests for tetrahydrocannabinol ( thc - an active component in cannabis ) in patients receiving orkambi . your doctor may request another test to verify results . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant , or are planning to have a baby , ask your doctor for advice before taking this medicine . it may be better to avoid using orkambi during pregnancy , if possible , and your doctor will help you decide what is best for you and your child . it is unknown if lumacaftor or ivacaftor are found in human milk . if you plan to breast - feed , ask your doctor for advice before taking orkambi . your doctor will decide whether to recommend that you stop breast - feeding or for you to stop lumacaftor / ivacaftor therapy . your doctor will take into account the benefit of breast - feeding for the child and the benefit of therapy for you . driving and using machines dizziness has been reported in patients receiving ivacaftor , a component of orkambi , which could influence the ability to drive or use machines . if you experience dizziness , you should not drive or use machines until these symptoms disappear . if a child experiences dizziness while taking orkambi , it is advised that the child does not ride a bike or do anything else that needs their full attention , until their symptoms disappear . orkambi contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dose , that is to say essentially ' sodium - free '.
do not take lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) if you are breast - feeding ( see section 2 below for more information ). do not take lynparza if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before taking lynparza . warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment with lynparza if you have low blood cell counts on testing . these may be low counts for red or white blood cells or low platelet counts . see section 4 for more information about these side effects , 75 including the signs and symptoms you need to look out for ( for example , fever or infection , bruising or bleeding ). rarely , these may be a sign of more serious problems with the bone marrow such as ' myelodysplastic syndrome ' ( mds ) or ' acute myeloid leukaemia ' ( aml ). if you experience any new or worsening symptoms of shortness of breath , coughing , or wheezing . a small number of patients treated with lynparza reported inflammation of the lungs ( pneumonitis ). pneumonitis is a serious condition that can often require hospital treatment . if you think any of these may apply to you , talk to your doctor , pharmacist or nurse before or during treatment with lynparza . tests and checks your doctor will check your blood before and during treatment with lynparza . you will have a blood test before treatment every month for the first year of treatment at regular intervals decided by your doctor after the first year of treatment . if your blood count falls to a low level , you may need to have a blood transfusion ( where you are given new blood or blood - based products from a donor ). other medicines and lynparza tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . this includes medicines obtained without a prescription and herbal medicines . this is because lynparza can affect the way some other medicines work . also , some other medicines can affect the way lynparza works . tell your doctor , pharmacist or nurse if you are taking or are planning to take any of the following medicines any other anticancer medicines a vaccine or a medicine that suppresses the immune system , as you may need to be closely monitored itraconazole , fluconazole - used for fungal infections telithromycin , clarithromycin , erythromycin - used for bacterial infections protease inhibitors boosted with ritonavir or cobicistat , boceprevir , telaprevir , nevirapine , efavirenz - used for viral infections , including hiv rifampicin , rifapentine , rifabutin - used for bacterial infections , including tuberculosis ( tb ) phenytoin , carbamazepine , phenobarbital - used as a sedative or to treat fits ( seizures ) and epilepsy herbal remedies containing st john ' s wort ( hypericum perforatum ) - used mainly for depression digoxin , diltiazem , furosemide , verapamil , valsartan used to treat heart conditions or high blood pressure bosentan used to treat pulmonary artery hypertension statins , for example simvastatin , pravastatin , rosuvastatin used to lower blood cholesterol levels dabigatran used to thin the blood glibenclamide , metformin , repaglinide used to treat diabetes ergot alkaloids used to treat migraines and headaches fentanyl used to treat cancer pain pimozide , quetiapine used to treat mental health problems cisapride used to treat stomach problems colchicine used to treat gout cyclosporine , sirolimus , tacrolimus used to suppress the immune system methotrexate used to treat cancer , rheumatoid arthritis and psoriasis . tell your doctor , pharmacist or nurse if you are taking any of the above or any other medicines . the medicines listed here may not be the only ones that could affect lynparza . lynparza with drink do not drink grapefruit juice while you are being treated with lynparza . it can affect the way the medicine works . contraception , pregnancy and breast - feeding you should not take lynparza if you are pregnant or might become pregnant . this is because it may harm an unborn baby . you should not become pregnant while taking this medicine . if you are having sex , you should use two effective methods of contraception while taking this medicine and for 1 month after taking the last dose of lynparza . it is not known whether lynparza may affect the effectiveness of some hormonal contraceptives . please tell your doctor if you are taking a hormonal contraceptive , as your doctor may recommend the addition of a non - hormonal contraceptive method . you should have a pregnancy test before starting lynparza , at regular times during treatment and 1 month after taking the last dose of lynparza . if you become pregnant during this time , you must talk to your doctor straight away . it is not known whether lynparza passes into breast milk . do not breast - feed if you are taking lynparza and for 1 month after taking the last dose of lynparza . if you are planning to breast - feed , tell your doctor . driving and using machines lynparza may influence your ability to drive and use machines . if you feel dizzy , weak or tired while taking lynparza , do not drive or use tools or machines .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions nyxoid will be supplied to you only after you or your carer have been taught how to use it . it is to be given right away and does not take the place of emergency medical care . emergency services should be called if an opioid overdose is suspected . the signs and symptoms of an opioid overdose can return after this nasal spray is given . if this happens , further doses may be given after 2 to 3 minutes using a new nasal spray . the patient should be monitored closely until emergency help has arrived after being given this medicine . conditions to look out for if you are physically dependent on opioids or if you have received high doses of opioids ( for example heroin , methadone , fentanyl , oxycodone , buprenorphine or morphine ). you may get strong withdrawal symptoms with this medicine ( see later in section 4 of this leaflet under ' conditions to look out for ') if you take opioids to control pain . the pain may increase when you receive nyxoid . if you use buprenorphine . nyxoid may not fully reverse breathing problems . tell your doctor if you have damage to the inside of your nose as this could affect how nyxoid works . children and adolescents nyxoid is not for use in children or adolescents under 14 years . receiving nyxoid close to giving birth tell your midwife or doctor if you have received nyxoid close to or during labour . your baby could suffer from sudden opioid withdrawal syndrome , which could be life - threatening if not treated . watch out for the following symptoms in your baby during the first 24 hours after the baby is born : seizures ( fits ) crying more than usual increased reflexes . other medicines and nyxoid tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregnancy , breastfeeding and fertility if you are pregnant or breastfeeding , think you may be pregnant , or are planning to have a baby , ask your doctor or pharmacist for advice before receiving a supply of this medicine . if you are given nyxoid while you are pregnant or breast - feeding , your baby should be closely monitored . driving and using machines after taking this medicine , you must not drive , operate machinery or engage in any other physically or mentally demanding activity for at least 24 hours , since the effects of opioids may recur .
do not use ovaleap : if you are allergic to follitropin alfa , follicle stimulating hormone ( fsh ) or any of the other ingredients of this medicine ( listed in section 6 ). if you have a tumour in your hypothalamus or pituitary gland ( parts of the brain ). if you are a woman with : - large ovaries or sacs of fluids within the ovaries ( ovarian cysts ) of unknown origin . - unexplained vaginal bleeding . - cancer in your ovaries , womb or breasts . - any condition that usually makes normal pregnancy impossible , such as ovarian failure ( early menopause ), fibroid tumours of the womb or malformed reproductive organs . if you are a man with : - testicular failure that is not treatable . do not use this medicine if any of the above applies to you . if you are not sure , talk to your doctor or pharmacist before using this medicine . warnings and precautions before the treatment is started you and your partner ' s fertility should be evaluated by a doctor experienced in treating fertility disorders . porphyria tell your doctor before you start treatment , if you or any member of your family have porphyria . this is a condition that may be passed on from parents to children which means that you have an inability to break down porphyrins ( organic compounds ). tell your doctor straight away if : your skin becomes fragile and easily blistered , especially skin that has been frequently in the sun , and / or you have stomach , arm or leg pain . if you experience the above symptoms your doctor may recommend that you stop treatment . ovarian hyper - stimulation syndrome ( ohss ) if you are a woman , this medicine increases your risk of developing ohss . this is when your follicles develop too much and become large cysts . talk to your doctor straight away if : you get pain in the lower part of the abdomen ( belly ), you gain any weight rapidly , you feel sick or are vomiting , you have difficulty in breathing . if you experience the above symptoms your doctor might ask you to stop using this medicine ( see also section 4 under " serious side effects in women "). if you are not ovulating and if the recommended dose and timing are followed , the occurrence of ohss is less likely . ovaleap treatment seldom causes severe ohss unless the medicine that is used for final follicular maturation ( containing human chorionic gonadotropin , hcg ) is given . if you are developing ohss your doctor may not give you any hcg in this treatment cycle . you may be told not to have sex or to use a barrier contraceptive method for at least 4 days . multiple pregnancy when using this medicine , you have a higher risk of being pregnant with more than one child ( i . e . " multiple pregnancy ", typically twins ) than if you conceived naturally . multiple pregnancy may lead to medical complications for you and your babies . you can reduce the risk of multiple pregnancy by using the right dose of this medicine at the right times . when undergoing assisted reproductive technology the risk of having a multiple pregnancy is related to your age , the quality and number of fertilised eggs or embryos placed inside you . miscarriage you are more likely to have a miscarriage than the average woman when undergoing assisted reproductive technology or stimulation of your ovaries to produce eggs . ectopic pregnancy you are more likely to have a pregnancy outside the womb ( an ectopic pregnancy ) than the average woman when undergoing assisted reproductive technology and if you have damaged fallopian tubes . birth defects when being conceived by assisted reproductive technology , a baby may have a slightly higher risk of birth defects than after natural conception . this could be related to multiple pregnancies or to parent characteristics such as maternal age and sperm characteristics . blood clotting problems ( thromboembolic events ) if you have ever had blood clots in your leg or lung , or a heart attack or stroke , or if your family have experienced these , inform your doctor . you might have a higher risk of these problems occurring or becoming worse with ovaleap treatment . men with too much fsh in their blood if you are a man , having too much natural fsh in your blood can be a sign of damaged testicles . this medicine usually does not work if you have this problem . if your doctor decides to try ovaleap treatment , they may monitor it by asking you to provide semen for analysis 4 to 6 months after starting treatment . children and adolescents this medicine is not indicated for use in children and adolescents less than 18 years of age . other medicines and ovaleap tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . if you use ovaleap with other medicines which help ovulation such as human chorionic gonadotropin ( hcg ) or clomifene citrate , this may increase the response of your follicles . if you use ovaleap at the same time as a " gonadotropin - releasing hormone " ( gnrh ) agonist or antagonist ( these medicines reduce your sex hormone levels and stop you ovulating ) you may need a higher dose of ovaleap to produce follicles . pregnancy and breast - feeding you should not use this medicine if you are pregnant or breast - feeding . driving and using machines this medicine does not affect your ability to drive and use machines . ovaleap contains sodium , benzalkonium chloride and benzyl alcohol this medicine contains less than 1 mmol sodium ( 23 mg ) per dose , that is to say essentially ' sodium - free '. this medicine also contains 0 . 02 mg per ml of benzalkonium chloride and 10 . 0 mg per ml of benzyl alcohol . ask your doctor or pharmacist for advice if you have a liver or kidney disease , and if you are pregnant or breast - feeding . this is because large amounts of benzyl alcohol can build - up in your body and may cause side effects ( called " metabolic acidosis ").
do not take voriconazole accord if you are allergic to voriconazole or any of the other ingredients of this medicine ( listed in section 6 ). it is very important that you inform your doctor or pharmacist if you are taking or have taken any other medicines , even those that are obtained without a prescription , or herbal medicines . the medicines in the following list must not be taken during your course of voriconazole accord treatment : 46 terfenadine ( used for allergy ) astemizole ( used for allergy ) cisapride ( used for stomach problems ) pimozide ( used for treating mental illness ) quinidine ( used for irregular heart beat ) rifampicin ( used for treating tuberculosis ) efavirenz ( used for treating hiv ) in doses of 400 mg and above once daily carbamazepine ( used to treat seizures ) phenobarbital ( used for severe insomnia and seizures ) ergot alkaloids ( e . g ., ergotamine , dihydroergotamine ; used for migraine ) sirolimus ( used in transplant patients ) ritonavir ( used for treating hiv ) in doses of 400 mg and more twice daily st john ' s wort ( herbal supplement ) warnings and precautions talk to your doctor , pharmacist or nurse before taking voriconazole accord if : you have had an allergic reaction to other azoles . you are suffering from , or have ever suffered from liver disease . if you have liver disease , your doctor may prescribe a lower dose of voriconazole accord . your doctor should also monitor your liver function while you are being treated with voriconazole accord by doing blood tests . you are known to have cardiomyopathy , irregular heart beat , slow heart rate or an abnormality of electrocardiogram ( ecg ) called ' long qtc syndrome '. you should avoid any sunlight and sun exposure while being treated . it is important to cover sun exposed areas of skin and use sunscreen with high sun protection factor ( spf ),, as an increased sensitivity of skin to the sun ' s uv rays can occur . these precautions are also applicable to children . while being treated with voriconazole accord : tell your doctor immediately if you develop o sunburn o severe skin rash or blisters . o bone pain if you develop skin disorders as described above , your doctor may refer you to a dermatologist , who after consultation may decide that it is important for you to be seen on a regular basis . there is a small chance that skin cancer could develop with long - term use of voriconazole accord . your doctor should monitor the function of your liver and kidney by doing blood tests . children and adolescents voriconazole accord should not be given to children younger than 2 years of age . other medicines and voriconazole accord please tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including those that are obtained without a prescription . some medicines , when taken at the same time as voriconazole accord , may affect the way voriconazole accord works or voriconazole accord may affect the way they work . tell your doctor if you are taking the following medicine , as treatment with voriconazole accord at the same time should be avoided if possible : ritonavir ( used for treating hiv ) in doses of 100 mg twice daily 47 tell your doctor if you are taking either of the following medicines , as treatment with voriconazole accord at the same time should be avoided if possible , and a dose adjustment of voriconazole may be required : rifabutin ( used for treating tuberculosis ). if you are already being treated with rifabutin your blood counts and side effects to rifabutin will need to be monitored . phenytoin ( used to treat epilepsy ). if you are already being treated with phenytoin your blood concentration of phenytoin will need to be monitored during your treatment with voriconazole accord and your dose may be adjusted . tell your doctor if you are taking any of the following medicines , as a dose adjustment or monitoring may be required to check that the medicines and / or voriconazole accord are still having the desired effect : warfarin and other anticoagulants ( e . g ., phenprocoumon , acenocoumarol ; used to slow down clotting of the blood ) ciclosporin ( used in transplant patients ) tacrolimus ( used in transplant patients ) sulfonylureas ( e . g ., tolbutamide , glipizide , and glyburide ) ( used for diabetes ) statins ( e . g ., atorvastatin , simvastatin ) ( used for lowering cholesterol ) benzodiazepines ( e . g midazolam , triazolam ) ( used for severe insomnia and stress ) omeprazole ( used for treating ulcers ) oral contraceptives ( if you take voriconazole accord whilst using oral contraceptives , you may get side effects such as nausea and menstrual disorders ) vinca alkaloids ( e . g ., vincristine and vinblastine ) ( used in treating cancer ) indinavir and other hiv protease inhibitors ( used for treating hiv ) non - nucleoside reverse transcriptase inhibitors ( e . g ., efavirenz , delavirdine , nevirapine ) ( used for treating hiv ) ( some doses of efavirenz can not be taken at the same time as voriconazole accord ) methadone ( used to treat heroin addiction ) alfentanil and fentanyl and other short - acting opiates such as sufentanil ( painkillers used for surgical procedures ) oxycodone and other long acting opiates such as hydrocodone ( used for moderate to severe pain ) non - steroidal anti - inflammatory drugs ( e . g ., ibuprofen , diclofenac ) ( used for treating pain and inflammation ) fluconazole ( used for fungal infections ) everolimus ( used for treating advanced kidney cancer and in transplant patients ) pregnancy and breast - feeding voriconazole accord must not be taken during pregnancy , unless indicated by your doctor . effective contraception must be used in women of childbearing potential . contact your doctor immediately if you become pregnant while taking voriconazole accord . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . driving and using machines voriconazole accord may cause blurring of vision or uncomfortable sensitivity to light . while affected , do not drive or operate any tools or machines . contact your doctor if you experience this . voriconazole accord contains lactose if you have been told by your doctor that you have an intolerance to some sugars , tell your doctor before taking voriconazole accord .
to make sure that the vaccination course is suitable for you or your child , it is important to tell your doctor , pharmacist or nurse if any of the points below apply to you or your child . if there is anything you do not understand , ask your doctor , pharmacist or nurse to explain . do not have the vaccine if you or your child have ever had a severe allergic reaction to any of the active substances or any of the other ingredients listed in section 6 . you or your child have ever had a severe allergic reaction to chicken or eggs or an antibiotic known as ' gentamicin '. if you are not sure , talk to your doctor , pharmacist or nurse before you are given the vaccine . warnings and precautions talk to your doctor , pharmacist or nurse before you are given mvabea if you or your child : have ever had a severe allergic reaction after any other vaccine injection , have ever fainted , after having an injection , have a problem with bleeding or you bruise easily , currently have a fever or an infection , are taking medicines that weaken the immune system , such as high - dose corticosteroids ( such as prednisone ) or chemotherapy ( cancer medicines ), have a weak immune system for example , due to hiv infection or an illness that runs in the family (' genetic disorder '). if any of the above apply to you or your child ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given mvabea . if you are at high risk of being in contact with the ebola virus , a booster vaccination with zabdeno may be recommended for you or your child . talk to your doctor , pharmacist or nurse if this applies to you or your child . if you or your child only have one of the vaccines , zabdeno or mvabea , it may give less protection from ebola virus disease than having a course of both vaccines . as with all vaccines , the zabdeno and mvabea 2 - dose course of vaccination may not fully protect everyone from ebola virus disease and it is not known how long you will be protected . people who have been given the 2 - dose course of vaccination should still take precautions to avoid coming into contact with ebola virus . washing your hands correctly is the most effective way to prevent the spread of dangerous germs , like ebola virus . it reduces the number of germs on the hands and so reduces their spread from person to person . proper hand washing methods are described below . use soap and water when hands are soiled with dirt , blood , or other body fluids . there is no need to use antimicrobial soaps for washing hands . use alcohol - based hand sanitiser when hands are not dirty . do not use alcohol - based hand sanitiser when hands are soiled with dirt , blood , or other body fluids . while in an area affected by ebola , it is important to avoid the following : contact with blood and body fluids ( such as urine , faeces , saliva , sweat , vomit , breast milk , semen , and vaginal fluids ). items that may have come in contact with an infected person ' s blood or body fluids ( such as clothes , bedding , needles , and medical equipment ). funeral or burial rituals that require handling the body of someone who died from ebola . contact with bats , apes and monkeys or with blood , fluids and raw meat prepared from these animals ( bushmeat ) or meat from an unknown source . contact with semen from a man who had ebola . you should follow safe sex practices until the virus is gone from the semen . talk to your doctor , pharmacist or nurse for advice about how long to maintain safe sex practices . children younger than 1 year of age mvabea must not be used in children younger than 1 year of age . other medicines and mvabea tell your doctor or pharmacist if you or your child are taking , have recently taken or might take , any other medicines or vaccines . pregnancy and breast - feeding ask your doctor or pharmacist for advice before having this vaccine if you or your child is pregnant or breast - feeding . also do this if you think you or your child may be pregnant or are planning to have a baby . driving and using machines mvabea has no known effect on the ability to drive and use machines . mvabea contains sodium mvabea contains less than 1mmol sodium ( 23 mg ) per dose of 0 . 5 ml , that is to say essentially ' sodium - free '.
do not receive bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine that are listed in section 6 if you have , or have ever had low levels of calcium in your blood do not receive this medicine if any of the above apply to you . if you are not sure , talk to your doctor or pharmacist before having bondronat . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronat for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonecrosis of the jaw , there are some precautions you should take . before receiving treatment , tell your doctor / nurse ( health care professional ) if : you have any problems with your mouth or teeth such as poor dental health , gum disease , or a planned tooth extraction you don ' t receive routine dental care or have not had a dental check up for a long time you are a smoker ( as this may increase the risk of dental problems ) you have previously been treated with a bisphosphonate ( used to treat or prevent bone disorders ) you are taking medicines called corticosteroids ( such as prednisolone or dexamethasone ) you have cancer . your doctor may ask you to undergo a dental examination before starting treatment with bondronat . while being treated , you should maintain good oral hygiene ( including regular teeth brushing ) and receive routine dental check - ups . if you wear dentures you should make sure these fit properly . if you are under dental treatment or will undergo dental surgery ( e . g . tooth extractions ), inform your doctor about your dental treatment and tell your dentist that you are being treated with bondronat . contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth , pain or swelling , non - healing of sores or discharge , as these could be signs of osteonecrosis of the jaw . talk to your doctor , pharmacist or nurse before receiving bondronat : if you are allergic to any other bisphosphonates if you have high or low levels of vitamin d , calcium or any other minerals if you have kidney problems if you have heart problems and the doctor recommended to limit your daily fluid intake cases of serious , sometimes fatal allergic reaction have been reported in patients treated with intravenous ibandronic acid . if you experience one of the following symptoms , such as shortness of breath / difficulty breathing , tight feeling in throat , swelling of tongue , dizziness , feeling of loss of consciousness , redness or swelling of face , body rash , nausea and vomiting , you should immediately alert your doctor or nurse ( see section 4 ). children and adolescents bondronat should not be used in children and adolescents below the age of 18 years . other medicines and bondronat tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is because bondronat can affect the way some other medicines work . also , some other medicines can affect the way bondronat works . in particular , tell your doctor or pharmacist if you are receiving a type of antibiotic injection called ' aminoglycoside ' such as gentamicin . this is because aminoglycosides and bondronat can both lower the amount of calcium in your blood . pregnancy and breast - feeding do not receive bondronat if you are pregnant , planning to get pregnant or if you are breast - feeding . ask your doctor or pharmacist for advice before taking this medicine . driving and using machines you can drive and use machines as it ' s expected that bondronat has no or negligible effect on your ability to drive and use machines . talk to your doctor first if you want to drive , use machines or tools . bondronat contains less than 1 mmol sodium ( 23 mg ) per vial , i . e . ' essentially sodium free '.
do not take zeposia : if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your healthcare professional has told you that you have a severely weakened immune system if you have had a heart attack , angina , stroke or mini - stroke ( transient ischemic attack - tia ), or certain types of severe heart failure in the last 6 months if you have certain types of irregular or abnormal heartbeats ( arrhythmia ) your doctor will check your heart before starting treatment if you have severe infection such as hepatitis or tuberculosis if you have cancer if you have severe liver problems if you are pregnant or a women of childbearing potential not using effective contraception . warnings and precautions talk to your doctor or pharmacist before taking zeposia if : you have a slow heart rate or you are taking or have recently taken medicines that slow your heart rate ( such as beta blockers or calcium channel blockers ); you have untreated severe breathing problems when you sleep ( severe sleep apnoea ); you have problems with your liver ; you have an infection ; you have low levels of a type of white blood cell - called lymphocytes ; you have never had , or are not sure if you have had chickenpox ; you have recently had or are planning to have a vaccination ; you or others notice worsening of your ms symptoms as well as any new or unfamiliar symptoms . these may be due to a rare infection of the brain called progressive multifocal leukoencephalopathy ( pml ); you have ever had problems with your vision or other symptoms of build - up of fluid in the central area of the retina called the macula ( a condition called macular oedema ); you have inflammation of the eye ( uveitis ); you have diabetes ( which can cause problems with your eyes ); you have severe lung disease ( pulmonary fibrosis or chronic obstructive pulmonary disease ); before you start taking zeposia , your doctor will check your heart using an electrocardiogram ( ecg ). if you have certain heart conditions your doctor will monitor you for at least the first 6 hours after your first dose . as zeposia can increase your blood pressure , your doctor may want to check your blood pressure regularly . while you are taking zeposia ( and for up to 3 months after you stop taking it ), you may get infections more easily . any infection that you already have may get worse . talk to your doctor if you develop an infection . as zeposia may increase the risk of skin cancer , you should limit your exposure to sun light and uv ( ultraviolet ) light , by wearing protective clothing and applying regular sunscreen ( with high sun protection factor ). during treatment with zeposia , if you develop a severe headache , feel confused , or have seizures ( fits ) and loss of vision , speak to your doctor straight away . these symptoms may be due to a syndrome called posterior reversible encephalopathy syndrome ( pres ). women of childbearing potential if used during pregnancy , zeposia can harm the unborn baby . before you start treatment with zeposia , your doctor will explain the risk to you and ask you to do a pregnancy test in order to ensure that you are not pregnant . your doctor will give you a card which explains why you should not become pregnant while taking zeposia . it also explains what you should do to avoid becoming pregnant while you are taking zeposia . you must use effective contraception during treatment and for 3 months after stopping treatment ( see section " pregnancy and breastfeeding "). if any of these apply to you , tell your doctor or pharmacist before taking zeposia . worsening of ms after stopping zeposia treatment tell your doctor straight away if you think your ms worsens after you have stopped treatment with zeposia ( see " if you stop taking zeposia " in section 3 ). children and adolescents do not give this medicine to children and adolescents aged under 18 years . this is because zeposia has not been studied in children and adolescents . other medicines and zeposia tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is because zeposia can affect the way some other medicines work . also some other medicines can affect the way zeposia works . in particular , before taking zeposia , tell your doctor or pharmacist if you are taking or have recently taken any of the following medicines : medicines which suppress or modulate your immune system ( e . g . ciclosporin and eltrombopag ) including other medicines used to treat ms , such as alemtuzumab , beta interferon , dimethyl fumarate , glatiramer acetate , mitoxantrone , natalizumab or teriflunomide gemfibrozil to reduce levels of fats or cholesterol in the blood clopidogrel , medicine used to prevent blood clots rifampicin , an antibiotic for treating tuberculosis and other serious infections medicines called monoamine oxidase inhibitors for treating depression ( e . g . phenelzine ) or parkinson ' s disease ( e . g . selegiline ) medicines that slow your heart rate ( such as beta blockers or calcium channel blockers ) certain type of vaccines . live attenuated vaccines should be avoided during and for 3 months after treatment . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . pregnancy do not use zeposia during pregnancy , if you are trying to become pregnant or if you are a woman who could become pregnant and you are not using effective contraception . if zeposia is used during pregnancy , there is a risk of harm to the unborn baby . if you are a woman who could become pregnant , your doctor will inform you about this risk before you start treatment with zeposia and will ask you to do a pregnancy test in order to ensure that you are not pregnant . you must use effective contraception while taking zeposia and for at least 3 months after you stop taking it . ask your doctor about reliable methods of contraception . your doctor will give you a card which explains why you should not become pregnant while taking 39 zeposia . if you do become pregnant while taking zeposia , tell your doctor straight away . your doctor will decide to stop treatment ( see " if you stop taking zeposia " in section 3 ). specialised pre - natal monitoring will be performed . breast - feeding you should not breast - feed while you are taking zeposia . zeposia can pass into breast milk and there is a risk of serious side effects for the baby . driving and using machines zeposia has no or negligible influence on your ability to drive and use machines .
don ' t use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using temybric ellipta - if you have asthma ( don ' t use temybric ellipta to treat asthma ) - if you have heart problems or high blood pressure - if you have liver problems - if you have tuberculosis ( tb ) of the lung , or any long standing or untreated infections - if you have an eye problem called narrow - angle glaucoma - if you have an enlarged prostate , difficulty passing urine or a blocking in your bladder - if you suffer from epilepsy - if you have thyroid gland problems - if you have low potassium in your blood - if you have a history of diabetes - if you experience blurred vision or other visual disturbances check with your doctor if you think any of these may apply to you . immediate breathing difficulties if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using your temybric ellipta inhaler : stop using this medicine and seek medical help immediately , as you may have a serious condition called paradoxical bronchospasm . eye problems during treatment with temybric ellipta if you get eye pain or discomfort , temporary blurring of vision , visual halos or coloured images as well as red eyes during treatment with temybric ellipta : stop using this medicine and seek medical help immediately , these may be signs of an acute attack of narrow - angle glaucoma . infection of the lung because you are using this medicine for copd , you may be at an increased risk of developing an infection of the lungs known as pneumonia . see section 4 ' possible side effects ' for information on symptoms to look out for while you are using this medicine . tell your doctor as soon as possible if you develop any of these symptoms . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and temybric ellipta tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . some medicines may affect how this medicine works , or make it more likely that you ' ll have side effects . these include : - medicines called beta blockers ( such as propranolol ), to treat high blood pressure or other heart problems - ketoconazole or itraconazole , to treat fungal infections - clarithromycin or telithromycin , to treat bacterial infections - ritonavir or cobicistat , to treat hiv infection - medicines that lower the amount of potassium in your blood , such as some diuretics ( water tablets ) 35 - other long - acting medicines similar to this medicine that are used to treat breathing problems , e . g . tiotropium , indacaterol . don ' t use temybric ellipta if you already use these medicines . tell your doctor or pharmacist if you are taking any of these . your doctor may wish to monitor you carefully if you are taking any of these medicines as they may increase the side effects of temybric ellipta . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . don ' t use this medicine if you are pregnant unless your doctor tells you that you can . it is not known whether the ingredients of this medicine can pass into breast milk . if you are breast - feeding , you must check with your doctor before you use temybric ellipta . don ' t use this medicine if you are breast - feeding unless your doctor tells you that you can . driving and using machines it is unlikely that this medicine will affect your ability to drive or use machines . temybric ellipta contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before using this medicine .
do not use zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you are allergic to other cephalosporin antibiotics if you have had previous severe allergic reactions to other antibiotics like penicillin or carbapenem . do not use zinforo if any of the above applies to you . if you are not sure , talk to your doctor or nurse before using zinforo . warnings and precautions talk to your doctor or nurse before using zinforo : if you have kidney problems ( your doctor may have to prescribe a lower dose ) if you have ever had fits ( seizures or convulsions ) if you have ever had any non - severe allergic reactions to other antibiotics like penicillin or carbapenem 26 if you have had severe diarrhoea whilst taking antibiotics in the past you may get another infection caused by another bacteria during or following treatment with zinforo . you may develop signs and symptoms of severe skin reactions such as fever , joint pain , skin rash , red scaly rash , skin bumps that contain pus , blisters or peeling of skin , red circular patches often with central blisters on the trunk , ulcers of mouth , throat , nose , genitals and eyes . if this happens talk to your doctor or nurse immediately . lab test you may develop an abnormal lab test ( called coombs test ) that looks for certain antibodies which may act against your red blood cells . if the level of your red blood cells fall your doctor may check to see if these antibodies have caused this . if any of the above apply to you ( or you are not sure ), talk to your doctor or nurse before using zinforo . other medicines and zinforo tell your doctor or nurse if you are using , have recently used or might use any other medicines . pregnancy and breast - feeding tell your doctor before using zinforo if you are pregnant . do not use this medicine during pregnancy unless your doctor has told you to . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . driving and using machines zinforo may cause side effects such as dizziness . this may impair your ability to drive or operate machinery .
do not take pregabalin pfizer : if you are allergic to pregabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabalin pfizer . some patients taking pregabalin pfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabalin pfizer has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , you should be careful until you are used to any effect the medicine might have . pregabalin pfizer may cause blurring or loss of vision , or other changes in eyesight , many of which are temporary . you should immediately tell your doctor if you experience any changes in your vision . some patients with diabetes who gain weight while taking pregabalin may need an alteration in their diabetic medicines . certain side effects may be more common , such as sleepiness , because patients with spinal cord injury may be taking other medicines to treat , for example , pain or spasticity , that have similar side effects to pregabalin and the severity of these effects may be increased when taken together . there have been reports of heart failure in some patients when taking pregabalin pfizer ; these patients were mostly elderly with cardiovascular conditions . before taking this medicine you should tell your doctor if you have a history of heart disease . there have been reports of kidney failure in some patients when taking pregabalin pfizer . if while taking pregabalin pfizer you notice decreased urination , you should tell your doctor as stopping the medicine may improve this . a small number of people being treated with anti - epileptics such as pregabalin pfizer have had thoughts of harming or killing themselves . if at any time you have these thoughts , immediately contact your doctor . when pregabalin pfizer is taken with other medicines that may cause constipation ( such as some types of pain medicines ) it is possible that gastrointestinal problems may occur ( e . g . constipation , blocked or paralysed bowel ). tell your doctor if you experience constipation , especially if you are prone to this problem . before taking this medicine you should tell your doctor if you have a history of alcoholism or any drug abuse or dependence . do not take more medicine than prescribed . there have been reports of convulsions when taking pregabalin pfizer or shortly after stopping pregabalin pfizer . if you experience a convulsion , contact your doctor immediately . there have been reports of reduction in brain function ( encephalopathy ) in some patients taking pregabalin pfizer when they have other conditions . tell your doctor if you have a history of any serious medical conditions , including liver or kidney disease . children and adolescents the safety and efficacy in children and adolescents ( under 18 years of age ) has not been established and therefore , pregabalin should not be used in this age group . other medicines and pregabalin pfizer tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregabalin pfizer and certain other medicines may influence each other ( interaction ). when taken with certain other medicines which have sedative effects ( including opioids ), pregabalin pfizer may potentiate these effects , and could lead to respiratory failure , coma and death . the degree of dizziness , sleepiness and decreased concentration may be increased if pregabalin pfizer is taken together with medicines containing : oxycodone ( used as a pain - killer ) lorazepam ( used for treating anxiety ) alcohol pregabalin pfizer may be taken with oral contraceptives . pregabalin pfizer with food , drink and alcohol pregabalin pfizer capsules may be taken with or without food . it is advised not to drink alcohol while taking pregabalin pfizer . pregnancy and breast - feeding pregabalin pfizer should not be taken during pregnancy or when breast - feeding , unless you are told otherwise by your doctor . effective contraception must be used by women of child - bearing potential . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . driving and using machines pregabalin pfizer may produce dizziness , sleepiness and decreased concentration . you should not drive , operate complex machinery or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities . pregabalin pfizer contains lactose monohydrate if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if you are taking any of the following medicines : - monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline , moclobemide , phenelzine , isocarboxazid , tranylcypromine ( e . g . for treatment of parkinson ' s disease or depression , or used for any other condition ). - pethidine ( a strong pain killer ). you must wait at least 7 days after stopping xadago treatment before starting treatment with mao inhibitors or pethidine . - if you have been told that you have severe liver problems - if you have an eye condition which might put you at risk of potential damage to your retina ( the light sensitive layers at the back of your eyes ), e . g . albinism ( lack of pigment in your skin and eyes ), retinal degeneration ( loss of cells from light sensitive layer at the back of the eye ), or uveitis ( inflammation inside of the eye ), inherited retinopathy ( inherited disorders of the vision ), or severe progressive diabetic retinopathy ( a progressive decrease of the vision due to diabetes ). warnings and precautions talk to your doctor before taking xadago - if you have liver problems - patients and carers should be made aware that certain compulsive behaviours such as compulsions , obsessive thoughts , pathological gambling , increased libido , hypersexuality , impulsive behaviour and compulsive spending or buying have been reported with other medicines for parkinson ' s disease . - uncontrollable jerky movements may occur or worsen when xadago is used together with levodopa . children and adolescents xadago is not recommended for use in children and adolescents , below 18 years old due to the lack of data on safety and efficacy in this population . other medicines and xadago tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines . ask your doctor for advice before taking any of the following medicines together with xadago : - cold or cough remedies containing dextromethorphan , ephedrine or pseudoephedrine - medicines called selective serotonin reuptake inhibitors ( ssris ) typically used to treat anxiety disorders , and some personality disorders ( e . g . fluoxetine or fluvoxamine ) - medicines called serotoninnorepinephrine reuptake inhibitors ( snris ), used in the treatment of major depression and other mood disorders , such as venlafaxine - medicines for high cholesterol such as rosuvastatin , pitavastatin , pravastatin - fluoroquinolone antibiotic such as ciprofloxacin - medicines that affect the immune system such as methotrexate - medicines to treat metastatic carcinoma such as topotecan - medicine to treat pain and inflammation such as diclofenac - medicines to treat type 2 diabetes such as glyburide , metformin - medicines to treat virus infection such as aciclovir , ganciclovir pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . pregnancy xadago should not be used during pregnancy or by women of childbearing potential not practicing adequate contraception . breast feeding xadago is likely to be excreted in breast milk . xadago should not be used during breast - feeding . driving and using machines somnolence and dizziness may occur during safinamide treatment ; you should be cautious about operating hazardous machines or driving , until you are reasonably certain that xadago does not affect you in any way . ask your doctor for advice prior to driving or using machines .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if you are a woman , especially if pregnant . zytiga is for use in male patients only . - if you have severe liver damage . - in combination with ra - 223 ( which is used to treat prostate cancer ). do not take this medicine if any of the above apply to you . if you are not sure , talk to your doctor or pharmacist before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if you have liver problems - if you have been told you have high blood pressure or heart failure or low blood potassium ( low blood potassium may increase the risk of heart rhythm problems ) - if you have had other heart or blood vessel problems - if you have an irregular or rapid heart rate - if you have shortness of breath 65 - if you have gained weight rapidly - if you have swelling in the feet , ankles , or legs - if you have taken a medicine known as ketoconazole in the past for prostate cancer - about the need to take this medicine with prednisone or prednisolone - about possible effects on your bones - if you have high blood sugar . tell your doctor if you have been told you have any heart or blood vessel conditions , including heart rhythm problems ( arrhythmia ), or are being treated with medicines for these conditions . tell your doctor if you have yellowing of the skin or eyes , darkening of the urine , or severe nausea or vomiting , as these could be signs or symptoms of liver problems . rarely , failure of the liver to function ( called acute liver failure ) may occur , which can lead to death . decrease in red blood cells , reduced sex drive ( libido ), muscle weakness and / or muscle pain may occur . zytiga must not be given in combination with ra - 223 due to a possible increase in the risk of bone fracture or death . if you plan to take ra - 223 following treatment with zytiga and prednisone / prednisolone , you must wait 5 days before starting treatment with ra - 223 . if you are not sure if any of the above apply to you , talk to your doctor or pharmacist before taking this medicine . blood monitoring zytiga may affect your liver , and you may not have any symptoms . when you are taking this medicine , your doctor will check your blood periodically to look for any effects on your liver . children and adolescents this medicine is not for use in children and adolescents . if zytiga is accidentally ingested by a child or adolescent , go to the hospital immediately and take the package leaflet with you to show to the emergency doctor . other medicines and zytiga ask your doctor or pharmacist for advice before taking any medicine . tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is important because zytiga may increase the effects of a number of medicines including heart medicines , tranquilisers , some medicines for diabetes , herbal medicines ( e . g ., st john ' s wort ) and others . your doctor may want to change the dose of these medicines . also , some medicines may increase or decrease the effects of zytiga . this may lead to side effects or to zytiga not working as well as it should . androgen deprivation treatment may increase the risk of heart rhythm problems . tell your doctor if you are receiving medicine - used to treat heart rhythm problems ( e . g . quinidine , procainamide , amiodarone and sotalol ); - known to increase the risk of heart rhythm problems [ e . g . methadone ( used for pain relief and part of drug addiction detoxification ), moxifloxacin ( an antibiotic ), antipsychotics ( used for serious mental illnesses )]. tell your doctor if you are taking any of the medicines listed above . zytiga with food - this medicine must not be taken with food ( see section 3 , " taking this medicine "). - taking zytiga with food may cause side effects . pregnancy and breast - feeding zytiga is not for use in women . - this medicine may cause harm to the unborn child if it is taken by women who are pregnant . - women who are pregnant or who may be pregnant should wear gloves if they need to touch or handle zytiga . - if you are having sex with a woman who can become pregnant , use a condom and another effective birth control method . - if you are having sex with a pregnant woman , use a condom to protect the unborn child . driving and using machines this medicine is not likely to affect your being able to drive and use any tools or machines . zytiga contains lactose and sodium - zytiga contains lactose ( a type of sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine . - this medicine also contains approximately 27 mg of sodium in a four tablet daily dose . to be taken into consideration by patients on a controlled sodium diet .
do not use hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if your child shows symptoms of infections , e . g . fever , wounds , feeling tired , dental problems ( see " warnings and precautions "). if your child has moderate or severe heart failure . it is important to tell your doctor if your child has had or has a serious heart condition ( see " warnings and precautions "). warnings and precautions talk to your doctor or pharmacist before using hefiya . allergic reaction if your child has allergic reactions with symptoms such as chest tightness , wheezing , dizziness , swelling or rash , do not inject more hefiya and contact your doctor immediately , since in rare cases , these reactions can be life - threatening . infection if your child has an infection , including long - term or localised infection ( for example leg ulcer ), consult your doctor before starting hefiya . if you are unsure , contact your doctor . your child might get infections more easily while he / she is receiving hefiya treatment . this risk may increase if your child ' s lung function is reduced . these infections may be more serious and include tuberculosis , infections caused by viruses , fungi , parasites or bacteria , or other unusual infectious organisms and sepsis ( blood poisoning ). in rare cases , these infections may be life - threatening . it is important to tell your doctor if your child shows symptoms such as fever , wounds , feeling tired or dental problems . your doctor may recommend temporarily stopping hefiya . tuberculosis ( tb ) as cases of tuberculosis have been reported in patients treated with adalimumab , your doctor will check your child for signs and symptoms of tuberculosis before starting hefiya . this will include a thorough medical evaluation including your child ' s medical history and screening tests ( for example chest x - ray and a tuberculin test ). the conduct and results of these tests should be recorded on your child ' s patient reminder card . it is very important that you tell your doctor if your child has ever had tuberculosis , or if he / she has been in close contact with someone who has had tuberculosis . tuberculosis can develop during therapy even if your child has had preventative treatment for tuberculosis . if symptoms of tuberculosis ( persistent cough , weight loss , listlessness , mild fever ), or any other infection appear during or after therapy tell your doctor immediately . travel / recurrent infection tell your doctor if your child has lived or travelled in regions where fungal infections such as histoplasmosis , coccidioidomycosis or blastomycosis are common . tell your doctor if your child has a history of recurrent infections or other conditions that increase the risk of infections . hepatitis b virus tell your doctor if your child is a carrier of the hepatitis b virus ( hbv ), if he / she has active hbv infection or if you think he / she might be at risk of contracting hbv . your doctor should test your child for hbv . adalimumab can reactivate hbv infection in people who carry this virus . in some rare cases , especially if your child is taking other medicines that suppress the immune system , reactivation of hbv infection can be life - threatening . surgery or dental procedures if your child is about to have surgery or dental procedures tell your doctor that your child is taking hefiya . your doctor may recommend temporarily stopping hefiya . demyelinating disease 84 if your child has or develops demyelinating disease ( a disease that affects the insulating layer around the nerves , such as multiple sclerosis ), your doctor will decide if he / she should receive or continue to receive hefiya . tell your doctor immediately if he / she experiences symptoms like changes in vision , weakness in arms or legs or numbness or tingling in any part of the body . vaccine certain vaccines contain living but weakened forms of disease - causing bacteria or viruses and should not be given during treatment with hefiya in case they cause infections . check with your doctor before your child receives any vaccines . it is recommended that , if possible , children be given all the scheduled vaccinations for their age before they start treatment with hefiya . if your child receives hefiya while she is pregnant , her baby may be at higher risk for getting an infection for up to about five months after the last dose she received during pregnancy . it is important that you tell her baby ' s doctors and other health care professionals about your child ' s hefiya use during herpregnancy so they can decide when her baby should receive any vaccine . heart failure it is important to tell your doctor if your child has had or has a serious heart condition . if he / she has mild heart failure and is being treated with hefiya , the heart failure status must be closely monitored by your doctor . if your child develops new or worsening symptoms of heart failure ( e . g . shortness of breath , or swelling of your feet ), you must contact your doctor immediately . fever , bruising , bleeding or looking pale in some patients the body may fail to produce enough of the blood cells that fight off infections or help stop bleeding . if your child develops a fever that does not go away , or he / she bruises or bleeds very easily or looks very pale , call your doctor right away . your doctor may decide to stop treatment . cancer there have been very rare cases of certain kinds of cancer in children and adults taking adalimumab or other tnf blockers . people with more serious rheumatoid arthritis who have had the disease for a long time may have a higher than average risk of getting lymphoma and leukaemia ( cancers that affect blood cells and bone marrow ). if your child takes hefiya , the risk of getting lymphoma , leukaemia , or other cancers may increase . on rare occasions , a specific and severe type of lymphoma has been observed in patients taking adalimumab . some of those patients were also treated with the medicines azathioprine or mercaptopurine . tell your doctor if your child is taking azathioprine or mercaptopurine with hefiya . in addition cases of non - melanoma skin cancer have been observed in patients taking adalimumab . if new areas of damaged skin appear during or after treatment or if existing marks or areas of damage change appearance , tell your doctor . there have been cases of cancers , other than lymphoma , in patients with a specific type of lung disease called chronic obstructive pulmonary disease ( copd ) treated with another tnf blocker . if your child has copd , or is a heavy smoker , you should discuss with your doctor whether treatment with a tnf blocker is appropriate . autoimmune diseases on rare occasions , treatment with hefiya could result in lupus - like syndrome . contact your doctor , if symptoms such as persistent unexplained rash , fever , joint pain or tiredness occur . children and adolescents do not give hefiya to children with polyarticular juvenile idiopathic arthritis below the age of 2 years . do not give hefiya to children with paediatric plaque psoriasis or paediatric ulcerative colitis below the age of 4 years . do not give hefiya to children with paediatric crohn ' s disease below the age of 6 years . do not use the 40 mg pre - filled syringe if doses other than 40 mg are recommended . other medicines and hefiya tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . hefiya can be taken together with methotrexate or certain disease - modifying anti - rheumatic agents ( sulfasalazine , hydroxychloroquine , leflunomide and injectable gold preparations ), corticosteroids or pain medications including non - steroidal anti - inflammatory drugs ( nsaids ). your child should not take hefiya with medicines containing the active substances anakinra or abatacept due to increased risk of serious infection . the combination of adalimumab as well as other tnf - antagonists and anakinra or abatacept is not recommended based upon the possible increased risk for infections , including serious infections and other potential pharmacological interactions . if you have questions , please ask your doctor . pregnancy and breast - feeding your child should consider the use of adequate contraception to prevent pregnancy and continue its use for at least 5 months after the last hefiya treatment . if your child is pregnant , thinks she may be pregnant or is planning to have a baby , ask her doctor for advice before taking this medicine . hefiya should only be used during a pregnancy if needed . according to a pregnancy study , there was no higher risk of birth defects when the mother had received adalimumab during pregnancy compared with mothers with the same disease who did not receive adalimumab . hefiya can be used during breast - feeding . if your child receives hefiya during her pregnancy , the baby may have a higher risk for getting an infection . it is important that you tell her baby ' s doctors and other health care professionals about her hefiya use during her pregnancy before the baby receives any vaccine ( for more information on vaccines see the " warnings and precautions " section ). driving and using machines hefiya may have a minor influence on the ability to drive , cycle or use machines . room spinning sensation ( vertigo ) and vision disturbances may occur after taking hefiya . hefiya contains sodium this medicine contains less than 1 mmol of sodium ( 23 mg ) per 0 . 4 ml dose , that is to say essentially ' sodium - free '.
do not take ritemvia if : you are allergic to rituximab , other proteins which are like rituximab , or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe active infection at the moment you have a weak immune system you have severe heart failure or severe uncontrolled heart disease and have granulomatosis with polyangiitis , microscopic polyangiitis or pemphigus vulgaris . do not have ritemvia if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before you are given ritemvia . warnings and precautions talk to your doctor , pharmacist or nurse before you are given ritemvia if : you have ever had or might now have a hepatitis infection . this is because in a few cases , ritemvia could cause hepatitis b to become active again , which can be fatal in very rare cases . patients who have ever had hepatitis b infection will be carefully checked by their doctor for signs of this infection . you have ever had heart problems ( such as angina , palpitations or heart failure ) or breathing problems . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given ritemvia . your doctor may need to take special care of you during your treatment with ritemvia . if you have granulomatosis with polyangiitis , microscopic polyangiitis or pemphigus vulgaris also tell your doctor if you think you may have an infection , even a mild one like a cold . the cells that are affected by ritemvia help to fight infection and you should wait until the infection has passed before you are given ritemvia . also please tell your doctor if you had a lot of infections in the past or suffer from severe infections . if you think you may need any vaccinations in the near future , including vaccinations needed to travel to other countries . some vaccines should not be given at the same time as ritemvia or in the months after you receive ritemvia . your doctor will check if you should have any vaccines before you receive ritemvia . children and adolescents talk to your doctor , pharmacist or nurse before you are given this medicine if you , or your child , are under 18 years of age . this is because there is not much information about the use of ritemvia in children and young people . other medicines and ritemvia tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . this includes medicines obtained without a prescription and herbal medicines . this is because ritemvia can affect the way some other medicines work . also some other medicines can affect the way ritemvia works . in particular , tell your doctor : if you are taking medicines for high blood pressure . you may be asked not to take these other medicines 12 hours before you are given ritemvia . this is because some people have a fall in their blood pressure while they are being given ritemvia . if you have ever taken medicines which affect your immune system such as chemotherapy or immune - suppressive medicines . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before 107 you are given ritemvia . pregnancy and breast - feeding you must tell your doctor or nurse if you are pregnant , think that you might be pregnant or are planning to become pregnant . this is because ritemvia can across the placenta and may affect your baby . if you can get pregnant , you and your partner must use an effective method of contraception while using ritemvia . you must also do this for 12 months after your last treatment with ritemvia . do not breast - feed while you are being treated with ritemvia . also do not breast - feed for 12 months after your last treatment with ritemvia . this is because ritemvia may pass into breast milk . driving and using machines it is not known whether ritemvia has an effect on you being able to drive or use any tools or machines . ritemvia contains sodium this medicine contains 52 . 6 mg sodium ( main component of cooking / table salt ) in each 10 ml vial . this is equivalent to 2 . 6 % of the recommended maximum daily dietary intake of sodium for an adult .
do not take capecitabine teva - if you are allergic to capecitabine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if you know that you have an allergy or over - reaction to this medicine , - if you previously have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - if you are pregnant or breast - feeding , - if you have severely low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), - if you have severe liver or kidney problems , - if you know that you do not have any activity of the enzyme dihydropyrimidine dehydrogenase ( dpd ) ( complete dpd deficiency ), - if you are being treated now or have been treated in the last 4 weeks with brivudine as part of herpes zoster ( chickenpox or shingles ) therapy . warnings and precautions talk to your doctor or pharmacist before taking capecitabine teva - if you know that you have a partial deficiency in the activity of the enzyme dihydropyrimidine dehydrogenase ( dpd ) - if you have a family member who has partial or complete deficiency of the enzyme dihydropyrimidine dehydrogenase ( dpd ) - if you have liver or kidney diseases - if you have or had heart problems ( for example an irregular heartbeat or pains to the chest , jaw and back brought on by physical effort and due to problems with the blood flow to the heart ) - if you have brain diseases ( for example , cancer that has spread to the brain , or nerve damage ( neuropathy ) - if you have calcium imbalances ( seen in blood tests ) - if you have diabetes - if you cannot keep food or water in your body because of severe nausea and vomiting - if you have diarrhoea - if you are , or become dehydrated - if you have imbalances of ions in your blood ( electrolyte imbalances , seen in tests ) - if you have a history of eye problems as you may need extra monitoring of your eyes - if you have a severe skin reaction dpd deficiency : dpd deficiency is a genetic condition that is not usually associated with health problems unless you receive certain medicines . if you have dpd deficiency and take capecitabine teva , you are at an increased risk of severe side effects ( listed under section 4 possible side effects ). it is recommended to test you for dpd deficiency before start of treatment . if you have no activity of the enzyme you should not take capecitabine teva . if you have a reduced enzyme activity ( partial deficiency ) your doctor might prescribe a reduced dose . if you have negative test results for dpd deficiency , severe and life - threatening side effects may still occur . contact your doctor immediately if you are concerned about any of the side effects or if you notice any additional side effects not listed in the leaflet ( see section 4 possible side effects ). children and adolescents capecitabine is not indicated in children and adolescents . do not give capecitabine to children and adolescents . other medicines and capecitabine teva before starting treatment , tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is extremely important , as taking more than one medicine at the same time can strengthen or weaken the effect of the medicines . you must not take brivudine ( an anti - viral medicines for treatment of shingles or chickenpox ) at the same time as capecitabine treatment ( including during any rest periods when you are not taking any capecitabine tablets ). if you have taken brivudine you must wait for at least 4 weeks after stoping brivudine before starting to take capecitabine . see also section " do not take capecitabine teva ". also , you need to be particularly careful if you are taking any of the following : - gout medicines ( allopurinol ), - blood - thinning medicines ( coumarin , warfarin ), - medicines for seizures or tremors ( phenytoin ), - certain medicines used to treat various cancers or virus infection ( interferon alpha ), - radiotherapy and certain medicines used to treat cancer ( folinic acid , oxaliplatin , bevacizumab , cisplatin , irinotecan ), - medicines used to treat folic acid deficiency . capecitabine teva with food and drink 43 you should take capecitabine teva no later than 30 minutes after meals . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . you must not take capecitabine teva if you are pregnant or think you might be . you must not breast - feed if you are taking capecitabine teva and for 2 weeks after the last dose . if you are a woman who could become pregnant you should use effective contraception during treatment with capecitabine teva and for 6 months after the last dose . if you are a male patient and your female partner could become pregnant , you should use effective contraception during treatment with capecitabine teva and for 3 months after the last dose . driving and using machines capecitabine teva may make you feel dizzy , nauseous or tired . it is therefore possible that capecitabine teva could affect your ability to drive a car or operate machines . capecitabine teva contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicinal product . capecitabine teva contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per film - coated tablet , that is to say essentially " sodium - free ".
do not take silodosin recordati if you are allergic to silodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking silodosin recordati if you are undergoing eye surgery because of cloudiness of the lens ( cataract surgery ), it is important that you immediately inform your eye specialist that you are using or have previously 26 used silodosin recordati . this is because some patients treated with this kind of medicine experienced a loss of muscle tone in the iris ( the coloured circular part of the eye ) during such a surgery . the specialist can take appropriate precautions with respect to medicine and surgical techniques to be used . ask your doctor whether or not you should postpone or temporarily stop taking silodosin recordati when undergoing cataract surgery . if you have ever fainted or felt dizzy when suddenly standing up , please inform your doctor before taking silodosin recordati . dizziness when standing up and occasionally fainting may occur when taking silodosin recordati , particularly when starting treatment or if you are taking other medicines that lower blood pressure . if this occurs , make sure you sit or lie down straight away until the symptoms have disappeared and inform your doctor as soon as possible ( see also section " driving and using machines "). if you have severe liver problems , you should not take silodosin recordati , as it was not tested in this condition . if you have problems with your kidneys , please ask your doctor for advice . if you have moderate kidney problems , your doctor will start silodosin recordati with caution and possibly with a lower dose ( see section 3 " dose "). if you have severe kidney problems , you should not take silodosin recordati . since a benign enlargement of the prostate and prostate cancer may present the same symptoms , your doctor will check you for prostate cancer before starting treatment with silodosin recordati . silodosin recordati does not treat prostate cancer . the treatment with silodosin recordati may lead to an abnormal ejaculation ( decrease in the amount of semen released during sex ) that may temporarily affect male fertility . this effect disappears after discontinuation of silodosin recordati . please inform your doctor if you are planning to have children . sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per capsule , that is to say essentially ' sodium - free '. children and adolescents do not give this medicine to children and adolescents below 18 years since there is no relevant indication for this age group . other medicines and silodosin recordati tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . tell your doctor in particular , if you take : medicines which lower blood pressure ( in particular , medicines called alpha1 - blockers , such as prazosin or doxazosin ) as there may be the potential risk that the effect of these medicines is increased whilst taking silodosin recordati . antifungal medicines ( such as ketoconazole or itraconazole ), medicines used for hiv - aids ( such as ritonavir ) or medicines used after transplants to prevent organ rejection ( such as cyclosporin ) because these medicines can increase the blood concentration of silodosin recordati . medicines used for treating problems in getting or keeping an erection ( such as sildenafil or tadalafil ), since the concomitant use with silodosin recordati might lead to a slight decrease in blood pressure . medicines for epilepsy or rifampicin ( a medicine to treat tubercolosis ), since the effect of silodosin recordati may be reduced . pregnancy and breast - feeding silodosin recordati is not intended for use by women . fertilty silodosin recordati may reduce the amount of sperm , and so could temporarily affect your ability to father a child . if you are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . driving and using machines do not drive or operate machines if you feel faint , dizzy , drowsy or have blurred vision .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if you are more than 3 months pregnant . ( it is also better to avoid kinzalmono in early pregnancy see pregnancy section .) if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . if any of the above applies to you , tell your doctor or pharmacist before taking kinzalmono . warnings and precautions talk to your doctor before taking kinzalmono if you are suffering or have ever suffered from any of the following conditions or illnesses : kidney disease or kidney transplant . renal artery stenosis ( narrowing of the blood vessels to one or both kidneys ). liver disease . heart trouble . raised aldosterone levels ( water and salt retention in the body along with imbalance of various blood minerals ). low blood pressure ( hypotension ), likely to occur if you are dehydrated ( excessive loss of body water ) or have salt deficiency due to diuretic therapy (' water tablets '), low - salt diet , diarrhoea , or vomiting . elevated potassium levels in your blood . diabetes . talk to your doctor before taking kinzalmono : if you are taking any of the following medicines used to treat high blood pressure : - an ace - inhibitor ( for example enalapril , lisinopril , ramipril ), in particular if you have diabetes - related kidney problems . - aliskiren . your doctor may check your kidney function , blood pressure , and the amount of electrolytes ( e . g . potassium ) in your blood at regular intervals . see also information under the heading " do not take kinzalmono ". if you are taking digoxin . you must tell your doctor if you think you are ( or might become ) pregnant . kinzalmono is not recommended in early pregnancy , and must not be taken if you are more than 3 months pregnant , as it may cause serious harm to your baby if used at that stage ( see pregnancy section ). in case of surgery or anaesthesia , you should tell your doctor that you are taking kinzalmono . kinzalmono may be less effective in lowering the blood pressure in black patients . children and adolescents the use of kinzalmono in children and adolescents up to the age of 18 years is not recommended . other medicines and kinzalmono tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . your doctor may need to change the dose of these other medications or take other precautions . in some cases you may have to stop taking one of the medicines . this applies especially to the medicines listed below taken at the same time with kinzalmono : lithium containing medicines to treat some types of depression . medicines that may increase blood potassium levels such as salt substitutes containing potassium , potassium - sparing diuretics ( certain ' water tablets '), ace inhibitors , angiotensin ii receptor antagonists , nsaids ( non steroidal anti - inflammatory medicines , e . g . aspirin or ibuprofen ), heparin , immunosuppressives ( e . g . cyclosporin or tacrolimus ), and the antibiotic trimethoprim . diuretics (' water tablets '), especially if taken in high doses together with kinzalmono , may lead to excessive loss of body water and low blood pressure ( hypotension ). if you are taking an ace - inhibitor or aliskiren ( see also information under the headings " do not take kinzalmono " and " warnings and precautions "). digoxin . the effect of kinzalmono may be reduced when you take nsaids ( non steroidal anti - inflammatory medicines , e . g . aspirin or ibuprofen ) or corticosteroids . kinzalmono may increase the blood pressure lowering effect of other medicines used to treat high blood pressure or of medicines with blood pressure lowering potential ( e . g . baclofen , amifostine ). furthermore , low blood pressure may be aggravated by alcohol , barbiturates , narcotics or antidepressants . you may notice this as dizziness when standing up . you should consult with your doctor if you need to adjust the dose of your other medicine while taking kinzalmono . pregnancy and breast - feeding pregnancy you must tell your doctor if you think you are ( or might become ) pregnant . your doctor will normally advise you to stop taking kinzalmono before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of kinzalmono . kinzalmono is not recommended in early pregnancy , and must not be taken when more than 3 months pregnant , as it may cause serious harm to your baby if used after the third month of pregnancy . breast - feeding tell your doctor if you are breast - feeding or about to start breast - feeding . kinzalmono is not recommended for mothers who are breast - feeding , and your doctor may choose another treatment for you if you wish to breast - feed , especially if your baby is newborn , or was born prematurely . driving and using machines some people feel dizzy or tired when taking kinzalmono . if you feel dizzy or tired , do not drive or operate machinery . kinzalmono contains sorbitol . if you are intolerant to some sugars , consult your doctor before taking kinzalmono .
do not use afstyla if you have had an allergic reaction to afstyla , or any of its ingredients ( listed in section 6 ). if you are allergic to hamster proteins . warnings and precautions traceability 46 it is strongly recommended that every time afstyla is given , you record the date of administration , the batch number and the injected volume in your treatment diary . talk to your doctor , pharmacist or nurse before using afstyla . allergic ( hypersensitivity ) reactions are possible . the product contain traces of hamster proteins ( see also " do not use afstyla "). if symptoms of allergic reactions occur , stop using the medicine immediately and contact your doctor . your doctor should inform you of the early signs of allergic reactions . these include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure and anaphylaxis ( a serious allergic reaction that causes severe difficulty in breathing , and dizziness ). the formation of inhibitors ( antibodies ) is a known complication that can occur during treatment with all factor viii medicines . these inhibitors , especially at high levels , stop the treatment working properly and you or your child will be monitored carefully for the development of these inhibitors . if you or your child  s bleeding is not being controlled with afstyla , tell your doctor immediately . if you have been told you have heart disease or are at risk for heart disease , tell your doctor or pharmacist . if you need a central venous access device ( cvad for injection of afstyla ), the risk of complications including local infections , bacteria in the blood ( bacteremia ) and the formation of a blood clot in the blood vessel ( thrombosis ) where the catheter is inserted should be considered by your doctor . other medicines and afstyla tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . during pregnancy and breast - feeding , afstyla should be given only if it is clearly needed . driving and using machines afstyla does not affect your ability to drive and use machines . afstyla contains sodium afstyla contains up to 7 mg ( 0 . 3 mmol ) sodium per ml after reconstitution . however depending on your body weight and your dose of afstyla , you could receive more than one vial . this should be taken into consideration if you are on a controlled sodium diet .
warnings and precautions talk to your doctor or nurse before receiving praxbind : - if you are allergic to idarucizumab or to any other of the substances listed in section 6 . - if you have a genetic disease called hereditary fructose intolerance . in this case , the substance sorbitol contained in this medicine may cause serious adverse reactions . they will take this into account before treating you with praxbind . this medicine will only remove dabigatran from your body . it will not remove other medicines used to prevent the formation of blood clots . after dabigatran has been removed from your body , you are not protected from the formation of blood clots . your doctor will continue treating you with medicines used to prevent the formation of blood clots as soon as your medical condition allows . children and adolescents there is no information on the use of praxbind in children . other medicines and praxbind tell your doctor if you are taking , have recently taken or might take any other medicines . this medicine has been designed to only bind to dabigatran . it is unlikely that praxbind will influence the effect of other medicines or that other medicines will influence praxbind . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before receiving this medicine . there is no information on the effects of this medicine in pregnant or breast - feeding women . praxbind does not affect any functions in the body as such , so your doctor may decide to give you this medicine , if the expected benefits outweigh any potential risks . praxbind contains sodium this medicine contains 50 mg sodium ( main component of cooking / table salt ) in each dose . this is equivalent to 2 . 5 % of the recommended maximum daily dietary intake of sodium for an adult .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before you begin treatment . warnings and precautions talk to your doctor , pharmacist or nurse before taking temomedac , 44 - as you should be observed closely for the development of a serious form of chest infection called pneumocystis jirovecii pneumonia ( pcp ). if you are a newly - diagnosed patient ( glioblastoma multiforme ) you may be receiving temomedac for 42 days in combination with radiotherapy . in this case , your doctor will also prescribe medicine to help you prevent this type of pneumonia ( pcp ). - if you have ever had or might now have a hepatitis b infection . this is because temomedac could cause hepatitis b to become active again , which can be fatal in some cases . patients will be carefully checked by their doctor for signs of this infection before treatment is started . - if you have low counts of red blood cells ( anaemia ), white blood cells and platelets , or blood clotting problems before starting the treatment , or if you develop them during treatment . your doctor may decide to reduce the dose , interrupt , stop or change your treatment . you may also need other treatments . in some cases , it may be necessary to stop treatment with temomedac . your blood will be tested frequently during treatment to monitor the side effects of temomedac on your blood cells . - as you may have a small risk of other changes in blood cells , including leukaemia . - if you have nausea ( feeling sick in your stomach ) and / or vomiting which are very common side effects of temomedac ( see section 4 ), your doctor may prescribe you a medicine ( an anti - emetic ) to help prevent vomiting . - if you vomit frequently before or during treatment , ask your doctor about the best time to take temomedac until the vomiting is under control . if you vomit after taking your dose , do not take a second dose on the same day . - if you develop fever or symptoms of an infection , contact your doctor immediately . - if you are older than 70 years of age , you might be more prone to infections , bruising or bleeding . - if you have liver or kidney problems , your dose of temomedac may need to be adjusted . children and adolescents do not give this medicine to children under the age of 3 years because it has not been studied . there is limited information in patients over 3 years of age who have taken temomedac . other medicines and temomedac tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregnancy , breast - feeding and fertility if you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . this is because you must not be treated with temomedac during pregnancy unless clearly indicated by your doctor . effective contraceptive precautions must be taken by both male and female patients who are taking temomedac ( see also " male fertility " below ). you should stop breast - feeding while receiving treatment with temomedac . male fertility temomedac may cause permanent infertility . male patients should use effective contraception and not father a child for up to 6 months after stopping treatment . it is recommended to seek advice on conservation of sperm prior to treatment . driving and using machines temomedac may make you feel tired or sleepy . in this case , do not drive or use any tools or machines or cycle until you see how this medicine affects you ( see section 4 ). temomedac contains lactose temomedac contains lactose ( a kind of sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine . temomedac contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per hard capsule , that is to say essentially ' sodium - free '. additional information for temomedac 20 mg hard capsules the excipient sunset yellow fcf ( e110 ) included in the capsules shell may cause allergic reactions .
do not take cialis if you : - are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking any form of organic nitrate or nitric oxide donors such as amyl nitrite . this is a group of medicines (" nitrates ") used in the treatment of angina pectoris (" chest pain "). cialis has been shown to increase the effects of these medicines . if you are taking any form of nitrate or are unsure tell your doctor . - have serious heart disease or recently had a heart attack within the last 90 days . - recently had a stroke within the last 6 months . - have low blood pressure or uncontrolled high blood pressure . - ever had loss of vision because of non - arteritic anterior ischemic optic neuropathy ( naion ), a condition described as " stroke of the eye ". - are taking riociguat . this drug is used to treat pulmonary arterial hypertension ( i . e ., high blood pressure in the lungs ) and chronic thromboembolic pulmonary hypertension ( i . e ., high blood pressure in the lungs secondary to blood clots ). pde5 inhibitors , such as cialis , have been shown to increase the hypotensive effects of this medicine . if you are taking riociguat or are unsure tell your doctor . warnings and precautions talk to your doctor before taking cialis . be aware that sexual activity carries a possible risk to patients with heart disease because it puts an extra strain on your heart . if you have a heart problem you should tell your doctor . before taking the tablets , tell your doctor if you have : - sickle cell anaemia ( an abnormality of red blood cells ). - multiple myeloma ( cancer of the bone marrow ). - leukaemia ( cancer of the blood cells ). - any deformation of your penis . - a serious liver problem . - a severe kidney problem . it is not known if cialis is effective in patients who have had : - pelvic surgery . - removal of all or part of the prostate gland in which nerves of the prostate are cut ( radical non - nerve - sparing prostatectomy ). if you experience sudden decrease or loss of vision , stop taking cialis and contact your doctor immediately . decreased or sudden hearing loss has been noted in some patients taking tadalafil . although it is not known if the event is directly related to tadalafil , if you experience decreased or sudden hearing loss , stop taking cialis and contact your doctor immediately . cialis is not intended for use by women . children and adolescents cialis is not intended for use by children and adolescents under the age of 18 . other medicines and cialis tell your doctor if you are taking , have recently taken or might take any other medicines do not take cialis if you are already taking nitrates . some medicines may be affected by cialis or they may affect how well cialis will work . tell your doctor or pharmacist if you are already taking : - an alpha blocker ( used to treat high blood pressure or urinary symptoms associated with benign prostatic hyperplasia ). - other medicines to treat high blood pressure . - riociguat . - a 5 - alpha reductase inhibitor ( used to treat benign prostatic hyperplasia ). - medicines such as ketoconazole tablets ( to treat fungal infections ) and protease inhibitors for treatment of aids or hiv infection . - phenobarbital , phenytoin and carbamazepine ( anticonvulsant medicines ). - rifampicin , erythromycin , clarithromycin or itraconazole . - other treatments for erectile dysfunction . cialis with drink and alcohol information on the effect of alcohol is in section 3 . grapefruit juice may affect how well cialis will work and should be taken with caution . talk to your doctor for further information . fertility when dogs were treated there was reduced sperm development in the testes . a reduction in sperm was seen in some men . these effects are unlikely to lead to a lack of fertility . driving and using machines some men taking cialis in clinical studies have reported dizziness . check carefully how you react to the tablets before driving or using machines . cialis contains lactose : if you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). if you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). warning and precautions talk to your doctor before taking enyglid : if you have liver problems . enyglid is not recommended in patients with moderate liver 28 disease . enyglid should not be taken if you have a severe liver disease ( see do not take enyglid ). if you have kidney problems . enyglid should be taken with caution . if you are about to have major surgery or you have recently suffered a severe illness or infection . at such times diabetic control may be lost . if you are under 18 or over 75 years of age . enyglid is not recommended . it has not been studied in these age groups . talk to your doctor if any of the above applies to you . enyglid may not be suitable for you . your doctor will advise you . children and adolescents do not take this medicine if you are under 18 years of age . if you get a hypo ( low blood sugar ) you may get a hypo ( short for hypoglycaemia ) if your blood sugar gets too low . this may happen : if you take too much enyglid if you exercise more than usual if you take other medicines or suffer from liver or kidney problems ( see other sections of 2 . what you need to know before you take enyglid ). the warning signs of a hypo may come on suddenly and can include : cold sweat , cool pale skin , headache , rapid heart beat , feeling sick , feeling very hungry , temporary changes in vision , drowsiness , unusual tiredness and weakness , nervousness or tremor , feeling anxious , feeling confused , difficulty in concentrating . if your blood sugar is low or you feel a hypo coming on eat glucose tablets or a high sugar snack or drink , then rest . when symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue repaglinide treatment . tell people you have diabetes and that if you pass out ( become unconscious ) due to a hypo , they must turn you on your side and get medical help straight away . they must not give you any food or drink . it could choke you . if severe hypoglycaemia is not treated , it can cause brain damage ( temporary or permanent ) and even death . if you have a hypo that makes you pass out , or a lot of hypos , talk to your doctor . the amount of enyglid , food or exercise may need to be adjusted . if your blood sugar gets too high your blood sugar may get too high ( hyperglycaemia ). this may happen : if you take too little enyglid , if you have an infection or a fever , if you eat more than usual , if you exercise less than usual . the warning signs of too high blood sugar appear gradually . they include : increased urination , feeling thirsty , dry skin and dry mouth . talk to your doctor . the amount of enyglid , food or exercise may need to be adjusted . other medicines and enyglid tell your doctor or pharmacist if you are taking or have recently taken any other medicines . you can take enyglid with metformin , another medicine for diabetes , if your doctor prescribes it . if you take gemfibrozil ( used to lower increased fat levels in the blood ) you should not take enyglid . your body ' s response to enyglid may change if you take other medicines , especially these : monoamine oxidase inhibitors ( maoi ) ( used to treat depression ). beta blockers ( used to treat high blood pressure orheart conditions ). ace - inhibitors ( used to treat heart conditions ). salicylates ( e . g . aspirin ). octreotide ( used to treat cancer ). nonsteroidal anti - inflammatory drugs ( nsaid ) ( a type of painkillers ). steroids ( anabolic steroids and corticosteroids used for anemia or to treat inflammation ). oral contraceptives ( birth control pills ). thiazides ( diuretics or ' water pills '). danazol ( used to treat breast cysts and endometriosis ). thyroid products ( used to treat low levels of thyroid hormones ). sympathomimetics ( used to treat asthma ). clarithromycin , trimethoprim , rifampicin ( antibiotic medicines ). itraconazole , ketokonazole ( antifungal medicines ). gemfibrozil ( used to treat high blood fats ). ciclosporin ( used to suppress the immune system ). deferasirox ( used to reduce chronic iron overload ) clopidogrel ( prevents blood clots ) phenytoin , carbamazepine , phenobarbital ( used to treat epilepsy ). st . john ' s wort ( herbal medicine ). enyglid with alcohol alcohol can change the ability of enyglid to reduce the blood sugar . watch for signs of a hypo . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . you should not take enyglid if you are pregnant or you are planning to become pregnant . you should not take enyglid if you are breast - feeding . driving and using machines your ability to drive or use a machine may be affected if your blood sugar is low or high . bear in mind that you could endanger yourself or others . please ask your doctor whether you can drive a car if you : have frequent hypos , have few or no warning signs of hypos .
do not use azacitidine mylan if you are allergic to azacitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . if you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before using azacitidine mylan : if you have decreased counts of platelets , red or white blood cells . if you have kidney disease . if you have liver disease . if you have ever had a heart condition or heart attack or any history of lung disease . blood test you will have blood tests before you begin treatment with azacitidine mylan and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your liver and kidneys are working properly . children and adolescents azacitidine mylan is not recommended for use in children and adolescents below the age of 18 . other medicines and azacitidine mylan tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . this is because azacitidine mylan may affect the way some other medicines work . also , some other medicines may affect the way azacitidine mylan works . pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . pregnancy you should not use azacitidine mylan during pregnancy as it may be harmful to the baby . use an effective method of contraception during and up to 3 months after treatment . tell your doctor straight away if you become pregnant during treatment . breast - feeding you must not breast - feed when using azacitidine mylan . it is not known if this medicine passes into human milk . fertility men should not father a child while receiving treatment with azacitidine mylan . use an effective method of contraception during and up to 3 months after treatment with this medicine . talk to your doctor if you wish to conserve your sperm before starting this treatment . driving and using machines do not drive or use any tools or machines if you experience side effects , such as tiredness .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have now or have had in the past respiratory problems such as asthma , severe chronic obstructive bronchitis ( severe lung disease which may cause wheeziness , difficulty in breathing and / or long - standing cough ), or other types of breathing problems . if you have severe hay fever . if you have a slow heartbeat , heart failure or a disorder of heart rhythm ( irregular heartbeat ). if the surface of your eye is cloudy . ask your doctor for advice if any of these applies to you . warning and precautions talk to your doctor before using duotrav if you have now or have had in the past coronary heart disease ( symptoms can include chest pain or tightness , breathlessness or choking ), heart failure , low blood pressure . disturbances of heart rate such as slow heartbeat . breathing problems , asthma or chronic obstructive pulmonary disease . poor blood circulation disease ( such as raynaud ' s disease or raynaud ' s syndrome ). diabetes ( as timolol may mask signs and symptoms of low blood sugar ). overactivity of the thyroid gland ( as timolol may mask signs and symptoms of thyroid disease ). myasthenia gravis ( chronic neuromuscular weakness ). cataract surgery . eye inflammation . if you need to have any type of surgery , tell your doctor that you are using duotrav as timolol may change the effects of some medicines used during anaesthesia . if you get any severe allergic reaction ( skin rash , redness and itching of the eye ) while using duotrav , whatever the cause , adrenaline treatment may not be as effective . it is therefore important to tell the doctor that you are using duotrav when you are to receive any other treatment . duotrav may change the colour of your iris ( the coloured part of your eye ). this change may be permanent . duotrav may increase the length , thickness , colour and / or number of your eyelashes and may cause unusual hair growth on your eyelids . travoprost may be absorbed through the skin and therefore should not be used by women who are pregnant or are attempting to become pregnant . if any of the medicine comes into contact with the skin then it should be washed off straight away . children duotrav is not to be used by children and adolescents under 18 years of age . other medicines and duotrav tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . duotrav can affect or be affected by other medicines you are using , including other eye drops for the treatment of glaucoma . tell your doctor if you are using or intend to use medicines to lower blood pressure , heart medicines including quinidine ( used to treat heart conditions and some types of malaria ), medicines to treat diabetes or the antidepressants fluoxetine or paroxetine . pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . do not use duotrav if you are pregnant unless your doctor considers it necessary . if you could get pregnant you must use adequate contraception whilst you use the medicine . do not use duotrav if you are breast - feeding . duotrav may get into your milk . driving and using machines you may find that your vision is blurred for a time just after you use duotrav . do not drive or use machines until this has worn off . duotrav contains hydrogenated castor oil and propylene glycol which may cause skin reactions and irritation .
do not use nplate : if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you are allergic to other medicines that are produced by dna technology using the micro - organism escherichia coli ( e . coli ). warnings and precautions if you stop taking nplate a low blood platelet count ( thrombocytopenia ) is likely to reoccur . if you stop taking nplate your platelet count will have to be monitored , and your doctor will discuss appropriate precautions with you . if you are at risk of blood clots or if blood clots are common in your family . the risk of blood clotting may also be increased if you : - have liver problems ; - are elderly ( 65 years ); - are bedridden ; - have cancer ; - are taking the contraceptive pill or hormone replacement therapy ; - have recently had surgery or suffered an injury ; - are obese ( overweight ); - are a smoker . talk to your doctor , pharmacist or nurse before using nplate . if you have very high blood platelet counts this may increase the risk of blood clotting . your doctor will adjust your dose of nplate to ensure that your platelet count does not become too high . bone marrow changes ( increased reticulin and possible bone marrow fibrosis ) long - term use of nplate may cause changes in your bone marrow . these changes may lead to abnormal blood cells or your body making less blood cells . the mild form of these bone marrow changes is called " increased reticulin " and has been observed in nplate clinical trials . it is not known if this may progress to a more severe form called " fibrosis ." signs of bone marrow changes may show up as abnormalities in your blood tests . your doctor will decide if abnormal blood tests mean that you should have bone marrow tests or if you should stop taking nplate . worsening of blood cancers your doctor may decide to take a bone marrow biopsy if they decide it is necessary to ensure that you have itp , and not another condition such as myelodysplastic syndrome ( mds ). if you have mds and receive nplate you may have an increase in your blast cell counts and your mds condition may worsen to become an acute myeloid leukaemia , which is a type of cancer of the blood . loss of response to romiplostim if you experience a loss of response or failure to maintain a platelet response with romiplostim treatment , your doctor will investigate the reasons why including whether you are experiencing increased bone marrow fibres ( reticulin ) or have developed antibodies which neutralise romiplostim ' s activity . children and adolescents nplate is not recommended for use in children aged under 1 year . other medicines and nplate tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . if you are also taking medicines which prevent blood clots ( anticoagulants or antiplatelet therapy ) there is a greater risk of bleeding . your doctor will discuss this with you . if you are taking corticosteroids , danazol , and / or azathioprine , which you may be receiving to treat your itp , these may be reduced or stopped when given together with nplate . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . nplate is not recommended for use if you are pregnant unless indicated by your doctor . it is not known whether romiplostim is present in human milk . nplate is not recommended for use if you are breast - feeding . a decision on whether to discontinue breast - feeding or discontinue therapy with romiplostim should be made taking into account the benefit of breast - feeding to your child and the benefit of romiplostim therapy to you . driving and using machines you should speak with your doctor before driving or using machines , as some side effects ( e . g . temporary bouts of dizziness ) may impair your ability to do so safely .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanor breezhaler , if any of the following applies to you : - you have kidney problems . - you have an eye problem called narrow - angle glaucoma . - you have difficulty passing urine . during treatment with tovanor breezhaler , stop taking this medicine and tell your doctor immediately : - if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using tovanor breezhaler ( signs of bronchospasm ). - if you experience difficulties in breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). - if you experience eye pain or discomfort , temporary blurring of vision , visual halos or coloured images in association with red eyes . these may be signs of an acute attack of narrow - angle glaucoma . tovanor breezhaler is used as a maintenance treatment for your copd . do not use this medicine to treat a sudden attack of breathlessness or wheezing . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and tovanor breezhaler tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this includes medicines similar to tovanor breezhaler used for your lung disease , such as ipratropium , oxitropium or tiotropium ( so called anticholinergics ). no specific side effects have been reported when tovanor breezhaler has been used together with other medicines used to treat copd such as reliever inhalers ( e . g . salbutamol ), methylxanthines ( e . g . theophylline ) and / or oral and inhaled steroids ( e . g . prednisolone ). pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . there are no data from the use of this medicine in pregnant women and it is not known whether the active substance of this medicine passes into human milk . driving and using machines it is unlikely that this medicine will affect your ability to drive and use machines . tovanor breezhaler contains lactose this medicine contains lactose . if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not use adasuve if you are allergic to loxapine or amoxapine ; if you have symptoms of wheezing or shortness of breath ; if you have lung problems like asthma or chronic obstructive pulmonary disease ( which your doctor may have called " copd "). warnings and precautions your doctor or nurse will talk to you before you use adasuve and determine whether it is appropriate for you . adasuve may cause narrowing of the airways ( bronchospasm ) and may cause you to wheeze , cough , feel chest tightness or have shortness of breath . typically , this will occur within 25 minutes of use . neuroleptic malignant syndrome ( nms ) is a set of symptoms that can occur if you are taking antipsychotic medicines , including adasuve . these symptoms can be high fever , rigid muscles , 47 irregular or fast heart rate or pulse . nms can cause death . do not use adasuve again if nms occurs . antipsychotic medicines like adasuve can cause movements that you may not be able to control including making faces , sticking out your tongue , smacking or puckering your lips , blinking rapidly , or moving your legs , arms or fingers rapidly . treatment with adasuve may have to be stopped if this occurs . adasuve should be used with caution in patients who are intoxicated or delirious . before treatment with adasuve , tell your doctor or nurse if you : have or had breathing problems like asthma or other chronic lung diseases such as bronchitis or emphysema have or had heart problems or stroke have or had low or high blood pressure have or had seizures ( convulsions ) have or had glaucoma ( increased pressure in the eye ) have or had urinary retention ( incomplete emptying of the bladder ) already used adasuve and you developed symptoms of wheezing or shortness of breath ever had muscle or eye movements you can ' t control , lack of coordination , sustained muscle contraction , or feeling restless or unable to sit still are an older person with dementia ( loss of memory and other mental abilities ). children and adolescents adasuve is not for use in children and adolescents under 18 years . other medicines and adasuve tell your doctor if you are using or have recently used or might use any other medicines , including : adrenaline medicines to treat a breathing problem medicines that may put you at a risk for seizures ( for example , clozapine , tricyclics or ssris , tramadol , mefloquine ) medicines to treat parkinson ' s disease lorazepam or other centrally acting medicines ( to treat anxiety , depression , pain , or to help you sleep ) or any other medicines that cause sleepiness recreational ( illegal ) drugs medicines like fluvoxamine , propranolol , and enoxacin and other medicines that inhibit a certain liver enzyme called " cyp450 1a2 ." medicines to treat schizophrenia , depression , or pain since you may be more at risk for seizures using adasuve and adrenaline together may cause your blood pressure to drop . adasuve with alcohol because adasuve affects the nervous system , alcohol should be avoided when using adasuve . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . you should not breast - feed for a period of 48 hours after receiving adasuve and should discard the milk produced in the meantime . the following symptoms may occur in newborn babies of mothers that have repeatedly used antipsychotic medicines in the last three months of their pregnancy : shaking , muscle stiffness and / or weakness , sleepiness , agitation , breathing problems , and difficulty in feeding . if your baby develops any of these symptoms you may need to contact your doctor . driving and using machines do not drive or use any tools or machines after using adasuve until you know how adasuve affects you since dizziness , sedation , and sleepiness have been reported as a potential side effect of adasuve .
do not use azacitidine betapharm if you are allergic to azacitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . if you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before using azacitidine betapharm : if you have decreased counts of platelets , red or white blood cells . if you have kidney disease . if you have liver disease . if you have ever had a heart condition or heart attack or any history of lung disease . blood test you will have blood tests before you begin treatment with azacitidine betapharm and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your liver and kidneys are working properly . children and adolescents azacitidine betapharm is not recommended for use in children and adolescents below the age of 18 . other medicines and azacitidine betapharm tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . this is because azacitidine betapharm may affect the way some other medicines work . also , some other medicines may affect the way azacitidine betapharm works . pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . pregnancy you should not use azacitidine betapharm during pregnancy as it may be harmful to the baby . use an effective method of contraception during and up to 3 months after treatment . tell your doctor straight away if you become pregnant during treatment . breast - feeding you must not breast - feed when using azacitidine betapharm . it is not known if this medicine passes into human milk . fertility men should not father a child while receiving treatment with azacitidine betapharm . use an effective method of contraception during and up to 3 months after treatment with this medicine . talk to your doctor if you wish to conserve your sperm before starting this treatment . driving and using machines do not drive or use any tools or machines if you experience side effects , such as tiredness .
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if you are an intermediate or extensive metaboliser and use medicines known as strong or moderate cyp2d6 inhibitors ( examples are quinidine and terbinafine ) used in combination 31 with strong or moderate cyp3a inhibitors ( examples are erythromycin and itraconazole ). the combination of these medicines will interfere with your body ' s ability to break down cerdelga and this can result in higher levels of the active substance in your blood ( see the section ' other medicines and cerdelga ' for an expanded list of medicines ). - if you are a poor metaboliser and use medicines known as strong cyp3a inhibitors ( for example itraconazole ). medicines of this type will interfere with your body ' s abilty to break down cerdelga and this can result in higher levels of the active substance in your blood ( see the section ' other medicines and cerdelga ' for an expanded list of medicines ). - if you are an extensive metaboliser and you have severely reduced liver function . - if you are an extensive metaboliser and you have mildly or moderately reduced liver function while taking a strong or moderate cyp2d6 inhibitor . warnings and precautions talk to your doctor or pharmacist before taking cerdelga , if you : are currently treated , or about to start treatment with any of the medicines listed in section ' other medicines and cerdelga .' have had a heart attack or heart failure . have a slow heart rate . have an irregular , or abnormal heart beat , inluding a heart condition called long qt syndrome . have any other heart problems . are taking an antiarrhythmic medicine ( used to treat irregular heart beat ) like quinidine , amiodarone or sotalol . are an extensive metaboliser and you have moderately reduced liver function . are an intermediate or poor metaboliser and you have any level of reduced liver function . are an intermediate or poor metaboliser and you have reduced kidney function . are an end stage renal disease ( esrd ) patient . children and adolescents cerdelga has not been tested in children and adolescents under 18 years of age . do not give this medicine to children or adolescents . other medicines and cerdelga please tell your doctor or pharmacist if you are using , or have recently used , or might use , any other medicines . medicines that must not be taken in combination with each other and cerdelga cerdelga must not be used with certain type of medicines . these medicines can interfere with your body ' s ability to break down cerdelga and this can result in higher levels of cerdelga in your blood . these medicines are known as strong or moderate cyp2d6 inhibitors and strong or moderate cyp3a inhibitors . there are many medicines in these categories and depending on how your body breaks down cerdelga the effects may differ from person to person . please speak to your doctor regarding these medicines before you start taking cerdelga . your doctor will determine which medicines you can use based on how fast your body breaks down eliglustat . medicines that may increase the level of cerdelga in the blood such as : paroxetine , fluoxetine , fluvoxamine , duloxetine , bupropion , moclobemide antidepressants ( used to treat depression ) dronedarone , quinidine , verapamil antiarrhythmic medicines ( used to treat irregular heartbeat ) ciprofloxacin , clarithromycin , erythromycin , telithromycin antibiotics ( used to treat infections ) terbinafine , itraconazole , fluconazole , posaconazole , voriconazole antifungals ( used to treat fungal infections ) mirabegron used to treat overactive bladders cinacalcet calcimimetic ( used in some dialysis patients and specific cancers ) 32 atazanavir , darunavir , fosamprenavir , indinavir , lopinavir , ritonavir , saquinavir , tipranavir antiretrovirals ( used to treat hiv ) cobicistat used to improve the effects of antiretrovirals ( used to treat hiv ) aprepitant antiemetic ( used to reduce vomiting ) diltiazem antihypertensive ( used to increase blood flow and decrease heart rate ) conivaptan diuretic ( used to increase low blood sodium levels ) boceprevir , telaprevir antiviral ( used to treat hepatitis c ) imatinib anticancer ( used to treat cancer ) amlopidine , ranolazine used to treat angina pectoris cilostazol used to treat cramp - like pain in your legs when you walk caused by insufficient blood supply in your legs isoniazid used to treat tuberculosis . cimetidine , ranitidine antacids ( used to treat indigestion ) goldenseal ( also known as hydrastis canadensis ) a herbal preparation obtained without a prescription , used as a digestive aid . medicines that may decrease the level of cerdelga in the blood : rifampicin , rifabutin antibiotics ( used to treat infections ) carbamazepine , phenobarbital , phenytoin anti - epileptics ( used to treat epilepsy and seizures ) st . john ' s wort ( also known as hypericum perforatum ) a herbal preparation obtained without a prescription , used to treat depression and other conditions cerdelga may increase the level of the following types of medicines in the blood : dabigatran anticoagulant ( used to thin the blood ) phenytoin anti - epileptic ( used to treat epilepsy and seizures ) nortryptyline , amitriptyline , imipramine , desipramine antidepressants ( used to treat depression ) phenothiazines antipsychotics ( used to treat schizophrenia and psychosis ) digoxin used to treat heart failure and atrial fibrillation colchicine used to treat gout metoprolol used to lower blood pressure and / or reduce heart rate dextromethorphan cough medicine atomoxetine used to treat attention deficit hyperactivity disorder ( adhd ) pravastatin used to lower cholesterol and prevent heart disease taking cerdelga with food and drink avoid consumption of grapefruit or grapefruit juice since it may increase the level of cerdelga in your blood . pregnancy , breast - feeding and fertility if you are pregnant , think that you may be pregnant or are planning to have a baby , tell your doctor who will discuss with you whether you can take this medicine during your pregnancy . the active substance in this medicine has been shown to pass in trace amounts into breast milk in animals . breast - feeding is not recommended during treatment with this medicine . tell your doctor if you are breast - feeding . there are no known effects on fertility at normal doses . driving and using machines cerdelga has negligible or no influence on the ability to drive and use machines . cerdelga contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zoledronic acid hospira :  if you are breast - feeding .  if you are allergic ( hypersensitive ) to zoledronic acid , another bisphosphonate ( the group of substances to which zoledronic acid belongs ), or any of the other ingredients of zoledronic acid hospira ( listed in section 6 ). warnings and precautions talk to your doctor before being given zoledronic acid hospira :  if you have or have had a kidney problem .  if you have or have had pain , swelling or numbness of the jaw , a feeling of heaviness in the jaw or loosening of a tooth . your doctor may recommend a dental examination before you start treatment with zoledronic acid hospira if you are having dental treatment or are due to undergo dental surgery , tell your dentist that you are being treated with zoledronic acid hospira and inform your doctor about your dental treatment . while being treated with zoledronic acid hospira , you should maintain good oral hygiene ( including regular teeth brushing ) and receive routine dental check - ups . contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth , pain or swelling , or non - healing of sores or discharge , as these could be signs of a condition called osteonecrosis of the jaw . patients who are undergoing chemotherapy and / or radiotherapy , who are taking steroids , who are undergoing dental surgery , who do not receive routine dental care , who have gum disease , who are smokers , or who were previously treated with a bisphosphonate ( used to treat or prevent bone disorders ) may have a higher risk of developing osteonecrosis of the jaw . reduced levels of calcium in the blood ( hypocalcaemia ), sometimes leading to muscle cramps , dry skin , burning sensation , have been reported in patients treated with zoledronic acid . irregular heart beat ( cardiac arrhythmia ), seizures , spasm and twitching ( tetany ) have been reported as secondary to severe hypocalcaemia . in some instances the hypocalcaemia may be life - threatening . if any of these apply to you , tell your doctor straight away . if you have pre - existing hypocalcaemia , it must be corrected before initiating the first dose of zoledronic acid hospira . you will be given adequate calcium and vitamin d supplements . patients aged 65 years and over zoledronic acid hospira can be given to people aged 65 years and over . there is no evidence to suggest that any extra precautions are needed . children and adolescents zoledronic acid hospira is not recommended for use in adolescents and children below the age of 18 years . other medicines and zoledronic acid hospira please tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . it is especially important that you tell your doctor if you are also taking : aminoglycosides ( medicines used to treat severe infections ), calcitonin ( a type of medicine used to treat post - menopausal osteoporosis and hypercalcaemia ), loop diuretics ( a type of medicine to treat high blood pressure or oedema ) or other calcium - lowering medicines , since the combination of these with bisphosphonates may cause the calcium level in the blood to become too low . thalidomide ( a medicine used to treat a certain type of blood cancer involving the bone ) or any other medicines which may harm your kidneys . any other medicines that contain zoledronic acid which is used to treat osteoporosis and other non - cancer diseases of the bone , or any other bisphosphonate , since the combined effects of these medicines taken together with zoledronic acid hospira are unknown . - anti - angiogenic medicines ( used to treat cancer ), since the combination of these with zoledronic acid hospira has been associated with an increased risk of osteonecrosis of the jaw ( onj ). pregnancy and breast - feeding you should not be given zoledronic acid hospira if you are pregnant . tell your doctor if you are or think that you may be pregnant . you must not be given zoledronic acid hospira if you are breast - feeding . ask your doctor for advice before taking any medicine while you are pregnant or breast - feeding . driving and using machines there have been very rare cases of drowsiness and sleepiness with the use of zoledronic acid hospira . you should therefore be careful when driving , using machines or performing other tasks that need full attention . zoledronic acid hospira contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dose , i . e . essentially " sodium - free ".
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - if you take an herbal medicine called st john ' s wort ( hypericum performatum ), used to treat depression and difficulty sleeping ( see section 2 under ' other medicines and varuby '). if you are not sure , talk to your doctor , pharmacist or nurse before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : 27 - you have severe liver or kidney problems - you need to take certain medicines which may reduce the effectiveness of varuby , such as : - rifampicin , to treat tuberculosis and other infections - carbamazepine , to treat epilepsy and nerve pain - phenobarbital , to treat epilepsy - enzalutamide , to treat prostate cancer - phenytoin , to treat epilepsy - efavirenz , to treat human immunodeficiency virus ( hiv ) - rifabutin , to treat tuberculosis and other infections - other medicines that contain an nk1 antagonist , such as aprepitant and a combination of netupitant and palonosetron hydrochloride ( for the prevention of nausea and vomiting associated with cancer chemotherapy ) ( see section 2 under ' other medicines and varuby ') children and adolescents varuby should not be taken by children and adolescents under 18 years because it has not been studied in this group . other medicines and varuby tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . varuby may affect how some other medicines work . these include : - propafenone ( used to treat irregular or abnormal heart beat ) - tamoxifen ( used to treat breast cancer ) - metoprolol ( used to treat high blood pressure and heart conditions ) - thioridazine ( used to treat psychiatric conditions like schizophrenia ) - pimozide ( used to treat psychiatric conditions like schizophrenia ) - morphine ( used to treat moderate to severe pain ) - methotrexate ( used to treat cancer , psoriasis , and rheumatoid arthritis ) - irinotecan ( used to treat cancer ) - topotecan ( used to treat cancer ) - mitoxantrone ( used to treat cancer ) - sulfasalazine ( used to treat bowel disease and rheumatoid arthritis ) - doxorubicin ( used in cancer chemotherapy ) - bendamustine ( used in the treatment of leukaemia ) - digoxin ( used to treat heart conditions ) - dabigatran ( used to prevent blood clots ) - colchicine ( used to treat gout ) - medicines called ' statins ,' such as atorvastatin , fluvastatin , rosuvastatin and simvastatin , that are used in the treatment of high levels of fats ( such as cholesterol ) in the blood - bosentan ( used to treat high blood pressure in the pulmonary artery ) - fexofenadine ( used to treat allergy symptoms ) pregnancy and breast - feeding there is no information on the effects of this medicine if taken during pregnancy . if you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . it is not known whether varuby is present in milk ; therefore , breast - feeding is not recommended during treatment with this medicine . it is important that you tell your doctor if you are breast - feeding or are planning to breast - feed before taking this medicine . driving and using machines varuby has minor influence on your ability to drive and use machines . you may feel dizzy or tired after taking this medicine . if this happens , do not drive or use any tools or machines . varuby contains lactose each dose ( two tablets ) contains 230 mg of lactose . if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicinal product .
follow all the doctor ' s instructions carefully . do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using enerzair breezhaler if any of the following applies to you : - if you have heart problems , including an irregular or fast heartbeat . - if you have thyroid gland problems . - if you have ever been told you have diabetes or high blood sugar . - if you suffer from seizures or fits . - if you have severe kidney problems . - if you have severe liver problems . - if you have a low level of potassium in your blood . - if you have an eye problem called angle - closure glaucoma . - if you have difficulty passing urine . - if you have tuberculosis ( tb ) of the lung , or any long standing or untreated infections . during treatment with enerzair breezhaler stop using this medicine and get medical help immediately if you have any of the following : - tightness of the chest , coughing , wheezing or breathlessness immediately after using enerzair breezhaler ( signs the medicine is unexpectedly tightening the airways , known as paradoxical bronchospasm ). - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). - eye pain or discomfort , temporary blurring of vision , visual haloes ( seeing bright circles around lights ) or coloured images in association with red eyes ( signs of an attack of angle - closure glaucoma ). children and adolescents do not give this medicine to children or adolescents ( below the age of 18 years ) because it has not been studied in this age group . other medicines and enerzair breezhaler tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . in particular , tell your doctor or pharmacist if you are using : - medicines that decrease the level of potassium in your blood . these include diuretics ( which increase urine production and can be used to treat high blood pressure , e . g . hydrochlorothiazide ), other bronchodilators such as methylxanthines used for breathing problems ( e . g . theophylline ) or corticosteroids ( e . g . prednisolone ). - tricyclic antidepressants or monoamine oxidase inhibitors ( medicines used in the treatment of depression ). - any medicines that may be similar to enerzair breezhaler ( contain similar active substances ); using them together may increase the risk of possible side effects . - medicines called beta blockers used to treat high blood pressure or other heart problems ( e . g . propranolol ) or to treat glaucoma ( e . g . timolol ). - ketoconazole or itraconazole ( medicines used to treat fungal infections ). - ritonavir , nelfinavir or cobicistat ( medicines used to treat hiv infection ). pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . your doctor will discuss with you whether you can use enerzair breezhaler . driving and using machines it is unlikely that this medicine will affect your ability to drive and use machines . enerzair breezhaler contains lactose this medicine contains about 25 mg of lactose per capsule . if you have been told by your doctor that you have an intolerance to some sugars , speak with your doctor before taking this medicine .
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopidogrel or any of the other ingredients of clopidogrel acino pharma gmbh ; if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; if you suffer from severe liver disease ; if you think any of these apply to you , or if you are in any doubt at all , consult your doctor before taking clopidogrel acino pharma gmbh . take special care with clopidogrel acino pharma gmbh : if any of the situations mentioned below apply to you , you should tell your doctor before taking clopidogrel acino pharma gmbh : if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ) - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ) - a recent serious injury - a recent surgery ( including dental ) - a planned surgery ( including dental ) in the next seven days if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred within the last seven days if you have kidney or liver disease while you are taking clopidogrel acino pharma gmbh : you should tell your doctor if a surgery ( including dental ) is planned . you should also tell your doctor immediately if you develop a medical condition ( also known as thrombotic thrombocytopenic purpura or ttp ) that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ' possible side effects '). if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). your doctor may order blood tests . children and adolescents clopidogrel acino pharma gmbh is not intended for use in children or adolescents . taking other medicines please tell your doctor or pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . some other medicines may influence the use of clopidogrel acino pharma gmbh or vice versa . you should specifically tell your doctor if you take - oral anticoagulants , medicines used to reduce blood clotting , - a non - steroidal anti - inflammatory medicine , usually used to treat painful and / or inflammatory conditions of muscle or joints - heparin or any other injectable medicine used to reduce blood clotting - omeprazole , esomeprazole or cimetidine , medicines to treat upset stomach - fluconazole , voriconazole , ciprofloxacin , or chloramphenicol , medicines to treat bacterial and fungal infections - fluoxetine , fluvoxamine , or moclobemide , medicines to treat depression - carbamazepine , or oxcarbazepine , medicines to treat some forms of epilepsy - ticlopidine , other antiplatelet agent . you should specifically tell your doctor if you take a non - steroidal anti - inflammatory medicinal product , usually used to treat painful and / or inflammatory conditions of muscle or joints , or if you take heparin , another medicine used to reduce blood clotting . acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever : an occasional use of acetylsalicylic acid ( no more than 1 , 000 mg in any 24 hour period ) should generally not cause a problem , but prolonged use in other circumstances should be discussed with your doctor . taking clopidogrel acino pharma gmbh with food and drink clopidogrel acino pharma gmbh may be taken with or without food . pregnancy and breast - feeding it is preferable not to take this product during pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking clopidogrel acino pharma gmbh . if you become pregnant while taking clopidogrel acino pharma gmbh , consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant . you should not breastfeed while taking this medicine . if you are breastfeeding or planning to breastfeed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines clopidogrel acino pharma gmbh is unlikely to affect your ability to drive or to use machines . important information about some of the ingredients of clopidogrel acino pharma gmbh : clopidogrel acino pharma gmbh contains hydrogenated castor oil which may cause stomach upset or diarrhoea .
do not take delstrigo : if you are allergic to doravirine , lamivudine or tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you are taking any of the following medicines : - carbamazepine , oxcarbazepine , phenobarbital , phenytoin ( medicines for seizure ) - rifampicin , rifapentine ( medicines for tuberculosis ) - st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ) or products that contain it - mitotane ( a medicine to treat cancer ) - enzalutamide ( a medicine to treat prostate cancer ) - lumacaftor ( a medicine to treat cystic fibrosis ) do not take delstrigo if the above applies to you . if you are not sure , talk to your doctor , pharmacist , or nurse before taking delstrigo . see also the list in section " other medicines and delstrigo ". warnings and precautions talk to your doctor , pharmacist , or nurse before taking delstrigo . passing hiv to others hiv is spread by contact with blood or through sexual contact with a person with hiv . you can still pass on hiv when taking delstrigo , although effective therapy lowers the risk . talk to your doctor about what you can do to avoid infecting other people . worsening of hepatitis b infection if you have both hiv and hepatitis b virus infections , your hepatitis b may get worse if you stop taking delstrigo . you may require blood tests for several months after stopping treatment . discuss your hepatitis b therapy with your doctor . new or worsening kidney problems , including kidney failure this can happen in some people who take delstrigo . your doctor will do blood tests to check your kidney function before and during treatment with delstrigo . bone problems this can happen in some people who take delstrigo . bone problems include bone pain , and bone softening or thinning ( which may lead to fractures ). joint or muscle pain or muscle weakness may also occur . your doctor may need to do additional tests to check your bones . immune reactivation syndrome this can happen when you start taking any hiv medicine , including delstrigo . your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time . tell your doctor right away if you start having any new symptoms after starting your hiv medicine . autoimmune disorders ( a condition that occurs when the immune system attacks healthy body tissue ) may also occur after you start taking medicines for the treatment of your hiv infection . autoimmune disorders may occur many months after the start of treatment . if you notice any symptoms of infection or other symptoms such as muscle weakness , weakness beginning in the hands and feet and moving up towards the trunk of the body , palpitations , tremor or hyperactivity , please inform your doctor immediately to seek necessary treatment . children and adolescents do not give this medicine to anybody aged less than 18 years . the use of delstrigo in people aged less than 18 years has not yet been studied . other medicines and delstrigo tell your doctor , pharmacist , or nurse if you are taking , have recently taken , or might take any other medicines . this is because other medicines may affect how delstrigo works , and delstrigo might affect the way some other medicines work . there are some medicines you must not take with delstrigo . see list under " do not take delstrigo " section . talk to your doctor before taking the following medicines with delstrigo as your doctor may need to change the dose of your medicines : bosentan ( a medicine to treat lung disease ) dabrafenib ( a medicine to treat skin cancer ) lesinurad ( a medicine to treat gout ) modafinil ( a medicine to treat excessive sleepiness ) nafcillin ( a medicine to treat some bacterial infections ) rifabutin ( a medicine to treat some bacterial infections such as tuberculosis ) telotristat ethyl ( a medicine to treat diarrhea in people with carcinoid syndrome ) thioridazine ( a medicine to treat psychiatric conditions such as schizophrenia ) if your doctor decides you should take these medicines with delstrigo , your doctor will prescribe a 100 mg tablet of doravirine to be taken daily , approximately 12 hours after your dose of delstrigo . your doctor may check your blood levels or monitor for side effects if you take the following medicines with delstrigo : ledipasvir / sofosbuvir ( medicines used to treat hepatitis c infection ) sirolimus ( a medicine used to control your body ' s immune response after a transplant ) sofosbuvir / velpatasvir ( medicines used to treat hepatitis c infection ) tacrolimus ( a medicine used to control your body ' s immune response after a transplant ) medicines ( usually liquids ) containing sorbitol and other sugar alcohols ( such as xylitol , mannitol , lactitol or maltitol ), if taken regularly pregnancy and breast - feeding if you are pregnant or breastfeeding , think you may be pregnant , or are planning to have a baby , talk to your doctor about the risks and benefits of taking delstrigo . it is preferable to avoid the use of delstrigo during pregnancy . this is because it has not been studied in pregnancy and it is not known if delstrigo will harm your baby while you are pregnant . women with hiv should not breastfeed because hiv can be passed on to babies through breast milk . talk with your doctor about the best way to feed your baby . driving and using machines use with caution when driving , riding a bicycle , or operating machines if you feel tired , dizzy , or sleepy after taking this medicine delstrigo tablets contains lactose if you have been told by your doctor that you have an intolerance to lactose , talk to your doctor before taking this medicine .
do not use spravato if you are allergic to esketamine , a similar medicine called ketamine used for anaesthesia , or any of the other ingredients of this medicine ( listed in section 6 ). if you have ever had certain conditions such as : - an aneurysm ( a weak spot in a blood vessel wall where it widens or bulges out ) - bleeding in the brain if you recently had a heart attack ( within 6 weeks ) this is because spravato can cause a temporary increase in blood pressure that may lead to serious complications in these conditions . do not use spravato if any of the above apply to you . if you are not sure , talk to your doctor before using spravato - your doctor will decide whether or not you can use this medicine . warnings and precautions talk to your doctor before using spravato if you have : a heart problem which is not well controlled such as : poor blood flow in the blood vessels of the heart frequently with chest pain ( such as angina ), high blood pressure , heart valve disease or heart failure 34 ever had problems with the blood supply to your brain ( such as a stroke ) ever had problems with drug abuse prescribed medicines or illegal drugs - or a problem with alcohol ever had a condition called psychosis - where you believe in things that are not true ( delusions ) or see , feel , or hear things that are not there ( hallucinations ) ever had a condition called bipolar disorder , or symptoms of mania ( where you become very over - active or over excited ) ever had an overactive thyroid that is not properly treated ( hyperthyroidism ) ever had lung problems causing breathing difficulty ( pulmonary insufficiency ), including chronic obstructive pulmonary disease ( copd ) sleep apnoea and are extremely overweight ever had slow or fast heartbeats causing shortness of breath , palpitations or chest discomfort , feeling light - headed or fainting had a serious head injury or serious problems affecting the brain , particularly where there is increased pressure in the brain severe liver problems . if any of the above apply to you ( or you are not sure ), talk to your doctor before using spravato . your doctor will decide whether you should use this medicine . depression getting worse tell your doctor or go to the nearest hospital straight away if you have thoughts of harming or killing yourself at any time . you may find it helpful to talk to a relative or a close friend if you are depressed and ask them if they think your depression is getting worse or if they are worried about your behaviour . you might ask them to read this leaflet . blood pressure spravato can increase your blood pressure for about 1 to 2 hours after you use it so your blood pressure will be measured before you start using spravato and after using it . if your blood pressure is high before using this medicine , your doctor will decide whether to start the medicine or wait until your blood pressure is lower . if your blood pressure goes up after using this medicine and stays high for more than a few hours , you may need to have some more tests . this medicine may cause a temporary increase in your blood pressure after taking a dose . your blood pressure will be checked before and after using this medicine . tell the medical staff right away if you get chest pain , shortness of breath , sudden severe headache , change in vision , or seizures ( fits ) after using this medicine . tell your doctor if you get any of the below while you are using spravato difficulty with your attention , judgment and thinking ( see also " driving and using machines " and " possible side effects "). during and after each use of this medicine , your doctor will check your condition and decide how long to monitor you . sleepiness ( sedation ), fainting , dizziness , spinning sensation , anxiety , or feeling disconnected from yourself , your thoughts , feelings , space and time ( dissociation ), difficulties in breathing ( respiratory depression ). tell the medical staff right away if your feel like you cannot stay awake or if you feel like you are going to pass out . pain when urinating or seeing blood in your urine these could be signs of bladder problems . these can occur with high doses of a similar medicine ( called ketamine ) used over a long period . tell your doctor if you get any of the above while you are taking spravato . elderly (> 65 years ) if you are elderly (> 65 years ), you will be carefully monitored as you may be at increased risk of falling when you start moving around after treatment . children and adolescents do not give this medicine to children and adolescents younger than 18 years of age . this is because spravato has not been studied for treatment - resistant depression in this age group . other medicines and spravato tell your doctor if you are taking , have recently taken or might take any other medicines . using spravato with certain medicines may cause side effects . especially tell your doctor if you take : medicines used to treat nervous disorders or severe pain ( for example , benzodiazepines , opioids ), or medicines or beverages containing alcohol stimulants such as those used for conditions such as narcolepsy or medicines for adhd ( for example , amphetamines , methylphenidate , modafanil , armodafinil ) medicines that can increase your blood pressure , such as , thyroid hormones , asthma medications such as xanthine derivatives , medications for child birth bleeding ( ergometrine ) and heart medication such as vasopressin . medicines for depression or parkinson ' s disease known as monoamine oxidase inhibitors ( maois ) ( for example , tranylcypromine , selegiline , phenelzine ). pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . contraception if you are able to become pregnant you must use contraception during treatment . talk with your doctor about suitable methods of contraception . pregnancy do not use spravato if you are pregnant . if you become pregnant while being treated with spravato , talk to your doctor straight away to decide whether to stop treatment and to learn about other options for treatment . breast - feeding do not use spravato if you are breast - feeding . talk to your doctor before using spravato if you are breast - feeding . your doctor will discuss with you whether to stop breast - feeding or stop using this medicine . your doctor will take into account the benefit of breast - feeding for you and your child , and the benefit of treatment for you . driving and using machines spravato can make you feel sleepy , dizzy , and have other side effects that can temporarily affect your ability to drive vehicles or use machines and do activities that need you to be completely alert . after being treated with this medicine , do not take part in these activities until the next day following a restful sleep .
do not take zelboraf : if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . warnings and precautions talk to your doctor before taking zelboraf . allergic reactions allergic reactions can happen while taking zelboraf and may be severe . stop taking zelboraf and get medical help immediately if you have any symptoms of an allergic reaction such as swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . severe skin reactions severe skin reactions can happen while taking zelboraf . stop taking zelboraf and talk to your doctor immediately if you get a skin rash with any of the following symptoms : blisters on your skin , blisters or sores in your mouth , peeling of your skin , fever , redness or swelling of your face , hands , or soles of your feet . previous history of cancer tell your doctor if you have had a different type of cancer than melanoma , as zelboraf may cause progression of certain types of cancers . radiation therapy reactions tell your doctor if you have had , or are going to have radiotherapy , as zelboraf may worsen radiation treatment side effects . heart disorder tell your doctor if you have a heart disorder , such as an alteration of the electrical activity of your heart called " qt prolongation ". your doctor will run tests to check that your heart is working properly before and during your treatment with zelboraf . if necessary , your doctor may decide to interrupt your treatment temporarily or stop it altogether . eye problems you should have your eyes examined by your doctor while you are taking zelboraf . tell your doctor immediately if you get eye pain , swelling , redness , blurred vision or other vision changes during your treatment . musculoskeletal / connective tissue disorder tell your doctor if you observe any unusual thickening of the palms of your hands accompanied by tightening of the fingers inward or any unusual thickening of the soles of your feet which may be painful . checks of your skin before , during and after treatment if you notice any changes in your skin while taking this medicine , please talk to your doctor as soon as possible . regularly during your treatment and up to 6 months after your treatment , your doctor needs to check your skin for a type of cancer called " cutaneous squamous cell carcinoma ". usually , this lesion appears on sun - damaged skin , remains local and can be cured by surgical removal . if your doctor finds this type of skin cancer , he or she will treat it or send you to another doctor for treatment . additionally , your doctor needs to inspect your head , your neck , your mouth , your lymph glands and you will undergo ct scans regularly . this is a precautionary measure in case a squamous cell carcinoma lesion would develop inside your body . genital examinations ( for women ) and anal examinations are also recommended before and at the end of your treatment . you may develop new melanoma lesions while taking zelboraf . these lesions are usually removed by surgery and patients continue their treatment . monitoring of these lesions occurs as outlined above for cutaneous squamous cell carcinoma . kidney or liver problems tell your doctor if you have kidney or liver problems . this may affect the activity of zelboraf . your doctor will also do some blood tests to check your liver and kidney functions before you start taking zelboraf and during treatment . sun protection if you are taking zelboraf , you may become more sensitive to sunlight and get sunburns that can be severe . during treatment , avoid exposing your skin to direct sunlight . if you do plan to go into the sun : wear clothing which protects your skin , including your head and face , arms and legs ; use a lip balm and a broad spectrum sunscreen ( minimum of sun protection factor ( spf ) 30 , re - applied every 2 to 3 hours ). this will help to protect you against sunburn . children and adolescents zelboraf is not recommended for children and adolescents . the effects of zelboraf in people younger than 18 years old are not known . other medicines and zelboraf before starting treatment , tell your doctor if you are taking , have recently taken or might use any other medicines ( including those you have bought for yourself from a pharmacy , supermarket or health store ). this is very important , as using more than one medicine at the same time can strengthen or weaken the effect of medicines . in particular , tell your doctor if you are taking : medicines that are known to affect the way your heart beats : medicines for heart rhythm problems ( e . g . quinidine , amiodarone ) medicines for depression ( e . g . amitriptyline , imipramine ) medicines for bacterial infections ( e . g . azithromycin , clarithromycin ) medicines for nausea and vomiting ( e . g . ondansetron , domperidone ). medicines that are mainly eliminated by metabolising proteins called cyp1a2 ( e . g caffeine , olanzapine , theophylline ), cyp3a4 ( e . g . some oral contraceptives ) or called cyp2c8 . medicines that influence a protein called p - gp or bcrp ( e . g . verapamil , cyclosporine , ritonavir , quinidine , itraconazole , gefitinib ). medicines that could be influenced by a protein called p - gp ( e . g . aliskiren , colchicine , digoxin , everolimus , fexofenadine ) or a protein called bcrp ( e . g . methotrexate , mitoxantrone , rosuvastatin ). medicines that stimulate the metabolising proteins called cyp3a4 or a metabolising process called glucuronidation ( e . g . rifampicin , rifabutin , carbamazepine , phenytoin or st john ' s wort ) medicines that strongly inhibit the metabolising protein called cyp3a4 ( e . g . ritonavir , saquinavir , telithromycin , ketoconazole , itraconazole , voriconazole , posaconazole , nefazodone , atazanavir ) a medicine used to prevent blood clots called warfarin a medicine called ipilimumab , another medicine for the treatment of melanoma . the combination of this medicine with zelboraf is not recommended due to increased toxicity to the liver . if you are taking any of these medicines ( or if you are not sure ), please talk to your doctor before taking zelboraf . pregnancy and breast - feeding use an appropriate method of contraception during your treatment and for at least 6 months after the end of your treatment . zelboraf may decrease the efficacy of some oral contraceptives . please tell your doctor if you are taking an oral contraceptive . zelboraf is not recommended for use during pregnancy unless your doctor considers that the benefit for the mother outweighs the risk for the baby . there is no information about the safety of zelboraf in pregnant women . tell your doctor if you are pregnant or planning to become pregnant . it is not known whether the ingredients in zelboraf pass into human milk . breast - feeding is not recommended during treatment with zelboraf . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . driving and using machines zelboraf has side effects that can affect your ability to drive or to operate machines . beware of fatigue or eye problems that could be a reason for not driving . important information about some of the ingredients of zelboraf this medicine contains less than 1 mmol sodium ( 23 mg ) per tablet , that is to say essentially ' sodium - free '.
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ). if you are allergic to other products called non - steroidal anti - inflammatory products usually used to treat painful and / or inflammatory conditions of muscles or joints . if you have a medical condition that includes the combination of asthma , nasal discharge ( runny nose ) and polyps ( a type of growth in the nose ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if you suffer from severe kidney disease . if you are in your last trimester of pregnancy . warnings and precautions if any of the situations mentioned below apply to you , you should tell your doctor before taking duoplavin : if you have a risk of bleeding such as : - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ). - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ). - a recent serious injury . - a recent surgery ( including dental ). - a planned surgery ( including dental ) in the next seven days . if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred in the last seven days . if you have kidney or liver disease . if you have a history of asthma or allergic reactions including allergy to any medicine used to treat your disease . if you have gout . if you drink alcohol , because of the increased risk of bleeding or gastrointestinal injury . if you have a condition known as glucose - 6 - phosphate dehydrogenase ( g6pd ) deficiency because of the risk of a particular form of anaemia ( low number of red blood cells ). while you are taking duoplavin : you should tell your doctor - if a surgery ( including dental ) is planned . - if you have any stomach or abdominal pain or bleeding in the stomach or bowels ( red stools or black stools ). you should also tell your doctor immediately if you develop a medical condition known as thrombotic thrombocytopenic purpura or ttp that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ). if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). your doctor may order blood tests . children and adolescents duoplavin is not intended for use in children or adolescents less than 18 years of age . there is a possible association between acetylsalicylic acid ( asa ) and reye ' s syndrome when products containing asa are given to children or adolescents with a viral infection . reye ' s syndrome is a very rare disease which can be fatal . other medicines and duoplavin tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . some other medicines may influence the use of duoplavin or vice versa . you should specifically tell your doctor if you take medicines that may increase your risk of bleeding such as : - oral anticoagulants , medicines used to reduce blood clotting , - asa or another non - steroidal anti - inflammatory medicine usually used to treat painful and / or inflammatory conditions of muscle or joints , - heparin or any other injectable medicine used to reduce blood clotting , - ticlopidine , other antiplatelet agent , 43 - a selective serotonin reuptake inhibitor ( including but not restricted to fluoxetine or fluvoxamine ), medicines usually used to treat depression , - rifampicin ( used to treat severe infections ) omeprazole or esomeprazole , medicines to treat upset stomach , methotrexate , a medicine used to treat severe joint disease ( rheumatoid arthritis ) or skin disease ( psoriasis ), acetazolamide , a medicine used to treat glaucoma ( increased ocular pressure ) or epilepsy or to increase urine flow , probenecid , benzbromarone , or sulfinpyrazone , medicines used to treat gout , fluconazole or voriconazole , medicines to treat fungal infections , efavirenz or tenofovir , or other anti - retroviral medicines ( used to treat hiv infections ), valproic acid , valproate or carbamazepine , medicines to treat some forms of epilepsy , the varicella vaccine , a medicine used to prevent chickenpox or shingles , within 6 weeks of taking duoplavin , or if you have active chickenpox or shingles infection ( see section 2 ' children and adolescents '), moclobemide , medicine to treat depression , repaglinide , medicine to treat diabetes , paclitaxel , medicine to treat cancer , nicorandil , medicine to treat cardiac chest pain , opioids : while you are treated with clopidogrel , you should inform your doctor before being prescribed any opioids ( used to treat severe pain ). you should stop other clopidogrel treatment while you are taking duoplavin . an occasional use of asa ( no more than 1 , 000 mg in any 24 - hour period ) should generally not cause a problem , but prolonged use of asa in other circumstances should be discussed with your doctor or pharmacist . pregnancy and breast - feeding do not take duoplavin during third trimester of pregnancy . it is preferable not to take this medicine during first and second trimesters of pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking duoplavin . if you become pregnant while taking duoplavin , consult your doctor immediately as it is recommended not to take duoplavin while you are pregnant . you should not breast - feed while using this medicine . if you are breast - feeding or planning to breast - feed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines duoplavin should not affect your ability to drive or to use machines . duoplavin contains lactose if you have been told by your doctor that you have an intolerance to some sugars ( e . g . lactose ), contact your doctor before taking this medicine . duoplavin contains hydrogenated castor oil this may cause stomach upset or diarrhoea .
do not use simbrinza - if you are allergic to brinzolamide or brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) - if you are allergic to sulphonamides ( examples include medicines used to treat diabetes and infections and also diuretics ( water tablets )) - if you are taking a monoamine oxidase ( mao ) inhibitors ( examples include medicines to treat depression or parkinson ' s disease ) or certain antidepressants . you must inform your doctor if you are taking any antidepressant medicines - if you have severe kidney problems - if you have too much acidity in your blood ( a condition called hyperchloraemic acidosis ) - in babies and infants aged less than 2 years . warnings and precautions talk to your doctor , optometrist ( optician ) or pharmacist before using simbrinza if you have now or have had in the past : - liver problems - a type of high pressure in the eyes called narrow - angle glaucoma - dry eyes or cornea problems - coronary heart disease ( symptoms can include chest pain or tightness , breathlessness or choking ), heart failure , high or low blood pressure - depression - disturbed or poor blood circulation ( such as raynaud ' s disease , raynaud ' s syndrome or cerebral insufficiency ). if you wear soft contact lenses , do not use the drops with your lenses in . see section " wearing contact lenses - simbrinza contains benzalkonium chloride " below ). children and adolescents simbrinza is not intended for use by children and adolescents aged below 18 years because it has not been studied in this age group . it is particularly important that the medicine is not used in children under the age of 2 years ( see section ' do not use simbrinza ' above ) because it is unlikely to be safe . other medicines and simbrinza tell your doctor , optometrist ( optician ) or pharmacist if you are using , have recently used , or might use any other medicines . simbrinza can affect or be affected by other medicines you are using , including other eye drops for the treatment of glaucoma . tell your doctor if you are taking or intend to take any of the following medicines : - medicines to lower blood pressure - heart medicines including digoxin ( used to treat heart conditions ) - other medicines for glaucoma that also treat altitude sickness known as acetazolamide , methazolamide and dorzolamide - medicines that can affect the metabolism , such as chlorpromazine , methylphenidate and reserpine - antiviral , antiretroviral ( used to treat human immunodeficiency virus ( hiv )) or antibiotic medicines - antiyeast or antifungal medicines - monoamine oxidase ( mao ) inhibitors , or antidepressants including amitriptyline , nortriptyline , clomipramine , mianserin , venlafaxine and duloxetine - anaesthetics - sedatives , opiates , or barbiturates you should also tell your doctor if the dose of any of your current medicines is changed . simbrinza with alcohol if you regularly consume alcohol , ask your doctor , optometrist ( optician ) or pharmacist for advice before taking this medicine . simbrinza can be affected by alcohol . pregnancy and breast - feeding if you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor , optometrist ( optician ) or pharmacist for advice before taking this medicine . women who may become pregnant are advised to use effective contraception during simbrinza treatment . the use of simbrinza is not recommended during pregnancy . do not use simbrinza unless clearly indicated by your doctor . if you are breast - feeding , simbrinza may pass into your milk . the use of simbrinza is not recommended during breast - feeding . driving and using machines you may find that your vision is blurred or abnormal for a time just after using simbrinza . simbrinza may also cause dizziness , drowsiness or tiredness in some patients . do not drive or use machines until the symptoms are cleared . wearing contact lenses - simbrinza contains benzalkonium chloride this medicine contains 0 . 15 mg benzalkonium chloride in each 5 ml , which is equivalent to 0 . 03 mg / ml . benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses . you should remove contact lenses before using this medicine and put them back 15 minutes afterwards . benzalkonium chloride may also cause eye irritation , especially if you have dry eyes or a disorder of the cornea ( the clear layer at the front of the eye ). if you feel abnormal eye sensation , stinging or pain in the eye after using this medicine , talk to your doctor .
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrastim or to any of the other ingredients of filgrastim ratiopharm . take special care with filgrastim ratiopharm - if you experience a cough , fever and difficulty breathing . it could be a consequence of a pulmonary disorder ( see section " 4 . possible side effects "). - if you have sickle cell disease ; or 57 - if you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section " 4 . possible side effects "). you will need to have regular blood tests whilst being treated with filgrastim ratiopharm to count the number of neutrophils and other white blood cells in your blood . this will tell your doctor how well the treatment is working and will also indicate if treatment needs to be continued . using other medicines please tell your doctor or pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor or pharmacist for advice before taking any medicine . filgrastim ratiopharm has not been tested in pregnant women . it is important to tell your doctor if you are pregnant , think you may be pregnant or plan to get pregnant , as the doctor may decide that you should not use this medicine . it is unknown whether filgrastim passes over to the breast milk . therefore , your doctor may decide that you should not use this medicine if you are breast - feeding . driving and using machines if you experience fatigue , do not drive or use any tools or machines . important information about some of the ingredients of filgrastim ratiopharm this medicine contains sorbitol ( a type of sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not take riluzole zentiva - if you are allergic to riluzole or any of the other ingredients of this medicine ( listed in section 6 ), - if you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ), - if you are pregnant or breast - feeding . warnings and precautions talk to your doctor before taking riluzole zentiva : - if you have any liver problems : yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick , being sick - if your kidneys are not working very well - if you have any fever : it may be due to a low number of white blood cells which can cause an increased risk of infection if any of the above applies to you , or if you are not sure , tell your doctor who will decide what to do . children and adolescents if you are less than 18 years of age , the use of riluzole zentiva is not recommended because there is no information available in this population . other medicines and riluzole zentiva tell your doctor if you are taking , have recently taken or might take any other medicines . pregnancy , breast - feeding and fertility you must not take riluzole zentiva if you are or think you may be pregnant , or if you are breast - feeding . if you think you may be pregnant , or if you intend to breast - feed , ask your doctor for advice before taking riluzole zentiva . driving and using machines you can drive or use any tools or machines , unless you feel dizzy or light headed after taking this medicine .
do not use emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment with emgality if : - you have a serious cardiovascular disease . emgality has not been studied in patients with serious cardiovascular diseases . look out for allergic reactions emgality can potentially cause serious allergic reactions . you must look out for signs of these reactions while you are using emgality . stop using emgality and tell your doctor or seek medical help 40 immediately if you notice any signs of a serious allergic reaction . such signs are listed under " serious side effects " in section 4 . children and adolescents this medicine should not be given to children and adolescents under 18 years of age because it has not been studied in this age group . other medicines and emgality tell your doctor , pharmacist or nurse if you are using , have recently used or might use any other medicines . pregnancy and breast - feeding if you are a woman able to have children , you are advised to avoid becoming pregnant while using emgality . if you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . it is preferable to avoid the use of emgality in pregnancy as the effects of this medicine in pregnant women are not known . if you are breast - feeding or are planning to breast - feed , talk to your doctor before using this medicine . you and your doctor should decide if you should breast feed and use emgality . driving and using machines galcanezumab could have a minor effect on your ability to drive and use machines . some patients have had vertigo whilst using emgality . emgality contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per 120 mg dose , that is to say it is essentially " sodium - free ".
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you are using other medicines to break down blood clots such as tissue plasminogen activator warnings and precautions talk to your doctor before using defitelio : if you are taking medicine that increases the risk of bleeding if you have heavy bleeding and need a blood transfusion if you are undergoing surgery if you have problems with blood circulation because your body cannot maintain a constant blood pressure . children and adolescents defitelio is not recommended in children less than 1 month of age . other medicines and defitelio tell your doctor if you are taking medicines to prevent blood clotting such as acetylsalicylic acid , heparins , warfarin , dabigatran , rivaroxaban or apixaban or if you are taking anti - inflammatory medicines ( e . g ., ibuprofen , naproxen , diclofenac and other non - steroidal anti - inflammatory medicines ). pregnancy and breast - feeding do not use defitelio if you are pregnant unless your disease requires treatment with defitelio . if you are sexually active and you or your partner could become pregnant , you both must use effective contraception during treatment with defitelio and for 1 week after stopping the treatment . driving and using machines it is not expected that defitelio will affect your ability to drive and operate machines . defitelio contains sodium this medicine contains less than 23 mg of sodium , which means it is essentially " sodium - free ".
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ) if you are taking ( by mouth or other ways that affect the whole body ) any of the following medicines - phenytoin , carbamazepine , oxcarbazepine or phenobarbital , used to treat epileptic seizures - rifampicin , rifabutin or rifapentine , antibiotics used to treat tuberculosis - dexamethasone , a steroid used to treat allergic and inflammatory diseases - medicines containing st . john ' s wort ( hypericum perforatum , a herbal preparation ). these medicines lower the effect of daklinza and may result in your treatment not working . if you take any of these medicines , tell your doctor immediately . since daklinza must always be used in combination with other medicines against hepatitis c infection , please make sure that you read the " do not take " section of the package leaflets for these medicines . if you are unsure of any information in the package leaflets , please contact your doctor or pharmacist . warnings and precautions talk to your doctor or pharmacist before taking daklinza . tell your doctor if any of the following applies : you currently take , or have taken in the last few months , the medicine amiodarone to treat irregular heartbeats ( your doctor may consider alternative treatments if you have taken this medicine ) you have a current or previous infection with the hepatitis b virus , since your doctor may want to monitor you more closely your liver is damaged and not functioning properly ( decompensated liver disease ) you have diabetes . you may need closer monitoring of your blood glucose levels and / or adjustment of your diabetes medication after starting daklinza . some diabetic patients have experienced low sugar levels in the blood ( hypoglycaemia ) after starting treatment with medicines like daklinza . tell your doctor immediately if you are taking any medicines for heart problems and during treatment you experience : shortness of breath light - headedness palpitations fainting children and adolescents daklinza is not recommended for patients below 18 years of age . daklinza has not yet been studied in children and adolescents . other medicines and daklinza tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is because daklinza may affect the way some medicines work . in addition some medicines may affect the way daklinza works . your doctor may need to adjust the dose of daklinza or you may not be able to take daklinza with certain medicines . do not take daklinza if you are taking any of the following medicines : phenytoin , carbamazepine , oxcarbazepine or phenobarbital , used to treat epileptic seizures rifampicin , rifabutin or rifapentine , antibiotics used to treat tuberculosis dexamethasone , a steroid used to treat allergic and inflammatory diseases medicines containing st . john ' s wort ( hypericum perforatum , a herbal preparation ). these medicines lower the effect of daklinza so your treatment will not work . if you take any of these medicines , tell your doctor immediately . tell your doctor or pharmacist if you take any of the following medicines : amiodarone or digoxin , used to treat irregular heart beats atazanavir / ritonavir , atazanavir / cobicistat , elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil fumarate combination tablet , etravirine , nevirapine or efavirenz , used to treat hiv infection boceprevir or telaprevir , used to treat hepatitis c infection clarithromycin , telithromycin or erythromycin , used to treat bacterial infections warfarin and other similar medicines called vitamin k antagonists used to thin the blood . your doctor may need to increase the frequency of your blood tests to check how well your blood can clot . dabigatran etexilate , used to to prevent blood clots 48 ketoconazole , itraconazole , posaconazole or voriconazole , used to treat fungal infections verapamil , diltiazem , nifedipine or amlodipine , used to decrease blood pressure rosuvastatin , atorvastatin , fluvastatin , simvastatin , pitavastatin or pravastatin , used to lower blood cholesterol oral contraceptives with some of these medicines , your doctor may need to adjust your dose of daklinza . pregnancy and contraception tell your doctor if you are pregnant , think you may be pregnant or are planning to become pregnant . if you become pregnant , stop taking daklinza and tell your doctor immediately . if you are pregnant you must not take daklinza . if you can become pregnant , use effective contraception during and for 5 weeks after your treatment with daklinza . daklinza is sometimes used together with ribavirin . ribavirin can harm your unborn baby . it is therefore very important that you ( or your partner ) do not become pregnant during this treatment . breast - feeding it is not known whether daklinza passes into human breast milk . you should not breastfeed during treatment with daklinza . driving and using machines some patients have reported dizziness , difficulty concentrating , and vision problems while taking daklinza with other medicines for their hepatitis c infection . if you have any of these side effects , do not drive or use any tools or machines . daklinza contains lactose if you have been told by your doctor that you have an intolerance to some sugars ( e . g . lactose ), talk to your doctor before taking daklinza . daklinza contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per maximum dose of 90 mg , that is to say essentially ' sodium - free '.
do not use proquad if the person to be vaccinated is allergic to any varicella vaccine or measles , mumps , or rubella vaccine or to any of the ingredients of this vaccine ( listed in section 6 ) including neomycin . if the person to be vaccinated has a blood disorder or any type of cancer that affects the immune system . if the person to be vaccinated is receiving treatment or taking medications that may weaken the immune system ( except low - dose corticosteroid therapy for asthma or replacement therapy ). if the person to be vaccinated has a weakened immune system because of a disease ( including aids ). if the person to be vaccinated has a family history of congenital or hereditary immunodeficiency , unless the immune competence of this person is demonstrated . if the person to be vaccinated has active untreated tuberculosis . if the person to be vaccinated has any illness with fever higher than 38 . 5 ; however , low - grade fever itself is not a reason to delay vaccination . if the person to be vaccinated is pregnant ( in addition , pregnancy should be avoided for 1 month after vaccination , see pregnancy and breast - feeding ). warnings and precautions if the person to be vaccinated has experienced any of the following , talk to the doctor or pharmacist before proquad is given : an allergic reaction to eggs or anything that contained egg . a history or family history of allergies or of convulsions ( fits ). a side effect after vaccination with measles , mumps , and / or rubella - containing vaccines that involved easy bruising or bleeding for longer than usual . an infection with human immunodeficiency virus ( hiv ) without showing symptoms of hiv disease . however , vaccination may be less effective than for uninfected persons ( see do not use proquad ). if you have a blood clotting disorder or low levels of platelets in your blood , the injection will be given under the skin . in rare circumstances , it is possible to catch chickenpox , including severe chickenpox , from a person who has been vaccinated with proquad . this may occur in persons who have not previously been vaccinated against chickenpox or had chickenpox , as well as persons who fall into one of the following categories : individuals with a lowered resistance to diseases . pregnant women who have either not had chickenpox or have not been vaccinated against chickenpox . newborn infants of mothers who have either not had chickenpox or have not been vaccinated against chickenpox . whenever possible , individuals who have been vaccinated with proquad should attempt to avoid close contact , for up to 6 weeks following the vaccination , with anyone who falls into one of the categories above . tell your doctor if there is anyone who falls into one of the categories above and is expected to be in close contact with the person being vaccinated . as with other vaccines , proquad may not completely protect all persons who are vaccinated . also , if the person to be vaccinated has already been exposed to the measles , mumps , rubella , or varicella virus but is not yet ill , proquad may not be able to prevent the illness from appearing . other medicines and proquad tell your doctor or pharmacist if the person to be vaccinated is taking or has recently taken any other medicines ( or other vaccines ). proquad can be given at the same time as other childhood vaccines such as prevenar , and / or hepatitis a vaccine , or with vaccines containing diphtheria , tetanus , acellular pertussis , haemophilus influenzae type b , inactivated poliomyelitis , or hepatitis b . a different place for the injection will be used for each vaccine . the doctor may delay vaccination for at least 3 months following blood or plasma transfusions , or administration of immune globulin ( ig ), or varicella - zoster immune globulin ( vzig ). after vaccination with proquad , ig or vzig should not be given for 1 month , unless your doctor tells you otherwise . if a tuberculin test is to be performed , it should be done either any time before , simultaneously with , or 4 to 6 weeks after vaccination with proquad . tell the doctor if the person to be vaccinated has recently received a vaccine or if one is scheduled to be given in the near future . the doctor will determine when proquad may be given . the use of salicylates ( for example , acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever ) should be avoided for 6 weeks following vaccination with proquad . pregnancy and breast - feeding proquad should not be given to pregnant women . women of child - bearing age should take the necessary precautions to avoid pregnancy for 1 month following vaccination . persons who are breast - feeding or who intend to breast - feed should tell the doctor . the doctor will decide if proquad should be given . if you are pregnant or breast - feeding , think you may be pregnant , or are planning to have a baby , ask your doctor or pharmacist for advice before taking this vaccine . proquad contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dose , that is to say essentially ' sodium - free '. proquad contains potassium this medicine contains less than 1 mmol potassium ( 39 mg ) per dose , that is to say essentially ' potassium - free '. proquad contains sorbitol the additive effect of concomitantly administered products containing sorbitol ( or fructose ) and dietary intake of sorbitol ( or fructose ) should be taken into account .
do not take jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - if you have a severe kidney impairment ( or your doctor classes the impairment as severe ) - if you have a liver impairment - if you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 - if you drink alcohol excessively - if you have a weakened immune system - if you are suffering from a serious infection such as tuberculosis or hiv - if you have ulcers in the stomach or in the intestines - if you have an inflammation of the mucous membrane of the mouth or mouth ulcers - if you are breast - feeding and additionally , for non - oncologic indications ( for non - cancer treatment ) if you are pregnant ( see section " pregnancy , breast - feeding and fertility ") - if you have had a live vaccine recently or are about to have one warnings and precautions important warning about the dose of jylamvo ( methotrexate ): this oral solution contains 2 mg methotrexate in 1 ml solution and the scaling of the dosing syringe is in ml and not mg . take jylamvo only once a week for the treatment of rheumatic or skin diseases ( ra , jia and psoriasis or psoriatic arthritis ). taking too much of jylamvo ( methotrexate ) may be fatal . please read section 3 of this leaflet very carefully . if you have any questions , please talk to your doctor or pharmacist before you take this medicine . talk to your doctor or pharmacist before taking jylamvo : - if you have diabetes mellitus treated with insulin - if you are suffering from inactive , chronic infections ( e . g . tuberculosis , hepatitis b or c , shingles [ herpes zoster ]) as they may flare up - if you have ever had any liver or kidney disease - if you have problems with your lung function - if you are particularly overweight - if you have an abnormal build - up of fluid in the abdomen ( ascites ) or around the lungs ( pleural effusions ) - if you are dried out ( dehydrated ) or suffer from conditions that result in dehydration ( vomiting , diarrhoea , constipation , inflammation of the mucous membrane of the mouth ) if you had skin problems after radiotherapy ( radiation dermatitis ) or sunburn , these reactions can recur after methotrexate therapy ( recall reaction ). enlarged lymph nodes ( lymphoma ) may occur in patients receiving low dose methotrexate and if this is the case , therapy must be stopped . acute bleeding from the lungs in patients with underlying rheumatologic disease has been reported with methotrexate . if you experience symptoms of spitting or coughing up blood you should contact your doctor immediately . diarrhoea can be a possible side effect of jylamvo and requires an interruption of therapy . if you suffer from diarrhoea please speak to your doctor . certain brain disorders ( encephalopathy / leukoencephalopathy ) have been reported in cancer patients receiving methotrexate . such side effects cannot be excluded when methotrexate is used to treat other diseases . psoriasis skin changes can become worse during treatment with methotrexate if you are under uv light . methotrexate temporarily affects sperm and egg production . methotrexate can cause miscarriage and severe birth defects . you and your partner should avoid having a baby if you are being given methotrexate at the time and for at least 6 months after the end of your treatment with methotrexate . see also section " pregnancy , breast - feeding and fertility ". recommended follow - up examinations and precautions severe side effects can occur even when methotrexate is used at low doses . your doctor must carry out investigations and laboratory tests in order to detect these effects as early as possible . before the beginning of treatment your doctor should perform blood tests before the beginning of treatment to check how well your kidneys and liver are working . you will possibly also have an x - ray of your chest . other tests may possibly be performed before and after treatment . do not miss your blood test appointments . if the results of any test are abnormal , the treatment will not be restarted until all the values have returned to normal . children , adolescents and elderly children , adolescents and the elderly treated with methotrexate should have particularly careful medical monitoring in order to detect important side effects quickly . this medicine is not recommended in children under 3 years of age as there is insufficient experience in this age group other medicines and jylamvo tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription and herbal or natural medicinal products . remember to inform your doctor about the treatment with jylamvo if you are prescribed another medicine during treatment . it is particularly important to tell your doctor if you are using the following medicines : - other medicines for rheumatoid arthritis or psoriasis , such as leflunomide , azathioprine ( also used to prevent rejection after an organ transplant ), sulfasalazine ( also used for ulcerative colitis ) - ciclosporin ( for supressing the immune system ) - non - steroidal anti - inflammatory drugs or salicylates ( medicines against pain and / or inflammation such as acetylsalicylic acid , diclofenac and ibuprofen or pyrazole ) - live vaccines - diuretics , that reduce fluid retention - medicines for lowering blood sugar levels such as metformin - retinoids ( for the treatment of psoriasis and other skin diseases ) - antiepileptic medicines ( prevention of seizures ) - barbiturates ( sleeping medicines ) - sedatives - oral contraceptives - probenecid ( for gout ) - antibiotics - pyrimethamine ( for the prevention and treatment of malaria ) - vitamin preparations containing folic acid - proton pump inhibitors ( for the treatment of heartburn , ulcers and some other stomach complaints ) - theophylline ( for breathing problems ) - mercaptopurine ( for the treatment of certain types of leukaemia ). - cancer treatments ( such as doxorubicin and procarbazine during high - dose methotrexate therapy ) jylamvo with food , drink and alcohol this medicine can be taken with or without food . when you have taken your dose , drink some water and swallow it to ensure you have taken your full dose and there is no methotrexate left in your mouth . you should not drink alcohol during treatment with jylamvo and should avoid drinking excessive 36 amounts of coffee , caffeinated drinks and black leaf tea . ensure that you drink a lot of fluids during treatment with jylamvo because dehydration ( the reduction of body water ) can increase the side effects of methotrexate . pregnancy do not use jylamvo during pregnancy except if your doctor has prescribed it for oncology treatment . methotrexate can cause birth defects , harm the unborn child or cause miscarriage . it is associated with malformations of the skull , face , heart and blood vessels , brain , and limbs . it is therefore very important that methotrexate is not given to pregnant women or to women who are planning to become pregnant unless used for oncology treatment . for non - oncological indications , in women of child - bearing age the possibility of a pregnancy must be ruled out , e . g . by pregnancy tests , before treatment is started . do not use jylamvo if you are trying to become pregnant . you must avoid becoming pregnant during treatment with methotrexate and for at least 6 months after the end of treatment . therefore you must ensure that you are taking effective contraception for the whole of this period ( see also section " warnings and precautions "). if you become pregnant during treatment or suspect you might be pregnant , speak to your doctor as soon as possible . if you do become pregnant during treatment , you should be offered advice regarding the risk of harmful effects on the child through treatment . if you want to become pregnant , you should speak with your doctor , who may refer you for specialist advice before the planned start of treatment . breast - feeding do not breast - feed during treatment as methotrexate passes into the breast milk . if your doctor considers that continuing treatment with methotrexate is essential , you must stop breast - feeding . male fertility the available evidence does not indicate an increased risk of malformations or miscarriage if the father takes methotrexate less than 30 mg ( 15 ml )/ week . however , a risk cannot be completely excluded and there is no information regarding higher methotrexate doses . methotrexate can have a genotoxic effect . this means that the medicine can cause genetic mutations . methotrexate can affect the production of sperm , which is associated with the possibility of birth defects . you should avoid fathering a child or to donate semen during treatment with methotrexate and for at least 6 months after the end of treatment . as treatment with methotrexate at higher doses commonly used in cancer treatment can cause infertility and genetic mutations , it may be advisable for male patients treated with methotrexate doses higher than 30 mg ( 15 ml )/ week to consider sperm preservation before the beginning of treatment ( see also section " warnings and precautions "). driving and using machines ! caution : this medicine can affect your capacity to react and your ability to drive . side effects affecting the central nervous system such as tiredness or dizziness can occur during treatment with jylamvo . in some cases the ability to drive or use machines may be affected . if you feel tired or dizzy , you should not drive a vehicle or use machines . jylamvo contains ethyl parahydroxybenzoate and sodium methyl parahydroxybenzoate ethyl parahydroxybenzoate ( e214 ) and sodium methyl parahydroxybenzoate ( e219 ) may cause allergic reactions ( possibly delayed ).
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enurev breezhaler , if any of the following applies to you : - you have kidney problems . - you have an eye problem called narrow - angle glaucoma . - you have difficulty passing urine . during treatment with enurev breezhaler , stop taking this medicine and tell your doctor immediately : - if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enurev breezhaler ( signs of bronchospasm ). - if you experience difficulties in breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). - if you experience eye pain or discomfort , temporary blurring of vision , visual halos or coloured images in association with red eyes . these may be signs of an acute attack of narrow - angle glaucoma . enurev breezhaler is used as a maintenance treatment for your copd . do not use this medicine to treat a sudden attack of breathlessness or wheezing . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and enurev breezhaler tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this includes medicines similar to enurev breezhaler used for your lung disease , such as ipratropium , oxitropium or tiotropium ( so called anticholinergics ). no specific side effects have been reported when enurev breezhaler has been used together with other medicines used to treat copd such as reliever inhalers ( e . g . salbutamol ), methylxanthines ( e . g . theophylline ) and / or oral and inhaled steroids ( e . g . prednisolone ). pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . there are no data from the use of this medicine in pregnant women and it is not known whether the active substance of this medicine passes into human milk . driving and using machines it is unlikely that this medicine will affect your ability to drive and use machines . enurev breezhaler contains lactose this medicine contains lactose . if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not take riximyo if you are allergic to rituximab , other proteins which are like rituximab , or any of the other ingredients of this medicine ( listed in section 6 ). you have a severe active infection at the moment you have a weak immune system . you have severe heart failure or severe uncontrolled heart disease and have granulomatosis with polyangiitis , microscopic polyangiitis or pemphigus vulgaris . do not have riximyo if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before you are given riximyo . warnings and precautions talk to your doctor , pharmacist or nurse before you are given riximyo if : you have ever had or might now have a hepatitis infection . this is because in a few cases , riximyo could cause hepatitis b to become active again , which can be fatal in very rare cases . patients who have ever had hepatitis b infection will be carefully checked by their doctor for signs of this infection . you have ever had heart problems ( such as angina , palpitations or heart failure ) or breathing problems . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given riximyo . your doctor may need to take special care of you during your treatment with riximyo . if you have granulomatosis with polyangiitis , microscopic polyangiitis or pemphigus vulgaris also tell your doctor if you think you may have an infection , even a mild one like a cold . the cells that are affected by riximyo help to fight infection and you should wait until the infection has passed before you are given riximyo . also please tell your doctor if you had a lot of infections in the past or suffer from severe infections . if you think you may need any vaccinations in the near future , including vaccinations needed to travel to other countries . some vaccines should not be given at the same time as riximyo or in the months after you receive riximyo . your doctor will check if you should have any vaccines before you receive riximyo . children and adolescents talk to your doctor , pharmacist or nurse before you are given this medicine if you , or your child , are under 18 years of age . this is because there is not much information about the use of rituximab in children and young people . other medicines and riximyo tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . this includes medicines obtained without a prescription and herbal medicines . this is 58 because riximyo can affect the way some other medicines work . also some other medicines can affect the way riximyo works . in particular , tell your doctor : if you are taking medicines for high blood pressure . you may be asked not to take these other medicines 12 hours before you are given riximyo . this is because some people have a fall in their blood pressure while they are being given riximyo . if you have ever taken medicines which affect your immune system such as chemotherapy or immune - suppressive medicines . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given riximyo . pregnancy and breast - feeding you must tell your doctor or nurse if you are pregnant , think that you might be pregnant or are planning to become pregnant . this is because riximyo can cross the placenta and may affect your baby . if you can get pregnant , you and your partner must use an effective method of contraception while using riximyo . you must also do this for 12 months after your last treatment with riximyo . do not breast - feed while you are being treated with riximyo . also do not breast - feed for 12 months after your last treatment with riximyo . this is because riximyo may pass into breast milk . driving and using machines rituximab may make you feel dizzy and may affect your ability to drive or use any tools or machines . if you feel dizzy , do not drive or use any tools or machines . riximyo contains sodium this medicine contains 2 . 3 mmol ( or 52 . 6 mg ) sodium per 10 ml vial . this medicine contains 11 . 5 mmol ( or 263 . 2 mg ) sodium per 50 ml vial . to be taken into consideration by patients on a controlled sodium diet .
do not use topotecan actavis - if you are allergic to topotecan or any of the other ingredients of this medicine ( listed in section 6 ); - if you are breast - feeding . you should stop breast - feeding before starting treatment with topotecan actavis ; - if your blood cell counts are too low . tell you doctor if you think any of these could apply to you . warnings and precautions talk to your doctor before using topotecan actavis : - if you have any kidney problems . your dose of topotecan actavis may need to be adjusted . topotecan actavis is not recommended in case of severe kidney impairment ; - if you have liver problems . topotecan actavis is not recommended in case of severe liver impairment ; - if you suffer from lung inflammation with signs such as cough , fever and difficulties in breathing , see also section 4 " possible side effects ". topotecan actavis may cause a decrease in the number of blood clotting cells ( platelets ). this can lead to severe bleeding from relatively small injuries such as a small cut . rarely , it can lead to more severe bleeding ( haemorrhage ). talk to your doctor for advice on how to minimize the risk of bleeding . the incidence of side effects is more frequent in patients who are in poor general health . the doctor will evaluate your general health during the treatment and you should tell him / her in case you have fever , infection or are in some ways feeling unwell . use in children and adolescents the experience in children and adolescents is limited and treatment is therefore not recommended . other medicines and topotecan actavis tell your doctor if you are taking , have recently taken or might take any other medicines . pregnancy and breast - feeding topotecan actavis should not be used in pregnant women , unless clearly necessary . if you are or think you might be pregnant , tell your doctor immediately . effective contraception methods should be used to avoid becoming pregnant / fathering a child while on treatment . ask your doctor for advice . patients who are concerned about their fertility should ask their doctor for counselling on fertility and family planning options prior to starting treatment . you must not breast - feed while on treatment with topotecan actavis . driving and using machines topotecan actavis can make you feel tired or weak . if you experience this , do not drive or use machines . topotecan actavis contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per vial , i . e . essentially ' sodium - free '.
do not take rivastigmine hexal - if you are allergic to rivastigmine ( the active substance in rivastigmine hexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if you have had a previous skin reaction suggestive of allergic contact dermatitis with rivastigmine . if this applies to you , tell your doctor and do not take rivastigmine hexal . warnings and precautions talk to your doctor before taking rivastigmine hexal - if you have , or have ever had , irregular or slow heartbeat . - if you have , or have ever had , an active stomach ulcer . - if you have , or have ever had , difficulties in passing urine . - if you have , or have ever had , seizures . - if you have , or have ever had , asthma or severe respiratory disease . - if you have , or have ever had impaired kidney function . - if you have , or have ever had , impaired liver function . - if you suffer from trembling . - if you have a low body weight . - if you have gastrointestinal reactions such as feeling sick ( nausea ), being sick ( vomiting ) and diarrhoea . you may become dehydrated ( losing too much fluid ) if vomiting or diarrhoea are prolonged . if any of these apply to you , your doctor may need to monitor you more closely while you are on this medicine . if you have not taken rivastigmine hexal for more than three days , do not take the next dose until you have talked to your doctor . children and adolescents there is no relevant use of rivastigmine hexal in the paediatric population in the treatment of alzheimer ' s disease . other medicines and rivastigmine hexal tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . rivastigmine hexal should not be given at the same time as other medicines with similar effects to rivastigmine hexal . rivastigmine hexal might interfere with anticholinergic medicines ( medicines used to relieve stomach cramps or spasms , to treat parkinson ' s disease or to prevent travel sickness ). rivastigmine hexal should not be given at the same time as metoclopramide ( a medicine used to relieve or prevent nausea and vomiting ). taking the two medicines together could cause problems such as stiff limbs and trembling hands . if you have to undergo surgery whilst taking rivastigmine hexal , tell your doctor before you are given any anaesthetics , because rivastigmine hexal may exaggerate the effects of some muscle relaxants during anaesthesia . caution when rivastigmine hexal is taken together with beta - blockers ( medicines such as atenolol used to treat hypertension , angina and other heart conditions ). taking the two medicines together could cause problems such as slowing of the heartbeat ( bradycardia ) leading to fainting or loss of consciousness . pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . if you are pregnant , the benefits of using rivastigmine hexal must be assessed against the possible effects on your unborn child . rivastigmine hexal should not be used during pregnancy unless clearly necessary . you should not breast - feed during treatment with rivastigmine hexal . driving and using machines your doctor will tell you whether your illness allows you to drive vehicles and use machines safely . rivastigmine hexal may cause dizziness and somnolence , mainly at the start of treatment or when increasing the dose . if you feel dizzy or sleepy , do not drive , use machines or perform any tasks that require your attention .
do not take cabometyx 45 - - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabometyx if you : - have high blood pressure - have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a blood vessel wall - have diarrhoea - have a recent history of significant bleeding - have had surgery within the last month ( or if surgical procedures are planned ), including dental surgery - have inflammatory bowel disease ( for example , crohn ' s disease or ulcerative colitis , diverticulitis , or appendicitis ) - have a recent history of blood clot in the leg , stroke , or heart attack - have liver or kidney disease . tell your doctor if any of these affect you . you may need treatment for them , or your doctor may decide to change your dose of cabometyx , or stop treatment altogether . see also section 4 " possible side effects ". children and adolescents cabometyx is not recommended for children or adolescents . the effects of cabometyx in people younger than 18 years old are not known . other medicines and cabometyx please tell your doctor or pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . this is because cabometyx can affect the way some other medicines work . also , some medicines can affect the way cabometyx works . this could mean that your doctor needs to change the dose ( s ) that you take . you should tell your doctor about every medicine , but in particular if taking : - medicines that treat fungal infections , such as itraconazole , ketoconazole , and posaconazole - medicines used to treat bacterial infections ( antibiotics ) such as erythromycin , clarithromycin , and rifampicin - allergy medicines such as fexofenadine and ranolazine - medicines used to treat epilepsy or fits such as phenytoin , carbamazepine , and phenobarbital - herbal preparations containing st . john ' s wort ( hypericum perforatum ), sometimes used for treating depression or depression - related conditions such as anxiety - medicines used to thin the blood , such as warfarin - medicines to treat high blood pressure or other heart conditions , such as aliskiren , ambrisentan , dabigatran etexilate , digoxin , talinolol , and tolvaptan - medicines for diabetes , such as saxagliptin and sitagliptin - medicines used to treat gout , such as colchicine - medicines used to treat hiv or aids , such as efavirenz , ritonavir , maraviroc and emtricitabine - medicines used to prevent transplant rejection ( ciclosporin ) and ciclosporin - based regimens in rheumatoid arthritis and psoriasis 46 oral contraceptives if you take cabometyx whilst using oral contraceptives , the oral contraceptives may be ineffective . you should also use a barrier contraceptive ( e . g . condom or diaphragm ) whilst taking cabometyx and for at least 4 months after treatment has finished . taking cabometyx with food you should not take cabometyx with food . you should not eat anything for at least 2 hours before taking cabometyx and for 1 hour after taking the medicine . avoid consuming grapefruit - containing products for as long as you are using this medicine , as they may increase the levels of cabometyx in your blood . pregnancy , breast - feeding and fertility avoid becoming pregnant while being treated with cabometyx . if you or your partner could become pregnant , use adequate contraception during treatment and for at least 4 months after treatment has finished . talk to your doctor about which methods of contraception are appropriate while you are taking cabometyx ( see also under other medicines and cabometyx , above ). tell your doctor if you or your partner become pregnant or plan to become pregnant while you are being treated with cabometyx . talk to your doctor before taking cabometyx if you or your partner are considering or planning to have a baby after your treatment has finished . there is a possibility your fertility could be affected by treatment with cabometyx . women taking cabometyx should not breast - feed during treatment and for at least 4 months after treatment has finished , as cabozantinib and / or its metabolites may be excreted in breast milk and be harmful to your child . driving and using machines use caution when driving or using machines . keep in mind that treatment with cabometyx may make you feel tired or weak and can affect your ability to drive or use machines . cabometyx contains lactose cabometyx contains lactose ( a type of sugar ). if you have been told by your doctor that you have an intolerance to some sugars , talk to your doctor before taking this medicine .
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of this medicine ( listed in section 6 ). - if you are breast - feeding ; you must discontinue breast - feeding during treatment with pemetrexed hospira . - if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving pemetrexed hospira . if you currently have or have previously had problems with your kidneys , talk to your doctor or hospital pharmacist as you may not be able to receive pemetrexed hospira . before each infusion you will have samples of your blood taken to evaluate if you have sufficient kidney and liver function and to check that you have enough blood cells to receive pemetrexed hospira . your doctor may decide to change the dose or delay treating you depending on your general condition and if your blood cell counts are too low . if you are also receiving cisplatin , your doctor will make sure that you are properly hydrated and receive appropriate treatment before and after receiving cisplatin to prevent vomiting . if you have had or are going to have radiation therapy , please tell your doctor , as there may be an early or late radiation reaction with pemetrexed hospira . if you have been recently vaccinated , please tell your doctor , as this can possibly cause bad effects with pemetrexed hospira . if you have heart disease or a history of heart disease , please tell your doctor . if you have an accumulation of fluid around your lungs , your doctor may decide to remove the fluid before giving you pemetrexed hospira . children and adolescents this medicine should not be used in children or adolescents , since there is no experience with this medicine in children and adolescents under 18 years of age . other medicines and pemetrexed hospira please tell your doctor if you are taking any medicine for pain or inflammation ( swelling ), such as medicines called " nonsteroidal anti - inflammatory drugs " ( nsaids ), including medicines purchased without a doctor ' s prescription ( such as ibuprofen ). there are many sorts of nsaids with different durations of activity . based on the planned date of your infusion of pemetrexed and / or on the status of your kidney function , your doctor needs to advise you on which medicines you can take and when you can take them . if you are unsure , ask your doctor or pharmacist if any of your medicines are nsaids . please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy if you are pregnant , think you may be pregnant or are planning to have a baby , tell your doctor . the use of pemetrexed should be avoided during pregnancy . your doctor will discuss with you the potential risk of taking pemetrexed during pregnancy . women must use effective contraception during treatment with pemetrexed . breast - feeding if you are breast - feeding , tell your doctor . breast - feeding must be discontinued during treatment with pemetrexed . fertility men are advised not to father a child during and up to 6 months following treatment with pemetrexed and should therefore use effective contraception during treatment with pemetrexed and for up to 6 months afterwards . if you would like to father a child during the treatment or in the 6 months following receipt of treatment , seek advice from your doctor or pharmacist . you may want to seek counselling on sperm storage before starting your therapy . driving and using machines pemetrexed hospira may make you feel tired . be careful when driving a car or using machines . pemetrexed hospira contains sodium pemetrexed hospira 100 mg powder for concentrate for solution for infusion this medicine contains less than 1 mmol sodium ( 23 mg ) per vial , that is to say essentially ' sodium - free '. pemetrexed hospira 500 mg powder for concentrate for solution for infusion this medicine contains 54 mg sodium ( main component of cooking / table salt ) in each vial . this is equivalent to 2 . 7 % of the recommended maximum daily dietary intake of sodium for an adult . pemetrexed hospira 1 , 000 mg powder for concentrate for solution for infusion this medicine contains 108 mg sodium ( main component of cooking / table salt ) in each vial . this is equivalent to 5 . 4 % of the recommended maximum daily dietary intake of sodium for an adult .
do not use ganfort eye drops , solution - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of ganfort ( listed in section 6 ) - if you have now or have had in past respiratory problems such as asthma , severe chronic obstructive bronchitis ( severe lung disease which may cause wheeziness , difficulty in breathing and / or long - standing cough ) - if you have heart problems such as low heart rate , heart block , or heart failure warnings and precautions before you use this medicine , tell your doctor if you have now or have had in the past - coronary heart disease ( symptoms can include chest pain or tightness , breathlessness or choking ), heart failure , low blood pressure , 44 - disturbances of heart rate such as slow heart beat - breathing problems , asthma or chronic obstructive pulmonary disease - poor blood circulation disease ( such as raynaud ' s disease or raynaud ' s syndrome ) - overactivity of the thyroid gland as timolol may mask signs and symptoms of thyroid disease - diabetes as timolol may mask signs and symptoms of low blood sugar - severe allergic reactions - liver or kidney problems - eye surface problems - separation of one of the layers within the eyeball after surgery to reduce the pressure in the eye - known risk factors for macular oedema ( swelling of the retina within the eye leading to worsening vision ), for example , cataract surgery tell your doctor before surgical anaesthesia that you are using ganfort as timolol may change effects of some medicines used during anaesthesia . ganfort may cause your eyelashes to darken and grow , and cause the skin around the eyelid to darken too . the colour of your iris may also go darker over time . these changes may be permanent . the change may be more noticeable if you are only treating one eye . ganfort may cause hair growth when in contact with the skin surface . children and adolescents ganfort should not be used in children and teenagers under 18 . other medicines and ganfort ganfort can affect or be affected by other medicines you are using , including other eye drops for the treatment of glaucoma . please tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . tell your doctor if you are using or intend to use medicines to lower blood pressure , heart medicine , medicines to treat diabetes , quinidine ( used to treat heart conditions and some types of malaria ) or medicines to treat depression known as fluoxetine and paroxetine . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . do not use ganfort if you are pregnant unless your doctor still recommends it . do not use ganfort if you are breast - feeding . timolol may get into your breast milk . ask your doctor for advice before taking any medicine during breast - feeding . driving and using machines ganfort may cause blurred vision in some patients . do not drive or use machines until the symptoms have cleared . ganfort contains benzalkonium chloride ganfort contains a preservative called benzalkonium chloride . this medicine contains 0 . 15 mg benzalkonium chloride in each 3 ml of solution which is equivalent to 0 . 05 mg / ml . benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses . you should remove contact lenses before using this medicine and put them back 15 minutes afterwards . benzalkonium chloride may also cause eye irritation , especially if you have dry eyes or disorders of the cornea ( the clear layer at the front of the eye ). if you feel abnormal eye sensation , stinging or pain in the eye after using this medicine , talk to your doctor .
do not take gefitinib mylan : - if you are allergic to gefitinib or any of the other ingredients of this medicine ( listed in section 6 ). - if you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking gefitinib mylan - if you have ever had any other lung problems . some lung problems may get worse during treatment with gefitinib mylan . - if you have ever had problems with your liver . children and adolescents gefitinib mylan is not indicated in children and adolescents under 18 years . other medicines and gefitinib mylan tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . in particular , tell your doctor or pharmacist if you are taking any of the following medicines : - phenytoin or carbamazepine ( for epilepsy ). - rifampicin ( for tuberculosis ). - itraconazole ( for fungal infections ). - barbiturates ( a type of medicine used for sleeping problems ). - herbal remedies containing st john ' s wort ( hypericum perforatum , used for depression and anxiety ). - proton - pump inhibitors , h2 - antagonists and antacids ( for ulcers , indigestion , heartburn and to reduce acids in the stomach ). these medicines may affect the way this medicine works . - warfarin ( a so - called oral anticoagulant , to prevent blood clots ). if you are taking a medicine containing this active substance , your doctor may need to do blood tests more often . if any of the above applies to you , or if you are not sure , check with your doctor or pharmacist before taking gefitinib mylan . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . it is recommended that you avoid becoming pregnant during treatment with this medicine because gefitinib mylan could harm your baby . do not take gefitinib mylan if you are breast - feeding for the safety of your baby . driving and using machines if you feel weak whilst taking this medicine , take care driving or using tools or machines . gefitinib mylan contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine . gefitinib mylan contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per tablet , that is to say essentially ' sodium - free '.
do not use reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you are pregnant ( see section on pregnancy ) warnings and precautions talk to your doctor before being given this medicine if : you are a  - thalassaemia patient and you have had your spleen removed . you may have a higher risk of getting a blood clot . your doctor will talk to you about other possible risk factors that may increase your risk these include : o hormone replacement therapy or o a previous blood clot your doctor may use preventive measures or medicines to reduce the chances of you getting a blood clot . you have ever had high blood pressure this is because reblozyl may increase it . your blood pressure will be checked before you are given reblozyl and throughout treatment . routine tests you will have a blood test before each dose of this medicine . this is because your doctor needs to make sure your haemoglobin level is suitable for you to be given treatment . if you have kidney problems , your doctor may perform additional tests . children and adolescents this medicine is not recommended for use in children and adolescents under 18 years . other medicines and reblozyl tell your doctor if you are taking , have recently taken or might take any other medicines . pregnancy do not use this medicine during pregnancy and for at least 3 months before getting pregnant . reblozyl may cause harm to your unborn baby . your doctor will arrange a pregnancy test before starting treatment . if you think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . breast - feeding do not breast - feed when using this medicine and for 3 months after your last dose . it is not known if it passes into the mother ' s milk . contraception you should use an effective method of contraception during treatment with reblozyl and for at least 3 months after your last dose . talk to your doctor about contraceptive methods that may be right for you while you are using this medicine . fertility if you are a woman , this medicine may cause fertility problems . this could affect your ability to have a baby . talk to your doctor for advice before using it . driving and using machines you may feel tired , dizzy , or faint , while using reblozyl . if this happens do not drive or use any tools or machines and contact your doctor straight away . reblozyl contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dose , that is to say essentially ' sodium - free '.
do not take fotivda : if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ); if you are taking st . john ' s wort ( also known as hypericum perforatum , a herbal remedy used for treatment of depression and anxiety ). warnings and precautions talk to your doctor , pharmacist or nurse before taking fotivda : if you have high blood pressure . fotivda can increase your blood pressure . your doctor will monitor your blood pressure regularly and , if it is too high , may either give you a medicine to lower it , or reduce your dose of fotivda . however , if your blood pressure remains too high , your doctor may decide to interrupt or to stop treatment with fotivda . if you are already taking a medicine to treat high blood pressure , and your doctor reduces the dose of fotivda or interrupts or stops treatment , you will be regularly checked for low blood pressure . if you have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a blood vessel wall . if you have had problems with blood clots . treatment with fotivda may raise the risk of developing a blood clot ( thrombus ) in your blood vessels that could break loose and be carried by the blood stream to block another blood vessel . tell your doctor if you have ever had one of the following : o a blood clot in your lungs ( with cough , chest pain , sudden shortness of breath or coughing up blood ), o blood clot in your legs or arms , eye , or brain ( with pain or swelling in your hands or feet , reduced vision , or changes in your mental state ) o a stroke , or signs and symptoms of a ' mini - stroke ' ( transient ischaemic attack ) o a heart attack o high blood pressure o diabetes o major surgery o multiple injuries such as broken bones and damage to internal organs o inability to move for a long period o heart failure which can cause shortness of breath or ankle swelling o inability to breathe , bluish colour on your skin , fingertips or lips , restlessness , anxiety , confusion , altered consciousness or sense of awareness , rapid , shallow breathing , a racing heart or excessive sweating . if you suffer or have suffered from any of these symptoms or are treated for heart failure : o shortness of breath ( dyspnoea ) when you exert yourself or when you lie down o feeling weak and tired o swelling ( oedema ) in your legs , ankles and feet o reduced ability to exercise o persistent cough or wheezing with white or pink blood - tinged phlegm signs and symptoms of heart failure will be monitored whilst you are taking your medicine . if necessary , your doctor may reduce your dose of fotivda , or interrupt or stop this treatment . if you have or are treated for an abnormal rate and rhythm of the heartbeat ( arrhythmia ). your doctor will monitor the effect of fotivda on your heart by recording the electrical activity of your heart ( an electrocardiogram ) or by measuring your blood calcium , magnesium and potassium levels during your treatment . if you have problems with your liver . your doctor will regularly monitor how well your liver is working before and during treatment with fotivda ( e . g . with blood tests ), and if necessary may need to reduce how often you take fotivda . if you have problems with your thyroid gland or use medicines to treat thyroid disease . treatment with fotivda may cause your thyroid gland to work less well than usual . your doctor will regularly monitor how well your thyroid gland is working before and during treatment with fotivda ( e . g . with blood tests ). talk to your doctor , pharmacist or nurse while taking fotivda : if you get shortness of breath or ankle swelling tell your doctor right away as these may be symptoms of heart failure . your doctor will monitor this , and depending on the severity may reduce your dose of fotivda , or interrupt or stop treatment with fotivda . if you have had problems with bleeding treatment with fotivda may increase the risk of bleeding . if you get bleeding problems ( with painful swollen stomach ( abdomen ), vomiting blood , coughing up blood , black stools , blood in 34 your urine , headache or changes in your mental state ), tell your doctor right away . treatment with fotivda may need to be temporarily stopped . if laboratory tests show that there is protein in your urine your doctor will monitor this at the beginning and during your treatment . depending on the results , your doctor may reduce your dose of fotivda , or interrupt or stop this treatment . if you suffer from a disease of the brain , called posterior reversible encephalopathy syndrome ( pres ) tell your doctor right away if you have symptoms such as headache , seizure ( fit ), lack of energy , confusion , blindness or other visual and neurologic disturbances such as weakness in an arm or a leg . if pres is diagnosed , your doctor will stop treatment with fotivda . if the skin on the palms of your hands and the soles of your feet become dry , cracked , scaling , or peeling , or is stinging or tingling these may be symptoms of a condition called hand foot skin reaction . your doctor will treat the condition and , depending on the severity , the doctor may reduce your dose of fotivda , or interrupt or stop this treatment . if you have symptoms of gastrointestinal perforation or fistula formation ( developing a hole in the stomach or intestine or abnormal passages forming between parts of the intestine ) such as severe stomach pain , chills , fever , nausea , vomiting or painful bowel obstruction , diarrhoea or rectal bleeding . your doctor will regularly monitor you for these symptoms during your treatment with fotivda . if you need to have an operation or another form of surgery your doctor may recommend that you temporarily stop taking fotivda if you have an operation or surgery , as it could affect wound healing . the printing ink used on the fotivda 890 microgram capsule contains tartrazine ( e102 ), which may cause allergic reactions . children and adolescents do not give fotivda to children and adolescents under 18 years of age . this medicine has not been studied in children and adolescents . other medicines and fotivda tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this includes herbal medicines and other medicines you have bought without a prescription . fotivda may work less well when taken with some medicines . tell your doctor if you are taking any of the following medicines ; they may decide to change your medication : dexamethasone ( a corticosteroid to reduce inflammation and treat disorders of the immune system ); rosuvastatin ( a medicine used to help lower cholesterol levels in your blood ); phenobarbital , phenytoin , carbamazepine ( used to treat epilepsy ); nafcillin , rifampicin , rifabutin , rifapentin ( antibiotics ); st . john ' s wort ( also known as hypericum perforatum , a herbal remedy used for treatment of depression and anxiety ) as this herbal remedy should not be used at the same time as fotivda . pregnancy , breast - feeding and fertility do not take fotivda if you are pregnant . tell your doctor who will discuss with you the risks of taking fotivda to you and your child . both you and your partner must use effective contraception . if you or your partner are taking hormonal contraceptives ( the pill , an implant or patch ) you must use an additional barrier method throughout treatment and for another month after completing treatment . do not breast - feed during treatment with fotivda , as it is not known whether the active ingredient in fotivda passes into breast - milk . talk to your doctor if you are already breast - feeding . talk to your doctor when planning a baby , as fotivda may affect the fertility of men and women . driving and using machines fotivda can have side effects that may affect your ability to drive or use machines . avoid driving or using machines if you feel weak , tired , or dizzy . see also section 4 " possible side effects ".
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , tenofovir disoproxil , or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). if you stopped treatment with any medicine containing tenofovir disoproxil on the advice of your doctor following problems with your kidney function . if you are taking one of these medicines : - alfuzosin ( used to treat an enlarged prostate gland ) - amiodarone , quinidine ( used to correct irregular heartbeats ) 47 - dabigatran ( used to prevent and treat blood clots ) - carbamazepine , phenobarbital , phenytoin ( used to prevent seizures ) - rifampicin ( used to prevent and treat tuberculosis and other infections ) - dihydroergotamine , ergotamine , ergometrine ( used to treat migraine headache ) - cisapride ( used to relieve certain stomach problems ) - st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ) or products that contain it - lovastatin , simvastatin ( used to lower blood cholesterol ) - pimozide , lurasidone ( used to treat abnormal thoughts or feelings ) - sildenafil ( used to treat pulmonary arterial hypertension a lung disease that makes breathing difficult ) - orally administered midazolam , triazolam ( used to help you sleep and / or relieve anxiety ) if any of these applies to you , you should not take stribild and you should tell your doctor immediately . warnings and precautions you must remain under the care of your doctor while taking stribild . you can still pass on hiv when taking this medicine , although the risk is lowered by effective antiretroviral therapy . discuss with your doctor the precautions needed to avoid infecting other people . this medicine is not a cure for hiv infection . while taking stribild you may still develop infections or other illnesses associated with hiv infection . talk to your doctor before taking stribild : if you have kidney problems , or have had kidney problems , or if tests have shown problems with your kidneys . your doctor will carefully consider whether to treat you with stribild . stribild may affect your kidneys . before starting treatment , your doctor will order blood tests to assess your kidney function . your doctor will also order blood tests during treatment to monitor your kidneys . stribild is not usually taken with other medicines that can damage your kidneys ( see other medicines and stribild ). if this is unavoidable , your doctor will monitor your kidney function more frequently . if you have liver problems or a history of liver disease , including hepatitis . patients with liver disease including chronic hepatitis b or c , who are treated with antiretrovirals , have a higher risk of severe and potentially fatal liver complications . if you have hepatitis b infection , your doctor will carefully consider the best treatment regimen for you . if you have hepatitis b infection liver problems may become worse after you stop taking stribild . it ' s important not to stop taking stribild without talking to your doctor : see section 3 , do not stop taking stribild . if you are over 65 . stribild has not been studied in patients over 65 years of age . if you are older than this and are prescribed stribild , your doctor will monitor you carefully . if any of these applies to you , talk to your doctor before taking stribild . while you are taking stribild once you start taking stribild , look out for : any signs of inflammation or infection bone problems if you notice any of these symptoms , tell your doctor immediately . children and adolescents do not give this medicine to children under 12 years of age . the use of stribild in children below 12 years of age and who weigh less than 35kg has not been studied . other medicines and stribild there are some medicines that should never be taken with stribild . these are mentioned above under the heading " do not take stribild - if you are taking one of these medicines ". tell your doctor or pharmacist if you are taking any other medicines or have recently taken any . stribild may interact with other medicines . as a result , the amounts of stribild or other medicines in your blood may be affected . this may stop your medicines from working properly , or may make any side effects worse . in some cases , your doctor may need to adjust your dose or check your blood levels . it is especially important to talk to your doctor if you are taking any of the following : any other medicines containing : - tenofovir disoproxil - tenofovir alafenamide - lamivudine - adefovir dipivoxil medicines that may damage your kidneys , examples include : - aminoglycosides ( such as streptomycin , neomycin and gentamicin ), vancomycin ( for bacterial infections ) - foscarnet , ganciclovir , cidofovir ( for viral infections ) - amphotericin b , pentamidine ( for fungal infections ) - interleukin - 2 , also called aldesleukin ( to treat cancer ) - non - steroidal anti - inflammatory drugs ( nsaids , to relieve bone or muscle pains ) it is also important to tell your doctor if you are taking any of the following types of medicines : antifungals , used to treat fungal infections , such as : - ketoconazole , itraconazole , voriconazole , fluconazole and posaconazole antivirals , used to treat hepatitis c infection : - ledipasvir / sofosbuvir , sofosbuvir / velpatasvir and sofosbuvir / velpatasvir / voxilaprevir antibiotics , used to treat bacterial infections including tuberculosis , containing : - rifabutin , clarithromycin or telithromycin antidepressants , used to treat depression : - medicines containing trazodone or escitalopram sedatives and hypnotics , used to treat anxiety : - buspirone , clorazepate , diazepam , estazolam , flurazepam and zolpidem immunosuppressants , used to control your body ' s immune response after a transplant , such as : - ciclosporin , sirolimus and tacrolimus 49 corticosteroids including : - betamethasone , budesonide , fluticasone , mometasone , prednisone , triamcinolone . these medicines are used to treat allergies , asthma , inflammatory bowel diseases , inflammatory conditions of the eyes , joints and muscles and other inflammatory conditions . if alternatives cannot be used , its use should only take place after medical evaluation and under close monitoring by your doctor for corticosteroid side effects . medicines used to treat diabetes : - metformin contraceptive pill , used to prevent pregnancy erectile dysfunction medicines , used to treat impotence , such as : - sildenafil , tadalafil and vardenafil heart medicines , such as : - digoxin , disopyramide , flecainide , lidocaine , mexiletine , propafenone , metoprolol , timolol , amlodipine , diltiazem , felodipine , nicardipine , nifedipine and verapamil medicines used to treat pulmonary arterial hypertension : - bosentan anticoagulants , used to prevent and treat blood clots , such as : - warfarin , edoxaban , apixaban and rivaroxaban bronchodilators , used to treat asthma and other lung - related problems : - salmeterol cholesterol lowering medicines , such as : - rosuvastatin , atorvastatin , pravastatin , fluvastatin and pitavastatin medicines used to treat gout : - colchicine antiplatelets , used to reduce the risk of blood clots such as : - clopidogrel medicines or oral supplements containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ), such as : - mineral supplements , vitamins ( including multivitamins ), antacids and laxatives if you are taking medicines , oral supplements , antacids or laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ), take them at least 4 hours before or at least 4 hours after stribild . tell your doctor if you are taking these or any other medicines . do not stop your treatment without contacting your doctor . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . tell your doctor immediately if you become pregnant , think you may be pregnant or are planning to have a baby . pregnant women should not take stribild . the amount of this medicine in your blood may decrease during pregnancy which may stop it from working properly . use effective contraception while taking stribild . do not breast - feed during treatment with stribild . this is because some of the active substances in this medicine pass into human breast milk . if you are a woman with hiv it is recommended that you do not breast - feed to avoid passing the virus to the baby in breast milk . driving and using machines stribild can cause dizziness , tiredness or insomnia . if you are affected while taking stribild , do not drive and do not use any tools or machines . stribild contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine . stribild contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per tablet , that is to say essentially ' sodium - free '.
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . if this has happened to you , tell your doctor . if you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before you take zyprexa . the use of zyprexa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements mainly of the face or tongue . if this happens after you have been given zyprexa tell your doctor . very rarely , medicines of this type cause a combination of fever , faster breathing , sweating , muscle stiffness and drowsiness or sleepiness . if this happens , contact your doctor at once . weight gain has been seen in patients taking zyprexa . you and your doctor should check your weight regularly . consider referral to a dietician or help with a diet plan if necessary . high blood sugar and high levels of fat ( triglycerides and cholesterol ) have been seen in patients taking zyprexa . your doctor should do blood tests to check blood sugar and certain fat levels before you start taking zyprexa and regularly during treatment . tell the doctor if you or someone else in your family has a history of blood clots , as medicines like these have been associated with the formation of blood clots . if you suffer from any of the following illnesses tell your doctor as soon as possible : stroke or " mini " stroke ( temporary symptoms of stroke ) parkinson ' s disease prostate problems a blocked intestine ( paralytic ileus ) liver or kidney disease blood disorders heart disease diabetes seizures if you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting ( being sick ) or usage of diuretics ( water tablets ) if you suffer from dementia , you or your carer / relative should tell your doctor if you have ever had a stroke or " mini " stroke . as a routine precaution , if you are over 65 years your blood pressure may be monitored by your doctor . children and adolescents zyprexa is not for patients who are under 18 years . other medicines and zyprexa only take other medicines while you are on zyprexa if your doctor tells you that you can . you might feel drowsy if zyprexa is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep ( tranquillisers ). tell your doctor if you are taking , have recently taken or might take any other medicines . in particular , tell your doctor if you are taking : medicines for parkinson ' s disease . carbamazepine ( an anti - epileptic and mood stabiliser ), fluvoxamine ( an antidepressant ) or ciprofloxacin ( an antibiotic ) - it may be necessary to change your zyprexa dose . zyprexa with alcohol do not drink any alcohol if you have been given zyprexa as together with alcohol it may make you feel drowsy . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . you should not be given this medicine when breast - feeding , as small amounts of zyprexa can pass into breast milk . the following symptoms may occur in newborn babies , of mothers that have used zyprexa in the last trimester ( last three months of their pregnancy ): shaking , muscle stiffness and / or weakness , sleepiness , agitation , breathing problems , and difficulty in feeding . if your baby develops any of these symptoms you may need to contact your doctor . driving and using machines there is a risk of feeling drowsy when you are given zyprexa . if this happens do not drive or operate any tools or machines . tell your doctor . zyprexa contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicinal product .
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia whilst being treated with prolia you may develop a skin infection with symptoms such as a swollen , red area of skin , most commonly in the lower leg , that feels hot and tender ( cellulitis ), and possibly with symptoms of fever . please tell your doctor immediately if you develop any of these symptoms . please tell your doctor if you have an allergy to latex ( the needle cover on the pre - filled syringe contains a derivative of latex ). you should also take calcium and vitamin d supplements while being on treatment with prolia . your doctor will discuss this with you . you may have low levels of calcium in your blood while receiving prolia . please tell your doctor immediately if you notice any of the following symptoms : spasms , twitches , or cramps in your muscle , and / or numbness or tingling in your fingers , toes or around your mouth , and / or seizures , confusion , or loss of consciousness . tell your doctor if you have or have ever had severe kidney problems , kidney failure or have needed dialysis or are taking medicines called glucocorticoids ( such as prednisolone or dexamethasone ), which may increase your risk of getting low blood calcium if you do not take calcium supplements . problems with your mouth , teeth or jaw a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported rarely ( may affect up to 1 in 1 , 000 people ) in patients receiving prolia for osteoporosis . the risk of onj increases in patients treated for a long time ( may affect up to 1 in 200 people if treated for 10 years ). onj can also occur after stopping treatment . it is important to try to prevent onj developing as it may be a painful condition that can be difficult to treat . in order to reduce the risk of developing onj , take the following precautions : before receiving treatment , tell your doctor or nurse ( health care professional ) if you : have any problems with your mouth or teeth such as poor dental health , gum disease , or a planned tooth extraction . don ' t receive routine dental care or have not had a dental check - up for a long time . are a smoker ( as this may increase the risk of dental problems ). have previously been treated with a bisphosphonate ( used to treat or prevent bone disorders ). are taking medicines called corticosteroids ( such as prednisolone or dexamethasone ). have cancer . your doctor may ask you to undergo a dental examination before you start treatment with prolia . while being treated , you should maintain good oral hygiene and receive routine dental check - ups . if you wear dentures you should make sure these fit properly . if you are under dental treatment or will undergo dental surgery ( e . g . tooth extractions ), inform your doctor about your dental treatment and tell your dentist that you are being treated with prolia . contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth , pain or swelling , or non - healing of sores or discharge , as these could be signs of onj . unusual thigh bone fractures some people have developed unusual fractures in their thigh bone while being treated with prolia . contact your doctor if you experience new or unusual pain in your hip , groin , or thigh . children and adolescents prolia is not recommended for children and adolescents under 18 years of age . the use of prolia in children and adolescents has not been studied . other medicines and prolia tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . it is especially important that you tell your doctor if you are being treated with another medicine containing denosumab . you should not take prolia together with another medicine containing denosumab . pregnancy and breast - feeding prolia has not been tested in pregnant women . it is important to tell your doctor if you are pregnant ; think you may be pregnant ; or plan to get pregnant . prolia is not recommended for use if you are pregnant . women of child - bearing potential should use effective methods of contraception while being treated with prolia and for at least 5 months after stopping treatment with prolia . if you become pregnant during treatment with prolia or less than 5 months after stopping treatment with prolia , please inform your doctor . it is not known whether prolia is excreted in breast milk . it is important to tell your doctor if you are breast - feeding or plan to do so . your doctor will then help you decide whether to stop breast - feeding , or whether to stop taking prolia , considering the benefit of breast - feeding to the baby and the benefit of prolia to the mother . if you are breast - feeding during prolia treatment , please inform your doctor . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines prolia has no or negligible influence on the ability to drive and use machines . prolia contains sorbitol this medicine contains 47 mg sorbitol in each ml of solution . prolia contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per 60 mg , that is to say essentially ' sodium - free '.
ambirix should not be given if : you are allergic to ambirix , or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue you have previously had an allergic reaction to any vaccine against hepatitis a or hepatitis b diseases you have a severe infection with a high temperature . the vaccine can be given after you have recovered . a minor infection such as a cold should not be a problem , but talk to your doctor first . ambirix should not be given if any of the above apply . if you are not sure , talk to your doctor , nurse or pharmacist before having ambirix . warnings and precautions talk to your doctor , nurse or pharmacist before having ambirix if : you need to be fully protected against hepatitis a and b infection within the next 6 months your doctor may recommend a different vaccine you have a bleeding problem or bruise easily - the injection may be given just under the skin instead of into a muscle to reduce the amount of bleeding or bruising you have immune system problems ( such as due to an illness , treatment or dialysis ) - the vaccine may not work fully . this means you may not be protected against one or both of the hepatitis a and b viruses . your doctor will run blood tests to see whether more injections are needed to help you be better protected you have fainted before or during a previous injection in case this happens again . fainting can occur ( mostly in adolescents ) following , or even before , any needle injection . if any of the above apply ( or you are not sure ), talk to your doctor , nurse or pharmacist before having ambirix . other medicines and ambirix tell your doctor if you are taking , have recently taken or might take any other medicines or vaccines . this includes medicines obtained without a prescription and herbal medicines . ask your doctor , nurse or pharmasist if you are not sure . if you are taking medicines that affect your body ' s immune response , you can still have ambirix if this is thought to be necessary . however , the vaccine may not work fully . this means that you may not be protected against one or both of the hepatitis a and b viruses . your doctor will run blood tests to see whether more injections are needed to help you be better protected . ambirix may need to be given at the same time as other vaccines for measles , mumps , rubella , diphtheria , tetanus , whooping cough ( pertussis ), poliomyelitis , haemophilus influenzae type b or some types of treatments for hepatitis infections called " immunoglobulins ". your doctor will make sure that the vaccines are injected into different parts of your body . pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think that you might be pregnant or are planning to have a baby , ask your doctor , nurse or pharmacist for advice before having this vaccine . ambirix is not usually given to women who are pregnant or breast - feeding . driving and using machines you may feel sleepy or dizzy after having ambirix . if this happens , do not drive , cycle or use any tools or machines . ambirix contains neomycin and sodium this vaccine contains neomycin ( an antibiotic ). ambirix should not be given if you are allergic to neomycin . this medicinal product contains less than 1 mmol sodium ( 9 mg ) per dose , i . e . essentially ' sodium - free '.
do not use bexsero - if you or your child are allergic to the active substances or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before you or your child receive bexsero : - if you or your child have a severe infection with a high temperature . if this is the case , then vaccination will be postponed . the presence of a minor infection , such as a cold , should not require postponement of the vaccination , but talk to your doctor or nurse first . - if you or your child have haemophilia or any other problem that may stop your blood from clotting properly , such as treatment with blood thinners ( anticoagulants ). talk to your doctor or nurse first . - if you or your child receive treatment that blocks the part of the immune system known as complement activation , such as eculizumab . even if you or your child have been vaccinated with bexsero you or your child remain at increased risk of disease caused by the neisseria meningitidis group b bacteria . - if your child was born prematurely ( before or at 28 weeks of pregnancy ), particularly if they had breathing difficulties . stopping breathing or irregular breathing for a short time may be more common in the first three days following vaccination in these babies and they may need special monitoring . - if you or your child have an allergy to the antibiotic kanamycin . if present , the kanamycin level in the vaccine is low . if you or your child may have an allergy to kanamycin , talk to your doctor or nurse first . fainting , feeling faint or other stress - related reactions can occur as a response to any needle injection . tell your doctor or nurse if you have experienced this kind of reaction previously . tell your doctor or nurse if you know that you or your child is allergic to latex . the tip cap of the syringe may contain natural rubber latex . the risk for developing an allergic reaction is very small , but your doctor or nurse needs to be aware of your allergy when deciding if you or your child should receive bexsero . there are no data on the use of bexsero in adults above 50 years of age . there are limited data on the use of bexsero in patients with chronic medical conditions or with weakened immunity . if you or your child have weakened immunity ( for example , due to the use of immunosuppressive medications , or hiv infection , or hereditary defects of the body ' s natural defence system ), it is possible that the effectiveness of bexsero is reduced . as with any vaccine , bexsero may not fully protect all of those who are vaccinated . other medicines and bexsero tell your doctor or nurse if you or your child are taking , have recently taken , or might take any other medicines , or have recently received any other vaccine . bexsero can be given at the same time as any of the following vaccine components : diphtheria , tetanus , whooping cough ( pertussis ), haemophilus influenzae type b , polio , hepatitis b , pneumococcus , measles , mumps , rubella , chickenpox , and meningococcus a , c , w , y . talk to your doctor or nurse for further information . when given at the same time with other vaccines bexsero must be given at separate injection sites . your doctor or nurse may ask you to give your child medicines that lower fever at the time and after bexsero has been given . this will help to reduce some of the side effects of bexsero . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before bexsero is given . your doctor may still recommend that you receive bexsero if you are at risk of exposure to meningococcal infection . driving and using machines bexsero has no or negligible influence on the ability to drive and use machines . however , some of the effects mentioned under section 4 " possible side effects " may temporarily affect the ability to drive or use machines . bexsero contains sodium chloride this medicinal product contains less than 1 mmol sodium ( 23 mg ) per dose , i . e . essentially ' sodium - free '.
do not take nitisinone mdk : - if you are allergic to nitisinone or any of the other ingredients of this medicine ( listed in section 6 ). do not breast - feed while taking this medicine , see section " pregnancy and breast - feeding ". warnings and precautions talk to your doctor or pharmacist before taking nitisinone mdk . - your eyes will be checked by an ophthalmologist before and regularly during nitisinone treatment . if you get red eyes or any other signs of effects on the eyes , contact your doctor immediately for an eye examination . eye problems could be a sign of inadequate dietary control ( see section 4 ). during the treatment , blood samples will be drawn in order for your doctor to check whether the treatment is adequate and to make sure that there are no possible side effects causing blood disorders . your liver will be checked at regular intervals because the disease affects the liver . follow - up by your doctor should be performed every 6 months . if you experience any side effects , shorter intervals are recommended . other medicines and nitisinone mdk tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . nitisinone mdk may interfere with the effect of other medicines , such as : - medicines for epilepsy ( such as phenytoin ) - medicines against blood clotting ( such as warfarin ) nitisinone mdk with food and drink if you start nitisinone mdk treatment by taking it with food , it is recommended that you carry on taking it with food throughout your course of treatment . pregnancy and breast - feeding the safety of this medicine has not been studied in pregnant and breast - feeding women . please contact your doctor if you plan to become pregnant . if you become pregnant you should contact your doctor immediately . do not breast - feed while taking this medicine , see section " do not take nitisinone mdk ". driving and using machines this medicine has minor influence on the ability to drive and use machines . however , if you experience side effects affecting your vision you should not drive or use machines until your vision is back to normal ( see section 4 " possible side effects ").
you must not be given docetaxel accord if you are allergic ( hypersensitive ) to docetaxel or any of the other ingredients of docetaxel accord ( listed in section 6 ). if the number of white blood cells is too low . if you have a severe liver disease . warnings and precautions before each treatment with docetaxel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetaxel accord . in case of white blood cells disturbances , you may experience associated fever or infections . tell your doctor , hospital pharmacist , or nurse immediately if you have abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or fever . these symptoms may be the first signs of a serious gastrointestinal toxicity , which could be fatal . your doctor should address them immediately . tell your doctor , hospital pharmacist or nurse if you have vision problems . in case of vision problems , in particular blurred vision , you should immediately have your eyes and vision examined . tell your doctor , hospital pharmacist or nurse if you have experienced an allergic reaction to previous paclitaxel therapy . tell your doctor , hospital pharmacist or nurse if you have heart problems . if you develop acute or worsening problems with your lungs ( fever , shortness of breath or cough ), please tell your doctor , hospital pharmacist or nurse immediately . your doctor may stop your treatment immediately . you will be asked to take premedication consisting of an oral corticosteroid such as dexamethasone , one day prior to docetaxel accord administration and to continue for one or two days after it in order to minimise certain undesirable effects which may occur after the infusion of docetaxel accord in particular allergic reactions and fluid retention ( swelling of the hands , feet , legs or weight gain ). during treatment , you may be given other medicines to maintain the number of your blood cells . severe skin problems such as stevens - johnson syndrome ( sjs ), toxic epidermal necrolysis ( ten ), acute generalized exanthematous pustulosis ( agep ) have been reported with docetaxel : - sjs / ten symptoms may include blistering , peeling or bleeding on any part of your skin ( including your lips , eyes , mouth , nose , genitals , hands or feet ) with or without a rash . you may also have flu - like symptoms at the same time , such as fever , chills or aching muscles . - agep symptoms may include a red , scaly widespread rash with bumps under the swollen skin ( including your skin folds , trunk , and upper extremities ) and blisters accompanied by fever . if you develop severe skin reactions or any of the reactions listed above , immediately contact your doctor or healthcare professional . docetaxel accord contains alcohol . discuss with your doctor if you suffer from alcohol dependency , epilepsy or liver impairment . see also section " docetaxel accord contains ethanol ( alcohol )" below . other medicines and docetaxel accord please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicine , including medicines obtained without a prescription . this is because docetaxel accord or the other medicine may not work as well as expected and you may be more likely to get a side effect . the amount of alcohol in this medicinal product may alter the effects of other medicines . pregnancy , breast - feeding and fertility ask your doctor for advice before being given any medicine . docetaxel accord must not be administered if you are pregnant unless clearly indicated by your doctor . you must not become pregnant during treatment with this medicine and must use an effective method of contraception during therapy , because docetaxel may be harmful for the unborn baby . if pregnancy occurs during your treatment , you must immediately inform your doctor . you must not breast - feed while you are treated with docetaxel . if you are a man being treated with docetaxel accord you are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment because docetaxel may alter male fertility . driving and using machines the amount of alcohol in this medicinal product may impair your ability to drive or use machines . you may experience side effects of this medicine that may impair your ability to drive , use tools or operate machines ( see section 4 possible side effects ). if this happens , do not drive or use any tools or machines before discussing with your doctor , nurse or hospital pharmacist . docetaxel accord contains ethanol ( alcohol ) docetaxel accord 20 mg / 1 ml contains 50 vol % ethanol anhydrous ( alcohol ), i . e . up to 395 mg ethanol anhydrous per vial , equivalent to 10 ml of beer or 4 ml wine . docetaxel accord 80 mg / 4 ml contains 50 vol % ethanol anhydrous ( alcohol ), i . e . up to 1 . 58 g ethanol anhydrous per vial , equivalent to 40 ml of beer or 17 ml wine . docetaxel accord 160 mg / 8 ml contains 50 vol % ethanol anhydrous ( alcohol ), i . e . up to 3 . 16 g ethanol anhydrous per vial , equivalent to 80 ml of beer or 33 ml wine . harmful for those suffering from alcoholism . to be taken into account in pregnant or breast - feeding , in children and high - risk groups such as patients with liver disease , or epilepsy . the amount of alcohol in this medicine may have effects on the central nervous system ( the part of the nervous system that includes the brain and spinal cord ).
do not take intuniv if : you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have low or high blood pressure , heart problems or have a family history of heart problems you have fainted recently you have thoughts or feelings of suicide you suffer from any other psychiatric conditions intuniv may affect your weight and height if taking for long periods , your doctor will therefore monitor your growth . do not stop taking intuniv without talking to your doctor . if you suddenly stop taking intuniv , you may develop withdrawal symptoms of increased heart rate and high blood pressure ( see section 4 ). if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking this medicine . this is because this medicine can make these problems worse . your doctor will routinely monitor you to see how this medicine affects you . children ( under 6 years old ) and adults ( 18 years and over ) this medicine should not be used in children under 6 years of age and adults 18 years and over because it is not known if it works or is safe . checks your doctor will do when you take intuniv before you start taking this medicine your doctor will check to make sure this medicine is safe for you and that it will help you . while you are taking this medicine your doctor will repeat these checks weekly during initial dosing , after dose adjustments , at least every 3 months for the first year and then at least twice a year . these checks may include : your blood pressure and heart rate and other checks on your heart if appropriate your response to treatment , in particular if it makes you sleepy or drowsy your height and weight you should talk to your doctor if you do not feel better or if you feel worse and very sleepy or drowsy after taking this medicine for around 6 weeks . your doctor may want to review your treatment 39 other medicines and intuniv tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this is because intuniv and some other medicines can affect each other . in particular , tell your doctor or pharmacist if you are taking any of the following types of medicines : medicines that lower your blood pressure ( antihypertensives ) medicines for epilepsy such as valproic acid medicines that make you sleepy ( sedatives ) medicines for mental health problems ( benzodiazepines , barbiturates and antipsychotics ) medicines that can affect the way intuniv is eliminated by the liver ( please see table below ) medicines used to treat aprepitant nausea and vertigo . atazanavir , efavirenz , etravirine , fosamprenavir , indinavir , nevirapine , ritonavir , saquinavir hiv infection . ciprofloxacin , chloramphenicol , clarithromycin , erythromycin , rifabutin , rifampicin , telithromycin bacterial infections . fluconazole , itraconazole , posaconazole , ketoconazole fungal infections . crizotinib , imatinib cancer . diltiazem , verapamil cardiovascular conditions . boceprevir , telaprevir viral hepatitis . suboxone substance dependence . bosentan cardiovascular conditions ( e . g . constriction of blood vessels in the lung ). carbamazepine , oxcarbazepine , phenobarbital , phenytoin , primidone used to control epilepsy . modafinil is a medicine that promotes alertness and is used to treat sleep disorders . st . john ' s wort is a herbal preparation that is used to treat depression . if any of the above apply to you or you are not sure , talk to your doctor or pharmacist before taking this medicine . intuniv with food , drinks and alcohol do not take this medicine with fatty foods ( e . g ., high fat breakfast ), as it may affect the way this medicine works . do not take grapefruit juice with this medicine as it can have an effect on the way this medicine works . do not drink alcohol when taking this medicine as it may make you sleepy or drowsy . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . do not take this medicine if you are pregnant or you are not using contraception . it is not known if intuniv will affect your unborn baby . do not breast - feed while taking intuniv unless told to do so by your doctor . driving and using machines you may feel dizzy and drowsy when taking this medicine , especially at the start of treatment and this may last for 2 to 3 weeks possibly longer . if this happens , do not drive , cycle , use any tools or machines or participate in activities that could cause injury until you know how this medicine affects you . fainting has also been reported but is not a common effect . intuniv contains lactose lactose is a type of sugar . if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine . intuniv contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per tablet , that is to say essentially ' sodium - free '.
do not use ecalta - if you are allergic to anidulafungin , other echinocandins ( e . g . caspofungin acetate ), or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist or nurse before using ecalta . your doctor may decide to monitor you - for liver function more closely if you develop liver problems during your treatment - if you are given anaesthetics during your treatment with ecalta for signs of an allergic reaction such as itching , wheezing , blotchy skin - for signs of an infusionrelated reaction which could include a rash , hives , itching , redness - for shortness of breath / breathing difficulties , dizziness or lightheadedness children and adolescents ecalta should not be given to patients under 1 month of age . other medicines and ecalta tell your doctor or pharmacist if you or your child are taking , have recently taken or might take any other medicines . pregnancy and breast - feeding the effect of ecalta in pregnant women is not known . therefore ecalta is not recommended during pregnancy . effective contraception should be used in women of childbearing age . contact your doctor immediately if you become pregnant while taking ecalta . the effect of ecalta in breast - feeding women is not known . ask your doctor or pharmacist for advice before taking ecalta while breast - feeding . ask your doctor or pharmacist for advice before taking any medicines . ecalta contains fructose this medicine contains fructose ( a type of sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicinal product . if you ( or your child ) have hereditary fructose intolerance ( hfi ), a rare genetic disorder , you ( or your child ) must not receive this medicine . patients with hfi cannot break down fructose in this medicine , which may cause serious side effects . you must tell your doctor before receiving this medicine if you ( or your child ) have hfi or if your child can no longer take sweet foods or drinks because they feel sick , vomit or get unpleasant effects such as bloating , stomach cramps or diarrhoea .
do not use adynovi : - if you are allergic to rurioctocog alfa pegol , octocog alfa or any of the other ingredients of this medicine ( listed in section 6 ) - if you are allergic to mouse or hamster proteins if you are unsure about this , ask your doctor . warnings and precautions talk to your doctor before using adynovi . there is a rare risk that you may experience an anaphylactic reaction ( a severe , sudden allergic reaction ) to adynovi . you should be aware of the early signs of allergic reactions such as rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , general feeling of being unwell , and dizziness . these could be early symptoms of anaphylactic shock ; additional symptoms may include extreme dizziness , loss of consciousness , and extreme difficulty in breathing . if any of these symptoms occur , stop the injection immediately and contact your doctor . severe symptoms , including difficulty in breathing and ( near ) fainting , require prompt emergency treatment . if you suffer from cardiac disease , please inform your doctor , as there is an increased risk of blood clotting ( coagulation ) complications . patients developing factor viii inhibitors the formation of inhibitors ( antibodies ) is a known complication that can occur during treatment with all factor viii medicines . these inhibitors , especially at high levels , stop the treatment working properly and you or your child will be monitored carefully for the development of these inhibitors . if you or your child  s bleeding is not being controlled with adynovi , tell your doctor immediately . catheter - related complications if you require a central venous access device ( cvad ), risk of cvad - related complications including local infections , presence of bacteria in the blood and catheter site thrombosis should be considered . children and adolescents adynovi can be used only in adolescents and adults ( 12 years and above ). the listed warnings and precautions also apply to adolescents . other medicines and adynovi tell your doctor if you are using , have recently used or might use any other medicines . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . haemophilia a occurs only rarely in women . therefore no experience regarding the use of adynovi during preganancy and breast - feeding is available . driving and using machines adynovi has no influence on your ability to drive or to use machines . adynovi contains sodium this medicine contains 0 . 45 mmol sodium ( 10 mg ) per vial . this should be taken into consideration by patients on a controlled sodium diet .
before starting treatment with this medicine , a doctor should check you and your partner for possible causes of your fertility problems . do not use rekovelle if : you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) you have a tumour of the uterus , ovaries , breasts , pituitary gland or hypothalamus you have enlarged ovaries or cysts on your ovaries ( unless caused by polycystic ovarian disease ) you suffer from bleeding from the vagina without any known cause you have had an early menopause you have malformations of the sexual organs which make a normal pregnancy impossible you have fibroids of the uterus which make a normal pregnancy impossible . warnings and precautions ovarian hyperstimulation syndrome gonadotropins like this medicine may cause ovarian hyperstimulation syndrome . this is when your follicles develop too much and become large cysts . talk to your doctor if you : have abdominal pain , discomfort or swelling have nausea are vomiting get diarrhoea gain weight have difficulty in breathing your doctor may ask you to stop using this medicine ( see section 4 ). if the recommended dose and schedule of administration are followed , ovarian hyperstimulation syndrome is less likely . blood clotting problems ( thromboembolic events ) clots in the blood vessels ( veins or arteries ) are more likely in women who are pregnant . infertility treatment can increase the risk of this happening , especially if you are overweight or you or someone in your family ( blood relative ) have a known blood clotting disease ( thrombophilia ). tell your doctor if you think this applies to you . twisting of ovaries there have been reports of twisting of ovaries ( ovarian torsion ) following assisted reproductive technology treatment . twisting of the ovary could cut off the blood flow to the ovary . multiple pregnancy and birth defects when undergoing assisted reproductive technology treatment the possibility of having a multiple pregnancy ( such as twins ) is mainly related to the number of embryos placed inside your womb , the quality of the embryos , and your age . multiple pregnancy may lead to medical complications for you and your babies . furthermore , the risk of birth defects may be slightly higher following infertility treatment , which is thought to be due to characteristics of the parents ( such as your age , and your partner ' s sperm characteristics ) and multiple pregnancy . pregnancy loss when undergoing assisted reproductive technology treatment , you are more likely to have a miscarriage than if you conceive naturally . pregnancy outside the uterus ( ectopic pregnancy ) when undergoing assisted reproductive technology treatment , you are more likely to have a pregnancy outside the uterus ( ectopic pregnancy ) than if you conceive naturally . if you have a history of tubal disease , you have an increased risk of ectopic pregnancy . ovarian and other reproductive system tumours there have been reports of ovarian and other reproductive system tumours in women who had undergone infertility treatment . it is not known if treatment with fertility medicines increase the risk of these tumours in infertile women . other medical conditions before starting to use this medicine , tell your doctor if : you have been told by another doctor that pregnancy would be dangerous for you you have kidney or liver disease children and adolescents ( under 18 years of age ) this medicine is not indicated in children and adolescents . other medicines and rekovelle tell your doctor if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding do not use this medicine if you are pregnant or breast - feeding . driving and using machines this medicine does not affect your ability to drive and use machines . rekovelle contains sodium this medicinal product contains less than 1 mmol sodium ( 23 mg ) per dose , i . e . essentially " sodium - free ".
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any other ingredients of this medicine ( listed in section 6 ). - if you think the above applies to you , don ' t use revinty ellipta until you have checked with your doctor . warnings and precautions talk to your doctor before you use revinty ellipta : - if you have liver disease , as you may be more likely to have side effects . if you have moderate or severe liver disease , your doctor will limit your dose to the lower strength of revinty ellipta ( 92 / 22 micrograms once daily ). - if you have heart problems or high blood pressure . - if you have tuberculosis ( tb ) of the lung , or any long standing or untreated infections . - if you have ever been told you have diabetes or high blood sugar . - if you have thyroid gland problems . - if you have low potassium in your blood . - if you experience blurred vision or other visual disturbances . check with your doctor before you use this medicine if you think any of these applies to you . while you ' re using revinty ellipta - contact your doctor if you experience blurred vision or other visual disturbances . - contact your doctor if you experience increased thirst , frequent urination or unexplained tiredness ( signs of high blood sugar ). immediate breathing difficulties if your breathing or wheezing gets worse straight after using revinty ellipta , stop using it and get medical help immediately . infection of the lung if you are using this medicine for copd you may be at an increased risk of developing an infection of the lungs known as pneumonia . see section 4 for information on symptoms to look out for while you are using this medicine . tell your doctor as soon as possible if you develop any of these symptoms . children and adolescents do not give this medicine to children under the age of 12 years for the treatment of asthma , or in children and adolescents of any age for the treatment of copd . other medicines and revinty ellipta tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicinesn . if you are not sure what your medicine contains talk to your doctor or pharmacist . some medicines may affect how this medicine works , or make it more likely that you will have side effects . these include : - beta - blockers , such as metoprolol , used to treat high blood pressure or a heart condition . - ketoconazole , to treat fungal infections . - ritonavir or cobicistat , to treat hiv infections . - long - acting beta2 - adrenergic agonists , such as salmeterol tell your doctor or pharmacist if you are taking any of these medicines . your doctor may wish to monitor you carefully if you are taking any of these medicines as they may increase the side effects of revinty ellipta . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . don ' t use this medicine if you are pregnant unless your doctor tells you that you can . it is not known whether the ingredients of this medicine can pass into breast milk . if you are breast - feeding , you must check with your doctor before you use revinty ellipta . don ' t use this medicine if you are breast - feeding unless your doctor tells you that you can . if you are breast - feeding , check with your doctor before you use revinty ellipta . driving and using machines this medicine is unlikely to affect your ability to drive or use machines . revinty ellipta contains lactose if you have been told by your doctor that you have an intolerance to some sugars , or to milk protein , contact to your doctor before using this medicine .
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ); if you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gnrh analogue ; if you have a moderate or severe kidney or liver disease ; if you are pregnant or breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before using orgalutran allergic reactions if you have an active allergic condition , please tell your doctor . your doctor will decide , depending on the severity , if additional monitoring is required during treatment . cases of allergic reactions have been reported , as early as with the first dose . allergic reactions , both generalised and local , including hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing and / or swallowing ( angioedema and / or anaphylaxis ) have been reported . ( see also section 4 .) if you have an allergic reaction , stop taking orgalutran and seek immediate medical assistance . latex allergy the needle cover contains dry natural rubber / latex which comes into contact with the needle and may cause allergic reactions . ovarian hyperstimulation syndrome ( ohss ) during or following hormonal stimulation of the ovaries , ovarian hyperstimulation syndrome may develop . this syndrome is related to the stimulation procedure with gonadotrophins . please refer to the package leaflet of the gonadotrophin - containing medicine prescribed for you . multiple births or birth defects the incidence of congenital malformations after assisted reproduction techniques may be slightly higher than after spontaneous conceptions . this slightly higher incidence is thought to be related to characteristics of the patients undergoing fertility treatment ( e . g . age of the woman , sperm characteristics ) and to the higher incidence of multiple gestations after assisted reproduction techniques . the incidence of congenital malformations after assisted reproduction techniques using orgalutran is not different from that after using other gnrh analogues in the course of assisted reproduction techniques . pregnancy complications there is a slightly increased risk of pregnancy outside of the uterus ( an ectopic pregnancy ) in women with damaged fallopian tubes . women weighing less than 50 kg or more than 90 kg the efficacy and safety of orgalutran has not been established in women weighing less than 50 kg or more than 90 kg . ask your doctor for further information . children and adolescents there is no relevant use of orgalutran in children or adolescents . other medicines and orgalutran tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . pregnancy , breast - feeding and fertility orgalutran should be used during controlled ovarian stimulation for assisted reproduction techniques ( art ). do not use orgalutran during pregnancy and breast - feeding . ask your doctor or pharmacist for advice before taking this medicine . driving and using machines the effects of orgalutran on ability to drive and use machines have not been studied . orgalutran contains sodium orgalutran contains less than 1 mmol sodium ( 23 mg ) per injection , that is to say essentially ' sodium - free '.
do not take blitzima if : you are allergic to rituximab , other proteins which are like rituximab , or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe active infection at the moment you have a weak immune system you have severe heart failure or severe uncontrolled heart disease and have granulomatosis with polyangiitis , microscopic polyangiitis or pemphigus vulgaris . do not have blitzima if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before you are given blitzima . warnings and precautions talk to your doctor , pharmacist or nurse before you are given blitzima if : you have ever had or might now have a hepatitis infection . this is because in a few cases , blitzima could cause hepatitis b to become active again , which can be fatal in very rare cases . patients who have ever had hepatitis b infection will be carefully checked by their doctor for signs of this infection . you have ever had heart problems ( such as angina , palpitations or heart failure ) or breathing problems . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given blitzima . your doctor may need to take special care of you during your treatment with blitzima . if you have granulomatosis with polyangiitis , microscopic polyangiitis or pemphigus vulgaris also tell your doctor if you think you may have an infection , even a mild one like a cold . the cells that are affected by blitzima help to fight infection and you should wait until the infection has passed before you are given blitzima . also please tell your doctor if you had a lot of infections in the past or suffer from severe infections . if you think you may need any vaccinations in the near future , including vaccinations needed to travel to other countries . some vaccines should not be given at the same time as blitzima or in the months after you receive blitzima . your doctor will check if you should have any vaccines before you receive blitzima . children and adolescents non - hodgkin ' s lymphoma blitzima can be used for the the treatment of children and adolescents , 6 months of age and older , with non - hodgkin ' s lymphoma , specifically cd20 positive diffuse large b - cell lymphoma ( dlbcl ), burkitt lymphoma ( bl )/ burkitt leukaemia ( mature b - cell acute leukaemia ) ( bal ) or burkitt - like lymphoma ( bll ). talk to your doctor , pharmacist or nurse before you are given this medicine if you , or your child , are under 18 years of age . granulomatosis with polyangiitis or microscopic polyangiitis blitzima can be used for treatment of children and adolescents , 2 years of age and older , with granulomatosis with polyangiitis ( formerly called wegener ' s granulomatosis ) or microscopic polyangiitis . there is not much information about the use of blitzima in children and adolescents with other diseases . talk to your doctor , pharmacist or nurse before you are given this medicine if you , or your child , are under 18 years of age . other medicines and blitzima tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . this includes medicines obtained without a prescription and herbal medicines . this is because blitzima can affect the way some other medicines work . also some other medicines can affect the way blitzima works . in particular , tell your doctor : if you are taking medicines for high blood pressure . you may be asked not to take these other medicines 12 hours before you are given blitzima . this is because some people have a fall in their blood pressure while they are being given blitzima . if you have ever taken medicines which affect your immune system such as chemotherapy or immune - suppressive medicines . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given blitzima . pregnancy and breast - feeding you must tell your doctor or nurse if you are pregnant , think that you might be pregnant or are planning to become pregnant . this is because blitzima can across the placenta and may affect your baby . if you can get pregnant , you and your partner must use an effective method of contraception while using blitzima . you must also do this for 12 months after your last treatment with blitzima . do not breast - feed while you are being treated with blitzima . also do not breast - feed for 12 months after your last treatment with blitzima . this is because blitzima may pass into breast milk . driving and using machines it is not known whether blitzima has an effect on you being able to drive or use any tools or machines . blitzima contains sodium this medicine contains 52 . 6 mg sodium ( main component of cooking / table salt ) in each 10 ml vial and 263 . 2 mg sodium ( main component of cooking / table salt ) in each 50 ml vial . this is equivalent to 2 . 6 % ( for 10ml vial ) and 13 . 2 % ( for 50ml vial ) of the recommended maximum daily dietary intake of sodium for an adult .
you are not to be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . if any of these applies to you , tell the doctor or nurse giving you the infusion . warnings and precautions talk to your doctor or nurse before you are given roactemra . if you experience allergic reactions such as chest tightness , wheezing , severe dizziness or light - headedness , swelling of the lips or skin rash during or after the infusion , then tell your doctor immediately . if you have any kind of infection , short - or long - term , or if you often get infections . tell your doctor immediately if you feel unwell . roactemra can reduce your body ' s ability to respond to infections and may make an existing infection worse or increase the chance of getting a new infection . if you have had tuberculosis , tell your doctor . your doctor will check for signs and symptoms of tuberculosis before starting roactemra . if symptoms of tuberculosis ( persistent cough , weight loss , listlessness , mild fever ), or any other infection appear during or after therapy tell your doctor immediately . if you have had intestinal ulcers or diverticulitis , tell your doctor . symptoms would include abdominal pain and unexplained changes in bowel habits with a fever . if you have liver disease , tell your doctor . before you use roactemra , your doctor may do a blood test to measure your liver function . if any patient has recently been vaccinated ( either adult or child ), or is planning a vaccination , tell your doctor . all patients , especially children , should be up - to - date with all their vaccinations before they start treatment with roactemra . certain types of vaccines should not be used while receiving roactemra . if you have cancer , tell your doctor . your doctor will have to decide if you can still be given roactemra . if you have cardiovascular risk factors such as raised blood pressure and raised cholesterol levels , tell your doctor . these factors need to be monitored while receiving roactemra . if you have moderate to severe kidney function problems , your doctor will monitor you . if you have persistent headaches . your doctor will perform blood tests before you are given roactemra , and during your treatment , to determine if you have a low white blood cell count , low platelet count or high liver enzymes . children and adolescents roactemra is not recommended for use in children under 2 years of age . if a child has a history of macrophage activation syndrome , ( activation and uncontrolled proliferation of specific blood cells ), tell your doctor . your doctor will have to decide if they can still be given roactemra . other medicines and roactemra tell your doctor if you are taking any other medicines ( or your child is , if they are the patient ), or have recently taken any . this includes medicines obtained without a prescription . roactemra can affect the way some medicines work , and the dose of these may require adjustment . if you are using medicines containing any of the following active substances , tell your doctor : methylprednisolone , dexamethasone , used to reduce inflammation simvastatin or atorvastatin , used to reduce cholesterol levels calcium channel blockers ( e . g . amlodipine ), used to treat raised blood pressure theophylline , used to treat asthma warfarin or phenprocoumon , used as a blood thinning agents phenytoin , used to treat convulsions ciclosporin , used to suppress your immune system during organ transplants benzodiazepines ( e . g . temazepam ), used to relieve anxiety . due to lack of clinical experience , roactemra is not recommended for use with other biological medicines for the treatment of ra , sjia or pjia . pregnancy , breast - feeding and fertility roactemra is not to be used in pregnancy unless clearly necessary . talk to your doctor if you are pregnant , may be pregnant , or intend to become pregnant . women of childbearing potential must use effective contraception during and up to 3 months after treatment . stop breast - feeding if you are to be given roactemra , and talk to your doctor . leave a gap of at least 3 months after your last treatment before you start breast - feeding . it is not known whether roactemra is passed into breast milk . the data available so far does not suggest any effect on fertility from this treatment . driving and using machines this medicine can cause dizziness . if you feel dizzy , do not drive or use machines . roactemra contains sodium this medicine contains 26 . 55 mg sodium per maximum dose of 1200 mg . take this into account if you are on a low - sodium diet . however , doses below 1025 mg of this medicine contain less than 23 mg sodium , so they are virtually sodium free .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using onbrez breezhaler if you have asthma ( in this case you should not use onbrez breezhaler ). if you have heart problems . if you have epilepsy . if you have thyroid gland problems ( thyrotoxicosis ). if you have diabetes . during treatment with onbrez breezhaler , stop using the medicine and tell your doctor immediately if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs of a condition called bronchospasm . tell your doctor immediately if your copd symptoms ( breathlessness , wheezing , cough ) do not improve or get worse . children and adolescents onbrez breezhaler should not be given to children or adolescents below the age of 18 years . other medicines and onbrez breezhaler tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . in particular , please tell your doctor if you are using : medicines for breathing problems that are similar to onbrez breezhaler ( i . e . medicines such as salmeterol and formoterol ). you may be more likely to get side effects . medicines called beta blockers that are used for high blood pressure or other heart problems ( such as propranolol ), or for the eye problem called glaucoma ( such as timolol ). medicines that lower the amount of potassium in your blood . these include : o steroids ( e . g . prednisolone ), o diuretics ( water tablets ) used for high blood pressure such as hydrochlorothiazide , o medicines for breathing problems such as theophylline . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before using this medicine . you should not use onbrez breezhaler unless your doctor tells you so . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines it is unlikely that onbrez breezhaler will affect your ability to drive and use machines . onbrez breezhaler contains lactose this medicine contains lactose ( milk sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before using this medicine .
do not take clopidogrel hcs if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain , if you suffer from severe liver disease . if you think any of these apply to you , or if you are in any doubt at all , consult your doctor before taking clopidogrel hcs . warnings and precautions if any of the situations mentioned below apply to you , you should tell your doctor before taking clopidogrel hcs : if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ). - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ). - a recent serious injury . - a recent surgery ( including dental ). - a planned surgery ( including dental ) in the next seven days . if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred within the last seven days . if you have kidney or liver disease . if you have had an allergy or reaction to any medicine used to treat your disease . while you are taking clopidogrel hcs : you should tell your doctor if a surgery ( including dental ) is planned . you should also tell your doctor immediately if you develop a medical condition ( also known as thrombotic thrombocytopenic purpura or ttp ) that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ' possible side effects '). if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). your doctor may order blood tests . children and adolescents do not give this medicine to children ( under 12 years of age ) because it does not work . other medicines and clopidogrel hcs tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines , including medicines obtained without a prescription . some other medicines may influence the use of clopidogrel hcs or vice versa . you should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as : o oral anticoagulants , medicines used to reduce blood clotting , o a non - steroidal anti - inflammatory medicine , usually used to treat painful and / or inflammatory conditions of muscle or joints , o heparin , or any other injectable medicine used to reduce blood clotting , o ticlopidine , other antiplatelet agent , o a selective serotonin reuptake inhibitor ( including but not restricted to fluoxetine or fluvoxamine ), medicines usually used to treat depression , - omeprazole or esomeprazole , medicines to treat upset stomach , 31 - fluconazole or voriconazole medicines to treat fungal infections , - efavirenz , a medicine to treat hiv ( human immunodeficiency virus ) infections , - carbamazepine , a medicine to treat some forms of epilepsy , - moclobemide , medicine to treat depression , - repaglinide , medicine to treat diabetes , - paclitaxel , medicine to treat cancer . if you have experienced severe chest pain ( unstable angina or heart attack ), you may be prescribed clopidogrel in combination with acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever . an occasional use of acetylsalicylic acid ( no more than 1 , 000 mg in any 24 hour period ) should generally not cause a problem , but prolonged use in other circumstances should be discussed with your doctor . pregnancy and breast - feeding it is preferable not to take this product during pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking clopidogrel hcs . if you become pregnant while taking clopidogrel hcs , consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant . you should not breast - feed while taking this medicine . if you are breast - feeding or planning to breast - feed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines clopidogrel hcs is unlikely to affect your ability to drive or to use machines . clopidogrel hcs contains hydrogenated castor oil this may cause stomach upset or diarrhoea .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ); if you are allergic to other antibiotics known as cephalosporins ; if you have had a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . this can include severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat ; or difficulty swallowing or breathing . tell your doctor if any of these apply to you . warnings and precautions talk to your doctor or nurse before you are given fetcroja : if you have ever had any allergic reaction to other antibiotics . see also section above , " do not use fetcroja "; if you have kidney problems . your doctor will adjust your dose to ensure you don ' t get too much or too little medicine ; if you suffer from diarrhoea during your treatment ; if you are on a low sodium diet ; if you have ever had seizures . talk to your doctor or nurse before you are given fetcroja . new infection although fetcroja can fight certain bacteria , there is a possibility that you may get a different infection caused by another organism during or after your treatment . your doctor will monitor you closely for any new infections and give you another treatment if necessary . blood / laboratory tests tell your doctor that you are taking fetcroja if you are going to have any blood / laboratory tests . this is because you may get an abnormal result . with something called a " coombs test " this looks for the presence of antibodies that can destroy red blood cells or may be affected by the response of your immune system to fetcroja . fetcroja may also result in false - positive results in urine dipstick tests ( urine protein or diabetes markers ). children and adolescents fetcroja should not be given to children and adolescents under the age of 18 . this is because it is not known if the medicine is safe to use in these age groups . other medicines and fetcroja tell your doctor or nurse if you are taking , have recently taken or might take any other medicines . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . driving and using machines fetcroja does not affect your ability to drive or operate machinery . fetcroja contains sodium this medicine contains 7 . 64 mmol ( 176 mg ) of sodium per vial . the total daily dose is 2 . 1 g , just greater than the who recommend daily maximum of 2 g sodium for an adult . talk to your doctor before you are given fetcroja if you are on a low sodium diet .
depocyte should not be given  if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ).  if you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with the use of depocyte . symptoms have included effects on the nervous system ( e . g . convulsions , pain , numbness or tingling , blindness or visual disturbances ). your doctor will check for these symptoms regularly . make sure you take as directed any dexamethasone tablets that you may have been prescribed , as they reduce the risk of unwanted effects caused by depocyte . if your side effects get worse or you notice any new side effects , tell your doctor . other medicines and depocyte please tell your doctor if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy , breast - feeding and fertility depocyte should not be given to pregnant women as it may harm an unborn child . women of childbearing potential should use a reliable contraceptive method to avoid pregnancy whilst being treated with depocyte . male patients undergoing depocyte treatment should use a reliable contraceptive method . women should not breast - feed during treatment as depocyte may enter breast milk . driving and using machines do not drive during treatment . do not operate any tools or machines during treatment .
follow all the doctor ' s instructions carefully . do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using bemrist breezhaler if any of the following applies to you : - if you have heart problems , including an irregular or fast heartbeat . - if you have thyroid gland problems . - if you have ever been told you have diabetes or high blood sugar . - if you suffer from seizures or fits . - if you have a low level of potassium in your blood . - if you have severe liver problems . - if you have tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . during treatment with bemrist breezhaler stop using this medicine and get medical help immediately if you have any of the following : - tightness of the chest , coughing , wheezing or breathlessness immediately after using bemrist breezhaler ( signs the medicine is unexpectedly tightening the airways , known as paradoxical bronchospasm ). - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). children and adolescents do not give this medicine to children below 12 years of age because it has not been studied in this age group . other medicines and bemrist breezhaler tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . in particular , tell your doctor or pharmacist if you are using : - medicines that decrease the level of potassium in your blood . these include diuretics ( which increase urine production and can be used to treat high blood pressure , e . g . hydrochlorothiazide ), other bronchodilators such as methylxanthines used for breathing problems ( e . g . theophylline ) or corticosteroids ( e . g . prednisolone ). - tricyclic antidepressants or monoamine oxidase inhibitors ( medicines used in the treatment of depression ). - any medicines that may be similar to bemrist breezhaler ( contain similar active substances ); using them together may increase the risk of possible side effects . - medicines called beta blockers used to treat high blood pressure or other heart problems ( e . g . propranolol ) or to treat glaucoma ( e . g . timolol ). - ketoconazole or itraconazole ( medicines used to treat fungal infections ) - ritonavir , nelfinavir or cobicistat ( medicines used to treat hiv infection ). pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . your doctor will discuss with you whether you can use bemrist breezhaler . driving and using machines it is unlikely that this medicine will affect your ability to drive and use machines . bemrist breezhaler contains lactose this medicine contains about 25 mg of lactose per capsule . if you have been told by your doctor that you have an intolerance to some sugars , speak with your doctor before taking this medicine .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if you think any of these apply to you , or if you are in any doubt at all , consult your doctor before taking zyllt . warnings and precautions if any of the situations mentioned below apply to you , you should tell your doctor before taking zyllt : if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ) - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ). - a recent serious injury - a recent surgery ( including dental ) - a planned surgery ( including dental ) in the next seven days if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred within the last seven days if you have kidney or liver disease if you have had an allergy or reaction to any medicine used to treat your disease . while you are taking zyllt : you should tell your doctor if a surgery ( including dental ) is planned . you should also tell your doctor immediately if you develop a medical condition ( also known as thrombotic thrombocytopenic purpura or ttp ) that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ' possible side effects '). if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). your doctor may order blood tests . children and adolescents do not give this medicine to children because it does not work . other medicines and zyllt tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . some other medicines may influence the use of zyllt or vice versa . you should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as : o oral anticoagulants , medicines used to reduce blood clotting , o a non - steroidal anti - inflammatory medicine , usually used to treat painful and / or inflammatory conditions of muscle or joints , o heparin or any other injectable medicine used to reduce blood clotting , o ticlopidine , other antiplatelet agent , o a selective serotonin reuptake inhibitor ( including but not restricted to fluoxetine or fluvoxamine ), medicines usually used to treat depression , - omeprazole or esomeprazole , medicines to treat upset stomach , - fluconazole or voriconazole , medicines to treat fungal infections , 31 - efavirenz or other anti - retroviral medicines ( used to treat hiv infections ), - carbamazepine a medicine to treat some forms of epilepsy , - moclobemide , medicine to treat depression , - repaglinide , medicine to treat diabetes , - paclitaxel , medicine to treat cancer , - opioids : while you are treated with clopidogrel , you should inform your doctor before being prescribed any opioid ( used to treat severe pain ). if you have experienced severe chest pain ( unstable angina or heart attack ), you may be prescribed zyllt in combination with acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever . an occasional use of acetylsalicylic acid ( no more than 1 , 000 mg in any 24 hour period ) should generally not cause a problem , but prolonged use in other circumstances should be discussed with your doctor . zyllt with food and drink zyllt may be taken with or without food . pregnancy and breast - feeding it is preferable not to take this medicine during pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking zyllt . if you become pregnant while taking zyllt , consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant . you should not breast - feed while taking this medicine . if you are breast - feeding or planning to breast - feed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines zyllt is unlikely to affect your ability to drive or to use machines . zyllt contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicinal product .
do not take lamivudine teva if you are allergic to lamivudine or any of the other ingredients of this medicine ( listed in section 6 ). check with your doctor if you think this applies to you . warnings and precautions 28 some people taking lamivudine teva or other similar medicines are more at risk of serious side effects . you need to be aware of the extra risks : if you have ever had other types of liver disease , such as hepatitis c . if you are seriously overweight ( especially if you are a woman ). talk to your doctor if any of these apply to you . you may need extra check - ups , including blood tests , while you are taking your medication . see section 4 for more information about the risks . do not stop taking lamivudine teva without your doctor ' s advice , as there is a risk of your hepatitis getting worse . when you stop taking lamivudine teva your doctor will monitor you for at least four months to check for any problems . this will mean taking blood samples to check for any raised liver enzyme levels , which may indicate liver damage . see section 3 for more information about how to take lamivudine teva . look out for important symptoms some people taking medicines for hepatitis b infection develop other conditions , which can be serious . you need to know about important signs and symptoms to look out for while you are taking lamivudine teva . read the information ' other possible side effects of therapy for hepatitis b ' in section 4 of this leaflet . protect other people hepatitis b infection is spread by sexual contact with someone who has the infection , or by transfer of infected blood ( for example , by sharing injection needles ). lamivudine teva will not stop you passing hepatitis b infection on to other people . to protect other people from becoming infected with hepatitis b : use a condom when you have oral or penetrative sex . do not risk blood transfer  for example , do not share needles . other medicines and lamivudine teva tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including herbal medicines or other medicines you bought without a prescription . remember to tell your doctor or pharmacist if you begin taking a new medicine while you are taking lamivudine teva . these medicines should not be used with lamivudine teva : medicines ( usually liquids ) containing sorbitol and other sugar alcohols ( such as xylitol , mannitol , lactitol or maltitol ), if taken regularly other medicines containing lamivudine , used to treat hiv infection ( sometimes called the aids virus ) emtricitabine ( used to treat hiv or hepatitis b infection ) cladribine , used to treat hairy cell leukaemia tell your doctor if you are being treated with any of these . pregnancy if you are pregnant , think you may be pregnant , or are planning to have a baby : talk to your doctor about the risks and benefits of taking lamivudine teva during your pregnancy . do not stop treatment with lamivudine teva without your doctor ' s advice . breast - feeding lamivudine teva can pass into breast - milk . if you are breast - feeding , or thinking about breast - feeding : 29 talk to your doctor before you take lamivudine teva . driving and using machines lamivudine teva may make you feel tired , which could affect your ability to drive or use machines . don ' t drive or use machines unless you are sure you ' re not affected . lamivudine teva contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per film - coated tablet , that is to say essentially " sodium - free ".
do not use nespo : if you have been diagnosed with high blood pressure which is not being controlled with other medicines prescribed by your doctor ; or if you are allergic to nespo ( darbepoetin alfa ), r - huepo or to any of the other ingredients in nespo . take special care with nespo please tell your doctor if you are suffering or have suffered from : high blood pressure which is being controlled with medicines prescribed by your doctor ; sickle cell anaemia ; epileptic fits ( seizures ); convulsions ( fits or seizures ); liver disease ; significant lack of response to drugs used to treat anaemia ; or an allergy to latex ( the needle cover on the pre - filled syinge contains a derivative of latex ). special warnings if you have symptoms which include unusual tiredness and a lack of energy this could mean you have pure red cell aplasia ( prca ), which has been reported in patients . prca means that the body has stopped or reduced the production of red blood cells which causes severe anaemia . if you experience these symptoms you should contact your doctor who will determine the best course of action to treat your anaemia . your doctor should try to keep your haemoglobin between 10 and 12 g / dl . if you have chronic renal failure there is an increased risk of serious problems with your heart or blood vessels ( cardiovascular events ) if your haemoglobin is kept too high . if you are a cancer patient you should be aware that nespo may act as a blood cell growth factor and in some circumstances may have a negative impact on your cancer . depending on your individual situation a blood transfusion may be preferable . please discuss this with your doctor . misuse by healthy people can cause life - threatening problems with the heart or blood vessels . using other medicines cyclosporin and tacrolimus may be affected by the number of red cells in your blood . it is important to tell your doctor if you are taking either of these drugs . please tell your doctor if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . using nespo with food and drink food and drink do not affect nespo . pregnancy and breast - feeding nespo has not been tested in pregnant women . it is important to tell your doctor if you : are pregnant ; think you may be pregnant ; or plan to get pregnant . it is not known whether darbepoetin alfa is excreted in human milk . you must stop breast - feeding if you use nespo . driving and using machines nespo should not affect your ability to drive or use machinery .
you must not be given macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor before you are given macugen . occasionally , an infection or bleeding in the eye can occur after macugen injection ( in the next two weeks ). it is important to identify and treat these types of conditions as soon as possible . please tell your doctor immediately if you notice any of the following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , increased number of small particles in your vision . if your doctor cannot be reached for any reason , an alternate doctor should be contacted immediately . in some patients the pressure inside the treated eye may increase for a short period directly after the injection . your doctor may monitor this after each injection . soon after the injection serious allergic reactions may occur . the symptoms you might experience and the instruction what to do in such cases are described in section 4 of this leaflet . children and adolescents macugen should not be used in children and adolescents under 18 years old . other medicines and macugen tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before macugen treatment . there is no experience of using macugen in pregnant women . macugen should not be used during pregnancy unless the potential benefit outweighs the potential risk to the unborn child . if you are pregnant discuss this with your doctor before treatment with macugen . macugen is not recommended during breastfeeding as it is not known whether macugen passes into human milk . ask your doctor or pharmacist for advice before starting macugen treatment . driving and using machines you may experience temporary visual blurring after receiving macugen . if you are affected , do not drive or use machines until this resolves . important information about some of the ingredients of macugen this medicine contains less than 1 mmol sodium ( 23 mg ) per 90 microlitre dose , i . e . essentially ' sodium - free ' ( see section 6 ).
do not use kepivance : - if you are allergic to palifermin , escherichia coli derived proteins or any other ingredients of this medicine ( listed in section 6 ). children kepivance is not recommended in children ( 0 to 18 years ). other medicines and kepivance tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . kepivance might interact with a medicine called heparin . please inform your doctor if you are receiving or have recently received heparin . pregnancy and breast - feeding kepivance has not been tested in pregnant women . it is important to tell your doctor if you : - are pregnant ; - think you may be pregnant ; or - plan to have a baby . if you are pregnant you should not use kepivance unless clearly necessary . it is not known whether kepivance is present in human milk . do not use kepivance if you are breast - feeding . ask your doctor or pharmacist for advice before taking this medicine .
do not take cinacalcet accordpharma : - if you are allergic to cinacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - if you have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor , pharmacist or nurse before taking cinacalcet accordpharma . before you start taking cinacalcet accordpharma , tell your doctor if you have or have ever had : - seizures ( fits or convulsions ). the risk of having seizures is higher if you have had them before ; - liver problems ; - heart failure . cinacalcet accordpharma reduces calcium levels . life threatening events and fatal outcomes associated with low calcium levels ( hypocalcaemia ) have been reported in adults and children treated with cinacalcet accordpharma . please tell your doctor if you experience any of the following which may be signs of low calcium levels : spasms , twitches , or cramps in your muscles , or numbness or tingling in your fingers , toes or around your mouth or seizures , confusion or loss of consciousness while being treated with cinacalcet accordpharma . low calcium levels can have an effect on your heart rhythm . tell your doctor if you experience an unusually fast or pounding heartbeat , if you have heart rhythm problems , or if you take medicines known to cause heart rhythm problems , while taking cinacalcet accordpharma . for additional information see section 4 . during treatment with cinacalcet accordpharma , tell your doctor : - if you start or stop smoking , as this may affect the way cinacalcet accordpharma works . children and adolescents children under the age of 18 with parathyroid cancer or primary hyperparathyroidism must not take cinacalcet accordpharma . if you are being treated for secondary hyperparathyroidism , your doctor should monitor your calcium levels before starting treatment with cinacalcet accordpharma and during treatment with cinacalcet accordpharma . you should inform your doctor if you experience any of the signs of low calcium levels as described above . cinacalcet accordpharma is only available as film - coated tablet . thus , it is not possible to administer cinacalcet accordpharma to paediatric patients that require less than a full 30 mg dose . if an alternate dose is required , other cinacalcet medicines offering such an option should be used . it is important that you take your dose of cinacalcet accordpharma as advised by your doctor . other medicines and cinacalcet accordpharma tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines particularly etelcalcetide or any other medicines that lower the level of calcium in your blood . you should not receive cinacalcet accordpharma together with etelcalcetide . tell your doctor if you are taking the following medicines medicines such as these can affect how cinacalcet accordpharma works : - medicines used to treat skin and fungal infections ( ketoconazole , itraconazole and voriconazole ); - medicines used to treat bacterial infections ( telithromycin , rifampicin and ciprofloxacin ); 48 - a medicine used to treat hiv infection and aids ( ritonavir ); - a medicine used to treat depression ( fluvoxamine ). cinacalcet accordpharma may affect how medicines such as the following work : - medicines used to treat depression ( amitriptyline , desipramine , nortriptyline and clomipramine ); - a medicine used to relieve cough ( dextromethorphan ); - medicines used to treat changes in heart rate ( flecainide and propafenone ); - a medicine used to treat high blood pressure ( metoprolol ). pregnancy , breast - feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . cinacalcet accordpharma has not been tested in pregnant women . in case of pregnancy , your doctor may decide to modify your treatment , as cinacalcet accordpharma might harm the unborn baby . it is not known whether cinacalcet accordpharma is excreted in human milk . your doctor will discuss with you if you should discontinue either breast - feeding or treatment with cinacalcet accordpharma . driving and using machines dizziness and seizures have been reported by patients taking cinacalcet accordpharma . if you experience these side effects , do not drive or operate machines .
do not take jentadueto - if you are allergic to linagliptin or metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if you have severely reduced kidney function . if you have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidosis " below ) or ketoacidosis . ketoacidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach pain , fast and deep breathing , sleepiness or your breath developing an unusual fruity smell . - if you ever had a diabetic pre - coma . - if you have a severe infection such as an infection affecting your lung or bronchial system or your kidney . severe infections may lead to kidney problems , which can put you at risk for lactic acidosis ( see ' warnings and precautions '). - if you have lost a lot of water from your body ( dehydration ), e . g . due to long - lasting or severe diarrhoea , or if you have vomited several times in a row . dehydration may lead to kidney problems , which can put you at risk for lactic acidosis ( see ' warnings and precautions '). - if you are treated for acute heart failure or have recently had a heart attack , have severe problems with your circulation ( such as shock ) or have breathing difficulties . this may lead to a lack in oxygen supply to tissue which can put you at risk for lactic acidosis ( see ' warnings and precautions '). - if you have liver problems . - if you drink alcohol to excess , either every day or only from time to time ( see section ' jentadueto with alcohol '). do not take jentadueto if any of the above applies to you . if you are not sure , talk to your doctor or pharmacist before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking jentadueto - if you have type 1 diabetes ( your body does not produce any insulin ). jentadueto should not be used to treat this condition . - if you are taking insulin or an anti - diabetic medicine known as ' sulphonylurea ', your doctor may want to reduce your dose of insulin or sulphonylurea when you take either of them together with jentadueto in order to avoid low blood sugar ( hypoglycaemia ). - if you have or have had a disease of the pancreas . if you have symptoms of acute pancreatitis , like persistent , severe abdominal pain , you should consult your doctor . if you encounter blistering of the skin it may be a sign for a condition called bullous pemphigoid . your doctor may ask you to stop jentadueto . if you are not sure if any of the above applies to you , talk to your doctor , pharmacist or nurse before taking jentadueto . diabetic skin problems are a common complication of diabetes . you are advised to follow the recommendations for skin and foot care that you are given by your doctor or nurse . risk of lactic acidosis . due to the metformin component , jentadueto may cause a very rare , but very serious complication called lactic acidosis , particularly if your kidneys are not working properly . the risk of developing lactic acidosis is also increased with uncontrolled diabetes , serious infections , prolonged fasting or alcohol intake , dehydration ( see further information below ), liver problems and any medical conditions in which a part of the body has a reduced supply of oxygen ( such as acute severe heart disease ). if any of the above apply to you , talk to your doctor for further instructions . stop taking jentadueto for a short time if you have a condition that may be associated with dehydration ( significant loss of body fluids ) such as severe vomiting , diarrhoea , fever , exposure to heat or if you drink less fluid than normal . talk to your doctor for further instruction . stop taking jentadueto and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis , as this condition may lead to coma . symptoms of lactic acidosis include : - vomiting - stomach ache ( abdominal pain ) - muscle cramps - a general feeling of not being well with severe tiredness - difficulty in breathing - reduced body temperature and heartbeat lactic acidosis is a medical emergency and must be treated in a hospital . if you need to have major surgery you must stop taking jentadueto during and for some time after the procedure . your doctor will decide when you must stop and when to restart your treatment with jentadueto . during treatment with jentadueto , your doctor will check your kidney function at least once a year or more frequently if you are elderly and / or if you have worsening kidney function . children and adolescents this medicine is not recommended for use in children and adolescents under 18 years . other medicines and jentadueto if you need to have an injection of a contrast medium that contains iodine into your bloodstream , for example in the context of an x - ray or scan , you must stop taking jentadueto before or at the time of the injection . your doctor will decide when you must stop and when to restart your treatment with jentadueto . tell your doctor if you are taking , have recently taken or might take any other medicines . you may need more frequent blood glucose and kidney function tests , or your doctor may need to adjust the dosage of jentadueto . it is especially important to mention the following : - medicines which increase urine production ( diuretics ) - medicines used to treat pain and inflammation ( nsaid and cox - 2 - inhibitors , such as ibuprofen and celecoxib ) - certain medicines for the treatment of high blood pressure ( ace inhibitors and angiotensin ii receptor antagonists ) - medicines that may change the amount of metformin in your blood , especially if you have reduced kidney function ( such as verapamil , rifampicin , cimetidine , dolutegravir , ranolazine , trimethoprime , vandetanib , isavuconazole , crizotinib , olaparib ). - carbamazepine , phenobarbital or phenytoin . these may be used to control fits ( seizures ) or chronic pain . - rifampicin . this is an antibiotic used to treat infections such as tuberculosis . - medicines used to treat diseases that involve inflammation , like asthma and arthritis ( corticosteroids ). - bronchodilators (  - sympathomimetics ) for the treatment of bronchial asthma . - alcohol - containing medicines . jentadueto with alcohol avoid excessive alcohol intake while taking jentadueto since this may increase the risk of lactic acidosis ( see section ' warnings and precautions '). pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . you should not use jentadueto if you are pregnant . it is unknown if this medicine is harmful to the unborn child . metformin passes into human milk in small amounts . it is not known whether linagliptin passes into human milk . talk to your doctor if you want to breast - feed while taking this medicine . driving and using machines jentadueto has no or negligible influence on the ability to drive and use machines . however , taking jentadueto in combination with medicines called sulphonylureas or with insulin can cause too low blood sugar level ( hypoglycaemia ), which may affect your ability to drive and use machines or work without safe foothold .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). do not take edurant in combination with any of the following medicines as they may affect the way edurant or the other medicine works : - carbamazepine , oxcarbazepine , phenobarbital , phenytoin ( medicines to treat epilepsy and prevent seizures ) - rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) - omeprazole , esomeprazole , lansoprazole , pantoprazole , rabeprazole , ( proton pump inhibitors that are medicines to prevent and treat stomach ulcers , heartburn or acid reflux disease ) - dexamethasone ( a corticosteroid used in a variety of conditions such as inflammation and allergic reactions ) when taken by mouth or injected , except as a single dose treatment - products that contain st john ' s wort ( hypericum perforatum ) ( a herbal product used for depression ). if you are taking any of the above , ask your doctor about alternatives . warnings and precautions talk to your doctor or pharmacist before taking edurant . edurant is not a cure for hiv infection . it is part of a treatment reducing the amount of virus in the blood . you can still pass on hiv when taking this medicine , although the risk is lowered by effective antiretroviral therapy . discuss with your physician the precautions needed to avoid infecting other people . edurant has only been used in a limited number of patients of 65 years or older . if you belong to this age group , please discuss the use of edurant with your doctor . tell your doctor about your situation make sure that you check the following points and tell your doctor if any of these apply to you . - tell your doctor if you have or have had problems with your liver , including hepatitis b and / or c , and / or problems with your kidneys . your doctor may evaluate how severe your liver or kidney disease is before deciding if you can take edurant . - tell your doctor immediately if you notice any symptoms of infections ( for example , fever , chills , sweats ). in some patients with advanced hiv infection and a history of opportunistic infection , signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is believed that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . - in addition to the opportunistic infections , autoimmune disorders ( a condition that occurs when the immune system attacks healthy body tissue ) may also occur after you start taking medicines for the treatment of your hiv infection . autoimmune disorders may occur many months after the start of treatment . if you notice any symptoms of infection or other symptoms such as muscle weakness , weakness beginning in the hands and feet and moving up towards the trunk of the body , palpitations , tremor or hyperactivity , please inform your doctor immediately to seek necessary treatment . - tell your doctor if you are taking any medicines that may cause a life - threatening irregular heartbeat ( torsade de pointes ). children edurant is not for use in children less than 12 years of age , because it has not been sufficiently studied in these patients . other medicines and edurant you must take edurant together with other hiv medicines . your doctor will advise on which hiv medicines can be combined with edurant and together you will decide which combination fits your needs best . follow your doctor ' s instruction carefully . some medicines may affect the levels of edurant in the blood when they are taken at the same time as edurant . tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . it is not recommended to combine edurant with other non - nucleoside reverse transcriptase inhibitors ( nnrtis ) such as delavirdine , efavirenz , etravirine , and nevirapine . the effects of edurant or other medicines might be influenced if you take edurant together with any of the following medicines . tell your doctor if you take : - rifabutin ( a medicine to treat some bacterial infections ). if you take this medicine while taking edurant , please carefully read how to take edurant in section 3 " instructions for proper use in adults and adolescents ( 12 to less than 18 years of age )". - clarithromycin , erythromycin ( antibiotics ) - cimetidine , famotidine , nizatidine , ranitidine ( h2 - receptor antagonists used to treat stomach or intestinal ulcers or used to relieve heartburn due to acid reflux ). if you take these medicines , 34 please carefully read how to take them in section 3 " instructions for proper use in adults and adolescents ( 12 to less than 18 years of age )". - antacids ( used to treat diseases related to the acid in the stomach ; for example , aluminium / magnesium hydroxide , calcium carbonate ). if you take these medicines , please carefully read how to take them in section 3 " instructions for proper use in adults and adolescents ( 12 to less than 18 years of age )". - methadone ( used to treat narcotic withdrawal and dependence ) - dabigatran etexilate ( anticoagulant ). pregnancy and breast - feeding tell your doctor immediately if you are pregnant or if you plan to become pregnant . pregnant women should discuss the use of edurant with their doctor . hiv infected mothers must not breastfeed , as there is a possibility of infecting the baby with hiv via breast milk . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines some patients may experience tiredness , dizziness or drowsiness during treatment with edurant . do not drive or operate machinery if you feel tired , dizzy or drowsy while taking edurant . edurant contains lactose if you have been told by your doctor that you have intolerance to some sugars , contact your doctor before taking this medicine .
to help manage your diabetes , it is important that you follow any diet and lifestyle advice from your doctor as well as taking avandamet . don ' t take avandamet : if you are allergic ( hypersensitive ) to rosiglitazone or metformin or any of the other ingredients of avandamet ( listed in section 6 ) if you have had a heart attack or severe angina , that ' s being treated in hospital if you have heart failure , or have had heart failure in the past if you have severe breathing difficulties if you have liver disease if you are a heavy drinker of alcohol if you regularly drink a lot , or if you have occasional sessions of heavy drinking ( binge drinking ) if you have had diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) if you have kidney disease 107 if you are very dehydrated or have a severe infection ( see ' while you take avandamet your doctor needs to know ' later in section 2 ) if you are going to have an x - ray using an injected dye ( see ' while you take avandamet your doctor needs to know ' later in section 2 ) if you are breast - feeding ( see ' pregnancy and breast - feeding ' later in section 2 ). check with your doctor if you think any of these apply to you . don ' t take avandamet . take special care with avandamet avandamet is not recommended for people aged under 18 , as the safety and effectiveness are not known . if you have been diagnosed with angina ( chest pain ), or peripheral arterial disease ( reduced blood flow to the legs ): check with your doctor , as avandamet may not be suitable for you . conditions to look out for avandamet and other medicines for diabetes can make some existing conditions worse , or cause serious side effects . you must look out for certain symptoms while you are taking avandamet , to reduce the risk of any problems . see ' conditions you need to look out for ' in section 4 . ovulation may restart women who are infertile due to a condition affecting their ovaries ( such as polycystic ovarian syndrome ), may start ovulating again when they start taking avandamet . if this applies to you , use appropriate contraception to avoid the possibility of an unplanned pregnancy ( see ' pregnancy and breast - feeding ' later in section 2 ). your kidney function will be checked your kidneys should be checked at least once a year more often if you are over 65 , or if your kidney function is close to abnormal . while you take avandamet your doctor needs to know : if you become dehydrated for example , after severe vomiting , diarrhoea or fever . these can lead to severe loss of water ( dehydration ). speak to your doctor , as you may need to stop taking avandamet for a short while . if you are going to have an operation under general anaesthetic . your doctor will advise you to stop taking avandamet for at least 48 hours before and after the operation . if you are going to have an x - ray using an injected dye . your doctor will advise you to stop taking avandamet before the x - ray and for 48 hours after it . the doctor will check your kidney function before restarting treatment . taking other medicines tell your doctor or pharmacist if you are taking any other medicines , if you ' ve taken any recently , or if you start taking new ones . this includes herbal medicines and other medicines you bought without a prescription . certain medicines are especially likely to affect the amount of sugar in your blood : steroids ( used to treat inflammation ) such as prednisolone or dexamethasone beta - 2 - agonists ( used to treat asthma ), such as salbutamol or salmeterol diuretics ( used to get rid of water ), such as furosemide or indapamide ace inhibitors ( used to treat high blood pressure ), such as enalapril or captopril gemfibrozil ( used to lower cholesterol ) rifampicin ( used to treat tuberculosis and other infections ) cimetidine ( used to reduce stomach acid ). tell a doctor or pharmacist if you are taking any of these . your blood sugar will be checked , and your dose of avandamet may need to be changed . pregnancy and breast - feeding avandamet is not recommended during pregnancy . if you are pregnant or could be pregnant , tell your doctor before you take avandamet . don ' t breast - feed while you are taking avandamet . the ingredients may pass into breast milk and so may harm your baby . driving and using machines this medicine should not affect your ability to drive or use machines . avandamet contains lactose avandamet tablets contain a small amount of lactose . patients who are intolerant to lactose or have a rare hereditary problem of galactose intolerance , the lapp lactase deficiency , or glucose - galactose malabsorption should not take this medicine .
do not take clopidogrel mylan 31 if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ); if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; if you suffer from severe liver disease ; if you think any of these apply to you , or if you are in any doubt at all , consult your doctor before taking clopidogrel mylan . warnings and precautions talk to your doctor before taking clopidogrel mylan if any of the situations mentioned below apply to you : if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding ( such as a stomach ulcer ) - a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints of your body ). - a recent serious injury - a recent surgery ( including dental ). - a planned surgery ( including dental ) in the next seven days . if you have had a clot in an artery of your brain ( ischaemic stroke ) which occurred within the last seven days . if you have kidney or liver disease . if you have had an allergy or reaction to any medicine used to treat your disease . while you are taking clopidogrel mylan : you should tell your doctor if a surgery ( including dental ) is planned . you should also tell your doctor immediately if you develop a medical condition ( also known as thrombotic thrombocytopenic purpura or ttp ) that includes fever and bruising under the skin that may appear as red pinpoint dots , with or without unexplained extreme tiredness , confusion , yellowing of the skin or eyes ( jaundice ) ( see section 4 ' possible side effects '). if you cut or injure yourself , it may take longer than usual for bleeding to stop . this is linked to the way your medicine works as it prevents the ability of blood clots to form . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you are concerned by your bleeding , you should contact your doctor straightaway ( see section 4 ' possible side effects '). your doctor may order blood tests . children and adolescents do not give this medicine to children because it does not work . other medicines and clopidogrel mylan tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . some other medicines may influence the use of clopidogrel mylan or vice versa . you should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as : o oral anticoagulants , medicines used to reduce blood clotting , o a non - steroidal anti - inflammatory medicine , usually used to treat painful and / or inflammatory conditions of muscle or joints , o heparin , or any other injectable medicine used to reduce blood clotting , o ticlopidine , other antiplatelet agent , o a selective serotonin reuptake inhibitor ( including but not restricted to fluoxetine or fluvoxamine ), medicines usually used to treat depression , o rifampicin ( used to treat severe infections ) 32 - omeprazole or esomeprazole , medicines to treat upset stomach , - fluconazole or voriconazole , medicines to treat fungal infections , - efavirenz , or other anti - retroviral medicines ( used to treat hiv infections ), - carbamazepine , a medicine to treat some forms of epilepsy , - moclobemide , medicine to treat depression , - repaglinide , medicine to treat diabetes , - paclitaxel , medicine to treat cancer , - opioids : while you are treated with clopidogrel , you should inform your doctor before being prescribed any opioid ( used to treat severe pain ). if you have experienced severe chest pain ( unstable angina or heart attack ), you may be prescribed clopidogrel mylan in combination with acetylsalicylic acid , a substance present in many medicines used to relieve pain and lower fever . an occasional use of acetylsalicylic acid ( no more than 1 , 000 mg in any 24 hour period ) should generally not cause a problem , but prolonged use in other circumstances should be discussed with your doctor . pregnancy and breast - feeding it is preferable not to take this medicine during pregnancy . if you are pregnant or suspect that you are pregnant , you should tell your doctor or your pharmacist before taking clopidogrel mylan . if you become pregnant while taking clopidogrel mylan , consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant . you should not breast - feed while taking this medicine . if you are breast - feeding or planning to breast - feed , talk to your doctor before taking this medicine . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines clopidogrel mylan is unlikely to affect your ability to drive or to use machines . clopidogrel mylan contains hydrogenated castor oil this may cause stomach upset or diarrhoea .
do not take doptelet if : - you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). if you are not sure , talk to your doctor or pharmacist before taking doptelet . warnings and precautions talk to your doctor or pharmacist before taking doptelet if : - you are at risk of blood clots in your veins or arteries , or members of your family have had blood clots . you may be at higher risk of blood clots as you get older or if : - you have had to stay in bed for a long time - you have cancer - you are taking the contraceptive birth control pill or hormone replacement therapy - you have recently had surgery or been injured 23 - you are very overweight - you smoke - you have advanced chronic liver disease . if any of the above applies to you , or you are not sure , talk to your doctor or pharmacist before taking doptelet . children and adolescents do not give doptelet to people less than 18 years old . the safety and effectiveness of this medicine in this age group is not known . other medicines and doptelet tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . pregnancy and breast - feeding if you are pregnant , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . doptelet is not recommended in pregnancy and in women who are able to have children and are not using contraception . if you are breast - feeding , ask your doctor or pharmacist for advice before taking doptelet . this medicine can pass into breast milk . your doctor will help you decide whether the benefit of breast - feeding outweighs any possible risks to your baby while you are breast - feeding . driving and using machines doptelet is not expected to affect you being able to drive , cycle or use tools or machines . doptelet contains lactose doptelet contains lactose ( a type of sugar ). if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicine .
do not take rapiscan : if you have slow heart rate ( high degree heart block or sinus node disease ), and don ' t have a pacemaker fitted . if you have chest pain that occurs unpredictably ( unstable angina ) and that has not improved after treatment . if you have low blood pressure ( hypotension ). if you have heart failure . if you are allergic to regadenoson or any of the other ingredients of rapiscan listed in section 6 of this leaflet . talk to your doctor or nurse before taking rapiscan your doctor needs to know before you are given rapiscan : if you have had a recent serious heart problem ( for example a heart attack or abnormal heart rhythms ). if you have a heart rhythm where your heartbeat is very fast or uneven ( atrial fibrillation or atrial flutter ) if you have high blood pressure that is not controlled , especially if this has been accompanied by recent episodes of nose bleed , headache or blurred or double vision . if you have had episodes of mini strokes ( called transient ischaemic attacks ) if you have a heart rhythm disorder called long qt syndrome . if you have episodes of heart block ( which can slow the heart down ) or a very slow heart rate . if you have any heart or blood vessel condition , particularly one that gets worse when your blood pressure decreases . these include low blood volume ( caused , for example , by severe diarrhoea or dehydration or taking water pills ), inflammation around the heart ( pericarditis ) and some forms of heart valve or artery disease ( for example , aortic or mitral stenosis ). if you have a condition that causes fits ( seizures ), such as epilepsy , or if you have ever had fits . if you have asthma or lung disease . if any of these apply to you , tell your doctor before you are given the injection . children and adolescents rapiscan should not be used in children and adolescents below the age of 18 years . other medicines and rapiscan please tell your doctor if you are taking or have recently taken any other medicines including medicines obtained without prescription . particular care should be taken with the following medicines : theophylline , a medicine used to treat asthma and other lung diseases , must not be used for at least 12 hours before you are given rapiscan because it can block the effect of rapiscan . dipyridamole , a medicine used to prevent blood clots , must not be used for at least two days before you are given rapiscan because it can change the effect of rapiscan . rapiscan with food and drink do not eat food or have drinks containing caffeine ( for example , tea , coffee , cocoa , cola or chocolate ) for at least 12 hours before you are given rapiscan . this is because caffeine can interfere with the effect of rapiscan . pregnancy and breast - feeding before you are given rapiscan , tell your doctor : if you are pregnant , think you are pregnant or planning to have a baby . there is no adequate information on the use of rapiscan in pregnant women . harmful effects have been seen in animal studies but it is not known if there is a risk to humans . your doctor will only give you rapiscan if it is clearly necessary . if you are breast - feeding . it is not known whether rapiscan can pass into breast milk and will only be given to you if your doctor thinks it is necessary . you should avoid breast - feeding for at least 10 hours after you are given rapiscan . ask your doctor for advice before using any medicine . driving and using machines rapiscan may make you feel dizzy . it may cause other symptoms ( headache or shortness of breath ) that could affect your ability to drive or use machinery . these effects usually do not last longer than 30 minutes . do not drive or operate machinery until these effects have improved . rapiscan contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per dose . after you have been given rapiscan , you will be given an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution which contains 45 mg of sodium . to be taken into consideration if you are on a controlled sodium diet .
do not take viagra  if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ).  if you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if you are taking any of these medicines which are often given for relief of angina pectoris ( or " chest pain "). if you are not certain , ask your doctor or pharmacist .  if you are using any of the medicines known as nitric oxide donors such as amyl nitrite (" poppers "), as the combination may also lead to a dangerous fall in your blood pressure .  if you are taking riociguat . this drug is used to treat pulmonary arterial hypertension ( i . e ., high blood pressure in the lungs ) and chronic thromboembolic pulmonary hypertension ( i . e ., high blood pressure in the lungs secondary to blood clots ). pde5 inhibitors , such as viagra 56 have been shown to increase the hypotensive effects of this medicine . if you are taking riociguat or are unsure tell your doctor .  if you have a severe heart or liver problem .  if you have recently had a stroke or a heart attack , or if you have low blood pressure .  if you have certain rare inherited eye diseases ( such as retinitis pigmentosa ).  if you have ever had loss of vision due to non - arteritic anterior ischaemic optic neuropathy ( naion ). warnings and precautions talk to your doctor , pharmacist or nurse before taking viagra  if you have sickle cell anaemia ( an abnormality of red blood cells ), leukaemia ( cancer of blood cells ), multiple myeloma ( cancer of bone marrow ).  if you have a deformity of your penis or peyronie ' s disease .  if you have problems with your heart . your doctor should carefully check whether your heart can take the additional strain of having sex .  if you currently have a stomach ulcer , or a bleeding problems ( such as haemophilia ).  if you experience sudden decrease or loss of vision , stop taking viagra and contact your doctor immediately . you should not use viagra with any other oral or local treatments for erectile dysfunction . you should not use viagra with treatments for pulmonary arterial hypertension ( pah ) containing sildenafil or any other pde5 inhibitors . you should not take viagra if you do not have erectile dysfunction . you should not take viagra if you are a woman . special considerations for patients with kidney or liver problems you should tell your doctor if you have kidney or liver problems . your doctor may decide on a lower dose for you . children and adolescents viagra should not be given to individuals under the age of 18 . other medicines and viagra tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . viagra tablets may interfere with some medicines , especially those used to treat chest pain . in the event of a medical emergency , you should tell your doctor , pharmacist or nurse that you have taken viagra and when you did . do not take viagra with other medicines unless your doctor tells you that you can . you should not take viagra if you are taking medicines called nitrates , as the combination of these medicines may lead to a dangerous fall in your blood pressure . always tell your doctor , pharmacist or nurse if you are taking any of these medicines that are often used for the relief of angina pectoris ( or " chest pain "). you should not take viagra if you are using any of the medicines known as nitric oxide donors such as amyl nitrite (" poppers ") as the combination may also lead to a dangerous fall in your blood pressure . tell your doctor or pharmacist if you are already taking riociguat . if you are taking medicines known as protease inhibitors , such as for the treatment of hiv , your doctor may start you on the lowest dose ( 25 mg ) of viagra . some patients who take alpha - blocker therapy for the treatment of high blood pressure or prostate enlargement may experience dizziness or light - headedness , which may be caused by low blood pressure upon sitting or standing up quickly . certain patients have experienced these symptoms when taking viagra with alpha - blockers . this is most likely to happen within 4 hours after taking viagra . to reduce the chance that these symptoms might happen , you should be on a regular daily dose of your alpha - blocker before you start viagra . your doctor may start you on a lower dose ( 25 mg ) of viagra . viagra with food and drink and alcohol viagra can be taken with or without food . however , you may find that viagra takes longer to start working if you take it with a heavy meal . drinking alcohol can temporarily impair your ability to get an erection . to get the maximum benefit from your medicine , you are advised not to drink excessive amounts of alcohol before taking viagra . pregnancy , breast - feeding and fertility viagra is not indicated for use by women . driving and using machines viagra can cause dizziness and can affect vision . you should be aware of how you react to viagra before you drive or use machinery . viagra contains lactose if you have been told by your doctor that you have an intolerance to some sugars , such as lactose , contact your doctor before taking viagra .
do not take sifrol : - if you are allergic to pramipexole or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifrol . tell your doctor if you have ( had ) or develop any medical conditions or symptoms , especially any of the following : - kidney disease . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). if you have advanced parkinson ' s disease and are also taking levodopa , you might develop dyskinesia during the up - titration of sifrol . - dystonia ( inability of keeping your body and neck straight and upright ( axial dystonia )). in particular , you may experience forward flexion of the head and neck ( also called antecollis ), forward bending of the lower back ( also called camptocormia ) or sidewards bending of the back ( also called pleurothotonus or pisa syndrome ). - sleepiness and episodes of suddenly falling asleep . - psychosis ( e . g . comparable with symptoms of schizophrenia ). - vision impairment . you should have regular eye examinations during treatment with sifrol . - severe heart or blood vessels disease . you will need to have your blood pressure checked regularly , especially at the beginning of treatment . this is to avoid postural hypotension ( a fall in blood pressure on standing up ). - augmentation . you may experience that symptoms start earlier than usual , be more intense and involve other limbs . tell your doctor if you or your family / carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse , drive or temptation to carry out certain activities that could harm yourself or others . these are called impulse control disorders and can include behaviours such as addictive gambling , excessive eating or spending , an abnormally high sex drive or preoccupation with an increase in sexual thoughts or feelings . your doctor may need to adjust or stop your dose . tell your doctor if you or your family / carer notices that you are developing mania ( agitation , feeling elated or over - excited ) or delirium ( decreased awareness , confusion or loss of reality ). your doctor may need to adjust or stop your dose . tell your doctor if you experience symptoms such as depression , apathy , anxiety , fatigue , sweating or pain after stopping or reducing your sifrol treatment . if the problems persist more than a few weeks , your doctor may need to adjust your treatment . tell your doctor if you are developing an inability of keeping your body and neck straight and upright ( axial dystonia ). if this happens , your doctor may want to adjust or change your medication . children and adolescents sifrol is not recommended for use in children or adolescents under 18 years . other medicines and sifrol tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . this includes medicines , herbal remedies , health foods or supplements that you have obtained without a prescription . you should avoid taking sifrol together with antipsychotic medicines . take care if you are taking the following medicines : - cimetidine ( to treat excess stomach acid and stomach ulcers ) - amantadine ( which can be used to treat parkinson ' s disease ) - mexiletine ( to treat irregular heartbeats , a condition known as ventricular arrhythmia ) - zidovudine ( which can be used to treat the acquired immune deficiency syndrome ( aids ), a disease of the human immune system ) - cisplatin ( to treat various types of cancers ) - quinine ( which can be used for the prevention of painful night - time leg cramps and for the treatment of a type of malaria known as falciparum malaria ( malignant malaria )) - procainamide ( to treat irregular heart beat ) if you are taking levodopa , the dose of levodopa is recommended to be reduced when you start treatment with sifrol . take care if you are using any medicines that calm you down ( have a sedative effect ) or if you are drinking alcohol . in these cases sifrol may affect your ability to drive and operate machinery . sifrol with food , drink and alcohol you should be cautious while drinking alcohol during treatment with sifrol . sifrol can be taken with or without food . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . your doctor will then discuss with you if you should continue to take sifrol . the effect of sifrol on the unborn child is not known . therefore , do not take sifrol if you are pregnant unless your doctor tells you to do so . sifrol should not be used during breast - feeding . sifrol can reduce the production of breast milk . also , it can pass into the breast milk and can reach your baby . if use of sifrol is unavoidable , breast - feeding should be stopped . ask your doctor or pharmacist for advice before taking any medicine . driving and using machines sifrol can cause hallucinations ( seeing , hearing or feeling things that are not there ). if affected , do not drive or use machines . sifrol has been associated with sleepiness and episodes of suddenly falling asleep , particularly in patients with parkinson ' s disease . if you experience these side effects , you must not drive or operate machinery . you should tell your doctor if this occurs .
do not use emadine if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . ask your doctor for advice . warning and precautions do not use emadine in children under the age of 3 years . if you wear contact lenses please see section ' emadine contains benzalkonium chloride below '. emadine is not recommended for use in patients over 65 years of age , as it has not been studied in clinical trials in this age group . emadine is not recommended for use in patients with kidney or liver problems . talk to your doctor or pharmacist before using emadine . other medicines and emadine tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . if you are using other eye drops at the same time as emadine , follow the advice at the end of section 3 " how to use emadine ". pregnancy , breast feeding and fertility if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . driving and using machines you may find that your vision is blurred for a time just after you use emadine . do not drive or use machines until your vision is clear . emadine contains benzalkonium chloride this medicine contains 0 . 5 mg or 1 mg benzalkonium chloride in each 5 or 10 ml , which are equivalent to 0 . 1 mg / ml . the preservative in emadine , benzalkonium chloride , may be absorbed by soft contact lenses and may change the colour of the contact lenses . you should remove contact lenses before using this medicine and put them back 15 minutes afterwards . benzalkonium chloride may also cause eye irritation , especially if you have dry eyes or disorders of the cornea ( the clear layer at the front of the eye ). if you feel abnormal eye sensation , stinging or pain in the eye after using this medicine , talk to your doctor .
do not take levetiracetam actavis if you are allergic to levetiracetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiracetam actavis if you suffer from kidney problems , follow your doctor ' s instructions . he / she may decide if your dose should be adjusted . if you notice any slow down in the growth or unexpected puberty development of your child , please contact your doctor . a small number of people being treated with anti - epileptics such as levetiracetam actavis have had thoughts of harming or killing themselves . if you have any symptoms of depression and / or suicidal ideation , please contact your doctor . tell your doctor or pharmacist if any of the following side effects gets serious or last longer than a few days : abnormal thoughts , feeling irritable or reacting more aggressively than usually , or if you or your family and friends notice important changes in mood or behaviour . children and adolescents levetiracetam actavis is not indicated in children and adolescents below 16 years on its own ( monotherapy ). other medicines and levetiracetam actavis tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . do not take macrogol ( a drug used as laxative ) for one hour before and one hour after taking levetiracetam as this may result in a loss of its effect . pregnancy and breast - feeding if you are pregnant or breastfeeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . levetiracetam can be used during pregnancy , only if after careful assessment it is considered necessary by your doctor . you should not stop your treatment without discussing this with your doctor . a risk of birth defects for your unborn child cannot be completely excluded . breast - feeding is not recommended during treatment . driving and using machines levetiracetam actavis may impair your ability to drive or operate any tools or machinery , as it may make you feel sleepy . this is more likely at the beginning of treatment or after an increase in the dose . you should not drive or use machines until it is established that your ability to perform such activities is not affected . levetiracetam actavis 750 mg tablets contain sunset yellow ( e110 ) sunset yellow ( e110 ) colouring agent may cause allergic reactions .
do not use incruse ellipta : 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if you think the above applies to you , don ' t use this medicine until you have checked with your doctor . warnings and precautions talk to your doctor before using this medicine : - if you have asthma ( don ' t use incruse ellipta to treat asthma ) - if you have heart problems - if you have an eye problem called narrow - angle glaucoma - if you have an enlarged prostate , difficulty passing urine or a blockage in your bladder - if you have severe liver problems check with your doctor if you think any of these may apply to you . immediate breathing difficulties if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using your incruse ellipta inhaler : stop using this medicine and seek medical help immediately , as you may have a serious condition called paradoxical bronchospasm . eye problems during treatment with incruse ellipta if you get eye pain or discomfort , temporary blurring of vision , visual halos or coloured images in association with red eyes during treatment with incruse ellipta : stop using this medicine and seek medical help immediately , these may be signs of an acute attack of narrow - angle glaucoma . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . other medicines and incruse ellipta tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . if you are not sure what your medicine contains talk to your doctor or pharmacist . in particular , tell your doctor or pharmacist if you are taking other long - acting medicines similar to this medicine for breathing problems , e . g . tiotropium . don ' t use incruse ellipta as well as these other medicines . if you are not sure what your medicine contains talk to your doctor or pharmacist . pregnancy and breast - feeding if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . don ' t use this medicine if you are pregnant unless your doctor tells you so . it is not known whether the ingredients of incruse ellipta can pass into breast milk . if you are breast - feeding , you must check with your doctor before you use incruse ellipta . driving and using machines it is unlikely that this medicine will affect your ability to drive or use machines . incruse ellipta contains lactose if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before using this medicine .
do not use nucala : - if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). check with your doctor if you think this applies to you . warnings and precautions talk to your doctor before using this medicine . worsening asthma 58 some people get asthma - related side effects , or their asthma may become worse , during treatment with nucala . tell your doctor or nurse if your asthma remains uncontrolled , or gets worse , after you start nucala treatment . allergic and injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when injected into the body ( see section 4 , ' possible side effects '). if you may have had a similar reaction to any injection or medicine : tell your doctor before you are given nucala . parasitic infections nucala may weaken your resistance to infections caused by parasites . if you already have a parasitic infection ; it should be treated before you start treatment with nucala . if you live in a region where these infections are common or if you are travelling to such a region : check with your doctor if you think any of these may apply to you . children and adolescents the pre - filled pen is not intended for use in children below 12 years of age . for children aged 6 - 11 years , contact your doctor who will prescribe the recommended dose of nucala which will be administered by a nurse or doctor . other medicines and nucala tell your doctor if you are taking , have recently taken or might take any other medicines . other medicines for asthma don ' t suddenly stop taking your preventer medicines for your asthma once you have started nucala . these medicines ( especially ones called corticosteroids ) must be stopped gradually , under the direct supervision of your doctor and dependant on your response to nucala . pregnancy and breast - feeding if you are pregnant , if you think you may be pregnant or are planning to have a baby , ask your doctor for advice before using this medicine . it is not known whether the ingredients of nucala can pass into breast milk . if you are breast - feeding , you must check with your doctor before you use nucala . driving and using machines the possible side effects of nucala are unlikely to affect your ability to drive or use machines . nucala contains sodium this medicine contains less than 1 mmol sodium ( 23 mg ) per 100 mg dose , i . e ., it is essentially " sodium - free ".
do not take ninlaro - if you are allergic to ixazomib or to any of the other any of the other ingredients of this medicine ( listed in section 6 ). if you are uncertain whether the condition above applies to you , talk to your doctor , pharmacist or nurse before taking ninlaro . warnings and precautions talk to your doctor , pharmacist or nurse before taking ninlaro if : you have a history of bleeding you have persistent nausea , vomiting or diarrhoea you have a history of nerve problems , to include tingling and numbness you have a history of swelling you have a persistent rash you have or have had liver or kidney problems as your dose may have to be adjusted . your doctor will examine you and you will be monitored closely during treatment . before starting ninlaro and during treatment , you will have blood tests to check that you have enough blood cells . children and adolescents ninlaro is not recommended for use in children and adolescents aged under 18 years . other medicines and ninlaro tell your doctor , pharmacist or nurse if you are taking , have recently taken or might take any other medicines . this includes any medicines obtained without a prescription , such as vitamins or herbal remedies . this is because other medicines can affect the way ninlaro works . in particular , tell your doctor , pharmacist or nurse if you are taking any of the following medicines : carbamazepine , phenytoin , rifampicin and st . john ' s wort ( hypericum perforatum ). these medicines should be avoided as they may reduce the effectiveness of ninlaro . pregnancy and breast - feeding ninlaro is not recommended during pregnancy as it may harm your unborn baby . breast - feeding should be stopped when taking ninlaro . avoid becoming pregnant or breast - feeding while being treated with ninlaro . if you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . if you are a woman of childbearing potential or a man who can father a child , you must use effective contraception during and for 90 days after treatment . women using hormonal contraceptives should additionally use a barrier method of contraception . tell doctor right away if you or your partner becomes pregnant while receiving ninlaro . as ninlaro is given in combination with lenalidomide , you should adhere to the pregnancy prevention programme of lenalidomide because lenalidomide can be harmful to the unborn child . see the package leaflets for lenalidomide and dexamethasone for additional information on pregnancy and breast - feeding driving and using machines ninlaro may affect your ability to drive or use machines . you may feel tired and dizzy while taking ninlaro . do not drive or operate machines if you have these side effects .
do not take palforzia - if you are allergic to any of the excipients ( other ingredients ) in this medicine ( listed in section 6 ). - if you have severe asthma or if your asthma is not under control ( as assessed by a doctor ). - if you have ever had a problem swallowing or long term problems with your digestive system . - if you have ever had a severe mast cell disorder ( as assessed by a doctor ). - if you had severe or life - threatening anaphylaxis within 60 days before starting treatment . warnings and precautions talk to your doctor before taking palforzia and tell your doctor about any medical conditions that you have . you must not take any peanut or peanut containing food in your diet whilst taking palforzia . it is important to keep a record of the batch number of your palforzia . so , every time you get a new package of palforzia , note down the date and the batch number ( which is on the packaging after " lot ") and keep this information in a safe place . palforzia does not treat the symptoms of peanut allergy and you must not take palforzia during an allergic reaction . your doctor will advise the best time to start treatment depending on any medical conditions that you have . palforzia contains the substance that patients with peanut allergy react to . allergic reactions to palforzia may occur during treatment . these reactions mostly occur during the first two hours after taking a palforzia dose and are usually mild or moderate but ocasionally can be severe . stop taking palforzia and get medical treatment straight away if you have any of the following symptoms : - trouble breathing - throat tightness or feeling of fulness in throat - trouble swallowing - change in voice - dizziness or fainting or feeling of impending doom - severe stomach cramps or pain , vomiting or diarrhoea - severe flushing or itching of the skin - worsening of asthma or of any other breathing condition - heartburn , difficult swallowing , pain with swallowing , stomach pain or chest pain that does not go away or worsens certain conditions or factors can increase the likelihood of an allergic reaction . these include : - worsening of asthma - having an open sore or other damage to the lining of the mouth or the passage leading from the mouth to the stomach ( oesophagus ) - exercising - having a hot bath or shower - being very tired or missing sleep - for women , having your period - taking certain pain medications such as aspirin or ibuprofen - drinking alcohol - being stressed - taking palforzia on an empty stomach there are actions you should take to avoid some of these factors from affecting you . these factors include : exercise , having a hot bath or shower , drinking alcohol , or taking this medicine on an empty stomach . see the sections on ' palforzia with food , drink and alcohol ' and ' dosing instructions ' for advice on what to do about these . for all other conditions or factors listed above , contact your doctor for advice if you experience allergic reactions during any of these . your doctor will prescribe adrenaline for you to self - inject , which you must have with you at all times in case you have a severe allergic reaction . your doctor will tell you how to recognise an allergic reaction and teach you when and how to use the adrenaline . talk to your doctor and read the adrenaline package leaflet if you have any questions about its use . if you use adrenaline , do not take any further doses of palforzia and seek emergency medical care immediately afterwards . desensitisation to peanut with palforzia takes time . the ability to tolerate gradually increasing small amounts of peanut has been shown after completion of all up - dosing levels of palforzia and after at least 3 months of maintenance therapy and this continues to improve over time . you must take palforzia every day to maintain the desensitisation it provides . missing any doses can lead to an increased risk of allergic reactions . palforzia treatment may not work in all patients . children and adolescents palforzia is intended for children and young people aged 4 to 17 years and those who become adults whilst on treatment . do not give this medicine to children aged less than 4 years because it is not known if palforzia is safe and effective in this age group . other medicines and palforzia tell your doctor if you are taking , have recently taken , or might take any other medicines . palforzia with food , drink and alcohol palforzia should not be mixed with liquid ( e . g ., water , milk , juice , soup , smoothie ). do not drink alcohol 2 hours before and 2 hours after taking palforzia as this may increase the likelihood of an allergic reaction . pregnancy , breast - feeding and fertility do not start treatment with palforzia if you are pregnant or planning to become pregnant . if you are pregnant or breast - feeding , think you may be pregnant , or are planning to have a baby , ask your doctor for advice before taking this medicine . driving and using machines palforzia may have a small effect on your ability to drive , cycle or operate machinery . exercise caution for 2 hours after taking a dose of palforzia in case you have an allergic reaction which affects your ability to drive , cycle , or use machinery . wait until all symptoms of such allergic reactions have gone away before driving , cycling , or using machinery .
do not take zerene if you have hypersensitivity ( an allergy ) to zaleplon or to any other ingredients of zerene sleep apnoea syndrome ( stopping breathing for short periods while asleep ) severe kidney or liver problems myasthenia gravis ( very weak or tired muscles ) severe breathing or chest problems if you are in any doubt about whether you have any of these conditions , do ask your doctor . children under 18 years of age must not take zerene . take special care with zerene never drink alcohol while you are being treated with zerene . alcohol can increase the undesirable effects of any medicine taken to help you sleep . use with extreme caution if you have ever been addicted to medicines or alcohol . if you are taking any medicines belonging to the sleep inducing group , including zerene , there is a possibility that you may become dependent on them . once physical dependence has developed , abrupt termination of treatment may be accompanied by withdrawal symptoms . these may consist of headaches , muscle pain , extreme anxiety , tension , restlessness , confusion and irritability . do not use zerene or any other sleeping medicine for longer than your doctor tells you to . do not use a second dose of zerene within a single night . if your sleeplessness persists or worsens after a short course of zerene treatment contact your doctor . there is a chance that you may experience a certain type of temporary memory loss ( amnesia ) and lack of coordination when taking sleep medicines . this can usually be avoided if you remain inactive for at least 4 hours after taking zerene . there is a chance that you may experience somnambulism ( sleepwalking ), including eating or driving while not fully awake with no memory of the event . if you experience these events , contact your doctor immediately . reactions like restlessness , agitation , irritability , aggressiveness , abnormal thinking , delusion , rages , nightmares , depersonalisation , hallucinations , psychoses , inappropriate behaviour , extroversion that seems out of character and other behavioural effects have been reported following use of any medicines belonging to the sleep inducing group , including zerene . these reactions may be active substance - induced , spontaneous in origin , or a result of an underlying psychiatric or physical disorder . they are more likely to occur in the elderly . if you experience these events , contact your doctor immediately . rare cases of severe allergic reactions have been reported . an allergic reaction may include a rash , itching , difficulty breathing or swelling of the face , lips , throat or tongue , or nausea and vomiting . if you experience any of these events , contact your doctor immediately . taking other medicines do not take any other medicines without asking your doctor or pharmacist first . this includes medicines that can be bought without a prescription . some can cause drowsiness and should not be taken while taking zerene . when zerene is taken with other medicines that act on the brain , the combination may make you more drowsy than it should . be aware that such combinations may cause you to feel drowsy the next day . these medicines include : substances used in the treatment of mental conditions ( antipsychotics , hypnotics , anxiolytics / sedatives , antidepressants ), medicines used for strong pain relief ( narcotic analgesics ), medicines used for the treatment of seizures / convulsions ( antiepileptic medicines ), medicines used for loss of feeling / insensibility ( anaesthetics ), and medicines used in the treatment of allergies ( sedative antihistamines ). you should tell your doctor or pharmacist if you are taking cimetidine ( a stomach medicine ) or erythromycin ( an antibiotic ). taking zerene with food and drink it is not recommended that you take zerene with or immediately after eating a large meal as it may work more slowly . swallow the capsule ( s ) with a small glass of water . never drink alcohol while you are being treated with zerene ( see " take special care with zerene "). pregnancy and breast - feeding tell your doctor if you are or intend to become pregnant . zerene should not be taken at these times because there are not enough clinical data available to assess its safety during pregnancy . tell your doctor if you are breast - feeding . zerene should not be taken at this time because there is not enough clinical data available to assess its safety during breast - feeding . driving and using machines zerene may make you feel drowsy , cause loss of concentration or memory or muscle weakness . this feeling may be even worse when you sleep for less than 7 to 8 hours after taking your medication . if affected do not drive or operate machinery . important information about some of the ingredients of zerene if you have been told by your doctor that you have an intolerance to some sugars , contact your doctor before taking this medicinal product .
